
<html lang="en"     class="pb-page"  data-request-id="bc6f53fc-a7c1-4687-8d7f-23e5781ff501"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2013.56.issue-23;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm4014373;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel S1P1 Receptor Agonists – Part 1: From Pyrazoles to Thiophenes" /></meta><meta name="dc.Creator" content="Martin H.  Bolli" /></meta><meta name="dc.Creator" content="Claus  Müller" /></meta><meta name="dc.Creator" content="Boris  Mathys" /></meta><meta name="dc.Creator" content="Stefan  Abele" /></meta><meta name="dc.Creator" content="Magdalena  Birker" /></meta><meta name="dc.Creator" content="Roberto  Bravo" /></meta><meta name="dc.Creator" content="Daniel  Bur" /></meta><meta name="dc.Creator" content="Patrick  Hess" /></meta><meta name="dc.Creator" content="Christopher  Kohl" /></meta><meta name="dc.Creator" content="David  Lehmann" /></meta><meta name="dc.Creator" content="Oliver  Nayler" /></meta><meta name="dc.Creator" content="Markus  Rey" /></meta><meta name="dc.Creator" content="Solange  Meyer" /></meta><meta name="dc.Creator" content="Michael  Scherz" /></meta><meta name="dc.Creator" content="Gunther  Schmidt" /></meta><meta name="dc.Creator" content="Beat  Steiner" /></meta><meta name="dc.Creator" content="Alexander  Treiber" /></meta><meta name="dc.Creator" content="Jörg  Velker" /></meta><meta name="dc.Creator" content="Thomas  Weller" /></meta><meta name="dc.Description" content="From a high-throughput screening campaign aiming at the identification of novel S1P1 receptor agonists, the pyrazole derivative 2 emerged as a hit structure. Medicinal chemistry efforts focused not..." /></meta><meta name="Description" content="From a high-throughput screening campaign aiming at the identification of novel S1P1 receptor agonists, the pyrazole derivative 2 emerged as a hit structure. Medicinal chemistry efforts focused not..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 22, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm4014373" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm4014373" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm4014373" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm4014373" /></link>
        
    
    

<title>Novel S1P1 Receptor Agonists – Part 1: From Pyrazoles to Thiophenes | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm4014373" /></meta><meta property="og:title" content="Novel S1P1 Receptor Agonists – Part 1: From Pyrazoles to Thiophenes" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0021.jpeg" /></meta><meta property="og:description" content="From a high-throughput screening campaign aiming at the identification of novel S1P1 receptor agonists, the pyrazole derivative 2 emerged as a hit structure. Medicinal chemistry efforts focused not only on improving the potency of the compound but in particular also on resolving its inherent instability issue. This led to the discovery of novel bicyclo[3.1.0]hexane fused thiophene derivatives. Compounds with high affinity and selectivity for S1P1 efficiently reducing the blood lymphocyte count in the rat were identified. For instance, compound 85 showed EC50 values of 7 and 2880 nM on S1P1 and S1P3, respectively, had favorable pharmacokinetic properties in rat and dog, distributed well into brain tissue, and efficiently and dose dependently reduced the blood lymphocyte count in the rat. After oral administration to spontaneously hypertensive rats, the S1P1 selective compound 85 showed no effect on mean arterial blood pressure and affected the heart rate during the wake phase of the animals only." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm4014373"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm4014373">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm4014373&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm4014373&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm4014373&amp;href=/doi/10.1021/jm4014373" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 9737-9755</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm4014168" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401468w" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel S1P<sub>1</sub> Receptor Agonists – Part 1: From Pyrazoles to Thiophenes</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin+H.++Bolli">Martin H. Bolli</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claus++M%C3%BCller">Claus Müller</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Boris++Mathys">Boris Mathys</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++Abele">Stefan Abele</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Magdalena++Birker">Magdalena Birker</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roberto++Bravo">Roberto Bravo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Bur">Daniel Bur</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Hess">Patrick Hess</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Kohl">Christopher Kohl</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Lehmann">David Lehmann</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oliver++Nayler">Oliver Nayler</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Markus++Rey">Markus Rey</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Solange++Meyer">Solange Meyer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Scherz">Michael Scherz</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gunther++Schmidt">Gunther Schmidt</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Beat++Steiner">Beat Steiner</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander++Treiber">Alexander Treiber</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%B6rg++Velker">Jörg Velker</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Weller">Thomas Weller</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Drug Discovery Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div><div class="corresp-info"><strong>*</strong>Phone: +41 61 565 65 65; fax: +41 61 565 65 00; e-mail: <a href="/cdn-cgi/l/email-protection#45282437312c2b6b272a29292c0524263120292c2a2b6b262a28"><span class="__cf_email__" data-cfemail="a7cac6d5d3cec989c5c8cbcbcee7c6c4d3c2cbcec8c989c4c8ca">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm4014373&amp;href=/doi/10.1021%2Fjm4014373" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 9737–9755</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 22, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 September 2013</li><li><span class="item_label"><b>Published</b> online</span>22 November 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 December 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm4014373" title="DOI URL">https://doi.org/10.1021/jm4014373</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9737%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMartin%2BH.%2BBolli%252C%2BClaus%2BM%25C3%25BCller%252C%2BBoris%2BMathys%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D23%26contentID%3Djm4014373%26title%3DNovel%2BS1P1%2BReceptor%2BAgonists%2B%25E2%2580%2593%2BPart%2B1%253A%2BFrom%2BPyrazoles%2Bto%2BThiophenes%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9755%26publicationDate%3DDecember%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm4014373"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1703</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">16</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm4014373" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel S1P1 Receptor Agonists – Part 1: From Pyrazoles to Thiophenes&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;H. Bolli&quot;},{&quot;first_name&quot;:&quot;Claus&quot;,&quot;last_name&quot;:&quot;Müller&quot;},{&quot;first_name&quot;:&quot;Boris&quot;,&quot;last_name&quot;:&quot;Mathys&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Abele&quot;},{&quot;first_name&quot;:&quot;Magdalena&quot;,&quot;last_name&quot;:&quot;Birker&quot;},{&quot;first_name&quot;:&quot;Roberto&quot;,&quot;last_name&quot;:&quot;Bravo&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Bur&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Hess&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Kohl&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Lehmann&quot;},{&quot;first_name&quot;:&quot;Oliver&quot;,&quot;last_name&quot;:&quot;Nayler&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Rey&quot;},{&quot;first_name&quot;:&quot;Solange&quot;,&quot;last_name&quot;:&quot;Meyer&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Scherz&quot;},{&quot;first_name&quot;:&quot;Gunther&quot;,&quot;last_name&quot;:&quot;Schmidt&quot;},{&quot;first_name&quot;:&quot;Beat&quot;,&quot;last_name&quot;:&quot;Steiner&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;Treiber&quot;},{&quot;first_name&quot;:&quot;Jörg&quot;,&quot;last_name&quot;:&quot;Velker&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Weller&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;9737-9755&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm4014373&quot;},&quot;abstract&quot;:&quot;From a high-throughput screening campaign aiming at the identification of novel S1P1 receptor agonists, the pyrazole derivative 2 emerged as a hit structure. Medicinal chemistry efforts focused not only on improving the potency of the compound but in particular also on resolving its inherent instability issue. This led to the discovery of novel bicyclo[3.1.0]hexane fused thiophene derivatives. Compounds with high affinity and selectivity for S1P1 efficiently reducing the blood lymphocyte count in the rat were identified. For instance, compound 85 showed EC50 values of 7 and 2880 nM on S1P1 and S1P3, respectively, had favorable pharmacokinetic properties in rat and dog, distributed well into brain tissue, and efficiently and dose dependently reduced the blood lymphocyte count in the rat. After oral administration to spontaneously hypertensive rats, the S1P1 selective compound 85 showed no effect on mean arterial blood pressure and affected the heart rate during the wake phase of the animals only.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4014373&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4014373" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4014373&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4014373" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4014373&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4014373" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm4014373&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4014373&amp;href=/doi/10.1021/jm4014373" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm4014373" /></input><a href="/doi/pdf/10.1021/jm4014373" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (940 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm4014373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm4014373%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DBolli%26date%3D2013%26atitle%3DNovel%2BS1P1%2BReceptor%2BAgonists%2B%25E2%2580%2593%2BPart%2B1%253A%2BFrom%2BPyrazoles%2Bto%2BThiophenes%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D23%26spage%3D9737%26epage%3D9755%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291241" title="Phenyls">Phenyls</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jmcmar.2013.56.issue-23/production/jmcmar.2013.56.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">From a high-throughput screening campaign aiming at the identification of novel S1P<sub>1</sub> receptor agonists, the pyrazole derivative <b>2</b> emerged as a hit structure. Medicinal chemistry efforts focused not only on improving the potency of the compound but in particular also on resolving its inherent instability issue. This led to the discovery of novel bicyclo[3.1.0]hexane fused thiophene derivatives. Compounds with high affinity and selectivity for S1P<sub>1</sub> efficiently reducing the blood lymphocyte count in the rat were identified. For instance, compound <b>85</b> showed EC<sub>50</sub> values of 7 and 2880 nM on S1P<sub>1</sub> and S1P<sub>3</sub>, respectively, had favorable pharmacokinetic properties in rat and dog, distributed well into brain tissue, and efficiently and dose dependently reduced the blood lymphocyte count in the rat. After oral administration to spontaneously hypertensive rats, the S1P<sub>1</sub> selective compound <b>85</b> showed no effect on mean arterial blood pressure and affected the heart rate during the wake phase of the animals only.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38432" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38432" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">With the recent approval of FTY720 (<b>1</b>, fingolimod, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) for the treatment of relapsing remitting multiple sclerosis (MS), a first sphingosine-1-phosphate (S1P, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) receptor agonist is now available to patients suffering from this debilitating disease.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> After oral administration, the prodrug <b>1</b> is phosphorylated to p-FTY720 (p-<b>1</b>) and is thus rendered a nonselective agonist of the five known S1P receptors.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7">(4-7)</a> It has been shown that sphingosine-1-phosphate receptor 1 (S1P<sub>1</sub>) agonism leads to sequestration of lymphocytes in lymph nodes and hereby prevents these immune cells from causing inflammation and tissue damage.<a onclick="showRef(event, 'ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11">(8-11)</a> Two hypotheses have been proposed to explain the observed effects. In a first hypothesis, the tightening of the lymphatic endothelial cell junctions was postulated to be the main reason for the inability of the lymphocytes to leave the lymphoid tissue.<a onclick="showRef(event, 'ref5 ref12 ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref5 ref12 ref13 ref14 ref15 ref16">(5, 12-16)</a> In a second hypothesis, the S1P concentration gradient<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> that exists between blood plasma and lymph was proposed as a driving force for lymphocytes to exit the lymph nodes and re-enter systemic circulation.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21">(18-21)</a> The activation of the S1P<sub>1</sub> receptor by synthetic agonists is thought to lead to receptor internalization and thus desensitization of the cell toward the external S1P gradient. According to this hypothesis, the S1P<sub>1</sub> receptor agonists therefore behave as functional antagonists. Indeed, S1P<sub>1</sub> receptor antagonists have recently been shown to also induce lymphocyte sequestration in rodents.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25">(22-25)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of sphingosine-1-phosphate, FTY720 (fingolimod, <b>1</b>), and p-FTY720 (p-<b>1</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to the benefit of lymphocyte sequestration, several reports also proposed direct effects of S1P receptor agonism in brain<a onclick="showRef(event, 'ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33">(26-33)</a> and other tissues.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> While agonism of the S1P<sub>1</sub>, and possibly the S1P<sub>5</sub> receptor,<a onclick="showRef(event, 'ref30 ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref30 ref35 ref36 ref37">(30, 35-37)</a> are beneficial in the context of treating MS, activation of the S1P<sub>3</sub> receptor is deemed an undesired property. Several reports showed that activation of the S1P<sub>3</sub> receptor leads to heart rate reduction,<a onclick="showRef(event, 'ref38 ref39 ref40 ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40 ref41 ref42 ref43">(38-43)</a> vaso- and bronchoconstriction,<a onclick="showRef(event, 'ref42 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref44">(42, 44)</a> blood pressure increase,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> pulmonary epithelial leakage,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and fibrosis<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> in rodents. More recently, however, Hamada et al. have shown that, in the rat, selectivity against S1P<sub>3</sub> is necessary but not sufficient for a compound to be devoid of effects on heart rate.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Furthermore, Fryer et al.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> carefully compared heart rate and arterial blood pressure recordings of Sprague–Dawley rats after iv infusion of the nonselective compound <b>1</b> with those obtained after treatment with the S1P<sub>3</sub> receptor sparing compound BAF312 (siponimod).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> These analyses suggest that, in the rat, the short-lasting heart rate decrease seen upon iv infusion of the two agonists is caused by S1P<sub>1</sub> receptor agonism while the arterial blood pressure increase observed with <b>1</b> is associated with S1P<sub>3</sub> activation. However, it is noteworthy that Fryer et al. observed no heart rate reduction after oral administration of <b>1</b> and siponimod to Sprague–Dawley rats. There is also a growing body of evidence suggesting that S1P<sub>1</sub> receptor activation triggers a transient heart rate reduction in humans.<a onclick="showRef(event, 'ref49 ref50 ref51 ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51 ref52 ref53 ref54">(49-54)</a></div><div class="NLM_p last">The studies summarized above defined the key properties we deemed desirable for S1P<sub>1</sub> agonists suitable for clinical development. Hence, a potential drug candidate needs to be selective against the S1P<sub>3</sub> receptor. In the rat, the pharmacokinetic (PK) properties of the compound should allow oral dosing in the low milligram range to obtain sustained 24 h maximal lymphocyte count (LC) reduction. The ability of an S1P<sub>1</sub> agonist to penetrate brain tissue was seen as a potential benefit when treating central nervous system related autoimmune diseases. Furthermore, we selected the spontaneously hypertensive rat to assess the cardiovascular safety profile of the compound. In the following paragraphs, we describe our efforts aiming at identifying compounds fulfilling the above-mentioned requirements. Compound <b>85</b>, which emerged from these efforts, showed EC<sub>50</sub> values of 7 and 2880 nM on the S1P<sub>1</sub> and S1P<sub>3</sub> receptors, respectively, had favorable PK properties in rat and dog, distributed well into brain tissue, and efficiently and dose dependently reduced the blood LC in the rat. After oral administration to spontaneously hypertensive rats, the S1P<sub>1</sub> selective compound <b>85</b> showed no effect on mean arterial blood pressure and affected the heart rate during the wake phase of the animals only.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07554" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07554" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis</h3><div class="NLM_p">The chlorovinyl ketone <b>14</b> represents a key intermediate in the syntheses of the compounds discussed in this account, and its preparation<a onclick="showRef(event, 'ref55 ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref55 ref56 ref57 ref58">(55-58)</a> started from (+)-3-carene <b>10</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Ozonolysis followed by oxidative workup furnished the heptanoic acid derivative <b>11</b>. Its corresponding ester <b>12</b> was cyclized in a Dieckmann reaction to form the cyclopentanone derivative <b>13</b>, which was then chlorinated under Appel conditions<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> to yield the desired chlorovinyl ketone <b>14</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of the Key Intermediate Chlorovinyl Ketone <b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) O<sub>3</sub>, MeOH, −65 °C, (ii) H<sub>2</sub>O<sub>2</sub>, rt to 35 °C, 2 h, 45–65%; (b) SOCl<sub>2</sub>, MeOH, 0 °C, 30 min, 70%; (c) NaOMe, MeOH, reflux 1 h, 90% crude; (d) PPh<sub>3</sub>, CCl<sub>4</sub>, CHCl<sub>3</sub>, 65 °C 1–3 h, 46–68%.</p></p></figure><div class="NLM_p">Treating diketone <b>13</b> with hydrazine hydrate in a mixture of methanol and acetic acid furnished the desired pyrazole scaffold <b>15</b><a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> that was then reacted with either a cinnamic acid derivative, a dihydrocinnamic acid, or 2-methoxybenzylamine in the presence of carbonyl di-imidazole (CDI) to give the corresponding amides <b>2</b>, <b>3</b>, and <b>4</b>, or urea <b>5</b>, respectively (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Pyrazole, Pyrrole, and Thiophene Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NH<sub>2</sub>NH<sub>2</sub>·H<sub>2</sub>O, AcOH, MeOH, rt, 1 h, 67%; (b) (dihydro-) cinnamic acid, EDC or TBTU, THF or DMF, 45–57% (compounds <b>2</b>–<b>4</b>); (c) 2-methoxy-benzyl amine, CDI, THF, rt, 1 h, then <b>15</b>, 50 °C, 1 h, 32% (compound <b>5</b>); (d) diethyl oxalate, KOtBu, THF, rt, 1 h; (e) MeOH, HOAc, NH<sub>2</sub>NH<sub>2</sub> H<sub>2</sub>O, rt, 30 min, 14% over two steps; (f) MeI, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 0 °C to rt, 2 h; (g) 2 N aq LiOH, H<sub>2</sub>O, CH<sub>3</sub>CN, 45 °C, 1 h, 25% (over two steps, + 27% of N2-methyl isomer); (h) (1) appropriate benzylamine, Hünig’s base, TBTU, DMF, rt, 4 h, 12–75%; for <b>27</b>, <b>28</b>: (2) 2-bromo-ethanol, 2 N NaOH, MeOH 85 °C, 24 h, 21–54%; (i) diethyl 2-aminomalonate HCl, NaOEt, EtOH, rt, 1 h; (j) 2 N aq LiOH, EtOH, 75 °C, 16 h; (k) TFA, DCM, rt, 15 min, 31–62% (over 3 steps); (l) NaHMDS, pentafluorophenyl 3-(2-methoxyphenyl)propanoate, THF, rt, 15 min, 34%; (m) glycine ethyl ester HCl, Et<sub>3</sub>N, NaHCO<sub>3</sub>, EtOH, 70 °C, 15 h; (n) NaOEt, EtOH, microwave 130 °C, 10 min, 25%; (o) 2 N aq LiOH, EtOH, 65 °C, 18 h, 96%; (p) NaOEt, HSCH<sub>2</sub>COOEt, EtOH, rt, 1 h; (q) NaOEt, EtOH, 75 °C, 1 h; (r) 2 N aq LiOH, EtOH, 75 °C, 2 h, rt, 16 h, 67% over 3 steps.</p></p></figure><div class="NLM_p">The preparation of the isomeric pyrazole scaffold <b>17</b> started from ketone <b>16</b>.<a onclick="showRef(event, 'ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref61 ref62">(61, 62)</a> Hence, Claisen condensation of <b>16</b> with diethyl oxalate under basic conditions gave the corresponding pyruvate intermediate that, upon treatment with hydrazine hydrate in methanol and acetic acid, cyclized to the desired pyrazole scaffold.<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63, 64)</a> Reacting the pyrazole intermediate with MeI in the presence of Cs<sub>2</sub>CO<sub>3</sub> furnished the N-alkylated pyrazole scaffold as an approximately 1:1 mixture of the two regioisomers. The mixture was separated by preparative high-performance liquid chromatography (HPLC; X-terra column), and structural assignment was confirmed by X-ray crystal structure analysis of one of the two isomers (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Ester hydrolysis under basic conditions gave the pyrazole carboxylic acid <b>17</b> that was coupled with 2-methoxybenzylamine to produce amide <b>7</b>.</div><div class="NLM_p">Reacting chlorovinyl ketone <b>14</b> with diethyl 2-aminomalonate<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> in the presence of sodium ethoxide followed by LiOH-mediated ester hydrolysis produced the 2-carboxylic acid derivative of pyrrole <b>18</b>, which upon exposure to TFA in DCM, rapidly decarboxylated to furnish pyrrole <b>18</b>.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> N-acylation to give <b>6</b> was achieved with moderate yield by reacting deprotonated pyrrole <b>18</b> with the appropriate carboxylic acid as its pentafluorophenyl ester. Pyrrole carboxylic acid <b>19</b> was prepared by reacting chlorovinyl ketone <b>14</b> with ethyl glycinate<a onclick="showRef(event, 'ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref67 ref68">(67, 68)</a> in the presence of Et<sub>3</sub>N and NaHCO<sub>3</sub> at 70 °C. Cyclization was achieved under microwave irradiation at 130 °C in the presence of sodium ethoxide. Lithium hydroxide mediated ester hydrolysis furnished the desired pyrrole carboxylic acid <b>19</b>. As this compound has a tendency to slowly decarboxylate, it is best purified at the ester stage. Amide coupling was achieved under standard conditions using TBTU as the coupling reagent and gave the target compound <b>8</b> in 12% yield. Finally, by treating chlorovinyl ketone <b>14</b> with methyl mercaptoacetate in the presence of sodium methoxide first at room temperature then at 75 °C followed by hydrolyzing the ester intermediate using aqueous LiOH produced the thiophene carboxylic acid <b>20</b> in good yield.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> As before, amide formation to obtain compounds <b>9</b> and <b>21</b>–<b>29</b> was achieved under standard coupling conditions using TBTU as the activating agent.<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70, 71)</a></div><div class="NLM_p">Starting from carboxylic acid <b>20</b>, the preparation of thiophene derivatives incorporating a propanone linker involved three steps (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). First, the carboxylic acid was transformed into the corresponding methylketone by treating <b>20</b> with MeLi. Progress of the reaction had to be carefully monitored to avoid overreaction to the tertiary alcohol. Then, condensation of methylketone <b>30</b> with an appropriately substituted benzaldehyde and subsequent reduction of the thus formed propenone using Pd/C and hydrogen gas furnished the propanone derivative of general structure <b>31</b> in usually good yield. As indicated in step (d) in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, further transformation of the phenol furnished the target compounds <b>32</b>–<b>65</b> and <b>67</b>–<b>70</b>. The carboxylic acid derivative <b>66</b> was obtained in a similar fashion by condensing 3-(4-formyl-2,6-dimethylphenyl)propenoic acid<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> to ketone <b>30</b> followed by reducing the corresponding propenone intermediate.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of 1-Thien-2-yl-propan-1-one Derivatives (for R<sub>1</sub> and R<sub>2</sub>, see Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeLi, diethyl ether, 35 °C, 1–2 h, 44–77%; (b) substituted benzaldehyde, KOH, EtOH, 60–80 °C, 4–6 h; 31%; or substituted benzaldehyde, ∼6 N HCl in 2-propanol, EtOH, rt, 20 h, 42–90%; or 3-(4-formyl-2,6-dimethyl-phenyl)-acrylic acid, 10% w/v NaOH in MeOH, rt, 3 d, 40% (for <b>66</b>); (c) H<sub>2</sub>, Pd/C, EtOH, THF, DIPEA (for <b>66</b>), rt, 1–18 h, 31–89%; (d) 2-bromoethanol (<b>33</b>–<b>45</b>), 3-bromopropanol (<b>46</b>) or (<i>R</i>)- or (<i>S</i>)-3-chloro-propane-1,2-diol (<b>47</b> and <b>48</b>), 2 N aq NaOH, NaI, 2-propanol, 70–90 °C, 4–24 h, 34–87%; or (2,2-dimethyl-1,3-dioxan-5-yl)methanol, Ph<sub>3</sub>P, DEAD, THF, rt, 24 h, 67%, then 6 N HCl in 2-propanol, H<sub>2</sub>O, THF, 1 h, 40% (<b>49</b>), or <b>41</b> or <b>46</b>, methanesulfonyl chloride, Hünig’s base, DCM, rt, 1 h, 84–95%, then appropriate amine or amino acid, Hünig’s base, DMF, 70–85 °C, 7–22 h, 46–73% (<b>50</b>–<b>56</b> and <b>58</b>–<b>60</b>), or epichlorohydrin, 3 N aq NaOH, 2-propanol, rt, 18 h, 63–77%, then ethanolamine, glycine or azetidine-3-carboxylic acid, EtOH, H<sub>2</sub>O, Hünig’s base, 65 °C, 3–5 h, 34–67% (<b>57</b>, <b>61</b>, and <b>62</b>); <b>54</b>, glycolic acid, Hünig’s base, TBTU, DCM, rt, 2 h, 35% (<b>63</b>); or <b>31</b> and epichlorohydrin as for <b>61</b>, then 7 N NH<sub>3</sub> in MeOH, 60–65 °C, 2–4 h, 64–85%, then glycolic acid, Hünig’s base, TBTU, DCM, rt, 1 h, 57% (<b>64</b>); or bromoacetic acid, 3 N NaOH, 2-propanol, 70 °C, 24 h; 15–24% (<b>65</b>); or <b>65</b>, appropriate amine, TBTU, Hünig’s base, DMF, rt, 30 min, 53–75% (<b>67</b>–<b>69</b>); or <b>50</b>, methanesulfonyl chloride, Hünig’s base, DCM, rt, 0.5–2 h, 34% (<b>70</b>).</p></p></figure><div class="NLM_p">The preparation of thiophene derivatives incorporating a five-membered heteroaromatic ring as linker between the thiophene and the phenyl ring is outlined in Schemes <a class="ref internalNav" href="#sch4" aria-label="4">4</a> and <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. The 5-thiophen-2-yl-1,2,4-oxadiazole derivative <b>78</b> was prepared by coupling thiophene-2-carboxylic acid <b>20</b> with <i>N</i>,4-dihydroxy-3,5-dimethylbenzamidine using TBTU as the activating agent. Cyclization of the hydroxyamidine ester intermediate to the 1,2,4-oxadiazole <b>71</b> was achieved by heating the crude coupling product in dioxane at 100 °C.<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72, 73)</a> The glycerol side chain in <b>78</b> was introduced by alkylating the phenol <b>71</b> with (<i>R</i>)-glycerol acetonide under Mitsunobu conditions followed by acid-mediated cleavage of the acetal protective group or by reacting <b>71</b> with (<i>S</i>)-3-chloropropane-1,2-diol. Coupling thiophene-2-carboxylic acid <b>20</b> with 4-(allyloxy)-3,5-dimethylbenzoic acid hydrazide followed by cyclization using Burgess’ reagent furnished the 1,3,4-oxadiazole <b>72</b>. On the other hand, using Lawesson’s reagent in the cyclization step gave access to the corresponding 1,3,4-thiadiazole <b>73</b>.<a onclick="showRef(event, 'ref73 ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref73 ref74 ref75">(73-75)</a> Osmium tetroxide mediated dihydroxylation of the allylic side chain delivered compounds <b>80</b> and <b>82</b> as 1:1 mixtures of the two epimers at the glycerol side chain. Coupling of thiophene-2-carboxylic acid <b>20</b> with 2-amino-4′-allyloxy-3′,5′-dimethyl-acetophenone followed by cyclization effected by either Burgess’ or Lawesson’s reagent gave access to the oxazole <b>76</b> or the thiazole <b>77</b>, respectively.<a onclick="showRef(event, 'ref75 ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref75 ref76 ref77">(75-77)</a> As before, dihydroxylation of the allylic ether furnished the desired diols <b>81</b> and <b>83</b> as a 1:1 mixture of epimers. The 3-thiophen-2-yl-1,2,4-oxadiazole derivative <b>79</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>) was prepared in analogy to <b>78</b>. Thus, reaction of chlorovinyl ketone <b>14</b> with thioacetic acid cyanomethyl ester under basic conditions furnished the 2-cyano-thiophene derivative that, after reaction with hydroxylamine hydrochloride, gave <i>N</i>-hydroxyamidine <b>74</b>.<a onclick="showRef(event, 'ref73 ref78'); return false;" href="javascript:void(0);" class="ref ref73 ref78">(73, 78)</a> Coupling of <b>74</b> with 3,5-dimethyl-4-hydroxy-benzoic acid followed by cyclization under Dean–Stark conditions produced the 1,2,4-oxadiazole <b>75</b> in good yield. Alkylation of the phenol moiety with (<i>S</i>)-3-chloro-propane-1,2-diol concluded the synthesis of <b>79</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Thiophene Derivatives with Five-Membered Heteroaromatic Linkers<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>,4-Dihydroxy-3,5-dimethylbenzamidine, TBTU, Hünig’s base, DMF, rt, 1–6 h; (b) dioxane or toluene, 100 °C, 18–24 h, 39–71% (over 2 steps); (c) (1) (<i>R</i>)-(2,2-dimethyl-1,3-dioxolan-4-yl)methanol, Ph<sub>3</sub>P, DEAD, THF, rt, 24 h, 66% (2) 6 N HCl in 2-propanol, H<sub>2</sub>O, THF, rt, 30 min, 59%; or 3-chloropropane-1,2-diol, 2 N NaOH, isopropanol, 65 °C, 10 h, 50%; (d) 4-(allyloxy)-3,5-dimethylbenzoic acid hydrazide, HOBt, EDC, Et<sub>3</sub>N, DCM, 0 °C, 16 h, 82%; (e) Burgess reagent, THF, microwave irradiation 110 °C, 5 min, 58-70% (for <b>72</b> and <b>76</b>) or Lawesson reagent, THF, microwave irradiation 110 °C, 5 min, 30–41% (for <b>73</b> and <b>77</b>); (f) OsO<sub>4</sub>, NMO, acetone, H<sub>2</sub>O, rt, 16–18 h, 15–48%; (g) 2-amino-4′-allyloxy-3′,5′-dimethyl-acetophenone,<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> HOBt, EDC HCl, Et<sub>3</sub>N, DCM, rt, 5 h, 51%.</p></p></figure><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0012.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Thiophene Derivatives with Five-Membered Heteroaromatic Linkers<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) thioacetic acid <i>S</i>-cyanomethylester, 2 N aq NaOH, THF, rt, 3 h; (b) 2 N aq NaOH, THF, 90 °C, 4 h, 59% (over 2 steps); (c) KOtBu; HONH<sub>2</sub>–HCl, MeOH, rt, 5 h, 85%; (d) 3,5-dimethyl-4-hydroxy benzoic acid, TBTU, Hünig’s base, DMF, rt, 2–3 h, 46%; (e) toluene, 110 °C, 35 h, 86%; or dioxane, 60 °C, 24 h, 41%; (f) (<i>S</i>)-3-chloro-propane-1,2-diol, 2 N aq NaOH, 2-propanol, 65 °C, 10 h, 18–38%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Early in Vitro Structure–Activity Relationship Studies Addressing the Instability of Pyrazole <b>2</b></h3><div class="NLM_p">From a high-throughput screening (HTS) campaign based on FLIPR technology using CHO cells stably expressing a chimeric S1P<sub>1</sub>-G<sub>αq5</sub> construct, compound <b>2</b> emerged as a hit structure. In a GTPγS assay using membranes of CHO cells overexpressing the human S1P<sub>1</sub> receptor, this compound showed an EC<sub>50</sub> value of 16 nM, and small changes in its structure led to analogues, such as compounds <b>3</b> or <b>4</b>, with single digit nanomolar activities on S1P<sub>1</sub> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Compounds <b>3</b> and <b>4</b> were more than 100-fold selective against S1P<sub>3</sub>. However, it soon became evident that the stability of the acyl pyrazole moiety, in particular in aqueous media, is insufficient for these molecules to serve as drugs.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Urea analogues such as compound <b>5</b> retained at least some of the affinity for S1P<sub>1</sub> but did not significantly ameliorate the instability problem. Similarly, replacing the pyrazole moiety by a pyrrole ring (e.g., pyrrole <b>6</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) delivered potent S1P<sub>1</sub> agonists for which in vivo efficacy on blood lymphocyte count reduction could be measured after oral dosing, but the compounds were still prone to hydrolyze in aqueous media. Analogues wherein the acyl group was attached to a carbon rather than a nitrogen atom of the five-membered heterocycle, as in compounds <b>7</b> and <b>8</b>, for instance, lost affinity for the S1P<sub>1</sub> receptor (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure and in vitro activity of the HTS hit <b>2</b> and close analogues thereof.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Some examples of close analogues of the HTS hit <b>1</b> prepared to overcome the instability of <b>2</b> in aqueous media.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">However, replacing the pyrrole in compound <b>8</b> by a thiophene furnished stable compounds with improved affinity for the S1P<sub>1</sub> receptor (e.g., compound <b>9</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). We therefore set out to explore the structure–activity relationship (SAR) of these novel thiophene derivatives in more detail.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> In Vitro SAR of Bicyclo[3.1.0]hexane-fused Thiophene Derivatives</h3><div class="NLM_p">Easy access to the thiophene-2-carboxamides, such as <b>9</b>, facilitated exploration of the SAR around the phenyl ring. First, several examples incorporating either a chlorine or a fluorine atom, a methyl or a methoxy group were prepared. Among these monosubstituted derivatives, the 2-methoxy compound <b>9</b> was clearly the most potent representative (data not shown). In a second step, we introduced another methoxy group to the phenyl ring (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). As it turned out, this additional group was only tolerated in the 4-position (compound <b>22</b>). In order to reduce the lipophilicity of the compound, we attached polar chains to the phenyl moiety. As illustrated by compound <b>25</b>, a glycolic acid moiety was not tolerated in position 4. Similarly, an ethylene glycol attached to position 2 or 3 led to inactive compounds (<b>26</b>, <b>27</b>). However, attaching the ethylene glycol to position 4 of the phenyl ring was tolerated (compound <b>28</b>) and in combination with a 2-methoxy substituent gave rise to compound <b>28</b> that showed a similar S1P<sub>1</sub> receptor affinity but a clearly reduced lipophilicity (clogP = 4.4) when compared to analogues <b>9</b> and <b>22</b> (both clogP = 5.2).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of the Substituents around the Phenyl Ring in the Thiophene-2-carboxamide Series</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0013.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> S1P<sub>1</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> [nM]</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> S1P<sub>3</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> [nM]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">2-methoxy</td><td class="colsep0 rowsep0" align="left">520</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">2,3-dimethoxy</td><td class="colsep0 rowsep0" align="left">7490</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">2,4-dimethoxy</td><td class="colsep0 rowsep0" align="left">450</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">2,5-dimethoxy</td><td class="colsep0 rowsep0" align="left">7280</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">2,6-dimethoxy</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">2-methoxy-4-(carboxymethoxy)</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">2-(2-hydroxyethoxy)</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">3-(2-hydroxyethoxy)</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">4-(2-hydroxyethoxy)</td><td class="colsep0 rowsep0" align="left">1800</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">2-methoxy-4-(2-hydroxyethoxy)</td><td class="colsep0 rowsep0" align="left">282</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values as determined in a GTPγS assay using membranes of CHO cells expressing either S1P<sub>1</sub> or S1P<sub>3</sub>;<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> EC<sub>50</sub> values represent geometric mean values of at least three independent measurements in duplicate. For details see the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div></div></div><div class="NLM_p">Meanwhile, we established the chemistry to get access to thiophene derivatives incorporating a ketone function in the linker (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>), and we prepared a set of compounds making use of the SAR knowledge acquired with the thiophene-2-carboxamides (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). We therefore prepared compound <b>32</b> incorporating an ethylene glycol side chain in position 4 of the phenyl ring. As already observed with the two pyrazoles <b>4</b> and <b>5</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), compound <b>32</b> lacking a nitrogen in the linker turned out to be considerably more potent on S1P<sub>1</sub> when compared to its amide linked analogue <b>28</b>. While keeping the ethylene glycol moiety in position 4 constant, we therefore evaluated the effect of an additional substituent at the phenyl ring in more detail. As illustrated with compounds <b>33</b> and <b>34</b>, a substituent in position 2 further improved the potency of the compound on S1P<sub>1</sub> and slightly decreased the activity on S1P<sub>3</sub>. In contrast, as shown with compounds <b>35</b> and <b>36</b>, a 2,6-disubstitution seriously hampered the affinity of the compound for S1P<sub>1</sub>. A substituent in the 3-position had a moderate effect on the S1P<sub>1</sub> potency (compounds <b>37</b>–<b>39</b>) only. Interestingly, while a 3,5-dimethoxy (<b>40</b>) substitution pattern resulted in a marked loss in affinity for S1P<sub>1</sub>, 3,5-dichloro (<b>42</b>) and in particular 3,5-dimethyl (<b>41</b>) and 3-chloro-5-methyl (<b>43</b>) substitutions furnished highly potent S1P<sub>1</sub> receptor agonists with good selectivity against S1P<sub>3</sub>. Among the various 3,5-disubstitutions evaluated, the 3,5-dichloro (<b>42</b>) and the 3-ethyl-5-methyl (<b>44</b>) patterns gave the best selectivity against S1P<sub>3</sub>. Compound <b>45</b> illustrates that combining the 3,5-disubstitution with a 2-substituent reduces the activity of the compound on S1P<sub>1</sub>, indicating that, at the phenyl ring, either a 2- or a 3,5-substitution is optimal for S1P<sub>1</sub> receptor affinity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of the Ethylene Glycol Substituted Phenyl Ring in the 1-Thien-2-yl propan-1-one Series</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0014.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> S1P<sub>1</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> [nM]</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> S1P<sub>3</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> [nM]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">none</td><td class="colsep0 rowsep0" align="left">15.0</td><td class="colsep0 rowsep0" align="left">1610</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">2-methoxy</td><td class="colsep0 rowsep0" align="left">4.6</td><td class="colsep0 rowsep0" align="left">2780</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">2-chloro</td><td class="colsep0 rowsep0" align="left">6.5</td><td class="colsep0 rowsep0" align="left">5200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">2,6-dimethoxy</td><td class="colsep0 rowsep0" align="left">3110</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">2,6-dimethyl</td><td class="colsep0 rowsep0" align="left">902</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">3-methoxy</td><td class="colsep0 rowsep0" align="left">28.6</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">3-methyl</td><td class="colsep0 rowsep0" align="left">5.8</td><td class="colsep0 rowsep0" align="left">2590</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">3-chloro</td><td class="colsep0 rowsep0" align="left">9.8</td><td class="colsep0 rowsep0" align="left">4630</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">3,5-dimethoxy</td><td class="colsep0 rowsep0" align="left">232</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">3,5-dimethyl</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">879</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">3,5-dichloro</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">4250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">3-chloro-5-methyl</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">1350</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">3-ethyl-5-methyl</td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">2,3,5-trimethyl</td><td class="colsep0 rowsep0" align="left">23.7</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values as determined in a GTPγS assay using membranes of CHO cells expressing either S1P<sub>1</sub> or S1P<sub>3</sub>;<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> EC<sub>50</sub> values represent geometric mean values of at least three independent measurements in duplicate. For details see the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div></div></div><div class="NLM_p">Keeping the 3,5-dimethyl substitution pattern at the phenyl ring constant, we then evaluated the effect of a large variety of polar side chains in position 4 (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). As compared to the ethylene glycol <b>41</b>, the propylene glycol analogue <b>46</b> was slightly less potent on both S1P<sub>1</sub> and S1P<sub>3</sub>. Introducing an additional hydroxy group to this side chain gave the 2,3-dihydroxy-propoxy derivatives <b>47</b> and <b>48</b>. As illustrated by these two compounds, the chirality in the side chain had a minimal effect on the potency of the compound. As observed in other series (data not shown), the (<i>S</i>)-configured side chain was slightly more potent on S1P<sub>1</sub> while both epimers showed comparable affinity for S1P<sub>3</sub>. The achiral diol <b>49</b> was less potent than diols <b>47</b> and <b>48</b>. Replacing the alcohol function in <b>46</b> by a primary (compound <b>50</b>) or secondary amine (compounds <b>51</b> and <b>52</b>) again furnished highly potent S1P<sub>1</sub> agonists with good selectivity against S1P<sub>3</sub>. The tertiary amine <b>53</b> represented a slightly less potent S1P<sub>1</sub> receptor agonist. Compounds <b>54</b>, <b>55</b>, and <b>56</b> incorporating an amino-propoxy chain were less potent on S1P<sub>1</sub> but also more selective against S1P<sub>3</sub> when compared to their corresponding amino-ethoxy analogues <b>50</b>, <b>51</b>, and <b>52</b>, respectively. As seen with compounds <b>46</b> and <b>47</b>, introducing an additional hydroxy group to the side chain to give compound <b>57</b> improved the affinity for S1P<sub>1</sub>. The three examples <b>58</b>–<b>60</b> illustrate that incorporating an amino acid into the side chain was tolerated and furnished highly potent S1P<sub>1</sub> receptor agonists. Even the two carboxylic acid groups in glutamate derivative <b>60</b> were well tolerated by the receptor. In this series, however, an additional hydroxy group attached to the amino-propoxy unit had only minimal effect on the potency of the compound and selectivity (compare <b>61</b> and <b>62</b> with <b>58</b> and <b>59</b>, respectively). In view of the above data, it is not surprising that also amides <b>63</b> and <b>64</b> were potent and selective S1P<sub>1</sub> receptor agonists. Interestingly, there is a marked difference in potency between the two carboxylic acids <b>65</b> and <b>66</b>. While the glycolic acid derivative <b>65</b> showed only moderate potency on the S1P<sub>1</sub> receptor (in line with observations made with compound <b>25</b>), the propanoic acid derivative <b>66</b> showed significant affinity for S1P<sub>1</sub>. The glycolic acid amide derivatives <b>68</b>, <b>69</b>, and in particular, <b>67</b> represent highly potent and selective S1P<sub>1</sub> receptor agonists. Finally, as illustrated by compound <b>70</b>, a sulfonamide moiety was also tolerated by S1P<sub>1</sub>. In brief, the compounds compiled in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> illustrate that a large variety of polar side chains attached to the 4-position of the phenyl ring are tolerated by the S1P<sub>1</sub> receptor. The wide range of functional groups tolerated in this part of the molecule clearly allows for fine-tuning of the physicochemical properties of the compound.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of Polar Side Chains in the 4-Position of the Phenyl Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0015.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0016.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">EC<sub>50</sub> values as determined in a GTPγS assay using membranes of CHO cells expressing either S1P<sub>1</sub> or S1P<sub>3</sub>;<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> EC<sub>50</sub> values represent geometric mean values of at least three independent measurements in duplicate. For details see the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Compound represents a 1:1 mixture of epimers with respect to the polar side chain.</p></div></div><div></div></div><div class="NLM_p">With a last set of compounds compiled in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, we explored the SAR of the linker between the thiophene and the phenyl ring. Inspired by the structure of S1P<sub>1</sub> selective agonist SEW2871<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a>, the propanone moiety was replaced by an oxadiazole and other five-membered heteroaromates. Interestingly, as illustrated by compounds <b>78</b>–<b>80</b>, replacing the propanone linker by an oxadiazole had little impact on the affinity of the compound for S1P<sub>1</sub>. However, all three oxadiazole derivatives were markedly more potent on S1P<sub>3</sub> and were therefore clearly less selective when compared to <b>47</b>. The oxazole <b>81</b> had a similar receptor affinity profile as its structurally closest oxadiazole analogues <b>78</b> and <b>80</b>. In contrast, the thiadiazole <b>82</b> and the thiazole <b>83</b> were both significantly less potent S1P<sub>1</sub> agonists.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of the Linker between the Thiophene and the Phenyl Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0017.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0018.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">EC<sub>50</sub> values as determined in a GTPγS assay using membranes of CHO cells expressing either S1P<sub>1</sub> or S1P<sub>3</sub>;<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> EC<sub>50</sub> values represent geometric mean values of at least three independent measurements in duplicate. For details see the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">1:1 mixture of epimers at 2,3-dihydroxy-propoxy side chain.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vivo Efficacy Assessment</h3><div class="NLM_p">Several compounds incorporating a carene-derived thiophene scaffold were assessed for their ability to reduce the peripheral blood LC in the rat, and a few examples are listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. The compounds were administered orally at a dose of 10 mg/kg to male Wistar rats, and the blood LC was measured shortly before and 3, 6, and 24 h after compound administration. A LC reduction of greater than or equal to 60% was considered to be the maximal effect that is observed under the described experimental conditions.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> As illustrated by the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, a large variety of side chains attached to position 4 of the phenyl ring led to in vivo active compounds. Clear differences in the pharmacodynamic profiles could be observed. For instance, while the propanone-linked compounds incorporating a mono- (<b>46</b>) or dialcohol (<b>47</b>), an amino acid (<b>61</b>), or a glycolamide (<b>64</b>) in the side chain reached maximal efficacy at 3 h and already showed partial recovery of LC at 6 h, compounds incorporating an amine or an amino alcohol side chain (<b>52</b> and <b>55</b>–<b>57</b>) reached maximal efficacy at 6 h. At 24 h, only amino alcohols <b>56</b> and <b>57</b> showed significant LC reductions. On the other hand, the four oxadiazole-linked compounds <b>78</b>–<b>80</b> and <b>84</b> already reached maximal efficacy at 3 h post-administration, and the LC remained maximally reduced at 6 h. Similar to the propanone-linked analogue <b>47</b>, the LC recovered 24 h after administration of the three compounds incorporating a glycerol side chain (<b>78</b>–<b>80</b>). On the other hand, the glycolamide <b>84</b> showed maximal LC reductions for 24 h and therefore displayed a much longer duration of action when compared to the propanone-linked analogue <b>64</b>. Studies with additional analogues revealed that compounds <b>47</b> and <b>64</b> and <b>78</b> and <b>84</b> are prototypical with respect to the in vivo behavior of propanone- and oxadiazole-linked thiophene derivatives, respectively. In part two of this communication series, we further illustrate that oxadiazole-linked compounds consistently show a higher LC reduction efficacy due to a more sustained PK when compared to their propanone analogues.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Effect on Blood LC after Oral Administration of 10 mg/kg Compound to Male Wistar Rats</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0019.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0020.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Data of pure (<i>S</i>)-enantiomer.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">This compound showed EC<sub>50</sub> values of 1.3 and 7.0 nM for S1P<sub>1</sub> and S1P<sub>3</sub>, respectively.</p></div></div><div></div></div><div class="NLM_p">The potency on S1P<sub>1</sub> and selectivity against S1P<sub>3</sub> was then further optimized in the oxadiazole series by combining a 3-ethyl-5-methyl substitution pattern with a propanoic acid chain in position 4 at the phenyl ring. This led to compound <b>85</b> showing EC<sub>50</sub> values of 7 and 2880 nM for S1P<sub>1</sub> and S1P<sub>3</sub>, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). A dose response of LC change in rats was established with oxadiazole <b>85</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Administration of 0.3 mg/kg <b>85</b> to Wistar rats displayed minimal if any blood lymphocyte sequestration. Administration of 1, 3, and 10 mg/kg had a clear, dose-dependent effect on the number of circulating lymphocytes. Rapid reversibility of the LC was observed at 1 and 3 mg/kg. At 10 mg/kg, the LC was maximally reduced for 24 h. For the three active doses of <b>85</b>, the reduction of the LC measured at 3 h demonstrates rapid onset of action. A PK experiment with oxadiazole <b>85</b> in the rat revealed that the compound was absorbed almost completely and reached a <i>C</i><sub>max</sub> of 4000 ng/mL at 2 h after administration (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). A rather low clearance and a volume of distribution clearly exceeding total body water resulted in a half-life of 4.9 h. The PK profile therefore showed a good correlation with the LC reductions in the rat.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Change of blood lymphocyte count after oral administration of <b>85</b> to male Wistar rats. □ vehicle (<i>n</i> = 5); ● 0.3 mg/kg (<i>n</i> = 5); ▲ 1 mg/kg (<i>n</i> = 5); ○ 3 mg/kg (<i>n</i> = 5); ■ 10 mg/kg (<i>n</i> = 5). For experimental details see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro Potency Profile (GTPγS EC<sub>50</sub> Values) of Compound <b>85</b> on Human (h) and Rat (r) S1P Receptors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">hS1P<sub>1</sub></th><th class="colsep0 rowsep0" align="center">hS1P<sub>2</sub></th><th class="colsep0 rowsep0" align="center">hS1P<sub>3</sub></th><th class="colsep0 rowsep0" align="center">hS1P<sub>4</sub></th><th class="colsep0 rowsep0" align="center">hS1P<sub>5</sub></th><th class="colsep0 rowsep0" align="center">rS1P<sub>1</sub></th><th class="colsep0 rowsep0" align="center">rS1P<sub>3</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EC<sub>50</sub><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> [nM]</td><td class="colsep0 rowsep0" align="left">7.0</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">2880</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">275</td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">6110</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">σ<sub>g</sub><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>n</i><a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values as determined in a GTPγS assay using membranes of CHO cells expressing either S1P<sub>1</sub> or S1P<sub>3</sub>;<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> EC<sub>50</sub> values represent geometric mean values of at least three independent measurements in duplicate. For details see the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Geometric standard deviation.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Number of independent measurements.</p></div></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Pharmacokinetic Data of Compound <b>85</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">pharmacokinetic parameters<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center"><i>F</i> [%]</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (<i>t</i><sub>max</sub>) [ng/mL]([h])</th><th class="colsep0 rowsep0" align="center">AUC<sub>0–24h</sub> [(ng·h)/mL]</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> [h]</th><th class="colsep0 rowsep0" align="center">clearance [mL/(min·kg)]</th><th class="colsep0 rowsep0" align="center">V<sub>ss</sub> [L/kg]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">97</td><td class="colsep0 rowsep0" align="left">4000 (2)</td><td class="colsep0 rowsep0" align="left">40 800</td><td class="colsep0 rowsep0" align="left">4.9</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">3160 (2)</td><td class="colsep0 rowsep0" align="left">39 300</td><td class="colsep0 rowsep0" align="left">6.9</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">0.45</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last"><i>F</i> = bioavailability; <i>C</i><sub>max</sub> = maximal plasma concentration; <i>t</i><sub>max</sub> = time at which <i>C</i><sub>max</sub> was reached; <i>t</i><sub>1/2</sub> = half-life determined with iv experiment; V<sub>ss</sub> = volume of distribution; oral dosing: 10 mg/kg in 3 Wistar rats, 3 mg/kg in 2 Beagle dogs; iv dosing: 1 mg/kg in 2 rats, 2 dogs; for experimental details see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></div></div><div class="NLM_p last">The PK profile in the Beagle dog was comparable (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). The compound was rapidly absorbed reaching high plasma concentrations. Clearance in the dog was lower than in the rat leading to an even longer half-life despite a smaller volume of distribution. Compound <b>85</b> distributed well into brain tissue reaching concentrations of 220, 2880, and 410 ng/g at 2, 6, and 24 h, respectively, after oral administration of 10 mg/kg to Wistar rats.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Cardiovascular Effects in Spontaneously Hypertensive Rats</h3><div class="NLM_p">In a next step, compound <b>85</b> was administered to conscious spontaneously hypertensive rats (SHR) equipped with a telemetry system allowing noninvasive monitoring of mean arterial blood pressure (MAP) and heart rate (HR).<a onclick="showRef(event, 'ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref82 ref83">(82, 83)</a> The compound was administered at doses of 3, 10, 30, and 100 mg/kg in the morning, that is, at the end of the wake phase of the animals. None of the doses induced a MAP increase that was observed with <b>1</b> using the same experimental conditions (Figures B and C, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). However, the HR recordings 24 h before (control) and after administration of compound <b>85</b> shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> clearly document that oral administration of compound <b>85</b> to SHR affects HR. As illustrated by the data summarized in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, the amplitude of the HR reduction as well as the overall extent of the effect as expressed by the area between the curves (ABC) followed a clear dose response. A dose of 3 mg/kg had no significant effect on HR. With the doses of 10, 30, and 100 mg/kg, the HR remained unchanged for the first 8 h after oral administration (sleep phase of the rats). However, about 8 h after dosing, a dose-dependent difference (ABC) between the HR of control and treated rats started to manifest, and the effect persisted for 8–10 h (i.e., for the entire wake phase of the animals). In fact, the HR increase normally observed during the wake phase of nontreated rats was completely abolished in animals treated with 30 and 100 mg/kg of compound <b>85</b>. At a dose of 10 mg/kg, the HR was maximally 23 bpm lower than that of the control at about 9 h after compound administration. On the basis of the PK experiment and the plasma exposure data obtained from the LC experiment, plasma concentrations of <b>85</b> were 4–6 μM at this time point and therefore at best reached the EC<sub>50</sub> value for the rat S1P<sub>3</sub> receptor. At 12 h, plasma concentrations were clearly below the EC<sub>50</sub> value on S1P<sub>3</sub>. At 30 and 100 mg/kg, the HRs were 32 and 37 bpm lower than those in the control rats, respectively. The ABC reached 250 bpm × h at 10 mg/kg and appeared to reach a plateau with 350 and 380 bpm × h at 30 and 100 mg/kg, respectively.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. HR in beats per minute (bpm) after oral administration of (A) vehicle, (B) 3, (C) 10, (D) 30, and (E) 100 mg/kg <b>85</b> to male SHR. The HR increase observed during the first 2 h is an artifact of the oral gavage. For experimental details see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> and Hess et al.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Results of dose response experiments of compounds (A, B) <b>85</b> and (C, D) <b>1</b> in male SHR. Maximal HR changes (ΔHR in bpm, A, C) and area between curves (ABC, in bpm h; B, D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We then speculated that the late onset of the effect on HR could be due to the slow formation of an active metabolite. However, the observation that compounds <b>56</b> and <b>57</b> (both tested at 100 mg/kg, for <b>57</b> see Figure D <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), but also <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, Figure E <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) displayed a very similar behavior in SH rats precluded this interpretation. It is important to note that maximal HR changes were clearly more pronounced with <b>1</b> than with compound <b>85</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) and that with <b>1</b> first signs of HR changes manifested earlier, that is, 3 h after dosing already. As p-<b>1</b> is a potent agonist of the S1P<sub>3</sub> receptor<a onclick="showRef(event, 'ref4 ref5 ref45'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref45">(4, 5, 45)</a> while compound <b>85</b> is highly selective for S1P<sub>1</sub> (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>), part of the HR effect observed with <b>1</b> can be attributed to S1P<sub>3</sub> receptor agonism. Fryer et al.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> observed a clear but only short-lasting HR reduction in anesthetized normotensive Sprague–Dawley rats after infusion of nonselective <b>1</b> and S1P<sub>1/5</sub> selective BAF312. However, these authors report that <b>1</b> and BAF312 had no significant effect on HR after oral dosing to conscious Sprague–Dawley rats. In contrast, we observed a significant, dose-dependent effect on HR during the wake phase of male SH rats. Our experiments therefore corroborate the observation by Hamada et al.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> that, in the rat, selectivity against S1P<sub>3</sub> alone is not sufficient for a compound to be devoid of effects on HR.</div><div class="NLM_p last">At this point, it remains unclear whether the HR effects observed in the SH rat with compound <b>85</b> are indeed associated with S1P<sub>1</sub> receptor agonism. Further experiments will be needed to address this question and may shed light on why effects on HR manifest during the wake phase of the rats only and hence significantly differ from the rapid but only transient HR reduction observed in humans.<a onclick="showRef(event, 'ref49 ref50 ref51 ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51 ref52 ref53 ref54">(49-54)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30164" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30164" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Starting from the hydrolytically susceptible HTS hit <b>2</b>, we developed stable, potent, and selective S1P<sub>1</sub> receptor agonists wherein the pyrazole in <b>2</b> was replaced by a thiophene. SAR studies of these novel S1P<sub>1</sub> agonists revealed that a ketone linker yields significantly more potent compounds as compared to analogues incorporating an amide between the thiophene and the phenyl ring. Replacing the linear propanone linker by an oxadiazole maintained the affinity for S1P<sub>1</sub> but also increased the potency on S1P<sub>3</sub>. A large variety of side chains in position 4 of the phenyl ring are tolerated, and either an additional 2- or a 3,5-substitution is optimal for S1P<sub>1</sub> agonistic activity. Within a given series of analogues, the 3-ethyl-5-methyl substitution provided compounds with the most pronounced selectivity against S1P<sub>3</sub>. The tolerance of a diverse set of polar side chains in position 4 as well as various linkers between the thiophene and the phenyl ring offered a handle to fine-tuning the physicochemical and pharmacodynamic properties of the compound. From the above SAR studies, the acid <b>85</b> emerged as a potent S1P<sub>1</sub> receptor agonist with high selectivity against S1P<sub>3</sub>. In Wistar rats, this compound showed an ED<sub>50</sub> of about 5 mg/kg for the sequestration of circulating lymphocytes at 24 h after oral compound administration. The compound was well absorbed in the rat and the dog, rapidly reached high plasma concentrations, and was cleared slowly. Despite its high selectivity against S1P<sub>3</sub>, compound <b>85</b> showed a marked inhibition of the HR increase that is usually observed during the wake phase of nontreated male SH rats. Further studies to better understand the factors influencing the HR and efforts to identify compounds devoid of this activity are certainly warranted.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07147" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07147" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Chemistry</h3><div class="NLM_p last">All reagents and solvents were used as purchased from commercial sources (Sigma–Aldrich, Switzerland, Lancaster Synthesis GmbH, Germany, Acros Organics, USA). Moisture sensitive reactions were carried out under an argon atmosphere. Progress of the reactions was followed either by thin-layer chromatography (TLC) analysis (Merck, 0.2 mm silica gel 60 F<sub>254</sub> on glass plates) or by liquid chromatography–mass spectrometry (LC-MS). LC-MS: Finnigan MSQ plus or MSQ surveyor (Dionex, Switzerland), with HP 1100 Binary Pump and DAD (Agilent, Switzerland); column: Zorbax SB-AQ, 3.5 μm, 120 Å, 4.6 mm × 50 mm (Agilent); gradient: 5–95% acetonitrile in water containing 0.04% of trifluoroacetic acid (TFA), within 1 min; flow: 4.5 mL/min; 40 °C; <i>t</i><sub>R</sub> is given in min. Purity of all final compounds was checked by an additional LC-MS analysis on a Waters Acquity UPLC system equipped with an ACQ-PDA detector, an ACQ-ESL detector, and an ACQ-SQ detector; column: ACQUITY UPLC BEH C18 1.7 μm, 2.1 mm × 50 mm; gradient: 2–98% acetonitrile containing 0.045% formic acid in water containing 0.05% formic acid over 1.8 min; flow: 1.2 mL/min; 60 °C. According to these LC-MS analyses, final compounds showed a purity of greater than 95% (UV at 230 and at 214 nm). Chiral integrity was proven by HPLC (chiral stationary phase): Hardware from UltiMate instrument series (Dionex): HPG-3200SD binary pump, WPS-3000 autosampler, TCC-3200 thermostatted column compartment, DAD-3000 detector, SRD-3400 degasser. ValveMate 2 (Gilson) solvent valves; column, solvent and retention time (<i>t</i><sub>R</sub>) as indicated, DEA = diethyl amine, TFA = trifluoroacetic acid, at 25 °C, flow 1 mL/min. No racemisation/epimerization was observed during the synthesis of the target compounds. LC-HRMS: Analytical pump: Waters Acquity Binary, Solvent Manager, MS: SYNAPT G2MS, source temperature: 150 °C, desolvation temperature: 400 °C; desolvatation gas flow: 400 L/h; cone gas flow: 10 L/h; extraction cone: 4 RF; lens: 0.1 V; sampling cone: 30; capillary: 1.5 kV; high-resolution mode; gain: 1.0; MS function: 0.2 s per scan, 120–1000 amu in full scan, centroid mode. Lock spray: Leucine enkephalin 2 ng/mL (556.2771 Da) scan time 0.2 s with interval of 10 s and average of 5 scans; DAD: Acquity UPLC PDA Detector. Column: Acquity UPLC BEH C18 1.7 μm, 2.1 mm × 50 mm from Waters, thermostatted in the Acquity UPLC Column Manager at 60 °C. Eluents: water and 0.05% formic acid; B: acetonitrile and 0.05% formic acid. Gradient: 2–98% B over 3.0 min. Flow: 0.6 mL/min. Detection: UV 214 nm and MS, <i>t</i><sub>R</sub> is given in minutes. Compound purity and identity was further confirmed by NMR spectroscopy (Varian Oxford; <sup>1</sup>H (300 MHz) or <sup>13</sup>C (75 MHz) or Bruker Avance II, 400 MHz UltraShield, <sup>1</sup>H (400 MHz), <sup>13</sup>C (100 MHz); chemical shifts are reported in parts per million (ppm) relative to tetramethylsilane (TMS), and multiplicities are given as s (singlet), d (doublet), t (triplet), q (quartet), quint (quintuplet), h (hextet), hept (heptuplet), or m (multiplet), br = broad, coupling constants are given in Hz). Several compounds have been prepared in a combinatorial library format on a 15–50 μmol scale. For those compounds, <sup>1</sup>H NMR spectra were acquired using nondeuterated 10 mM DMSO stock solutions submitted for biological testing.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> The solvent and water signals were suppressed by irradiation at 2.54 and 3.54 ppm, respectively. As a consequence, signal integrals close to those two frequencies are not always accurate. The numbers of protons given in the description represent observed values. In some cases, signals close to either of the two solvent signals were not visible as they were suppressed by irradiation. Compound purification: compounds were purified by either flash column chromatography (CC) on silica gel 60 (Fluka Sigma–Aldrich, Switzerland), or by preparative HPLC (Waters XBridge Prep C18, 5 μm, OBD, 19 mm × 50 mm, or Waters X-terra RP18, 19 mm × 50 mm, 5 μm, gradient of acetonitrile in water containing 0.4% of formic acid, flow 75 mL/min), or by MPLC (Labomatic MD-80-100 pump, Linear UVIS-201 detector; column: 350 mm × 18 mm, Labogel-RP-18–5s-100, gradient: 10% MeOH in water to 100% MeOH). X-ray diffraction: To determine the molecular structure of the 2-methyl isomer of compound <b>17</b>, a crystal of the compound was mounted on a Bruker Nonius diffractometer equipped with a CCD detector, and reflections were measured using monochromatic Mo Kα radiation. The structure was solved by direct methods using SIR92, and refinement was performed with CRYSTALS. Full matrix least-squares refinement was performed with anisotropic temperature factors for all atoms except hydrogen that were included at calculated positions with isotropic temperature factors. Coordinates, anisotropic temperature factors, and bond lengths and angles were deposited with the Cambridge Crystrallographic Data Centre; CCDC code: 969024. Purity of all target compounds was assessed using the two independent LC-MS methods described above: (1) a Zorbax SB-AQ, 5 μm, 120 Å, 4.6 mm × 50 mm (Agilent) column eluting with a gradient of 5–95% acetonitrile in water containing 0.04% of trifluoroacetic acid, within 1 min, flow: 4.5 mL/min; and (2) an ACQUITY UPLC BEH C18 1.7 μm, 2.1 mm × 50 mm column eluting with a gradient of 2–98% acetonitrile containing 0.045% formic acid in water containing 0.05% formic acid over 1.8 min; flow 1.2 mL/min. In addition, important compounds were analyzed by LC-HRMS as described above. Purity and identity of the target compounds was further corroborated by NMR spectroscopy, and chiral integrity was proven by HPLC using chiral stationary phases. No racemisation/epimerization was observed during the synthesis of the target compounds. According to these LC-MS analyses, final compounds showed a purity of greater than or equal to 95% (UV at 230 and at 214 nm).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> In Vitro Potency Assessment</h3><div class="NLM_p last">Data (EC<sub>50</sub>) are given as geometric means (<i>X</i><sub>geo</sub>) with geometric standard deviation (σ<sub>g</sub>). The upper and lower 95% confidence limits are calculated as X<sub>geo</sub>*σ<sub>g</sub><sup>2</sup> and X<sub>geo</sub>/σ<sub>g</sub><sup>2</sup>, respectively (results not shown). GTPγS binding assays were performed in 96-well polypropylene microtiter plates in a final volume of 200 μL. Membrane preparations of CHO cells expressing recombinant human S1P<sub>1,</sub> S1P<sub>2</sub>, S1P<sub>3</sub>, S1P<sub>4</sub>, or S1P<sub>5</sub> or rat S1P<sub>1</sub> or S1P<sub>3</sub> receptors were used. Assay conditions were 20 mM Hepes, pH 7.4, 100 mM NaCl, 5 mM MgCl<sub>2</sub>, 0.1% fatty acid free BSA, 0.5 μM (for S1P<sub>2</sub>, S1P<sub>5</sub>), 1 μM (for S1P<sub>1</sub>, S1P<sub>4</sub>) or 3 μM GDP (for S1P<sub>3</sub>), 2.5% DMSO, and 50 pM <sup>35</sup>S-GTPγS. Test compounds were dissolved, diluted, and preincubated with the membranes, in the absence of <sup>35</sup>S-GTPγS, in 150 μL of assay buffer at room temperature for 30 min. After addition of 50 μL of <sup>35</sup>S-GTPγS in assay buffer, the reaction mixture was incubated for 1 h at room temperature. The assay was terminated by filtration of the reaction mixture through a Multiscreen GF/C plate, prewetted with ice-cold 50 mM Hepes pH 7.4, 100 mM NaCl, 5 mM MgCl<sub>2</sub>, 0.4% fatty acid free BSA, using a Cell Harvester. The filterplates were then washed with ice-cold 10 mM Na<sub>2</sub>HPO<sub>4</sub>/ NaH<sub>2</sub>PO<sub>4</sub> (70%/30%, w/w) containing 0.1% fatty acid free BSA. Then, the plates were dried at 50 °C and sealed, 25 μL of MicroScint20 was added, and the membrane-bound <sup>35</sup>S-GTPγS was determined on the TopCount. Specific <sup>35</sup>S-GTPγS binding was determined by subtracting nonspecific binding (the signal obtained in the absence of agonist) from maximal binding (the signal obtained with 10 μM S1P). The EC<sub>50</sub> of a test compound is the concentration of a compound inducing 50% of specific binding. PK in the rat. Wistar rats (RCC Ltd., Biotechnology and Animal Breeding Division, Füllinsdorf, Switzerland) were used for PK experiments after an acclimatization period of at least 7 days after delivery. Animals foreseen for iv dosing underwent surgery to receive a catheter implanted into the jugular vein. Animals foreseen for oral dosing did not undergo surgery, and blood samples were taken sublingually under light anesthesia with isoflurane. Compounds were administered intravenously via the tail vein at doses of 1 mg/kg body weight formulated as solutions in an aqueous mixed micellar vehicle based on phospholipids and bile acids. Oral administration at doses of 10 mg/kg was performed by gavage. Oral formulations were dispersions prepared by addition of a DMSO stock solution of the compounds to succinylated gelatin (7.5% w/v) in water. Serial blood samples of 0.25 mL each were taken predose and at 30 min, 1, 2, 3, 4, 6, 8, and 24 h postdose into vials containing EDTA as anticoagulant. For the iv applications, additional samples were obtained 2, 10, and 20 min after dosing. Plasma was separated by centrifugation and stored at −20 °C. All animals had free access to food during the entire duration of the experiments. Plasma samples from the rat were analyzed using liquid chromatography coupled to mass spectrometry (LC-MS-MS) after protein precipitation with MeOH and centrifugation at 3220<i>g</i> for 20 min at 4 °C. Using 1.25 μL of plasma on the column, lower and upper limits of quantification were 41 and 10 000 ng/mL for compound <b>85</b>, respectively. PK parameters were estimated with the WinNonlin software (Pharsight Corporation, Mountain View, CA, USA) using noncompartmental analysis. Brain penetration in the rat. At 2, 6, and 24 h after dosing, male Wistar rats (<i>n</i> = 2) were anaesthetised with 5% isoflurane and sacrificed by opening the diaphragm. A blood sample was taken, plasma was prepared, and the brain was slowly perfused with 10 mL of 0.9% NaCl trough the carotid. The whole brain was then removed and homogenized in an equal volume of ice-cold 0.1 M sodium phosphate buffer, pH 7.4, using a IKA-WERKE ultraturrax T25 tissue homogenizer for 10 s, and the brain homogenate was snap frozen in liquid nitrogen. Drug concentrations were then determined as described for plasma, using a calibration curve from blanco brain homogenate. PK in the dog. The PK profile of compound <b>85</b> was determined in the male Beagle dog. The compound was administered iv at a dose of 1 mg/kg as a solution in miced micelles and orally at a dose of 3 mg/kg as a dispersion in succinylated gelatin (7.5% w/v) in water. In vivo efficacy of the target compounds was assessed by measuring the circulating lymphocytes after oral administration of 3–100 mg/kg target compound to normotensive male Wistar rats. The animals were housed in climate-controlled conditions with a 12 h light/dark cycle and had free access to normal rat chow and drinking water. Blood was collected before and 3, 6, and 24 h after drug administration. Full blood was subjected to hematology using Beckman Coulter Ac.T 5diff CP (Beckman Coulter International SA, Nyon, Switzerland). The effect on lymphocyte count (%LC) was calculated for each animal as the difference between the LC at a given time point and the predose value (= 100%). All data are presented as mean ± SEM. Statistical analyses were performed by analysis of variance (ANOVA) using Statistica (StatSoft) and the Student–Newman–Keuls procedure for multiple comparisons. The null hypothesis was rejected when <i>p</i> < 0.05. Because of interindividual variability and the circadian rhythm of the number of circulating lymphocytes, a compound showing relative changes in the range of −20% to +40% is considered inactive. A LC reduction in the range of −60 to −75% represents the maximal effect to be observed under the conditions of the experiment. For formulation, the compounds were dissolved in DMSO. This solution was added to a stirred solution of succinylated gelatin (7.5% w/v) in water. The resulting milky suspension containing a final concentration of 5% DMSO was administred to the animals by gavage. A mixture of 95% succinylated gelatin (7.5% w/v) in water and 5% DMSO served as the vehicle. Telemetric in vivo studies.<a onclick="showRef(event, 'ref82 ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref82 ref83 ref84">(82-84)</a> The effect of compound <b>85</b> on MAP and HR was assessed by oral administration of <b>85</b> as a suspension in succinylated gelatin (7.5% w/v) in water to male SHR equipped with a telemetric system recording arterial blood pressure and HR. Compound administation took place in the morning, that is, during the sleep phase of the animals. For both of these parameters, each animal served as its own control by using the data of the last 24 h before treatment. An area between curve (ABC) was calculated between the control and the treatment period to assess the efficacy of the compound. Maximal mean arterial blood pressure change was extracted from the moving average over 6 h of the blood pressure recordings.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (3b<i>S</i>,4a<i>R</i>)-3,4,4-Trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>c</i>]thiophene-1-carboxylic Acid (<b>20</b>)</h3><div class="NLM_p last">To a solution of sodium (2.80 g, 122 mmol) in ethanol (400 mL), a solution of mercapto-acetic acid ethyl ester (14.64 g, 122 mmol) in ethanol (40 mL) was added. The solution was stirred for 5 min before (1<i>S</i>,5<i>R</i>)-2-(1-chloro-(<i>E</i>)-ethylidene)-6,6-dimethyl-bicyclo[3.1.0]hexan-3-one (15.0 g, 81.2 mmol) in ethanol (40 mL) was added dropwise. The solution became slightly warm (approximately 30 °C) and turned orange to brown. A fine precipitate formed. Stirring was continued at rt for 1 h. Then, a solution of sodium (2.24 g, 97.5 mmol) in ethanol (75 mL) was added rapidly, and the mixture was heated to 75 °C for 1 h. A 2 N aq solution of LiOH (75 mL) was added and stirring was continued at 75 °C for 2 h and then at rt for 16 h. About two-thirds of the solvent was removed in vacuo, and the remaining mixture was diluted with water (250 mL) and extracted with DCM (200 mL). The organic extract was washed twice with 1 N aq (100 mL). The combined aqueous layers are acidified by adding 2N aq HCl and extracted three times with diethyl ether (3 × 300 mL). The organic extracts are dried over MgSO<sub>4</sub> and evaporated. The remaining residue was suspended in acetonitrile, filtered, washed with additional acetonitrile, and dried under high vacuum to give thiophene carboxylic acid <b>20</b> (12.02 g, 67%) as a pale yellow to beige crystalline powder. LC-MS: <i>t</i><sub>R</sub> = 0.95 min, [M + 1]<sup>+</sup> = 223.00 (calcd 223.08). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 3.04–2.92 (m, 1 H), 2.83 (d, <i>J</i> = 19.3 Hz, 1 H), 2.39 (s, 3 H), 1.91–1.87 (m, 2 H), 1.13 (s, 3 H), 0.73 (s, 3 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 168.4, 160.1, 146.8, 137.2, 117.5, 36.2, 30.0, 29.1, 26.6, 22.8, 14.4, 14.1.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (3b<i>S</i>,4a<i>R</i>)-<i>N</i>-(2-Methoxybenzyl)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>c</i>]thiophene-1-carboxamide (<b>9</b>)</h3><div class="NLM_p last">A solution of (3b<i>S</i>,4a<i>R</i>)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclo-propa[3,4]cyclopenta[1,2-<i>c</i>]thiophene-1-carboxylic acid <b>20</b> (30.0 mg, 135 μmol), TBTU (47.7 mg, 148 μmol), and Hünig’s base (57.6 mg, 445 μmol) in DMF (1.2 mL) was stirred at rt for 30 min before a solution of 2-methoxy-benzylamine (3.3 mg, 0.022 mmol) in DMF (0.2 mL) was added. The mixture was allowed to stand at rt for 1 h before it was subjected to purification by preparative HPLC (Grom-Sil 120 ODS-4-HE, 30 mm × 75 mm, 10 μm particle size, gradient of 20–95% acetonitrile in water containing 0.5% formic acid) to give <b>9</b> (45 mg, 98%) as a colorless lyophilizate. LC-MS: <i>t</i><sub>R</sub> = 1.08 min, [M + 1]<sup>+</sup> = 342.18 (calcd 342.15). <sup>1</sup>H NMR (H<sub>6</sub>-DMSO, solvent suppression): δ 7.64 (t br, <i>J</i> = 4.8 Hz, 1 H), 7.17 (t, <i>J</i> = 7.7 Hz, 1 H), 7.06 (d, <i>J</i> = 7.3 Hz, 1 H), 6.83 (t, <i>J</i> = 7.3 Hz, 1 H), 4.32 (d, <i>J</i> = 5.2 Hz, 2 H), 3.79 (s, 3 H), 2.93 (dd, <i>J</i> = 6.3, 18.3 Hz, 1 H), 2.74 (d, <i>J</i> = 18.5 Hz, 1 H), 2.31 (s, 3 H), 1.86–1.99 (m, 2 H), 1.08 (s, 3 H), 0.68 (s, 3 H). LC-HRMS: <i>t</i><sub>R</sub> = 2.14 min, [M + H]/<i>z</i> = 342.1528, found 342.1530.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (3b<i>S</i>,4a<i>R</i>)-<i>N</i>-(3-(2-Hydroxyethoxy)benzyl)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>c</i>]thiophene-1-carboxamide (<b>27</b>)</h3><div class="NLM_p">(a) To a solution of thiophene carboxylic acid <b>20</b> (222 mg, 1.00 mmol) in DMF (15 mL), TBTU (353 mg, 1.10 mmol) and Hünig’s base (427 mg, 3.30 mmol) was added. The mixture was allowed to stand at rt for 20 min before 3-hydroxybenzylamine (160 mg, 1.00 mmol) and Hünig’s base (142 mg, 1.10 mmol) were added as a solution in DMF (1.5 mL). The mixture was stirred at rt for 3 h, treated with formic acid (2 mL), and directly separated by preparative HPLC (Phenomenex AQUA, 30 mm × 75 mm, gradient of acetonitrile in water containing 0.5% of formic acid) to give (3b<i>S</i>,4a<i>R</i>)-<i>N</i>-(3-hydroxybenzyl)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>c</i>]thiophene-1-carboxamide (126 mg, 38%) as a pale yellow resin. LC-MS: <i>t</i><sub>R</sub> = 0.97 min, [M + 1]<sup>+</sup> = 328.25 (calcd 328.14). <sup>1</sup>H NMR (H<sub>6</sub>-DMSO, solvent suppression): δ 9.35 (s, 1 H), 7.94 (t br, <i>J</i> = 5.6 Hz, 1 H), 7.09 (t, <i>J</i> = 7.8 Hz, 1 H), 6.64–6.71 (m, 2 H), 6.60 (d, <i>J</i> = 8.3 Hz, 1 H), 4.28 (d, <i>J</i> = 6.1 Hz, 2 H), 2.92 (dd, <i>J</i><sub>1</sub> = 18.6 Hz, <i>J</i><sub>2</sub> = 6.6 Hz, 1 H), 2.77 (d, <i>J</i> = 18.3 Hz, 1 H), 2.32 (s, 3 H), 1.84–2.02 (m, 2 H), 1.08 (s, 3 H), 0.68 (s, 3 H).</div><div class="NLM_p last">(b) To a solution of the above phenol (7.5 mg, 23 μmol) in MeOH (1 mL) and 2 M aq NaOH (0.1 mL), a catalytic amount of NaI and 2-bromoethanol (11.5 mg, 92 μmol) were added. The mixture was stirred at 85 °C for 24 h before another portion of 2 M aq NaOH was added, and the mixture was separated by preparative HPLC (Waters XTerra Prep MS C18 19 mm × 50 mm 5 μm, gradient of acetonitrile in water containing 0.85% of Et<sub>2</sub>NH) to give <b>27</b> (1.83 mg, 21%) as a colorless resin. LC-MS: <i>t</i><sub>R</sub> = 0.97 min, [M + 1]<sup>+</sup> = 372.15 (calcd 372.16); <sup>1</sup>H NMR (H<sub>6</sub>-DMSO, solvent suppression): δ 7.96 (t, <i>J</i> = 5.9 Hz, 1 H), 7.21 (t, <i>J</i> = 8.1 Hz, 1 H), 6.78–6.87 (m, 2 H), 6.78 (d, <i>J</i> = 7.8 Hz, 1 H), 4.90 (t, <i>J</i> = 4.9 Hz, 1 H), 4.32 (d, <i>J</i> = 5.1 Hz, 2 H), 3.91–3.97 (m, 2 H), 3.65–3.73 (m, 2 H), 2.92 (dd, <i>J</i><sub>1</sub> = 18.6 Hz, <i>J</i><sub>2</sub> = 6.1 Hz, 1 H), 2.75 (d, <i>J</i> = 18.6 Hz, 1 H), 2.31 (s, 3 H), 1.86–1.96 (m, 2 H), 1.07 (s, 3 H), 0.66 (s, 3 H).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 1-((3b<i>S</i>,4a<i>R</i>)-3,4,4-Trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclo-penta[1,2-<i>c</i>]thiophen-1-yl)ethanone (<b>30</b>)</h3><div class="NLM_p last">To a solution of <b>20</b> (12.0 g, 54 mmol) in diethyl ether (600 mL), MeLi (1.6 M, 72 mL, 115 mmol, 1.6 M in diethyl ether) was slowly added. Progress of the reaction was carefully monitored by LC-MS. Upon completion of the addition, stirring was continued at rt for 10 min. The reaction was quenched by carefully adding the mixture to ice/water (400 mL). The organic layer was separated, dried over MgSO<sub>4</sub>, and filtered, and the solvent was evaporated. The crude product was purified by CC on silica gel eluting with heptane/EA 4:1 to give the title compound (8.81 g, 74%) as a pale yellow oil. LC-MS: <i>t</i><sub>R</sub> = 1.03 min, [M + 1]<sup>+</sup> = 221.20 (calcd 221.10). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 3.00 (ddd, <i>J</i> = 1.8, 4.7, 18.8 Hz, 1 H), 2.80 (d, <i>J</i> = 18.8 Hz, 1 H), 2.38 (s, 6 H), 1.93–1.90 (m, 2 H), 1.14 (s, 3 H), 0.74 (s, 3 H).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 3-(4-(2-Hydroxyethoxy)phenyl)-1-((3b<i>S</i>,4a<i>R</i>)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>c</i>]thiophen-1-yl)propan-1-one (<b>32</b>)</h3><div class="NLM_p">(a) A solution of 4-hydroxybenzaldehyde (346 mg, 2.84 mmol) and <b>30</b> (500 mg, 2.27 mmol) in ethanol (20 mL) and approximately 6 N HCl in isopropanol (4 mL) was stirred at rt for 20 h. The dark brown solution was diluted with diethyl ether and washed with saturated aq NaHCO<sub>3</sub> solution and water. The aqueous phases are extracted with diethyl ether. The combined organic extracts are dried over MgSO<sub>4</sub> and evaporated. The crude product was purified by crystallization from MeOH to give (<i>E</i>)-3-(4-hydroxyphenyl)-1-((3b<i>S</i>,4a<i>R</i>)-3,4,4-trimethyl-3b,4,4a,5-tetrahydro-cyclopropa[3,4]cyclopenta[1,2-<i>c</i>]thio-phen-1-yl)prop-2-en-1-one (694 mg, 75%) as an olive powder. LC-MS: <i>t</i><sub>R</sub> = 1.05 min, [M + 1]<sup>+</sup> = 325.22 (calcd 325.13). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.70 (d, <i>J</i> = 15.8 Hz, 1 H), 7.51 (d, <i>J</i> = 8.8 Hz, 2 H), 7.10 (d, <i>J</i> = 15.2 Hz, 1 H), 6.89 (d, <i>J</i> = 8.2 Hz, 2 H), 5.72 (s, 1 H), 3.13 (dd, <i>J</i> = 5.9, 18.8 Hz, 1 H), 2.94 (d, <i>J</i> = 18.8 Hz, 1 H), 2.42 (s, 3 H), 1.98–1.89 (m, 2 H), 1.13 (s, 3 H), 0.74 (s, 3 H).</div><div class="NLM_p">(b) A mixture of (<i>E</i>)-3-(4-hydroxyphenyl)-1-((3b<i>S</i>,4a<i>R</i>)-3,4,4-trimethyl-3b,4,4a,5-tetrahydro-cyclopropa[3,4]cyclopenta[1,2-c]thiophen-1-yl)prop-2-en-1-one (690 mg, 2.13 mmol) and Pd/C (200 mg, 10% Pd) in ethanol (25 mL) and THF (25 mL) was stirred at rt for 3 h under H<sub>2</sub> (1.5 bar). The mixture was filtered, the filtrate was evaporated, and the crude product was purified by CC on silica gel eluting with heptane/EA 7:3 to give 3-(4-hydroxyphenyl)-1-((3b<i>S</i>,4a<i>R</i>)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclo-propa[3,4] cyclopenta[1,2-<i>c</i>]thiophen-1-yl)propan-1-one <b>31</b> (616 mg, 88%) as a colorless foam. LC-MS: <i>t</i><sub>R</sub> = 1.05 min, [M + 1]<sup>+</sup> = 327.24 (calcd 327.14). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.11–7.05 (m, 2 H), 6.78–6.70 (m, 2 H), 4.75 (s, 1 H), 3.04–2.90 (m, 5 H), 2.78 (d, <i>J</i> = 18.8 Hz, 1 H), 2.37 (s, 3 H), 1.91–1.85 (m, 2 H), 1.11 (s, 3 H), 0.70 (s, 3 H).</div><div class="NLM_p last">(c) Alkylation was carried out as described for <b>33</b>. LC-MS: <i>t</i><sub>R</sub> = 1.05 min, [M + 1]<sup>+</sup> = 371.19 (calcd 371.17). <sup>1</sup>H NMR (H<sub>6</sub>-DMSO, solvent suppression): δ 7.08 (d, <i>J</i> = 8.0 Hz, 2 H), 6.77 (d, <i>J</i> = 7.9 Hz, 2 H), 4.88 (t, <i>J</i> = 5.4 Hz, 1 H), 3.91 (t, <i>J</i> = 4.4 Hz, 2 H), 3.64–3.72 (m, 2 H), 2.92–2.96 (m, 1 H), 2.76 (t, <i>J</i> = 7.5 Hz, 2 H), 2.71 (d, <i>J</i> = 18.8 Hz, 1 H), 2.32 (s, 3 H), 1.88–1.92 (m, 2 H), 1.08 (s, 3 H), 0.65 (s, 3 H). LC-HRMS: <i>t</i><sub>R</sub> = 1.44 min, [M + H]/<i>z</i> = 371.1680, found 371.1684.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 3-(4-(2-Hydroxyethoxy)-2-methoxyphenyl)-1-((3b<i>S</i>,4a<i>R</i>)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>c</i>]thiophen-1-yl)propan-1-one (<b>33</b>)</h3><div class="NLM_p">(a) A stirred solution of (1a<i>S</i>,5a<i>R</i>)-1-(1,1,2-trimethyl-1,1a,5,5a-tetrahydro-3-thia-cyclopropa[a]pen-talen-4-yl)-ethanone (535 mg, 1.70 mmol), 4-hydroxy-2-methoxybenzaldehyde (335 mg, 2.20 mmol), and NaOH (2.60 g, 65.0 mmol) in MeOH (25 mL) was heated to 70 °C for 4 h. The mixture was diluted with water (150 mL) and extracted with diethyl ether (75 mL). The pH of the aqueous phase was adjusted to pH = 10 by adding saturated aq NH<sub>4</sub>Cl solution, and the solution was extracted twice with DCM (2 × 70 mL). The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was separated by preparative HPLC to afford 3-(4-hydroxy-2-methoxy-phenyl)-1-((1a<i>S</i>,5aR<i>)</i>-1,1,2-trimethyl-1,1a,5,5a-tetrahydro-3-thia-cyclo-propa[a]pentalen-4-yl)-propenone (450 mg, 75%) as a yellow solid. LC-MS: <i>t</i><sub>R</sub> = 1.06 min, [M + 1]<sup>+</sup> = 355.20 (calcd 355.14). <sup>1</sup>H NMR (D<sub>6</sub>-DMSO): δ 10.15 (s, 1 H), 7.73 (d, <i>J</i> = 15.2 Hz, 1 H), 7.55 (d, <i>J</i> = 8.8 Hz, 1 H), 7.23 (d, <i>J</i> = 15.8 Hz, 1 H), 6.47–6.40 (m, 2 H), 3.84 (s, 3 H), 3.12 (dd, <i>J</i> = 6.4, 18.8 Hz, 1 H), 2.88 (d, <i>J</i> = 18.8 Hz, 1 H), 2.07 (s, 3 H), 2.02–1.93 (m, 2 H), 1.11 (s, 3 H), 0.70 (s, 3 H).</div><div class="NLM_p">(b) To a solution of 3-(4-hydroxy-2-methoxy-phenyl)-1-((1a<i>S</i>,5a<i>R</i>)-1,1,2-trimethyl-1,1a,5,5a-tetrahydro-3-thia-cyclo-propa[a]pentalen-4-yl)-propenone (443 mg, 1.25 mmol) in ethanol (30 mL) was added Pd/C (450 mg, 10% Pd). The resulting suspension was stirred at rt for 2 h under 1 atm H<sub>2</sub>. The mixture was filtered over Celite, and the filtrate was evaporated. The residue was purified by preparative HPLC to give 3-(4-hydroxy-2-methoxy-phenyl)-1-((1a<i>S</i>,5a<i>R</i>)-1,1,2-trimethyl-1,1a,5,5a-tetrahydro-3-thia-cyclopropa[a]pent-alen-4-yl)-propan-1-one (162 mg, 36%) as a slightly yellow resin. LC-MS: <i>t</i><sub>R</sub> = 1.06 min, [M + 1]<sup>+</sup> = 357.10 (calcd 357.15). <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 6.88 (d, <i>J</i> = 8.2 Hz, 1 H), 6.37 (d, <i>J</i> = 2.3 Hz, 1 H), 6.26 (dd, <i>J</i> = 2.3, 8.2 Hz, 1 H), 3.76 (s, 3 H), 3.00–2.74 (m, 6 H), 2.04 (s, 3 H), 1.98–1.89 (m, 2 H), 1.12 (s, 3 H), 0.70 (s, 3 H).</div><div class="NLM_p last">(c) To a solution of the above phenol (80 mg, 0.225 mmol) in isopropanol (7 mL) and 2 N aq NaOH (2.8 mL), NaI (10 mg) and 2-bromoethanol (156 mg, 1.25 mmol) were added. The mixture was stirred at 65 °C for 24 h before it was treated with acetic acid (0.3 mL) and concentrated. The crude product was dissolved in MeOH (8 mL) and purified by HPLC (Waters Xterra MS 18, 75 mm × 30 mm i.d., 10 μm, gradient of acetonitrile in water containing 0.74% diethylamine) to give the title compound (81 mg, 90%) as a pale yellow resin. LC-MS: <i>t</i><sub>R</sub> = 1.06 min, [M + 1]<sup>+</sup> = 401.18 (calcd 401.18). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.06 (d, <i>J</i> = 8.2 Hz, 1 H), 6.47 (d, <i>J</i> = 2.3 Hz, 1 H), 6.41 (dd, <i>J</i><sub>1</sub> = 8.2 Hz, <i>J</i><sub>2</sub> = 2.3 Hz, 1 H), 4.05–4.09 (m, 2 H), 3.92–3.98 (m, 2 H), 3.81 (s, 3 H), 2.90–3.01 (m, 5 H), 2.79 (d, <i>J</i> = 18.8 Hz, 1 H), 2.38 (s, 3 H), 1.86–1.90 (m, 2 H), 1.12 (s, 3 H), 0.72 (s, 3 H). LC-HRMS: <i>t</i><sub>R</sub> = 2.11 min, [M + H]/<i>z</i> = 401.1786, found 401.1790.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (2<i>R</i>/<i>S</i>)-3-((2-Hydroxy-3-((2-hydroxyethyl)amino)propoxy)-3,5-dimethylphenyl)-1-((3b<i>S</i>,4a<i>R</i>)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>c</i>]thiophen-1-yl)propan-1-one (<b>57</b>)</h3><div class="NLM_p">(a) A solution of 3,5-dimethyl-4-hydroxybenzaldehyde (2.21 g, 14.7 mmol) and <b>30</b> (2.70 g, 12.3 mmol) in ethanol (50 mL) and approximately 6 N HCl in isopropanol (25 mL) was stirred at rt for 90 min. The dark brown solution was diluted with diethyl ether and washed with a 1:1 mixtue of 1 N aq NaOH and saturated aq NaHCO<sub>3</sub> solution and water. The aqueous phases were extracted with diethyl ether. The combined organic extracts were dried over MgSO<sub>4</sub> and evaporated. The crude product was purified by CC on silica gel eluting with heptane/EA 7:3 to give (<i>E</i>)-3-(4-hydroxy-3,5-dimethylphenyl)-1-((3b<i>S</i>,4a<i>R</i>)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclo-propa[3,4]cyclopenta[1,2-<i>c</i>]thio-phen-1-yl)prop-2-en-1-one (3.28 g, 76%) as a yellow powder. LC-MS: <i>t</i><sub>R</sub> = 1.12 min, [M + 1]<sup>+</sup> = 353.31 (calcd 353.16). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.65 (d, <i>J</i> = 15.8 Hz, 1 H), 7.24 (s, 2 H), 7.06 (d, <i>J</i> = 15.8 Hz, 1 H), 5.08 (s, 1 H), 3.12 (dd, <i>J</i> = 5.9, 18.8, 1 H), 2.95 (d, <i>J</i> = 18.8 Hz, 1 H), 2.41 (s, 3 H), 2.28 (s, 6 H), 1.96–1.89 (m, 2 H), 1.13 (s, 3 H), 0.75 (s, 3 H).</div><div class="NLM_p">(b) A mixture of (<i>E</i>)-3-(4-hydroxy-3,5-dimethylphenyl)-1-((3b<i>S</i>,4a<i>R</i>)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>c</i>]thiophen-1-yl)prop-2-en-1-one (3.0 g, 8.51 mmol) and Pd/C (500 mg, 10% Pd) in ethanol (50 mL) and THF (50 mL) was stirred at rt for 4 h under H<sub>2</sub> (1.5 bar). The mixture was filtered, the filtrate was evaporated, and the crude product was purified by CC on silica gel eluting with heptane/EA 1:1 to give 3-(4-hydroxy-3,5-dimethylphenyl)-1-((3b<i>S</i>,4a<i>R</i>)-3,4,4-trimethyl-3b,4,4a,5-tetrahydro-cyclopropa[3,4]cyclopenta[1,2-<i>c</i>]thiophen-1-yl)propan-1-one <b>31</b> (3.0 g, 99%) as a yellow foam. LC-MS: <i>t</i><sub>R</sub> = 1.11 min, [M + 1]<sup>+</sup> = 355.33 (calcd 355.17). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 6.84 (s, 2 H), 4.62 (s, 1 H), 3.05–2.76 (m, 5 H), 2.39 (s, 3 H), 2.23 (s, 6 H), 1.94–1.87 (m, 2 H), 1.13 (s, 3 H), 0.72 (s, 3 H).</div><div class="NLM_p">(c) A solution of <b>31</b> (10.6 g, 29.9 mmol) in isopropanol (100 mL) and 3 N aq. NaOH (50 mL) was treated with epichlorohydrin (8.31 g, 89.8 mmol). The dark red reaction mixture was stirred at rt for 24 h. The mixture was diluted with diethyl ether (300 mL) and washed with saturated aq. NaHCO<sub>3</sub> followed by water. The organic layer was dried over MgSO<sub>4</sub> and evaporated. The crude product was purified by CC on silica gel eluting with heptane/EA 4:1 to give 3-(3,5-dimethyl-4-(oxiran-2-ylmethoxy)phenyl)-1-((3b<i>S</i>,4a<i>R</i>)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>c</i>]thiophen-1-yl)propan-1-one (9.57 g, 78%, mixture of diastereoisomers) as an almost colorless oil. LC-MS: <i>t</i><sub>R</sub> = 1.16 min, [M + 1]<sup>+</sup> = 411.17 (calcd 411.20). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 6.85 (s, 2 H), 4.04–3.97 (m, 1 H), 3.77–3.69 (s, 1 H), 3.52–3.44 and 3.38–3.32 (2m, 1 H), 3.05–2.84 (m, 6 H), 2.79 (d, <i>J</i> = 18.8 Hz, 1 H), 2.72–2.68 (m, 1 H), 2.38 (s, 3 H), 2.26 (s, 6 H), 1.92–1.86 (m, 2 H), 1.11 (s, 3 H), 0.71 (s, 3 H).</div><div class="NLM_p last">(d) A solution of 3-(3,5-dimethyl-4-(oxiran-2-ylmethoxy)phenyl)-1-((3b<i>S</i>,4a<i>R</i>)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>c</i>]thiophen-1-yl)propan-1-one (4.55 g, 11.1 mmol) in ethanol (50 mL) was treated with ethanolamine (2.71 g, 44.3 mmol) The reaction mixture was stirred at 65 °C for 3 h before it was diluted with diethyl ether (400 mL) and washed twice with water (2 × 200 mL). The aqueous washings were extracted back with diethyl ether (400 mL). The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by MPLC eluting with 90–50% water in MeOH. Product containing fractions were extracted with diethyl ether. The organic extract was dried over MgSO<sub>4</sub>, filtered, and evaporated to give the title compound <b>57</b> (3.51 g, 67%) as a pale yellow foam. LC-MS: <i>t</i><sub>R</sub> = 0.88 min, [M + 1]<sup>+</sup> = 472.27 (calcd 472.25). HPLC with chiral stationary phase (Chiralpak AD-H 250 mm × 4.6 mm i.d., 5 μm; 50% ethanol, 50% MeOH containing 0.05% DEA): <i>t</i><sub>R</sub> = 6.7 min, 52%, <i>t</i><sub>R</sub> = 8.0 min, 48%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 6.85 (s, 2 H), 4.21–4.30 (m, 1 H), 3.81 (t, <i>J</i> = 5.0 Hz, 2 H), 3.77 (d, <i>J</i> = 5.2 Hz, 2 H), 3.55 (s br, 4 H), 2.85–3.07 (m, 9 H), 2.81 (d, <i>J</i> = 18.8 Hz, 1 H), 2.39 (s, 3 H), 2.24 (s, 6 H), 1.88–1.93 (m, 2 H), 1.13 (s, 3 H), 0.72 (s, 3 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 191.9, 156.0, 153.4, 147.2, 136.9, 136.5, 130.6, 129.2, 128.9, 74.1, 68.6, 60.1, 51.7, 51.2, 42.2, 36.1, 29.9, 29.8, 29.7, 25.4, 22.7, 16.3, 14.4, 14.1. LC-HRMS: <i>t</i><sub>R</sub> = 1.52 min, [M + H]/<i>z</i> = 472.2521, found 472.2530.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-((2<i>R</i>/<i>S</i>)-3-(2,6-Dimethyl-4-(3-oxo-3-((3b<i>S</i>,4a<i>R</i>)-3,4,4-trimethyl-3b,4,4a,5-tetrahydro-cyclopropa[3,4]cyclopenta[1,2-<i>c</i>]thiophen-1-yl)propyl)phenoxy)-2-hydroxy-propyl)-2-hydroxyacetamide (<b>64</b>)</h3><div class="NLM_p">(a) A solution of 3-(3,5-dimethyl-4-(oxiran-2-ylmethoxy)phenyl)-1-((3b<i>S</i>,4a<i>R</i>)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>c</i>]thiophen-1-yl)propan-1-one (800 mg, 1.95 mmol) in 6 N NH<sub>3</sub> in MeOH (10 mL) was stirred at 60 °C for 4 h in a sealed vessel. The crude product was purified on preparative TLC plates using DCM containing 15% of MeOH to give 3-(4-(3-amino-2-hydroxypropoxy)-3,5-dimethylphenyl)-1-((3b<i>S</i>,4a<i>R</i>)-3,4,4-trimethyl-3b,4,4a,5-tetrahydro-cyclopropa[3,4] cyclopenta[1,2-<i>c</i>]thiophen-1-yl)propan-1-one (554 mg, 66%) as a colorless foam. LC-MS: <i>t</i><sub>R</sub> = 0.87 min, [M + 1]<sup>+</sup> = 428.05 (calcd 428.23).</div><div class="NLM_p last">(b) To a solution of the above amine (70 mg, 164 μmol) in DCM (3 mL) was added Hünig’s base (85 mg, 655 μmol), TBTU (74 mg, 229 μmol), and glycolic acid (19 mg, 246 μmol), and the reaction mixture was stirred at rt for 1 h before it was separated on preparative TLC plates with DCM containing 10% of MeOH to give <b>64</b> (45 mg, 57%) as a pale yellow resin. LC-MS: <i>t</i><sub>R</sub> = 0.98 min, [M + 1]<sup>+</sup> = 486.04 (calcd 486.23). HPLC with chiral stationary phase (Chiralpak AD-H 250 mm × 4.6 mm i.d., 5 μm; 80% heptane containing 0.05% DEA, 20% ethanol containing 0.05% DEA): <i>t</i><sub>R</sub> = 12.1 min, 47%, <i>t</i><sub>R</sub> = 13.9 min, 53%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 6.91 (t br, <i>J</i> = 5.0 Hz, 1 H), 6.86 (s, 2 H), 4.09–4.20 (m, 3 H), 3.68–3.85 (m, 3 H), 3.41–3.52 (m, 1 H), 3.19 (s br, 1 H), 2.84–3.01 (m, 5 H), 2.79 (d, <i>J</i> = 18.8 Hz, 1 H), 2.38 (s, 3 H), 2.24 (s, 6 H), 1.84–1.94 (m, 2 H), 1.11 (s, 3 H), 0.71 (s, 3 H). LC-HRMS: <i>t</i><sub>R</sub> = 1.36 min, [M + H]/<i>z</i> = 486.2314, found 486.2318.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (<i>S</i>)-3-(2,6-Dimethyl-4-(5-((3b<i>S</i>,4a<i>R</i>)-3,4,4-trimethyl-3b,4,4a,5-tetrahydro-cyclopropa[3,4]cyclopenta[1,2-<i>c</i>]thiophen-1-yl)-1,2,4-oxadiazol-3-yl)phenoxy)-propane-1,2-diol (<b>78</b>)</h3><div class="NLM_p">(a) To dry MeOH (190 mL) was carefully added K-<i>tert</i>-butylate (18.68 g, 166 mmol) followed by hydroxylamine hydrochloride (9.92 g, 143 mmol). The suspension was stirred for 30 min before 3,5-dimethyl-4-hydroxybenzonitrile (7.00 g, 47.6 mmol) was added. The mixture was refluxed for 32 h; then, the suspension was diluted by adding 2 N aq HCl. The solution was extracted twice with DCM (100 mL). The aqueous layer was basified (pH 9) by adding solid NaHCO<sub>3</sub> and extracted five times with DCM followed by four times with EA. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated to dryness to give 4,<i>N</i>-dihydroxy-3,5-dimethyl-benzamidine (7.9 g, 92%) as a colorless solid. LC-MS: <i>t</i><sub>R</sub> = 0.62 min, [M + 1]<sup>+</sup> = 181.14 (calcd 181.10). <sup>1</sup>H NMR (D<sub>6</sub>-DMSO): δ 9.25 (s, 1 H), 8.36 (s, 1 H), 7.21 (s, 2 H), 5.54 (s, 2 H), 2.14 (s, 6 H).</div><div class="NLM_p">(b) A solution of <b>20</b> (3.00 g, 13.5 mmol), TBTU (4.77 g, 14.9 mmol), and DIPEA (7.62 mL, 44.5 mmol) in DMF (30 mL) was stirred for 10 min at rt before 4,<i>N</i>-dihydroxy-3,5-dimethyl-benzamidine (2.68 g, 14.9 mmol) was added. The solution was stirred for further 20 min, formic acid (6 mL) was added, and the solution was chromatographed by preparative HPLC (Grom-Sil 120 ODS-4-HE, 30 mm × 75 mm, gradient of acetonitrile in water containing 0.5% formic acid) to give 4-hydroxy-3,5-dimethyl-<i>N</i>-(((3b<i>S</i>,4a<i>R</i>)-3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-<i>c</i>]thiophene-1-carbonyl) oxy)benzimidamide (4.1 g, 79%) as a colorless solid. LC-MS: <i>t</i><sub>R</sub> = 1.03 min, [M + 1]<sup>+</sup> = 385.18 (calcd 385.16). <sup>1</sup>H NMR (D<sub>6</sub>-DMSO): δ 8.65 (s, 1 H), 7.30 (s, 2 H), 6.38 (s br, 2 H), 3.04(dd, <i>J</i> = 5.9, 18.8 Hz, 1 H), 2.75 (d, <i>J</i> = 18.8 Hz, 1 H), 2.36 (s, 3 H), 2.18 (s, 6 H), 2.01–1.88 (m, 2 H), 1.10 (s, 3 H), 0.70 (s, 3 H).</div><div class="NLM_p">(c) A suspension of the above hydroxyamidine ester (4.0 g, 10.4 mmol) in toluene (400 mL) was stirred at 100 °C for 24 h before the solvent was removed under reduced pressure. The residue was dissolved in DCM and purified by CC on silica gel eluting with hexane/EA 5:1 to give <b>71</b> (1.5 g, 39%) as a colorless solid. LC-MS: <i>t</i><sub>R</sub> = 1.37 min, [M + 1]<sup>+</sup> = 367.13 (calcd 367.15). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.75 (s, 2 H), 4.90 (s, 1 H), 3.12 (dd, <i>J</i> = 5.9, 18.8 Hz, 1 H), 2.94 (d, <i>J</i> = 18.8 Hz, 1 H), 2.44 (s, 3 H), 2.32 (s, 6 H), 2.02–1.94 (m, 2 H), 1.16 (s, 3 H), 0.77 (s, 3 H).</div><div class="NLM_p last">(d) To a solution of <b>71</b> (10 mg, 27 μmol) in isopropanol (1 mL), 3-chloropropane-1,2-diol (15 mg, 135 μmol) and 2 N aq NaOH (0.2 mL) were added. The reaction mixture was shaken for 10 h at 65 °C and then directly separated by preparative HPLC (Waters XTerra Prep MS C18 19 mm × 50 mm, 5 μm, gradient of acetonitrile in water containing 0.85% of diethylamine) to give <b>78</b> (6 mg, 50%) as a colorless lyophilizate. LC-MS: <i>t</i><sub>R</sub> = 1.02 min, [M + 1]<sup>+</sup> = 440.88 (calcd 441.18). HPLC with chiral stationary phase (Chiralpak AD-H 250 mm × 4.6 mm i.d., 5 μm; 50% ethanol, 50% MeOH containing 0.1% TFA): <i>t</i><sub>R</sub> = 10.3 min, 100%, ((<i>R</i>)-epimer: <i>t</i><sub>R</sub> = 12.4 min). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.78 (s, 2 H), 4.08–4.18 (m, 1 H), 3.78–3.92 (m, 4 H), 3.11 (dd, <i>J</i><sub>1</sub> = 6.0 Hz, <i>J</i><sub>2</sub> = 18.8 Hz, 1 H), 2.94 (d, <i>J</i> = 18.7 Hz, 1 H), 2.71 (d, <i>J</i> = 4.4 Hz, 1 H), 2.43 (s, 3 H), 2.35 (s, 6 H), 2.06 (s br, 1 H), 1.92–2.01 (m, 2 H), 1.15 (s, 3 H), 0.76 (s, 3 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 171.4, 168.2, 157.5, 156.7, 147.0, 135.2, 131.4, 128.4, 122.8, 111.0, 73.3, 71.0, 63.8, 36.4, 30.1, 28.8, 26.6, 22.9, 16.3, 14.5, 13.9. LC-HRMS: <i>t</i><sub>R</sub> = 2.39 min, [M + H]/<i>z</i> = 441.1848, found 441.1848.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 3-{2-Ethyl-6-methyl-4-[5-((1a<i>S</i>,5a<i>R</i>)-1,1,2-trimethyl-1,1a,5,5a-tetrahydro-3-thia-cyclopropa[a]pentalen-4-yl)-[1,2,4]oxadiazol-3-yl]-phenyl}-propionic Acid (<b>85</b>)</h3><div class="NLM_p">(a) 2-Ethyl-6-methylaniline (15.0 g, 111 mmol) was added to an ice-cold solution of H<sub>2</sub>SO<sub>4</sub> (150 mL) in water (250 mL). The solution was treated with ice (150 g) before a solution of NaNO<sub>2</sub> (10.7 g, 155 mmol) in water (150 mL) and ice (50 g) was added dropwise. The mixture was stirred at 0 °C for 1 h. 50% aq. H<sub>2</sub>SO<sub>4</sub> (200 mL) was added, and stirring was continued at rt for 18 h. The mixture was extracted with DCM, and the organic extracts were dried over MgSO<sub>4</sub> and evaporated. The crude product was purified by CC on silica gel eluting with heptane/EA 9:1 to give 2-ethyl-6-methyl-phenol (8.6 g, 57%) as a crimson oil. LC-MS: <i>t</i><sub>R</sub> = 0.89 min. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.03–6.95 (m, 2 H), 6.80 (t, <i>J</i> = 7.6 Hz, 1 H), 4.60 (s, 1 H), 2.64 (q, <i>J</i> = 7.6 Hz, 2 H), 2.25 (s, 3 H), 1.24 (t, <i>J</i> = 7.6 Hz, 3 H).</div><div class="NLM_p">(b) A solution of 2-ethyl-6-methyl-phenol (8.40 g, 61.7 mmol) and hexamethylene tetraamine (12.97 g, 92.5 mmol) in acetic acid (60 mL) and water (14 mL) was heated to 115 °C. The water was distilled off at 117 °C and collected with a Dean–Stark apparatus. Then, the water separator was replaced by a reflux condensor, and the mixture was refluxed for 3 h. The mixture was cooled to rt, diluted with water (100 mL), and extracted with EA. The organic extract was washed with saturated aq NaHCO<sub>3</sub>, dried over MgSO<sub>4</sub>, and evaporated. The remaining solid was dissolved in EA and treated with heptane to initialize crystallization. The solid material was collected and dried to give 3-ethyl-4-hydroxy-5-methyl-benzaldehyde (3.13 g, 31%) as a colorless crystalline powder. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.83 (s, 1 H), 7.58–7.53 (m, 2 H), 5.30 (s br, 1 H), 2.69 (q, <i>J</i> = 7.6 Hz, 2 H), 2.32 (s, 3 H), 1.28 (t, <i>J</i> = 7.6 Hz, 3 H).</div><div class="NLM_p">(c) To an ice-cooled solution of 5-ethyl-4-hydroxy-3-methylbenzaldehyde (10.0 g, 60.9 mmol) in DCM (50 mL) and pyridine (15 mL), trifluoromethanesulfonic acid anhydride (18.9 g, 67 mmol) was added over a period of 20 min. Upon complete addition, the ice bath was removed, and the reaction was stirred for a further 2 h at rt. The mixture was diluted with DCM (150 mL), washed three times with water, dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by flash chromatography on silica gel eluting with heptane/EA 9:1 to give trifluoro-methanesulfonic acid 2-ethyl-4-formyl-6-methyl-phenyl ester (10.75 g, 60%) as a pale yellow oil. LC-MS: <i>t</i><sub>R</sub> = 1.07 min. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.98 (s, 1 H), 7.70 (s, 1 H), 7.66 (s, 1 H), 2.85 (q, <i>J</i> = 10.1 Hz, 2 H), 2.48 (s, 3 H), 1.30 (t, <i>J</i> = 10.2 Hz, 3 H).</div><div class="NLM_p">(d) To a stirred solution of the above triflate (10.7 g, 36.1 mmol) in dry DMF (75 mL) was sequentially added triethylamine (7.3 g, 72.2 mmol), methyl acrylate (31.1 g, 361 mmol), DPPP (819 mg, 1.99 mmol), and Pd(OAc)<sub>2</sub> (405 mg, 1.81 mmol) under nitrogen. The mixture was stirred at 115 °C for 5 h, cooled to rt, diluted with diethyl ether (350 mL), and washed twice with 1 N aq HCl and once with saturated aq NaHCO<sub>3</sub> solution. The organic extract was dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by flash chromatography on silica gel eluting with heptane/EA 19:1 to give 3-(2-ethyl-4-formyl-6-methyl-phenyl)-acrylic acid methyl ester (5.93 g, 71%) as a colorless liquid. LC-MS: <i>t</i><sub>R</sub> = 0.99 min. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.97 (s, 1 H), 7.83 (d, <i>J</i> = 16.4 Hz, 1 H), 7.60 (s, 1 H), 7.57 (s, 1 H), 6.09 (d, <i>J</i> = 16.4 Hz, 1 H), 3.84 (s, 3 H), 2.72 (q, <i>J</i> = 7.5 Hz, 2 H), 2.39 (s, 3 H), 1.22 (t, <i>J</i> = 7.5 Hz, 3 H).</div><div class="NLM_p">(e) A suspension of 3-(2-ethyl-4-formyl-6-methyl-phenyl)-acrylic acid methyl ester (5.93 g, 25.53 mmol) in MeOH (140 mL) and 2 N aq NaOH (45 mL) was stirred at rt for 1 h. The MeOH was evaporated, and the aqueous solution was extracted twice with DCM. The aqueous layer was acidified with 37% aq HCl. The precipitate that formed was collected, washed with water, and dried. The product was further purified by recrystallization from EA (100 mL) to give 3-(2-ethyl-4-formyl-6-methyl-phenyl)-acrylic acid (4.2 g, 75%) as yellow crystals. LC-MS: <i>t</i><sub>R</sub> = 0.87 min. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.98 (s, 1 H), 7.97 (d, <i>J</i> = 16.4 Hz, 1 H), 7.62 (s, 1 H), 7.59 (s, 1 H), 6.14 (d, <i>J</i> = 16.4 Hz, 1 H), 2.75 (q, <i>J</i> = 7.5 Hz, 2 H), 2.42 (s, 3 H), 1.24 (t, <i>J</i> = 7.5 Hz, 3 H).</div><div class="NLM_p">(f) To a solution of 3-(2-ethyl-4-formyl-6-methyl-phenyl)-acrylic acid (2.75 g, 12.6 mmol) and DIPEA (1.8 g, 13.8 mmol) in ethanol (80 mL), Pd/C (275 mg, 10% Pd, moistened with 50% water) was added. The mixture was stirred for 16 h at rt under 1 atm of H<sub>2</sub>. The catalyst was filtered off, and the filtrate was concentrated. The residue was dissolved in EA, washed with 2 N aq HCl followed by 1 N aq HCl and brine. The organic extract was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to give 3-(2-ethyl-4-hydroxymethyl-6-methyl-phenyl)-propionic acid (2.8 g, 99%) as a white solid. LC-MS: <i>t</i><sub>R</sub> = 0.76 min. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.06 (s, 1 H), 7.04 (s, 1 H), 4.62 (s, 2 H), 2.97–3.05 (m, 2 H), 2.67 (q, <i>J</i> = 7.5 Hz, 2 H), 2.47–2.55 (m, 2 H), 2.35 (s, 3 H), 1.24 (t, <i>J</i> = 7.5 Hz, 3 H).</div><div class="NLM_p">(g) A solution of 3-(2-ethyl-4-hydroxymethyl-6-methyl-phenyl)-propionic acid (2.8 g, 12.6 mmol) in acetic acid (50 mL) was treated with MnO<sub>2</sub> (3.9 g, 45.4 mmol), and the resulting mixture was stirred at 80 °C for 4 h. The mixture was filtered, and the filtrate was concentrated. The crude product was purified by CC on silica gel eluting with DCM to give 3-(2-ethyl-4-formyl-6-methyl-phenyl)-propionic acid (1.76 g, 63%) as a beige solid. LC-MS: <i>t</i><sub>R</sub> = 0.86 min. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.93 (s, 1 H), 7.57 (s, 1 H), 7.53 (s, 1 H), 3.03–3.12 (m, 2 H), 2.74 (q, <i>J</i> = 7.5 Hz, 2 H), 2.49–2.57 (m, 3 H), 2.43 (s, 3 H), 1.28 (t, <i>J</i> = 7.6 Hz, 3 H).</div><div class="NLM_p">(h) A solution of 3-(2-ethyl-4-formyl-6-methyl-phenyl)-propionic acid (1.67 g, 7.58 mmol) and hydroxylamine hydrochloride (780 mg, 11.36 mmol) in 1-methyl-2-pyrrolidone was heated to 80 °C for 30 min in the microwave (300 W, active cooling during irradiation). The reaction mixture was diluted with diethyl ether and washed with water and brine. The organic extract was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to give 3-(4-cyano-2-ethyl-6-methyl-phenyl)-propionic acid (1.55 g, 94%) as a beige solid. LC-MS: <i>t</i><sub>R</sub> = 0.89 min. <sup>1</sup>H NMR (D<sub>6</sub>-DMSO): δ 12.25 (s, 1 H), 7.45 (s, 2 H), 2.91–2.84 (m, 2 H), 2.67–2.59 (m, 2 H), 2.35–2.30 (m, 5 H), 1.14 (t, <i>J</i> = 7.6 Hz, 3 H).</div><div class="NLM_p">(i) Potassium <i>tert</i>-butoxide (2.71 g, 24.1 mmol) was carefully dissolved in MeOH (25 mL). To this solution, hydroxylamine hydrochloride (1.44 g, 20.7 mmol) followed by 3-(4-cyano-2-ethyl-6-methyl-phenyl)-propionic acid (1.50 g, 6.90 mmol) dissolved in MeOH (7.5 mL) was added. The mixture was refluxed for 8 h, and the solvent was evaporated. The residue was dissolved in 2 N aq HCl and extracted with EA. The pH of the aqueous phase was adjusted to pH 5 by adding saturated aq NaHCO<sub>3</sub>, and the mixture was extracted three times with EA. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, evaporated, and dried to give 3-[2-ethyl-4-(<i>N</i>-hydroxycarbamimidoyl)-6-methyl-phenyl]-propionic acid (1.4 g, 81%) as a white solid. LC-MS: <i>t</i><sub>R</sub> = 0.60 min, [M + 1]<sup>+</sup> = 251.17 (calcd 251.14). <sup>1</sup>H NMR (D<sub>6</sub>-DMSO): δ 9.48 (s br, 1 H), 7.33 (s, 1 H), 7.31 (s, 1 H), 5.72 (s br, 1 H), 2.83–2.89 (m, 2 H), 2.63 (q, <i>J</i> = 7.4 Hz, 2 H), 2.31–2.37 (m, 2 H), 2.30 (s, 3 H), 1.18 (t, <i>J</i> = 7.4 Hz, 3 H).</div><div class="NLM_p">(j) To a solution of (1a<i>S</i>, 5a<i>R</i>)-1,1,2-trimethyl-1,1a,5,5a-tetrahydro-3-thia-cyclopropa[a]pentalene-4-carboxylic acid <b>20</b> (270 mg 1.22 mmol) in DMF (3 mL), TBTU (390 mg, 1.22 mmol) and DIPEA (518 mg, 4.0 mmol) were added. The reaction mixture was stirred at rt for 5 min before a solution of 3-[2-ethyl-4-(<i>N</i>-hydroxycarbamimidoyl)-6-methyl-phenyl]-propionic acid (305 mg, 1.22 mmol) in DMF (2 mL) was added. Stirring was continued at rt for 1 h. The mixture was diluted with formic acid (0.5 mL) and acetonitrile (5 mL) and separated by preparative HPLC (Grom-Sil 120 ODS-4-HE, 30 mm × 75 mm, 10 μm, 10–95% acetonitrile in water containing 0.5% formic acid) to afford (1a<i>S</i>,5a<i>R</i>)-1,1,2-trimethyl-1,1a,5,5a-tetrahydro-3-thia-cyclopropa[a]pentalene-4-carboxylic acid <i>N</i>-(3-ethyl-5-methyl-4-(2-carboxy-ethyl)-<i>N</i>-hydroxybenzamidine) ester (260 mg, 47%) as a white solid. LC-MS: <i>t</i><sub>R</sub> = 1.05 min, [M + 1]<sup>+</sup> = 455.32.</div><div class="NLM_p last">(k) A suspension of (1a<i>S</i>,5a<i>R</i>)-1,1,2-trimethyl-1,1a,5,5a-tetrahydro-3-thia-cyclopropa[a]pentalene-4-carboxylic acid <i>N</i>-(3-ethyl-5-methyl-4-(2-(hydroxy-carboxy)-ethyl)-<i>N</i>-hydroxybenzamidine) ester (255 mg, 0.561 mmol) in toluene (10 mL) was heated to 85 °C for 24 h and then at 105 °C for 3 days. The mixture was cooled to rt, and the solvent was evaporated. The residue was dissolved in DMF and separated by preparative HPLC (Grom-Sil 120 ODS-4-HE, 30 mm × 75 mm, 10 μm, 70–100% acetonitrile in water containing 0.5% formic acid) to afford title compound <b>85</b> (150 mg, 61%) as a white crystalline solid. LC-MS: <i>t</i><sub>R</sub> = 1.19 min, [M + 1]<sup>+</sup> = 437.28 (calcd 437.19). <sup>1</sup>H NMR (D<sub>6</sub>-DMSO): δ 12.26 (s, 1 H), 7.64 (s, 1 H), 7.63 (s, 1 H), 3.08 (dd, <i>J</i> = 6.4, 19.3 Hz, 1 H), 2.94–2.89 (m, 2 H), 2.84 (d, <i>J</i> = 18.2 Hz, 1 H), 2.69 (q, <i>J</i> = 7.6 Hz, 2 H), 2.41 (s, 3 H), 2.39–2.33 (m, 5 H), 2.05 (d, <i>J</i> = 5.8 Hz, 1 H), 1.99 (t, <i>J</i> = 5.8 Hz, 1 H), 1.19 (t, <i>J</i> = 7.6 Hz, 3 H), 1.11 (s, 3 H), 0.70 (s, 3 H). <sup>13</sup>C NMR (D<sub>6</sub>-DMSO): δ 174.1, 171.1, 168.3, 156.9, 147.2, 143.2, 141.2, 137.6, 135.8, 126.9, 125.3, 124.3, 110.5, 36.2, 34.0, 29.9, 28.7, 26.6, 25.7, 24.6, 22.8, 19.9, 16.0, 14.8, 14.0. LC-HRMS: <i>t</i><sub>R</sub> = 2.56 min, [M + H]/<i>z</i> = 437.1899, found 437.1896.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34"><a href="/doi/suppl/10.1021/jm4014373">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57003" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57003" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental details on synthesis and characterization of all target compounds and corresponding building blocks not described in the main text are given; the structure of compound <b>17</b> as determined by single crystal X-ray analysis; figures showing mean arterial blood pressure (MAP) recordings in telemetrized SHR after administration of compound <b>85</b>, and heart rate recordings in SHR after administration of compounds <b>1</b> and <b>57</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm4014373/suppl_file/jm4014373_si_001.pdf">jm4014373_si_001.pdf (1.92 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The corresponding data set has been deposited at the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, United Kingdom, <a href="http://www.ccdc.cam.ac.uk/" class="extLink">http://www.ccdc.cam.ac.uk/</a>, under the following deposition number: 969024 (isomer of compound <b>17</b>, see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</p><div class="testing" data-doi="10.1021/jm4014373" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin H. Bolli</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#107d716264797e3e727f7c7c7950717364757c797f7e3e737f7d"><span class="__cf_email__" data-cfemail="d9b4b8abadb0b7f7bbb6b5b5b099b8baadbcb5b0b6b7f7bab6b4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claus Müller</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Boris Mathys</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Abele</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Magdalena Birker</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberto Bravo</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Bur</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Hess</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Kohl</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Lehmann</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oliver Nayler</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Rey</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Solange Meyer</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Scherz</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gunther Schmidt</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beat Steiner</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander Treiber</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jörg Velker</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Weller</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, Allschwil CH-4123, Switzerland</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2858e4686-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68860" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68860" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors gratefully acknowledge their colleagues Céline Bortolamiol, Maxime Boucher, Stéphane Delahaye, Julien Grimont, Hakim Hadana, Julie Hoerner, Benedikt Hofstetter, François LeGoff, Heidemarie Kletzl, Daniel Leuenberger, Claire Maciejasz, Céline Mangold, Katalin Menyhart, Matthias Merrettig, Christine Metzger, Christine Seeger, Jürgen Seifert, Virginie Sippel, Mireille Tena Stern, Marco Tschanz, Gaby von Aesch, Daniel Wanner, and Aude Weigel for the excellent work done and Martine Clozel and Walter Fischli for support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i37" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i37"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i38" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i38"> Abbreviations Used</h2><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">BuLi</td><td class="NLM_def"><p class="first last">butyl lithium</p></td></tr><tr><td class="NLM_term">CC</td><td class="NLM_def"><p class="first last">column chromatography</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last">carbonyldiimidazole</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DEAD</td><td class="NLM_def"><p class="first last">diethyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DPPP</td><td class="NLM_def"><p class="first last">1,3-bis(diphenylphosphino)propane</p></td></tr><tr><td class="NLM_term">EA</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylamino-propyl)carbodiimide</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last"><i>N</i>-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">LC</td><td class="NLM_def"><p class="first last">lymphocyte count</p></td></tr><tr><td class="NLM_term">LDA</td><td class="NLM_def"><p class="first last">lithium diisopropyl amide</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">NMO</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-morpholine-<i>N</i>-oxide</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">PPh<sub>3</sub></td><td class="NLM_def"><p class="first last">triphenylphosphine</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SHR</td><td class="NLM_def"><p class="first last">spontaneously hypertensive rats</p></td></tr><tr><td class="NLM_term">TBTU</td><td class="NLM_def"><p class="first last"><i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">S1P</td><td class="NLM_def"><p class="first last">sphingosine 1-phosphate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63632" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63632" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 85 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Kappos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalban, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polman, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korn, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radue, E. W.</span><span> </span><span class="NLM_article-title">Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1056%2FNEJMoa052643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=16971719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsFKku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=1124-1140&author=L.+Kapposauthor=J.+Antelauthor=G.+Comiauthor=X.+Montalbanauthor=P.+O%E2%80%99Connorauthor=C.+H.+Polmanauthor=T.+Haasauthor=A.+A.+Kornauthor=G.+Karlssonauthor=E.+W.+Radue&title=Oral+Fingolimod+%28FTY720%29+for+Relapsing+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Oral fingolimod (FTY720) for relapsing multiple sclerosis</span></div><div class="casAuthors">Kappos, Ludwig; Antel, Jack; Comi, Giancarlo; Montalban, Xavier; O'Connor, Paul; Polman, Chris H.; Haas, Tomas; Korn, Alexander A.; Karlsson, Goeril; Radue, Ernst W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1124-1140</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Fingolimod (FTY720) is a new oral immunomodulating agent under evaluation for the treatment of relapsing multiple sclerosis.  We randomly assigned 281 patients to receive oral fingolimod, at a dose of 1.25 mg or 5.0 mg, or a placebo once daily, and we followed these patients for 6 mo with magnetic resonance imaging (MRI) and clin. evaluations (core study, months 0 to 6).  The primary end point was the total no. of gadolinium-enhanced lesions recorded on T1-weighted MRI at monthly intervals for 6 mo.  In an extension study in which the investigators and patients remained unaware of the dose assignments (months 7 to 12), patients who received placebo underwent randomization again to one of the fingolimod doses.  A total of 255 patients completed the core study.  The median total no. of gadolinium-enhanced lesions on MRI was lower with 1.25 mg of fingolimod (1 lesion, P < 0.001) and 5.0 mg of fingolimod (3 lesions, P = 0.006) than with placebo (5 lesions).  The annualized relapse rate was 0.77 in the placebo group, as compared with 0.35 in the group given 1.25 mg of fingolimod (P = 0.009) and 0.36 in the group given 5.0 mg of fingolimod (P = 0.01).  For the 227 patients who completed the extension study, the no. of gadolinium-enhanced lesions and relapse rates remained low in the groups that received continuous fingolimod, and both measures decreased in patients who switched from placebo to fingolimod.  Adverse events included nasopharyngitis, dyspnea, headache, diarrhea, and nausea.  Clin. asymptomatic elevations of alanine aminotransferase levels were more frequent with fingolimod (10 to 12%, vs. 1% in the placebo group).  One case of the posterior reversible encephalopathy syndrome occurred in the 5.0-mg group.  Fingolimod was also assocd. with an initial redn. in the heart rate and a modest decrease in the forced expiratory vol. in 1 s.  In this proof-of-concept study, fingolimod reduced the no. of lesions detected on MRI and clin. disease activity in patients with multiple sclerosis.  Evaluation in larger, longer-term studies is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA4MSvDIuvV7Vg90H21EOLACvtfcHk0lgsT1-TxOSjmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsFKku78%253D&md5=2a84e8f5fb92091782406da9dcbc1453</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa052643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa052643%26sid%3Dliteratum%253Aachs%26aulast%3DKappos%26aufirst%3DL.%26aulast%3DAntel%26aufirst%3DJ.%26aulast%3DComi%26aufirst%3DG.%26aulast%3DMontalban%26aufirst%3DX.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%26aulast%3DPolman%26aufirst%3DC.%2BH.%26aulast%3DHaas%26aufirst%3DT.%26aulast%3DKorn%26aufirst%3DA.%2BA.%26aulast%3DKarlsson%26aufirst%3DG.%26aulast%3DRadue%26aufirst%3DE.%2BW.%26atitle%3DOral%2520Fingolimod%2520%2528FTY720%2529%2520for%2520Relapsing%2520Multiple%2520Sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D1124%26epage%3D1140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Kappos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radue, E.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohlfeld, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabresi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selmaj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agoropoulou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leyk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang-Auberson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtin, P.</span><span> </span><span class="NLM_article-title">A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1056%2FNEJMoa0909494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=20089952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvVWltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=387-401&author=L.+Kapposauthor=E.-W.+Radueauthor=P.+O%E2%80%99Connorauthor=C.+Polmanauthor=R.+Hohlfeldauthor=P.+Calabresiauthor=K.+Selmajauthor=C.+Agoropoulouauthor=M.+Leykauthor=L.+Zhang-Aubersonauthor=P.+Burtin&title=A+Placebo-Controlled+Trial+of+Oral+Fingolimod+in+Relapsing+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis</span></div><div class="casAuthors">Kappos, Ludwig; Radue, Ernst-Wilhelm; O'Connor, Paul; Polman, Chris; Hohlfeld, Reinhard; Calabresi, Peter; Selmaj, Krzysztof; Agoropoulou, Catherine; Leyk, Malgorzata; Zhang-Auberson, Lixin; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">387-401</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Oral fingolimod, a sphingosine-1-phosphate-receptor modulator that prevents the egress of lymphocytes from lymph nodes, significantly improved relapse rates and end points measured on magnetic resonance imaging (MRI), as compared with either placebo or i.m. interferon beta-1a, in phase 2 and 3 studies of multiple sclerosis.  METHODS: In our 24-mo, double-blind, randomized study, we enrolled patients who had relapsing-remitting multiple sclerosis, were 18 to 55 years of age, had a score of 0 to 5.5 on the Expanded Disability Status Scale (which ranges from 0 to 10, with higher scores indicating greater disability), and had one or more relapses in the previous year or two or more in the previous 2 years.  Patients received oral fingolimod at a dose of 0.5 mg or 1.25 mg daily or placebo.  End points included the annualized relapse rate (the primary end point) and the time to disability progression (a secondary end point).  RESULTS: A total of 1033 of the 1272 patients (81.2%) completed the study.  The annualized relapse rate was 0.18 with 0.5 mg of fingolimod, 0.16 with 1.25 mg of fingolimod, and 0.40 with placebo (P < 0.001 for either dose vs. placebo).  Fingolimod at doses of 0.5 mg and 1.25 mg significantly reduced the risk of disability progression over the 24-mo period (hazard ratio, 0.70 and 0.68, resp.; P = 0.02 vs. placebo, for both comparisons).  The cumulative probability of disability progression (confirmed after 3 mo) was 17.7% with 0.5 mg of fingolimod, 16.6% with 1.25 mg of fingolimod, and 24.1% with placebo.  Both fingolimod doses were superior to placebo with regard to MRI-related measures (no. of new or enlarged lesions on T2 -weighted images, gadolinium-enhancing lesions, and brain-vol. loss; P < 0.001 for all comparisons at 24 mo).  Causes of study discontinuation and adverse events related to fingolimod included bradycardia and atrioventricular conduction block at the time of fingolimod initiation, macular edema, elevated liver-enzyme levels, and mild hypertension.  CONCLUSIONS: As compared with placebo, both doses of oral fingolimod improved the relapse rate, the risk of disability progression, and end points on MRI.  These benefits will need to be weighed against possible long-term risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZV83ylA8IarVg90H21EOLACvtfcHk0lgsT1-TxOSjmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvVWltr4%253D&md5=0c1a63e4b8850f3579b2a8f6c7f28ac0</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0909494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0909494%26sid%3Dliteratum%253Aachs%26aulast%3DKappos%26aufirst%3DL.%26aulast%3DRadue%26aufirst%3DE.-W.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%26aulast%3DPolman%26aufirst%3DC.%26aulast%3DHohlfeld%26aufirst%3DR.%26aulast%3DCalabresi%26aufirst%3DP.%26aulast%3DSelmaj%26aufirst%3DK.%26aulast%3DAgoropoulou%26aufirst%3DC.%26aulast%3DLeyk%26aufirst%3DM.%26aulast%3DZhang-Auberson%26aufirst%3DL.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DA%2520Placebo-Controlled%2520Trial%2520of%2520Oral%2520Fingolimod%2520in%2520Relapsing%2520Multiple%2520Sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D387%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Cohen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Mechanisms of Fingolimod’s Efficacy and Adverse Effects in Multiple Sclerosis</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1002%2Fana.22426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=21520239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVyhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2011&pages=759-777&author=J.+A.+Cohenauthor=J.+Chun&title=Mechanisms+of+Fingolimod%E2%80%99s+Efficacy+and+Adverse+Effects+in+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis</span></div><div class="casAuthors">Cohen, Jeffrey A.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">759-777</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Until recently, all approved multiple sclerosis (MS) disease treatments were administered parenterally.  Oral fingolimod was approved in Sept. 2010 by the US Food and Drug Administration to reduce relapses and disability progression in relapsing forms of MS.  In the clin. trials that led to approval, fingolimod reduced not only acute relapses and magnetic resonance imaging lesion activity but also disability progression and brain vol. loss, suggesting preservation of tissue.  Fingolimod's mechanism of action in MS is not known with certainty.  Its active form, fingolimod-phosphate (fingolimod-P), is a sphingosine 1-phosphate receptor (S1PR) modulator that inhibits egress of lymphocytes from lymph nodes and their recirculation, potentially reducing trafficking of pathogenic cells into the central nervous system (CNS).  Fingolimod also readily penetrates the CNS, and fingolimod-P formed in situ may have direct effects on neural cells.  Fingolimod potently inhibits the MS animal model, exptl. autoimmune encephalomyelitis, but is ineffective in mice with selective deficiency of the S1P1 S1PR subtype on astrocytes despite normal expression in the immune compartment.  These findings suggest that S1PR modulation by fingolimod in both the immune system and CNS, producing a combination of beneficial anti-inflammatory and possibly neuroprotective/reparative effects, may contribute to its efficacy in MS.  In clin. trials, fingolimod was generally safe and well tolerated.  Its interaction with S1PRs in a variety of tissues largely accounts for the reported adverse effects, which were seen more frequently with doses 2.5 to 10× the approved 0.5mg dose.  Fingolimod's unique mechanism of action distinguishes it from all other currently approved MS therapies.  Ann Neurol 2011;69:759-777.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaQ9gv8GATt7Vg90H21EOLACvtfcHk0lilejrQz9EtAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVyhtLo%253D&md5=8444099f3b8b40bf8fd529e374eaf294</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fana.22426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22426%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DJ.%2BA.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DMechanisms%2520of%2520Fingolimod%25E2%2580%2599s%2520Efficacy%2520and%2520Adverse%2520Effects%2520in%2520Multiple%2520Sclerosis%26jtitle%3DAnn.%2520Neurol.%26date%3D2011%26volume%3D69%26spage%3D759%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieschl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zollinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">21453</span><span class="NLM_x">–</span> <span class="NLM_lpage">21457</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1074%2Fjbc.C200176200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=11967257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+Immune+Modulator+FTY720+Targets+Sphingosine+1-Phosphate+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span></div><div class="casAuthors">Brinkmann, Volker; Davis, Michael D.; Heise, Christopher E.; Albert, Rainer; Cottens, Sylvain; Hof, Robert; Bruns, Christian; Prieschl, Eva; Baumruker, Thomas; Hiestand, Peter; Foster, Carolyn A.; Zollinger, Markus; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21453-21457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis.  In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation.  FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms.  Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compd. is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis.  Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6zyZnHOYNbVg90H21EOLACvtfcHk0lilejrQz9EtAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D&md5=b59856fffa9ebae7fb8182d18daa025f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200176200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200176200%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520Immune%2520Modulator%2520FTY720%2520Targets%2520Sphingosine%25201-Phosphate%2520Receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-349&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstromauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.-J.+Sheiauthor=D.+Cardauthor=C.+A.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+Lymphocyte+Trafficking+by+Sphingosine-1-Phosphate+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520Lymphocyte%2520Trafficking%2520by%2520Sphingosine-1-Phosphate%2520Receptor%2520Agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornancin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dévay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechtcheriakova, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urtz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span> </span><span class="NLM_article-title">Phosphorylation of the Immunomodulatory Drug FTY720 by Sphingosine Kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">47408</span><span class="NLM_x">–</span> <span class="NLM_lpage">47415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1074%2Fjbc.M307687200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=13129923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Cqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=47408-47415&author=A.+Billichauthor=F.+Bornancinauthor=P.+D%C3%A9vayauthor=D.+Mechtcheriakovaauthor=N.+Urtzauthor=T.+Baumruker&title=Phosphorylation+of+the+Immunomodulatory+Drug+FTY720+by+Sphingosine+Kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of the Immunomodulatory Drug FTY720 by Sphingosine Kinases</span></div><div class="casAuthors">Billich, Andreas; Bornancin, Frederic; Devay, Piroska; Mechtcheriakova, Diana; Urtz, Nicole; Baumruker, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">47408-47415</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The immunomodulatory drug FTY720 is phosphorylated in vivo, and the resulting FTY720 phosphate as a ligand for sphingosine-1-phosphate receptors is responsible for the unique biol. effects of the compd.  So far, phosphorylation of FTY720 by murine sphingosine kinase (SPHK) 1a had been documented.  We found that, while FTY720 is also phosphorylated by human SPHK1, the human type 2 isoform phosphorylates the drug 30-fold more efficiently, because of a lower Km of FTY720 for SPHK2.  Similarly, murine SPHK2 was more efficient than SPHK1a.  Among splice variants of the human SPHKs, an N-terminally extended SPHK2 isoform was even more active than SPHK2 itself.  Further SPHK superfamily members, namely ceramide kinase and a "SPHK-like" protein, failed to phosphorylate sphingosine and FTY720.  Thus, only SPHK1 and 2 appear to be capable of phosphorylating FTY720.  Using selective assay conditions, SPHK1 and 2 activities in murine tissues were measured.  While activity of SPHK2 toward sphingosine was generally lower than of SPHK1, FTY720 phosphorylation was higher under conditions favoring SPHK2.  In human endothelial cells, while activity of SPHK1 toward sphingosine was 2-fold higher than of SPHK2, FTY720 phosphorylation was 7-fold faster under SPHK2 assay conditions.  Finally, FTY720 was poorly phosphorylated in human blood as compared with rodent blood, in line with the low activity of SPHK1 and in particular of SPHK2 in human blood.  To conclude, both SPHK1 and 2 are capable of phosphorylating FTY720, but SPHK2 is quant. more important than SPHK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR5e-dVWnBT7Vg90H21EOLACvtfcHk0lj7KKklmaNb4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Cqtr0%253D&md5=26820503680682863dc76a69ea02fc7e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M307687200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M307687200%26sid%3Dliteratum%253Aachs%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DD%25C3%25A9vay%26aufirst%3DP.%26aulast%3DMechtcheriakova%26aufirst%3DD.%26aulast%3DUrtz%26aufirst%3DN.%26aulast%3DBaumruker%26aufirst%3DT.%26atitle%3DPhosphorylation%2520of%2520the%2520Immunomodulatory%2520Drug%2520FTY720%2520by%2520Sphingosine%2520Kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D47408%26epage%3D47415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Sobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Killer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span> </span><span class="NLM_article-title">Sphingosine-1-Phosphate (S1P) Receptor Agonists Mediate Pro-fibrotic Responses in Normal Human Lung Fibroblasts via S1P<sub>2</sub> and S1P<sub>3</sub> Receptors and Smad-Independent Signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">14839</span><span class="NLM_x">–</span> <span class="NLM_lpage">14851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=14839-14851&author=K.+Sobelauthor=K.+Menyhartauthor=N.+Killerauthor=B.+Renaultauthor=Y.+Bauerauthor=R.+Studerauthor=B.+Steinerauthor=M.+H.+Bolliauthor=O.+Naylerauthor=J.+Gatfield&title=Sphingosine-1-Phosphate+%28S1P%29+Receptor+Agonists+Mediate+Pro-fibrotic+Responses+in+Normal+Human+Lung+Fibroblasts+via+S1P2+and+S1P3+Receptors+and+Smad-Independent+Signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSobel%26aufirst%3DK.%26aulast%3DMenyhart%26aufirst%3DK.%26aulast%3DKiller%26aufirst%3DN.%26aulast%3DRenault%26aufirst%3DB.%26aulast%3DBauer%26aufirst%3DY.%26aulast%3DStuder%26aufirst%3DR.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DGatfield%26aufirst%3DJ.%26atitle%3DSphingosine-1-Phosphate%2520%2528S1P%2529%2520Receptor%2520Agonists%2520Mediate%2520Pro-fibrotic%2520Responses%2520in%2520Normal%2520Human%2520Lung%2520Fibroblasts%2520via%2520S1P2%2520and%2520S1P3%2520Receptors%2520and%2520Smad-Independent%2520Signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D14839%26epage%3D14851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">Expression of the Sphingosine 1-Phosphate Receptor, S1P<sub>1</sub>, on T-cells Controls Thymic Emigration</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">15396</span><span class="NLM_x">–</span> <span class="NLM_lpage">15401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=15396-15401&author=M.+L.+Allendeauthor=J.+L.+Dreierauthor=S.+Mandalaauthor=R.+L.+Proia&title=Expression+of+the+Sphingosine+1-Phosphate+Receptor%2C+S1P1%2C+on+T-cells+Controls+Thymic+Emigration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DDreier%26aufirst%3DJ.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DExpression%2520of%2520the%2520Sphingosine%25201-Phosphate%2520Receptor%252C%2520S1P1%252C%2520on%2520T-cells%2520Controls%2520Thymic%2520Emigration%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D15396%26epage%3D15401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Matloubian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinamon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesneski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Lymphocyte Egress from Thymus and Peripheral Lymphoid Organs Is Dependent on S1P Receptor 1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2004&pages=355-360&author=M.+Matloubianauthor=C.+G.+Loauthor=G.+Cinamonauthor=M.+J.+Lesneskiauthor=Y.+Xuauthor=V.+Brinkmannauthor=M.+L.+Allendeauthor=R.+L.+Proiaauthor=J.+G.+Cyster&title=Lymphocyte+Egress+from+Thymus+and+Peripheral+Lymphoid+Organs+Is+Dependent+on+S1P+Receptor+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatloubian%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DC.%2BG.%26aulast%3DCinamon%26aufirst%3DG.%26aulast%3DLesneski%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DLymphocyte%2520Egress%2520from%2520Thymus%2520and%2520Peripheral%2520Lymphoid%2520Organs%2520Is%2520Dependent%2520on%2520S1P%2520Receptor%25201%26jtitle%3DNature%26date%3D2004%26volume%3D427%26spage%3D355%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neway, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koprak, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Potent S1P Receptor Agonists Replicate the Pharmacologic Actions of the Novel Immune Modulator FTY720</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3351</span><span class="NLM_x">–</span> <span class="NLM_lpage">3355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3351-3355&author=J.+J.+Haleauthor=W.+Newayauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+Rosenbachauthor=J.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=G.+C.+Kooauthor=S.+L.+Koprakauthor=J.+J.+Jacksonauthor=H.+Rosenauthor=S.+Mandala&title=Potent+S1P+Receptor+Agonists+Replicate+the+Pharmacologic+Actions+of+the+Novel+Immune+Modulator+FTY720"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DNeway%26aufirst%3DW.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKoo%26aufirst%3DG.%2BC.%26aulast%3DKoprak%26aufirst%3DS.%2BL.%26aulast%3DJackson%26aufirst%3DJ.%2BJ.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DPotent%2520S1P%2520Receptor%2520Agonists%2520Replicate%2520the%2520Pharmacologic%2520Actions%2520of%2520the%2520Novel%2520Immune%2520Modulator%2520FTY720%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3351%26epage%3D3355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thangada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">S1P1-Selective In Vivo-Active Agonists from High-Throughput Screening: Off-the-Shelf Chemical Probes of Receptor Interactions, Signaling, and Fate</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">715</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1016%2Fj.chembiol.2005.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=15975516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=703-715&author=E.+Joauthor=M.+G.+Sannaauthor=P.+J.+Gonzalez-Cabreraauthor=S.+Thangadaauthor=G.+Tigyiauthor=D.+A.+Osborneauthor=T.+Hlaauthor=A.+L.+Parrillauthor=H.+Rosen&title=S1P1-Selective+In+Vivo-Active+Agonists+from+High-Throughput+Screening%3A+Off-the-Shelf+Chemical+Probes+of+Receptor+Interactions%2C+Signaling%2C+and+Fate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">S1P1-Selective In Vivo-Active Agonists from High- Throughput Screening: Off-the-Shelf Chemical Probes of Receptor Interactions, Signaling, and Fate</span></div><div class="casAuthors">Jo, Euijung; Sanna, M. Germana; Gonzalez-Cabrera, Pedro J.; Thangada, Shobha; Tigyi, Gabor; Osborne, Daniel A.; Hla, Timothy; Parrill, Abby L.; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">703-715</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The essential role of the sphingosine 1-phosphate (S1P) receptor S1P1 in regulating lymphocyte trafficking was demonstrated with the S1P1-selective nanomolar agonist, SEW2871.  Despite its lack of charged headgroup, the tetraarom. compd. SEW2871 binds and activates S1P1 through a combination of hydrophobic and ion-dipole interactions.  Both S1P and SEW2871 activated ERK, Akt, and Rac signaling pathways and induced S1P1 internalization and recycling, unlike FTY720-phosphate, which induces receptor degrdn.  Agonism with receptor recycling is sufficient for alteration of lymphocyte trafficking by S1P and SEW2871.  S1P1 modeling and mutagenesis studies revealed that residues binding the S1P headgroup are required for kinase activation by both S1P and SEW2871.  Therefore, SEW2871 recapitulates the action of S1P in all the signaling pathways examd. and overlaps in interactions with key headgroup binding receptor residues, presumably replacing salt-bridge interactions with ion-dipole interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2m1otCJEz8LVg90H21EOLACvtfcHk0liMlC6LetGHsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGht7Y%253D&md5=31a1a616e98d96ba6d9dfbb0a38ed39c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DJo%26aufirst%3DE.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26aulast%3DThangada%26aufirst%3DS.%26aulast%3DTigyi%26aufirst%3DG.%26aulast%3DOsborne%26aufirst%3DD.%2BA.%26aulast%3DHla%26aufirst%3DT.%26aulast%3DParrill%26aufirst%3DA.%2BL.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DS1P1-Selective%2520In%2520Vivo-Active%2520Agonists%2520from%2520High-Throughput%2520Screening%253A%2520Off-the-Shelf%2520Chemical%2520Probes%2520of%2520Receptor%2520Interactions%252C%2520Signaling%252C%2520and%2520Fate%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D703%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">McVerry, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. G. N.</span><span> </span><span class="NLM_article-title">In vitro and in Vivo Modulation of Vascular Barrier Integrity by Sphingosine 1-Phosphate: Mechanistic Insights</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1016%2Fj.cellsig.2004.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=15494205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD2cXos1eqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=131-139&author=B.+J.+McVerryauthor=J.+G.+N.+Garcia&title=In+vitro+and+in+Vivo+Modulation+of+Vascular+Barrier+Integrity+by+Sphingosine+1-Phosphate%3A+Mechanistic+Insights"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights</span></div><div class="casAuthors">McVerry, Bryan J.; Garcia, Joe G. N.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-139</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P), a biol. active lipid growth factor, induces robust endothelial cell activation resulting in cellular locomotion, vascular maturation and angiogenesis.  Recent work by our lab. has demonstrated S1P to enhance the cellular barrier function of the vascular endothelium.  S1P-induced modulation of vascular permeability is effected through profound cytoskeletal reorganization initiated by cell surface receptor-mediated G protein activation and downstream signaling via the Rho family of small GTPases.  The details of the downstream signaling mechanism remain an active area of in vitro investigation.  Translational investigation suggests a profound impact of S1P administration in the modulation of edema formation in disease state manifest as acute inflammatory lung injury in which increased vascular permeability is a hallmark feature.  These data support an exciting potential therapeutic role for S1P in vascular barrier enhancement necessary for the treatment of critically ill patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4F51YD2iELLVg90H21EOLACvtfcHk0liMlC6LetGHsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXos1eqs78%253D&md5=4d45ffb844dbe0853e55fb0a92a9b409</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2004.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2004.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DMcVerry%26aufirst%3DB.%2BJ.%26aulast%3DGarcia%26aufirst%3DJ.%2BG.%2BN.%26atitle%3DIn%2520vitro%2520and%2520in%2520Vivo%2520Modulation%2520of%2520Vascular%2520Barrier%2520Integrity%2520by%2520Sphingosine%25201-Phosphate%253A%2520Mechanistic%2520Insights%26jtitle%3DCell.%2520Signalling%26date%3D2005%26volume%3D17%26spage%3D131%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Wei, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matheu, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahalan, M. D.</span><span> </span><span class="NLM_article-title">Sphingosine 1-Phosphate Type 1 Receptor Agonism Inhibits Transendothelial Migration of Medullary T Cells to Lymphatic Sinuses</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1228</span><span class="NLM_x">–</span> <span class="NLM_lpage">1235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1038%2Fni1269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=16273098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlShur3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=1228-1235&author=S.+H.+Weiauthor=H.+Rosenauthor=M.+P.+Matheuauthor=M.+G.+Sannaauthor=S.-K.+Wangauthor=E.+Joauthor=C.-H.+Wongauthor=I.+Parkerauthor=M.+D.+Cahalan&title=Sphingosine+1-Phosphate+Type+1+Receptor+Agonism+Inhibits+Transendothelial+Migration+of+Medullary+T+Cells+to+Lymphatic+Sinuses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses</span></div><div class="casAuthors">Wei, Sindy H.; Rosen, Hugh; Matheu, Melanie P.; Sanna, M. Germana; Wang, Sheng-Kai; Jo, Euijung; Wong, Chi-Huey; Parker, Ian; Cahalan, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1228-1235</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate type 1 (S1P1) receptor agonists cause sequestration of lymphocytes in secondary lymphoid organs by a mechanism that is not well understood.  One hypothesis proposes that agonists act as "functional antagonists" by binding and internalizing S1P1 receptors on lymphocytes; a second hypothesis proposes instead that S1P1 agonists act on endothelial cells to prevent lymphocyte egress from lymph nodes.  Here, 2-photon imaging of living T cells in explanted lymph nodes after treatment with S1P1 agonists or antagonists has provided insight into the mechanism by which S1P1 agonists function.  The selective S1P1 agonist SEW2871 caused reversible slowing and "log-jamming" of T cells between filled medullary cords and empty sinuses, whereas motility was unaltered in diffuse cortex.  Removal or antagonist competition of SEW2871 permitted recovery of T cell motility in the parenchyma of the medulla and resumption of migration across the stromal endothelial barrier, leading to refilling of sinuses.  The authors' results provide visualization of transendothelial migration of T cells into lymphatic sinuses and suggest that S1P1 agonists act mainly on endothelial cell S1P1 receptors to inhibit lymphocyte migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT6yH1S8NBXbVg90H21EOLACvtfcHk0liMlC6LetGHsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlShur3E&md5=1e8e381a3808c9231937e05a0c010b73</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fni1269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1269%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DS.%2BH.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMatheu%26aufirst%3DM.%2BP.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DWang%26aufirst%3DS.-K.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DWong%26aufirst%3DC.-H.%26aulast%3DParker%26aufirst%3DI.%26aulast%3DCahalan%26aufirst%3DM.%2BD.%26atitle%3DSphingosine%25201-Phosphate%2520Type%25201%2520Receptor%2520Agonism%2520Inhibits%2520Transendothelial%2520Migration%2520of%2520Medullary%2520T%2520Cells%2520to%2520Lymphatic%2520Sinuses%26jtitle%3DNat.%2520Immunol.%26date%3D2005%26volume%3D6%26spage%3D1228%26epage%3D1235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surh, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHeyzer-Williams, M. G.</span><span> </span><span class="NLM_article-title">Rapid Induction of Medullary Thymocyte Phenotypic Maturation and Egress Inhibition by Nanomolar Sphingosine 1-Phosphate Receptor Agonist</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">10907</span><span class="NLM_x">–</span> <span class="NLM_lpage">10912</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=10907-10912&author=H.+Rosenauthor=C.+Alfonsoauthor=C.+D.+Surhauthor=M.+G.+McHeyzer-Williams&title=Rapid+Induction+of+Medullary+Thymocyte+Phenotypic+Maturation+and+Egress+Inhibition+by+Nanomolar+Sphingosine+1-Phosphate+Receptor+Agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DAlfonso%26aufirst%3DC.%26aulast%3DSurh%26aufirst%3DC.%2BD.%26aulast%3DMcHeyzer-Williams%26aufirst%3DM.%2BG.%26atitle%3DRapid%2520Induction%2520of%2520Medullary%2520Thymocyte%2520Phenotypic%2520Maturation%2520and%2520Egress%2520Inhibition%2520by%2520Nanomolar%2520Sphingosine%25201-Phosphate%2520Receptor%2520Agonist%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D10907%26epage%3D10912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Don, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsolais, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matheu, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, W.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahalan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Enhancement of Capillary Leakage and Restoration of Lymphocyte Egress by a Chiral S1P1 Antagonist in Vivo</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">434</span><span class="NLM_x">–</span> <span class="NLM_lpage">441</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1038%2Fnchembio804" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=434-441&author=M.+G.+Sannaauthor=S.-K.+Wangauthor=P.+J.+Gonzalez-Cabreraauthor=A.+Donauthor=D.+Marsolaisauthor=M.+P.+Matheuauthor=S.+H.+Weiauthor=I.+Parkerauthor=E.+Joauthor=W.-C.+Chengauthor=M.+D.+Cahalanauthor=C.-H.+Wongauthor=H.+Rosen&title=Enhancement+of+Capillary+Leakage+and+Restoration+of+Lymphocyte+Egress+by+a+Chiral+S1P1+Antagonist+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnchembio804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio804%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DWang%26aufirst%3DS.-K.%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26aulast%3DDon%26aufirst%3DA.%26aulast%3DMarsolais%26aufirst%3DD.%26aulast%3DMatheu%26aufirst%3DM.%2BP.%26aulast%3DWei%26aufirst%3DS.%2BH.%26aulast%3DParker%26aufirst%3DI.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DCheng%26aufirst%3DW.-C.%26aulast%3DCahalan%26aufirst%3DM.%2BD.%26aulast%3DWong%26aufirst%3DC.-H.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DEnhancement%2520of%2520Capillary%2520Leakage%2520and%2520Restoration%2520of%2520Lymphocyte%2520Egress%2520by%2520a%2520Chiral%2520S1P1%2520Antagonist%2520in%2520Vivo%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D8%26spage%3D434%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Marsolais, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Chemical Modulators of Sphingosine-1-phosphate Receptors as Barrier-Oriented Therapeutic Molecules</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=297-307&author=D.+Marsolaisauthor=H.+Rosen&title=Chemical+Modulators+of+Sphingosine-1-phosphate+Receptors+as+Barrier-Oriented+Therapeutic+Molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarsolais%26aufirst%3DD.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DChemical%2520Modulators%2520of%2520Sphingosine-1-phosphate%2520Receptors%2520as%2520Barrier-Oriented%2520Therapeutic%2520Molecules%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D297%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataraman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaud, J.</span><span> </span><span class="NLM_article-title">The Vascular S1P Gradient—Cellular Sources and Biological Significance</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1781</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1781&publication_year=2008&pages=477-482&author=T.+Hlaauthor=K.+Venkataramanauthor=J.+Michaud&title=The+Vascular+S1P+Gradient%E2%80%94Cellular+Sources+and+Biological+Significance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHla%26aufirst%3DT.%26aulast%3DVenkataraman%26aufirst%3DK.%26aulast%3DMichaud%26aufirst%3DJ.%26atitle%3DThe%2520Vascular%2520S1P%2520Gradient%25E2%2580%2594Cellular%2520Sources%2520and%2520Biological%2520Significance%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2008%26volume%3D1781%26spage%3D477%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Dorsam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graeler, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seroogy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voice, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetzl, E. J.</span><span> </span><span class="NLM_article-title">Transduction of Multiple Effects of Sphingosine 1-Phosphate (S1P) on T Cell Functions by the S1P<sub>1</sub> G Protein-Coupled Receptor</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">3500</span><span class="NLM_x">–</span> <span class="NLM_lpage">3507</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2003&pages=3500-3507&author=G.+Dorsamauthor=M.+H.+Graelerauthor=C.+Seroogyauthor=Y.+Kongauthor=J.+K.+Voiceauthor=E.+J.+Goetzl&title=Transduction+of+Multiple+Effects+of+Sphingosine+1-Phosphate+%28S1P%29+on+T+Cell+Functions+by+the+S1P1+G+Protein-Coupled+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDorsam%26aufirst%3DG.%26aulast%3DGraeler%26aufirst%3DM.%2BH.%26aulast%3DSeroogy%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DY.%26aulast%3DVoice%26aufirst%3DJ.%2BK.%26aulast%3DGoetzl%26aufirst%3DE.%2BJ.%26atitle%3DTransduction%2520of%2520Multiple%2520Effects%2520of%2520Sphingosine%25201-Phosphate%2520%2528S1P%2529%2520on%2520T%2520Cell%2520Functions%2520by%2520the%2520S1P1%2520G%2520Protein-Coupled%2520Receptor%26jtitle%3DJ.%2520Immunol.%26date%3D2003%26volume%3D171%26spage%3D3500%26epage%3D3507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Schwab, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Finding a Way Out: Lymphocyte Egress from Lymphoid Organs</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1301</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1038%2Fni1545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=18026082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlajtr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=1295-1301&author=S.+R.+Schwabauthor=J.+G.+Cyster&title=Finding+a+Way+Out%3A+Lymphocyte+Egress+from+Lymphoid+Organs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Finding a way out: lymphocyte egress from lymphoid organs</span></div><div class="casAuthors">Schwab, Susan R.; Cyster, Jason G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1295-1301</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The egress of lymphocytes from the thymus and secondary lymphoid organs into circulatory fluids is essential for normal immune function.  The discovery that a small-mol. inhibitor of lymphocyte exit, FTY720, is a ligand for sphingosine 1-phosphate (S1P) receptors led to studies demonstrating that S1P receptor type 1 (S1P1) is needed in T cells and B cells for their egress from lymphoid organs.  S1P exists in higher concns. in blood and lymph than in lymphoid organs, and this differential is also required for lymphocyte exit.  Transcriptional and post-translational mechanisms regulate S1P1 and thus the egress of lymphocytes.  In this review we discuss the body of evidence supporting a model in which lymphocyte egress is promoted by encounter with S1P at exit sites.  We relate this model to work examg. the effects of S1P receptor agonists on endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWY-Rk111SmLVg90H21EOLACvtfcHk0ljWxMJpJi-e7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlajtr7J&md5=ccf7ef06130d3ebd218707ac92618f36</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fni1545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1545%26sid%3Dliteratum%253Aachs%26aulast%3DSchwab%26aufirst%3DS.%2BR.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DFinding%2520a%2520Way%2520Out%253A%2520Lymphocyte%2520Egress%2520from%2520Lymphoid%2520Organs%26jtitle%3DNat.%2520Immunol.%26date%3D2007%26volume%3D8%26spage%3D1295%26epage%3D1301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Pappu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelissen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regard, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camerer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coughlin, S. R.</span><span> </span><span class="NLM_article-title">Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=295-298&author=R.+Pappuauthor=S.+R.+Schwabauthor=I.+Cornelissenauthor=J.+P.+Pereiraauthor=J.+B.+Regardauthor=Y.+Xuauthor=E.+Camererauthor=Y.-W.+Zhengauthor=Y.+Huangauthor=J.+G.+Cysterauthor=S.+R.+Coughlin&title=Promotion+of+Lymphocyte+Egress+into+Blood+and+Lymph+by+Distinct+Sources+of+Sphingosine-1-Phosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPappu%26aufirst%3DR.%26aulast%3DSchwab%26aufirst%3DS.%2BR.%26aulast%3DCornelissen%26aufirst%3DI.%26aulast%3DPereira%26aufirst%3DJ.%2BP.%26aulast%3DRegard%26aufirst%3DJ.%2BB.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DCamerer%26aufirst%3DE.%26aulast%3DZheng%26aufirst%3DY.-W.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26aulast%3DCoughlin%26aufirst%3DS.%2BR.%26atitle%3DPromotion%2520of%2520Lymphocyte%2520Egress%2520into%2520Blood%2520and%2520Lymph%2520by%2520Distinct%2520Sources%2520of%2520Sphingosine-1-Phosphate%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D295%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Sensken, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagarajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graeler, M. H.</span><span> </span><span class="NLM_article-title">Local Inactivation of Spingosine 1-Phosphate in Lymph Nodes Induces Lymphopenia</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">3432</span><span class="NLM_x">–</span> <span class="NLM_lpage">3440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=3432-3440&author=S.-C.+Senskenauthor=M.+Nagarajanauthor=C.+Bodeauthor=M.+H.+Graeler&title=Local+Inactivation+of+Spingosine+1-Phosphate+in+Lymph+Nodes+Induces+Lymphopenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSensken%26aufirst%3DS.-C.%26aulast%3DNagarajan%26aufirst%3DM.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DGraeler%26aufirst%3DM.%2BH.%26atitle%3DLocal%2520Inactivation%2520of%2520Spingosine%25201-Phosphate%2520in%2520Lymph%2520Nodes%2520Induces%2520Lymphopenia%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26spage%3D3432%26epage%3D3440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Berst, F.; Grosche, P.; Janser, P.; Zecri, F.; Bollbuck, B.</span><span> </span><span class="NLM_article-title">N-Biaryl (Hetero) Arylsulphonamide Derivatives Useful in the Treatment of Diseases Mediated by Lymphocyte Interactions</span>. WO2008028937 A1, March 13,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=F.+Berst&author=P.+Grosche&author=P.+Janser&author=F.+Zecri&author=B.+Bollbuck&title=N-Biaryl+%28Hetero%29+Arylsulphonamide+Derivatives+Useful+in+the+Treatment+of+Diseases+Mediated+by+Lymphocyte+Interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerst%26aufirst%3DF.%26atitle%3DN-Biaryl%2520%2528Hetero%2529%2520Arylsulphonamide%2520Derivatives%2520Useful%2520in%2520the%2520Treatment%2520of%2520Diseases%2520Mediated%2520by%2520Lymphocyte%2520Interactions%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Tarrasón, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aulí, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustafa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolgachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domènech, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prats, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domínguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auilar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calbet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pont, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunkel, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godessart, N.</span><span> </span><span class="NLM_article-title">The Sphingosine-1-phosphate Receptor-1 Antagonist, W146, Causes Early and Short-Lasting Peripheral Blood Lymphophenia in Mice</span> <span class="citation_source-journal">Int. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1773</span><span class="NLM_x">–</span> <span class="NLM_lpage">1779</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1016%2Fj.intimp.2011.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtl2rtbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=1773-1779&author=G.+Tarras%C3%B3nauthor=M.+Aul%C3%ADauthor=S.+Mustafaauthor=V.+Dolgachevauthor=M.+T.+Dom%C3%A8nechauthor=N.+Pratsauthor=M.+Dom%C3%ADnguezauthor=R.+L%C3%B3pezauthor=N.+Auilarauthor=M.+Calbetauthor=M.+Pontauthor=G.+Milliganauthor=S.+L.+Kunkelauthor=N.+Godessart&title=The+Sphingosine-1-phosphate+Receptor-1+Antagonist%2C+W146%2C+Causes+Early+and+Short-Lasting+Peripheral+Blood+Lymphophenia+in+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice</span></div><div class="casAuthors">Tarrason, Gema; Auli, Mariona; Mustafa, Sanam; Dolgachev, Vladislav; Domenech, Maria Teresa; Prats, Neus; Dominguez, Maria; Lopez, Rosa; Aguilar, Nuria; Calbet, Marta; Pont, Merce; Milligan, Graeme; Kunkel, Steven L.; Godessart, Nuria</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1773-1779</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Agonists of the sphingosine-1-phosphate (S1P) receptors, like fingolimod (FTY720), are a novel class of immunomodulators.  Administration of these compds. prevents the egress of lymphocytes from primary and secondary lymphoid organs causing peripheral blood lymphopenia.  Although it is well established that lymphopenia is mediated by S1P receptor type 1 (S1P1), the exact mechanism is still controversial.  The most favored hypothesis states that S1P1 agonists cause internalization and loss of the cell surface receptor on lymphocytes, preventing them to respond to S1P.  Hence, S1P1 agonists would behave in vivo as functional antagonists of the receptor.  For this hypothesis to be valid, a true S1P1 antagonist should also induce lymphopenia.  However, it has been reported that S1P1 antagonists fail to show this effect, arguing against the concept.  Our study demonstrates that a S1P1 antagonist, W146, induces a significant but transient blood lymphopenia in mice and a parallel increase in CD4+ and CD8+ lymphocytes in lymph nodes.  Treatment with W146 also causes the accumulation of mature T cells in the medulla of the thymus and moreover, it induces lung edema.  We show that both the S1P1 antagonist and a S1P1 agonist cause lymphopenia in vivo in spite of their different effects on receptor expression in vitro.  Although the antagonist purely blocks the receptor and the agonist causes its disappearance from the cell surface, the response to the endogenous ligand is prevented in both cases.  Our results support the hypothesis that lymphopenia evoked by S1P1 agonists is due to functional antagonism of S1P1 in lymphocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrmlMSoa8mELVg90H21EOLACvtfcHk0lhfI8-t0DizZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtl2rtbrM&md5=e41b01746cd1fe520bfb36508dfca689</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2011.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2011.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DTarras%25C3%25B3n%26aufirst%3DG.%26aulast%3DAul%25C3%25AD%26aufirst%3DM.%26aulast%3DMustafa%26aufirst%3DS.%26aulast%3DDolgachev%26aufirst%3DV.%26aulast%3DDom%25C3%25A8nech%26aufirst%3DM.%2BT.%26aulast%3DPrats%26aufirst%3DN.%26aulast%3DDom%25C3%25ADnguez%26aufirst%3DM.%26aulast%3DL%25C3%25B3pez%26aufirst%3DR.%26aulast%3DAuilar%26aufirst%3DN.%26aulast%3DCalbet%26aufirst%3DM.%26aulast%3DPont%26aufirst%3DM.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DKunkel%26aufirst%3DS.%2BL.%26aulast%3DGodessart%26aufirst%3DN.%26atitle%3DThe%2520Sphingosine-1-phosphate%2520Receptor-1%2520Antagonist%252C%2520W146%252C%2520Causes%2520Early%2520and%2520Short-Lasting%2520Peripheral%2520Blood%2520Lymphophenia%2520in%2520Mice%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2011%26volume%3D11%26spage%3D1773%26epage%3D1779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Fujii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtake, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukasawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiozawa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goitsuka, R.</span><span> </span><span class="NLM_article-title">Lymphopenia Induced by a Novel Selective S1P<sub>1</sub> Antagonist Structurally Unrelated to S1P</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1821</span><span class="NLM_x">, </span> <span class="NLM_fpage">600</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1821&publication_year=2012&pages=600-606&author=Y.+Fujiiauthor=H.+Ohtakeauthor=N.+Onoauthor=T.+Haraauthor=T.+Sakuraiauthor=S.+Takahashiauthor=T.+Takayamaauthor=Y.+Fukasawaauthor=F.+Shiozawaauthor=N.+Tsukaharaauthor=T.+Hirayamaauthor=Y.+Igarashiauthor=R.+Goitsuka&title=Lymphopenia+Induced+by+a+Novel+Selective+S1P1+Antagonist+Structurally+Unrelated+to+S1P"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DY.%26aulast%3DOhtake%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DN.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DTakayama%26aufirst%3DT.%26aulast%3DFukasawa%26aufirst%3DY.%26aulast%3DShiozawa%26aufirst%3DF.%26aulast%3DTsukahara%26aufirst%3DN.%26aulast%3DHirayama%26aufirst%3DT.%26aulast%3DIgarashi%26aufirst%3DY.%26aulast%3DGoitsuka%26aufirst%3DR.%26atitle%3DLymphopenia%2520Induced%2520by%2520a%2520Novel%2520Selective%2520S1P1%2520Antagonist%2520Structurally%2520Unrelated%2520to%2520S1P%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2012%26volume%3D1821%26spage%3D600%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Fujii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtake, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakazawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goitsuka, R.</span><span> </span><span class="NLM_article-title">Amelioration of Collagen-Induced Arthritis by a Novel S1P<sub>1</sub> Antagonist with Immunomodulatory Activities</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">188</span><span class="NLM_x">, </span> <span class="NLM_fpage">206</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2012&pages=206-215&author=Y.+Fujiiauthor=T.+Hirayamaauthor=H.+Ohtakeauthor=N.+Onoauthor=T.+Inoueauthor=T.+Sakuraiauthor=T.+Takayamaauthor=K.+Matsumotoauthor=N.+Tsukaharaauthor=S.+Hidanoauthor=N.+Harimaauthor=K.+Nakazawaauthor=Y.+Igarashiauthor=R.+Goitsuka&title=Amelioration+of+Collagen-Induced+Arthritis+by+a+Novel+S1P1+Antagonist+with+Immunomodulatory+Activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DY.%26aulast%3DHirayama%26aufirst%3DT.%26aulast%3DOhtake%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DN.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DT.%26aulast%3DTakayama%26aufirst%3DT.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DTsukahara%26aufirst%3DN.%26aulast%3DHidano%26aufirst%3DS.%26aulast%3DHarima%26aufirst%3DN.%26aulast%3DNakazawa%26aufirst%3DK.%26aulast%3DIgarashi%26aufirst%3DY.%26aulast%3DGoitsuka%26aufirst%3DR.%26atitle%3DAmelioration%2520of%2520Collagen-Induced%2520Arthritis%2520by%2520a%2520Novel%2520S1P1%2520Antagonist%2520with%2520Immunomodulatory%2520Activities%26jtitle%3DJ.%2520Immunol.%26date%3D2012%26volume%3D188%26spage%3D206%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweitzer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persohn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balatoni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuschel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span> </span><span class="NLM_article-title">Brain Penetration of the Oral Immunomodulatory Drug FTY720 and Its Phosphorylation in the Central Nervous System during Experimental Autoimmune Encephalomyelitis: Consequences for Mode of Action in Multiple Sclerosis</span> <span class="citation_source-journal">J. Pharmcol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1124%2Fjpet.107.127183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=17682127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ynsLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2007&pages=469-476&author=C.+A.+Fosterauthor=L.+M.+Howardauthor=A.+Schweitzerauthor=E.+Persohnauthor=P.+C.+Hiestandauthor=B.+Balatoniauthor=R.+Reuschelauthor=C.+Beerliauthor=M.+Schwartzauthor=A.+Billich&title=Brain+Penetration+of+the+Oral+Immunomodulatory+Drug+FTY720+and+Its+Phosphorylation+in+the+Central+Nervous+System+during+Experimental+Autoimmune+Encephalomyelitis%3A+Consequences+for+Mode+of+Action+in+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis</span></div><div class="casAuthors">Foster, Carolyn A.; Howard, Laurence M.; Schweitzer, Alain; Persohn, Elke; Hiestand, Peter C.; Balatoni, Balazs; Reuschel, Roland; Beerli, Christian; Schwartz, Manuela; Billich, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">469-476</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">FTY720 [2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride] is an oral sphingosine-1-phosphate receptor modulator under development for the treatment of multiple sclerosis (MS).  The drug is phosphorylated in vivo by sphingosine kinase 2 to its bioactive form, FTY720-P.  Although treatment with FTY720 is accompanied by a redn. of the peripheral lymphocyte count, its efficacy in MS and exptl. autoimmune encephalomyelitis (EAE) may be due to addnl., direct effects in the central nervous system (CNS).  We now show that FTY720 localizes to the CNS white matter, preferentially along myelin sheaths.  Brain trough levels of FTY720 and FTY720-P in rat EAE are of the same magnitude and dose dependently increase; they are in the range of 40 to 540 ng/g in the brain tissue at efficacious doses and exceed blood concns. severalfold.  In a rat model of chronic EAE, prolonged treatment with 0.03 mg/kg was efficacious, but limiting the dosing period failed to prevent EAE despite a significant decrease in blood lymphocytes.  FTY720 effectiveness is likely due to a culmination of mechanisms involving redn. of autoreactive T cells, neuroprotective influence of FTY720-P in the CNS, and inhibition of inflammatory mediators in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq37e2tpDlreLVg90H21EOLACvtfcHk0ljxImkn9dJz4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ynsLfP&md5=a4f414517a4b567e8d8905f0da2b4706</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.127183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.127183%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DHoward%26aufirst%3DL.%2BM.%26aulast%3DSchweitzer%26aufirst%3DA.%26aulast%3DPersohn%26aufirst%3DE.%26aulast%3DHiestand%26aufirst%3DP.%2BC.%26aulast%3DBalatoni%26aufirst%3DB.%26aulast%3DReuschel%26aufirst%3DR.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DSchwartz%26aufirst%3DM.%26aulast%3DBillich%26aufirst%3DA.%26atitle%3DBrain%2520Penetration%2520of%2520the%2520Oral%2520Immunomodulatory%2520Drug%2520FTY720%2520and%2520Its%2520Phosphorylation%2520in%2520the%2520Central%2520Nervous%2520System%2520during%2520Experimental%2520Autoimmune%2520Encephalomyelitis%253A%2520Consequences%2520for%2520Mode%2520of%2520Action%2520in%2520Multiple%2520Sclerosis%26jtitle%3DJ.%2520Pharmcol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D323%26spage%3D469%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Balatoni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storch, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swoboda, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schönborn, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koziel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambrou, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span> </span><span class="NLM_article-title">FTY720 Sustains and Restores Neuronal Function in the DA Rat Model of MOG-Induced Experimental Autoimmune Encephalomyelitis</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">316</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1016%2Fj.brainresbull.2007.06.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=17845905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWhs7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=307-316&author=B.+Balatoniauthor=M.+K.+Storchauthor=E.-M.+Swobodaauthor=V.+Sch%C3%B6nbornauthor=A.+Kozielauthor=G.+N.+Lambrouauthor=P.+C.+Hiestandauthor=R.+Weissertauthor=C.+A.+Foster&title=FTY720+Sustains+and+Restores+Neuronal+Function+in+the+DA+Rat+Model+of+MOG-Induced+Experimental+Autoimmune+Encephalomyelitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis</span></div><div class="casAuthors">Balatoni, Balazs; Storch, Maria K.; Swoboda, Eva-M.; Schoenborn, Vinzenz; Koziel, Agnieszka; Lambrou, George N.; Hiestand, Peter C.; Weissert, Robert; Foster, Carolyn A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">307-316</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">FTY720 (fingolimod) is an oral sphingosine 1-phosphate (S1P) receptor modulator under development for the treatment of multiple sclerosis (MS).  To elucidate its effects in the central nervous system (CNS), we compared functional parameters of nerve conductance in the DA rat model of myelin oligodendrocyte glycoprotein (MOG)-induced exptl. autoimmune encephalomyelitis (EAE) after preventive and therapeutic treatment.  We demonstrate that prophylactic therapy protected against the emergence of EAE symptoms, neuropathol., and disturbances to visual and somatosensory evoked potentials (VEP, SEP).  Moreover, therapeutic treatment from day 25 to 45 markedly reversed paralysis in established EAE and normalized the electrophysiol. responses, correlating with decreased demyelination in the brain and spinal cord.  The effectiveness of FTY720 in this model is likely due to several contributing factors.  Evidence thus far supports its role in the redn. of inflammation and preservation of blood-brain-barrier integrity.  FTY720 may also act via S1P receptors in glial cells to promote endogenous repair mechanisms that complement its immunomodulatory action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFwogDXcfLFrVg90H21EOLACvtfcHk0ljxImkn9dJz4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWhs7jL&md5=5fb8cec643e3ca6d7b35eaf3b020b873</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresbull.2007.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresbull.2007.06.023%26sid%3Dliteratum%253Aachs%26aulast%3DBalatoni%26aufirst%3DB.%26aulast%3DStorch%26aufirst%3DM.%2BK.%26aulast%3DSwoboda%26aufirst%3DE.-M.%26aulast%3DSch%25C3%25B6nborn%26aufirst%3DV.%26aulast%3DKoziel%26aufirst%3DA.%26aulast%3DLambrou%26aufirst%3DG.%2BN.%26aulast%3DHiestand%26aufirst%3DP.%2BC.%26aulast%3DWeissert%26aufirst%3DR.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26atitle%3DFTY720%2520Sustains%2520and%2520Restores%2520Neuronal%2520Function%2520in%2520the%2520DA%2520Rat%2520Model%2520of%2520MOG-Induced%2520Experimental%2520Autoimmune%2520Encephalomyelitis%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2007%26volume%3D74%26spage%3D307%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Dev, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullershausen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilbe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mir, A.</span><span> </span><span class="NLM_article-title">Brain Sphingosine-1-phosphate Receptors: Implication for FTY720 in the Treatment of Multiple Sclerosis</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1016%2Fj.pharmthera.2007.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=17961662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2008&pages=77-93&author=K.+K.+Devauthor=F.+Mullershausenauthor=H.+Mattesauthor=R.+R.+Kuhnauthor=G.+Bilbeauthor=D.+Hoyerauthor=A.+Mir&title=Brain+Sphingosine-1-phosphate+Receptors%3A+Implication+for+FTY720+in+the+Treatment+of+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis</span></div><div class="casAuthors">Dev, Kumlesh K.; Mullershausen, Florian; Mattes, Henri; Kuhn, Rainer R.; Bilbe, Graeme; Hoyer, Daniel; Mir, Anis</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-93</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Multiple sclerosis (MS) is an autoimmune, neurol. disability with unknown etiol.  The current therapies available for MS work by an immunomodulatory action, preventing T-cell- and macrophage-mediated destruction of brain-resident oligodendrocytes and axonal loss.  Recently, FTY720 (fingolimod) was shown to significantly reduce relapse rates in MS patients and is currently in Phase III clin. trials.  This drug attenuates trafficking of harmful T cells entering the brain by regulating sphingosine-1-phosphate (S1P) receptors.  Here, we outline the direct roles that S1P receptors play in the central nervous system (CNS) and discuss addnl. modalities by which FTY720 may provide direct neuroprotection in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYlyd4S2EeELVg90H21EOLACvtfcHk0ljxImkn9dJz4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtL3J&md5=d5cf04a35f8bb06f3e094d2e75c698c0</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DDev%26aufirst%3DK.%2BK.%26aulast%3DMullershausen%26aufirst%3DF.%26aulast%3DMattes%26aufirst%3DH.%26aulast%3DKuhn%26aufirst%3DR.%2BR.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DMir%26aufirst%3DA.%26atitle%3DBrain%2520Sphingosine-1-phosphate%2520Receptors%253A%2520Implication%2520for%2520FTY720%2520in%2520the%2520Treatment%2520of%2520Multiple%2520Sclerosis%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D117%26spage%3D77%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Miron, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antel, J. P.</span><span> </span><span class="NLM_article-title">Central Nervous System-Directed Effects of FTY720 (Fingolimod)</span> <span class="citation_source-journal">J. Neurol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1016%2Fj.jns.2008.06.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=18678377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1eitr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=2008&pages=13-17&author=V.+E.+Mironauthor=A.+Schubartauthor=J.+P.+Antel&title=Central+Nervous+System-Directed+Effects+of+FTY720+%28Fingolimod%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Central nervous system-directed effects of FTY720 (fingolimod)</span></div><div class="casAuthors">Miron, Veronique E.; Schubart, Anna; Antel, Jack P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Neurological Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">13-17</span>CODEN:
                <span class="NLM_cas:coden">JNSCAG</span>;
        ISSN:<span class="NLM_cas:issn">0022-510X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  FTY720, also known as fingolimod, is an orally administered sphingosine-1-phosphate (S1P) analog that is under investigation as a therapy for both relapsing-remitting (RR) and progressive forms of multiple sclerosis (MS).  The demonstrated beneficial effect of FTY720 on disease activity in RR-MS patients and in the animal model exptl. autoimmune encephalomyelitis (EAE) is largely attributed to effects on the systemic immune system.  In addn., unlike other current systemic immuno-modulators used in MS, the lipophilic nature of FTY720 allows it to cross the blood-brain barrier (BBB).  Since S1P receptors are expressed on all cell types, FTY720 has the potential to exert effects directly on the BBB and on resident cells of the CNS.  The latter include cells implicated in regulating immune reactivity within the CNS (astrocytes, microglia), those that are targeted by the disease process (oligodendrocytes, neurons), and those involved in repair (oligodendrocyte progenitor cells).  In vitro studies document the dose-dependent effects of FTY720 on neural cell survival, differentiation, and cytoskeletal dynamics.  Animal model studies, specifically EAE, indicate an overall neuroprotective effect of FTY720 mediated at least in part by its actions within the CNS.  Ongoing studies will need to define the direct and indirect (via immune-modulation) effects of FTY720 on the CNS across the broad clin. spectrum of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUQKb02aQLcLVg90H21EOLACvtfcHk0ljO4UPQCGqxSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1eitr3P&md5=9077c2ceb142106644dc112dfbb1bc10</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.jns.2008.06.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jns.2008.06.031%26sid%3Dliteratum%253Aachs%26aulast%3DMiron%26aufirst%3DV.%2BE.%26aulast%3DSchubart%26aufirst%3DA.%26aulast%3DAntel%26aufirst%3DJ.%2BP.%26atitle%3DCentral%2520Nervous%2520System-Directed%2520Effects%2520of%2520FTY720%2520%2528Fingolimod%2529%26jtitle%3DJ.%2520Neurol.%2520Sci.%26date%3D2008%26volume%3D274%26spage%3D13%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Miron, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soliven, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antel, J. P.</span><span> </span><span class="NLM_article-title">Cyclical and Dose-Dependent Responses of Adult Human Mature Oligodendrocytes to Fingolimod</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">1143</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.2353%2Fajpath.2008.080478" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=18772343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CjtL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2008&pages=1143-1152&author=V.+E.+Mironauthor=J.+A.+Hallauthor=T.+E.+Kennedyauthor=B.+Solivenauthor=J.+P.+Antel&title=Cyclical+and+Dose-Dependent+Responses+of+Adult+Human+Mature+Oligodendrocytes+to+Fingolimod"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclical and dose-dependent response of adult human mature oligodendrocytes to fingolimod</span></div><div class="casAuthors">Miron, Veronique E.; Hall, Jeffery A.; Kennedy, Timothy E.; Soliven, Betty; Antel, Jack P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1143-1152</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Fingolimod is a sphingosine-1-phosphate (S1P) analog that has been used in clin. trials as a systemic immunomodulatory therapy for multiple sclerosis.  Fingolimod readily accesses the central nervous system, raising the issue of its direct effects on neural cells.  We assessed the effects of active fingolimod on dissocd. cultures of mature, myelin-producing oligodendrocytes (OLGs) derived from adult human brain.  Human OLGs express S1P receptor transcripts in relative abundance of S1P5>S1P3>S1P1, with undetectable levels of S1P4.  Low doses of fingolimod (100 pmol/L to 1 nmol/L) induced initial membrane elaboration (2 days), subsequent retraction (4 days), and recurrence of extension with prolonged treatment (8 days).  Higher doses (10 nmol/L to 1 μmol/L) caused the opposite modulation of membrane dynamics.  Retraction was rescued by co-treatment with the S1P3/S1P5 pathway antagonist, suramin, and was assocd. with RhoA-mediated cytoskeletal signaling.  Membrane elaboration was mimicked using the S1P1 agonist SEW2871.  Fingolimod rescued human OLGs from serum and glucose deprivation-induced apoptosis, which was reversed with suramin co-treatment and mimicked using an S1P5 agonist.  High doses of fingolimod induced an initial down-regulation of S1P5 mRNA levels relative to control (4 h), subsequent up-regulation (2 days), and recurrent down-regulation (8 days).  S1P1 mRNA levels were inversely regulated compared with S1P5.  These results indicate that fingolimod modulates maturity- and species-specific OLG membrane dynamics and survival responses that are directly relevant for myelin integrity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtGHQOOEJgsrVg90H21EOLACvtfcHk0ljO4UPQCGqxSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CjtL%252FN&md5=392836c44953f7a1d88767a5f88ef04a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2008.080478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2008.080478%26sid%3Dliteratum%253Aachs%26aulast%3DMiron%26aufirst%3DV.%2BE.%26aulast%3DHall%26aufirst%3DJ.%2BA.%26aulast%3DKennedy%26aufirst%3DT.%2BE.%26aulast%3DSoliven%26aufirst%3DB.%26aulast%3DAntel%26aufirst%3DJ.%2BP.%26atitle%3DCyclical%2520and%2520Dose-Dependent%2520Responses%2520of%2520Adult%2520Human%2520Mature%2520Oligodendrocytes%2520to%2520Fingolimod%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2008%26volume%3D173%26spage%3D1143%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H.-P.</span><span> </span><span class="NLM_article-title">Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=91-101&author=J.+Chunauthor=H.-P.+Hartung&title=Mechanism+of+Action+of+Oral+Fingolimod+%28FTY720%29+in+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DHartung%26aufirst%3DH.-P.%26atitle%3DMechanism%2520of%2520Action%2520of%2520Oral%2520Fingolimod%2520%2528FTY720%2529%2520in%2520Multiple%2520Sclerosis%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2010%26volume%3D33%26spage%3D91%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Lee, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Neurological S1P Signalling as an Emerging Mechanism of Action of Oral FTY720 (Fingolimod) in Multiple Sclerosis</span> <span class="citation_source-journal">Arch. Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1567</span><span class="NLM_x">–</span> <span class="NLM_lpage">1574</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1007%2Fs12272-010-1008-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlOqtr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=1567-1574&author=C.+W.+Leeauthor=J.+W.+Choiauthor=J.+Chun&title=Neurological+S1P+Signalling+as+an+Emerging+Mechanism+of+Action+of+Oral+FTY720+%28Fingolimod%29+in+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (Fingolimod) in multiple sclerosis</span></div><div class="casAuthors">Lee, Chang Wook; Choi, Ji Woong; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1567-1574</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">A review.  FTY720 (fingolimod, Novartis) is a promising investigational drug for relapsing forms of multiple sclerosis (MS), an autoimmune and neurodegenerative disorder of the central nervous system.  It is currently under FDA review in the United States, and could represent the first approved oral treatment for MS.  Extensive, ongoing clin. trials in Phase II/III have supported both the efficacy and safety of FTY720.  FTY720 itself is not bioactive, but when phosphorylated (FTY720-P) by sphingosine kinase 2, it becomes active through modulation of 4 of the 5 known G protein-coupled sphingosine 1-phosphate (S1P) receptors.  The mechanism of action (MOA) is thought to be immunol., where FTY720 alters lymphocyte trafficking via S1P1.  However, MOA for FTY720 in MS may also involve a direct, neurol. action within the central nervous system in view of documented S1P receptor-mediated signaling influences in the brain, and this review considers observations that support an emerging neurol. MOA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph7gXXxPKanLVg90H21EOLACvtfcHk0ljO4UPQCGqxSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlOqtr%252FK&md5=92caa8d7d6e2fcaa4d9d1286314b8d87</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs12272-010-1008-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-010-1008-5%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DNeurological%2520S1P%2520Signalling%2520as%2520an%2520Emerging%2520Mechanism%2520of%2520Action%2520of%2520Oral%2520FTY720%2520%2528Fingolimod%2529%2520in%2520Multiple%2520Sclerosis%26jtitle%3DArch.%2520Pharm.%2520Res.%26date%3D2010%26volume%3D33%26spage%3D1567%26epage%3D1574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kipp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amor, S.</span><span> </span><span class="NLM_article-title">FTY720 on the Way from the Base Camp to the Summit of the Mountain: Relevance for Remyelination</span> <span class="citation_source-journal">Mult. Scler. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1177%2F1352458512438723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Cit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=258-263&author=M.+Kippauthor=S.+Amor&title=FTY720+on+the+Way+from+the+Base+Camp+to+the+Summit+of+the+Mountain%3A+Relevance+for+Remyelination"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination</span></div><div class="casAuthors">Kipp, M.; Amor, S.</div><div class="citationInfo"><span class="NLM_cas:title">Multiple Sclerosis Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">258-263</span>CODEN:
                <span class="NLM_cas:coden">MSJUAP</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  FTY720 (fingolimod; Gilenya), a sphingosine 1-phosphate (S1P) receptor modulator, is the first oral disease-modifying therapy to be approved for the treatment of relapsing-remitting multiple sclerosis.  FTY720 is rapidly converted in vivo to the active S-fingolimod-phosphate, which binds to S1P receptors.  This action inhibits egress of lymphocytes from the lymph nodes, preventing entry into the blood and thus infiltration into the central nervous system.  More recent studies, however, convincingly show that FTY720 crosses the blood-brain barrier, where it is thought to act on S1P receptors on cells within the central nervous system, such as astrocytes, oligodendrocytes or microglia.  Here we discuss the evidence showing that FTY720 also plays a role in remyelination and repair within the brain.  While the mechanisms of action still require firm elucidation, it is clear that FTY720 could also be reparative, extending its therapeutic potential for multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKA78G9IbOg7Vg90H21EOLACvtfcHk0li1HM5F_MKQ_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Cit78%253D&md5=ecd15c846c60079f5f794e9f5ce239cc</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1177%2F1352458512438723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1352458512438723%26sid%3Dliteratum%253Aachs%26aulast%3DKipp%26aufirst%3DM.%26aulast%3DAmor%26aufirst%3DS.%26atitle%3DFTY720%2520on%2520the%2520Way%2520from%2520the%2520Base%2520Camp%2520to%2520the%2520Summit%2520of%2520the%2520Mountain%253A%2520Relevance%2520for%2520Remyelination%26jtitle%3DMult.%2520Scler.%2520J.%26date%3D2012%26volume%3D18%26spage%3D258%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Awad, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouse, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khutsishvili, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okusa, M. D.</span><span> </span><span class="NLM_article-title">Chronic Sphingosine 1 - Phosphate 1 Receptor Activation Attenuates Early-Stage Diabetic Nephropathy Independent of Lymphocytes</span> <span class="citation_source-journal">Kidney Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1090</span><span class="NLM_x">–</span> <span class="NLM_lpage">1098</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1038%2Fki.2010.544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltlyju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=1090-1098&author=A.+S.+Awadauthor=M.+D.+Rouseauthor=K.+Khutsishviliauthor=L.+Huangauthor=W.+K.+Boltonauthor=K.+R.+Lynchauthor=M.+D.+Okusa&title=Chronic+Sphingosine+1+-+Phosphate+1+Receptor+Activation+Attenuates+Early-Stage+Diabetic+Nephropathy+Independent+of+Lymphocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes</span></div><div class="casAuthors">Awad, Alaa S.; Rouse, Michael D.; Khutsishvili, Konstantine; Huang, Liping; Bolton, W. Kline; Lynch, Kevin R.; Okusa, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1090-1098</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P), a pleiotropic lipid mediator, binds to five related G-protein-coupled receptors to exert its effects.  As S1P1 receptor (S1P1R) activation blocks kidney inflammation in acute renal injury, we tested whether activation of S1P1Rs ameliorates renal injury in early-stage diabetic nephropathy (DN) in rats.  Urinary albumin excretion increased in vehicle-treated diabetic rats (single injection of streptozotocin), compared with controls, and was assocd. with tubule injury and increased urinary tumor necrosis factor-α (TNF-α) at 9 wk.  These effects were significantly reduced by FTY720, a non-selective, or SEW2871, a selective S1P1R agonist.  Interestingly, only FTY720 was assocd. with reduced total lymphocyte levels.  Albuminuria was reduced by SEW2871 in both Rag-1 (T- and B-cell deficient) and wild-type diabetic mice after 6 wk, suggesting that the effect was independent of lymphocytes.  Another receptor, S1P3R, did not contribute to the FTY720-mediated protection, as albuminuria was also reduced in diabetic S1P3R knockout mice.  Further, both agonists restored WT-1 staining along with podocin and nephrin mRNA expression, suggesting podocyte protection.  This was corroborated in vitro, as SEW2871 reduced TNF-α and vascular endothelial growth factor mRNA expression in immortalized podocytes grown in media contg. high glucose.  Whether targeting kidney S1P1Rs will be a useful therapeutic measure in DN will need direct testing.  Kidney International (2011) 79, 1090-1098; doi:10.1038/ki.2010.544; published online 2 Feb. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Mrjewsi7q7Vg90H21EOLACvtfcHk0li1HM5F_MKQ_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltlyju78%253D&md5=a1948344ffbd1bb4a86de1e1edb6f25d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fki.2010.544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fki.2010.544%26sid%3Dliteratum%253Aachs%26aulast%3DAwad%26aufirst%3DA.%2BS.%26aulast%3DRouse%26aufirst%3DM.%2BD.%26aulast%3DKhutsishvili%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DBolton%26aufirst%3DW.%2BK.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DOkusa%26aufirst%3DM.%2BD.%26atitle%3DChronic%2520Sphingosine%25201%2520-%2520Phosphate%25201%2520Receptor%2520Activation%2520Attenuates%2520Early-Stage%2520Diabetic%2520Nephropathy%2520Independent%2520of%2520Lymphocytes%26jtitle%3DKidney%2520Int.%26date%3D2011%26volume%3D79%26spage%3D1090%26epage%3D1098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Miron, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwin, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarjour, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soliven, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antel, J. P.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">2682</span><span class="NLM_x">–</span> <span class="NLM_lpage">2694</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.2353%2Fajpath.2010.091234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=20413685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptFKrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2010&pages=2682-2694&author=V.+E.+Mironauthor=S.+K.+Ludwinauthor=P.+J.+Darlingtonauthor=A.+A.+Jarjourauthor=B.+Solivenauthor=T.+E.+Kennedyauthor=J.+P.+Antel&title=Fingolimod+%28FTY720%29+Enhances+Remyelination+Following+Demyelination+of+Organotypic+Cerebellar+Slices"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices</span></div><div class="casAuthors">Miron, Veronique E.; Ludwin, Samuel K.; Darlington, Peter J.; Jarjour, Andrew A.; Soliven, Betty; Kennedy, Timothy E.; Antel, Jack P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2682-2694</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Remyelination, which occurs subsequent to demyelination, contributes to functional recovery and is mediated by oligodendrocyte progenitor cells (OPCs) that have differentiated into myelinating cells.  Therapeutics that impact remyelination in the CNS could be crit. determinants of long-term functional outcome in multiple sclerosis (MS).  Fingolimod is a S1P receptor modulator in MS clin. trials due to systemic anti-inflammatory properties, yet may impact cells within the CNS by crossing the blood-brain barrier.  Previous studies using isolated dissocd. cultures indicate that neural cells express S1P receptors and respond to receptor engagement.  Our objective was to assess the effects of fingolimod on myelinrelated processes within a multicellular environment that maintains physiol. cell-cell interactions, using organotypic cerebellar slice cultures.  Fingolimod treatment had no impact on myelin under basal conditions.  Fingolimod treatment subsequent to lysolecithin-induced demyelination enhanced remyelination and process extension by OPCs and mature oligodendrocytes, while increasing microglia nos. and immunoreactivity for the astrocytic marker glial fibrillary acidic protein.  The no. of phagocytosing microglia was not increased by fingolimod.  Using S1P receptor specific agonists and antagonists, we detd. that fingolimod-induced effects on remyelination and astrogliosis were mediated primarily through S1P3 and S1P5, whereas enhanced microgliosis was mediated through S1P1 and S1P5.  Taken together, these data demonstrate that fingolimod modulates multiple neuroglial cell responses, resulting in enhanced remyelination in organotypic slice cultures that maintain the complex cellular interactions of the mammalian brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGradvge9335h7Vg90H21EOLACvtfcHk0li1HM5F_MKQ_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptFKrs7c%253D&md5=6e7efa55ed7482a64dad66c6ec384de8</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2010.091234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2010.091234%26sid%3Dliteratum%253Aachs%26aulast%3DMiron%26aufirst%3DV.%2BE.%26aulast%3DLudwin%26aufirst%3DS.%2BK.%26aulast%3DDarlington%26aufirst%3DP.%2BJ.%26aulast%3DJarjour%26aufirst%3DA.%2BA.%26aulast%3DSoliven%26aufirst%3DB.%26aulast%3DKennedy%26aufirst%3DT.%2BE.%26aulast%3DAntel%26aufirst%3DJ.%2BP.%26atitle%3DFingolimod%2520%2528FTY720%2529%2520Enhances%2520Remyelination%2520Following%2520Demyelination%2520of%2520Organotypic%2520Cerebellar%2520Slices%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2010%26volume%3D176%26spage%3D2682%26epage%3D2694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Mattes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dev, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouhelal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barske, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasparini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mir, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osinde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasdelen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haessig, S.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Selective and Potent Orally Active S1P5 Agonists</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1693</span><span class="NLM_x">–</span> <span class="NLM_lpage">1696</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1693-1696&author=H.+Mattesauthor=K.+K.+Devauthor=R.+Bouhelalauthor=C.+Barskeauthor=F.+Gaspariniauthor=D.+Gueriniauthor=A.+K.+Mirauthor=D.+Orainauthor=M.+Osindeauthor=A.+Picardauthor=C.+Duboisauthor=E.+Tasdelenauthor=S.+Haessig&title=Design+and+Synthesis+of+Selective+and+Potent+Orally+Active+S1P5+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMattes%26aufirst%3DH.%26aulast%3DDev%26aufirst%3DK.%2BK.%26aulast%3DBouhelal%26aufirst%3DR.%26aulast%3DBarske%26aufirst%3DC.%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DMir%26aufirst%3DA.%2BK.%26aulast%3DOrain%26aufirst%3DD.%26aulast%3DOsinde%26aufirst%3DM.%26aulast%3DPicard%26aufirst%3DA.%26aulast%3DDubois%26aufirst%3DC.%26aulast%3DTasdelen%26aufirst%3DE.%26aulast%3DHaessig%26aufirst%3DS.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Selective%2520and%2520Potent%2520Orally%2520Active%2520S1P5%2520Agonists%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1693%26epage%3D1696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Choi, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teo, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">FTY720 (Fingolimod) Efficacy in an Animal Model of Multiple Sclerosis Requires Astrocyte Sphingosine 1-Phosphate Receptor 1 (S1P<sub>1</sub>) Modulation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">751</span><span class="NLM_x">–</span> <span class="NLM_lpage">756</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=751-756&author=J.+W.+Choiauthor=S.+E.+Gardellauthor=D.+R.+Herrauthor=R.+Riveraauthor=C.-W.+Leeauthor=K.+Noguchiauthor=S.+T.+Teoauthor=Y.+C.+Yungauthor=M.+Luauthor=G.+Kennedyauthor=J.+Chun&title=FTY720+%28Fingolimod%29+Efficacy+in+an+Animal+Model+of+Multiple+Sclerosis+Requires+Astrocyte+Sphingosine+1-Phosphate+Receptor+1+%28S1P1%29+Modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DGardell%26aufirst%3DS.%2BE.%26aulast%3DHerr%26aufirst%3DD.%2BR.%26aulast%3DRivera%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.-W.%26aulast%3DNoguchi%26aufirst%3DK.%26aulast%3DTeo%26aufirst%3DS.%2BT.%26aulast%3DYung%26aufirst%3DY.%2BC.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DKennedy%26aufirst%3DG.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DFTY720%2520%2528Fingolimod%2529%2520Efficacy%2520in%2520an%2520Animal%2520Model%2520of%2520Multiple%2520Sclerosis%2520Requires%2520Astrocyte%2520Sphingosine%25201-Phosphate%2520Receptor%25201%2520%2528S1P1%2529%2520Modulation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D751%26epage%3D756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Selecting against S1P<sub>3</sub> Enhances the Acute Cardiovascular Tolerability of 3-(N-Benzyl)aminopropylphosphonic Acid S1P Receptor Agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3501</span><span class="NLM_x">–</span> <span class="NLM_lpage">3505</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3501-3505&author=J.+J.+Haleauthor=G.+Dohertyauthor=L.+Tothauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+Rosenbachauthor=J.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Forrestauthor=S.-Y.+Sunauthor=S.+Westauthor=H.+Xieauthor=N.+Nomuraauthor=H.+Rosenauthor=S.+Mandala&title=Selecting+against+S1P3+Enhances+the+Acute+Cardiovascular+Tolerability+of+3-%28N-Benzyl%29aminopropylphosphonic+Acid+S1P+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DToth%26aufirst%3DL.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DSelecting%2520against%2520S1P3%2520Enhances%2520the%2520Acute%2520Cardiovascular%2520Tolerability%2520of%25203-%2528N-Benzyl%2529aminopropylphosphonic%2520Acid%2520S1P%2520Receptor%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3501%26epage%3D3505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1124%2Fjpet.103.062828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=14747617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=758-768&author=M.+Forrestauthor=S.-Y.+Sunauthor=R.+Hajduauthor=J.+Bergstromauthor=D.+Cardauthor=G.+Dohertyauthor=J.+Haleauthor=C.+Keohaneauthor=C.+Meyersauthor=J.+Milliganauthor=S.+Millsauthor=N.+Nomuraauthor=H.+Rosenauthor=M.+Rosenbachauthor=G.-J.+Sheiauthor=I.+I.+Singerauthor=M.+Tianauthor=S.+Westauthor=V.+Whiteauthor=J.+Xieauthor=R.+L.+Proiaauthor=S.+Mandala&title=Immune+Cell+Regulation+and+Cardiovascular+Effects+of+Sphingosine+1-Phosphate+Receptor+Agonists+in+Rodents+Are+Mediated+via+Distinct+Receptor+Subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span></div><div class="casAuthors">Forrest, M.; Sun, S.-Y.; Hajdu, R.; Bergstrom, J.; Card, D.; Doherty, G.; Hale, J.; Keohane, C.; Meyers, C.; Milligan, J.; Mills, S.; Nomura, N.; Rosen, H.; Rosenbach, M.; Shei, G.-J.; Singer, I. I.; Tian, M.; West, S.; White, V.; Xie, J.; Proia, R. L.; Mandala, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">758-768</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a bioactive lysolipid with pleiotropic functions mediated through a family of G protein-coupled receptors, S1P1,2,3,4,5.  Physiol. effects of S1P receptor agonists include regulation of cardiovascular function and immunosuppression via redistribution of lymphocytes from blood to secondary lymphoid organs.  The phosphorylated metabolite of the immunosuppressant agent FTY720 (2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol) and other phosphonate analogs with differential receptor selectivity were investigated.  No significant species differences in compd. potency or rank order of activity on receptors cloned from human, murine, and rat sources were obsd.  All synthetic analogs were high-affinity agonists on S1P1, with IC50 values for ligand binding between 0.3 and 14 nM.  The correlation between S1P1 receptor activation and the ED50 for lymphocyte redn. was highly significant (p < 0.001) and lower for the other receptors.  In contrast to S1P1-mediated effects on lymphocyte recirculation, three lines of evidence link S1P3 receptor activity with acute toxicity and cardiovascular regulation: compd. potency on S1P3 correlated with toxicity and bradycardia; the shift in potency of phosphorylated-FTY720 for inducing lymphopenia vs. bradycardia and hypertension was consistent with affinity for S1P1 relative to S1P3; and toxicity, bradycardia, and hypertension were absent in S1P3-/- mice.  Blood pressure effects of agonists in anesthetized rats were complex, whereas hypertension was the predominant effect in conscious rats and mice.  Immunolocalization of S1P3 in rodent heart revealed abundant expression on myocytes and perivascular smooth muscle cells consistent with regulation of bradycardia and hypertension, whereas S1P1 expression was restricted to the vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKo2vpih4eoLVg90H21EOLACvtfcHk0liQB2euMBLMXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D&md5=27183d4991bffbc5d2b88174b1386d5a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062828%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DC.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DSinger%26aufirst%3DI.%2BI.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DImmune%2520Cell%2520Regulation%2520and%2520Cardiovascular%2520Effects%2520of%2520Sphingosine%25201-Phosphate%2520Receptor%2520Agonists%2520in%2520Rodents%2520Are%2520Mediated%2520via%2520Distinct%2520Receptor%2520Subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D758%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P<sub>1</sub> and S1P<sub>3</sub>, Respectively, Regulate Lymphocyte Recirculation and Heart Rate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">13839</span><span class="NLM_x">–</span> <span class="NLM_lpage">13848</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=13839-13848&author=M.+G.+Sannaauthor=J.+Liaoauthor=E.+Joauthor=C.+Alfonsoauthor=M.-Y.+Ahnauthor=M.+S.+Petersonauthor=B.+Webbauthor=S.+Lefebvreauthor=J.+Chunauthor=N.+Grayauthor=H.+Rosen&title=Sphingosine+1-Phosphate+%28S1P%29+Receptor+Subtypes+S1P1+and+S1P3%2C+Respectively%2C+Regulate+Lymphocyte+Recirculation+and+Heart+Rate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DAlfonso%26aufirst%3DC.%26aulast%3DAhn%26aufirst%3DM.-Y.%26aulast%3DPeterson%26aufirst%3DM.%2BS.%26aulast%3DWebb%26aufirst%3DB.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DSphingosine%25201-Phosphate%2520%2528S1P%2529%2520Receptor%2520Subtypes%2520S1P1%2520and%2520S1P3%252C%2520Respectively%252C%2520Regulate%2520Lymphocyte%2520Recirculation%2520and%2520Heart%2520Rate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D13839%26epage%3D13848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Salomone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyndall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ip, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waeber, C.</span><span> </span><span class="NLM_article-title">Analysis of Sphingosine 1-Phosphate Receptors Involved in Constriction of Isolated Cerebral Arteries with Receptor Null Mice and Pharmacological Tools</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1038%2Fsj.bjp.0707581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=18026125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlyntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=140-147&author=S.+Salomoneauthor=E.+M.+Pottsauthor=S.+Tyndallauthor=P.+C.+Ipauthor=J.+Chunauthor=V.+Brinkmannauthor=C.+Waeber&title=Analysis+of+Sphingosine+1-Phosphate+Receptors+Involved+in+Constriction+of+Isolated+Cerebral+Arteries+with+Receptor+Null+Mice+and+Pharmacological+Tools"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools</span></div><div class="casAuthors">Salomone, S.; Potts, E. M.; Tyndall, S.; Ip, P. C.; Chun, J.; Brinkmann, V.; Waeber, C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-147</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: Sphingosine 1-phosphate (S1P) selectively and potently constricts isolated cerebral arteries, but this response has not been pharmacol. characterized.  Exptl. approach: The receptor subtype(s) involved in S1P-induced cerebrovascular constriction were characterized using genetic (S1P2 and S1P3 receptor null mice) and pharmacol. tools (phospho-FTY720, a S1P1/3/4/5 receptor agonist; SEW2871, a S1P1 receptor agonist, JTE-013, a S1P2 receptor antagonist, VPC23019, a S1P1/3 receptor antagonist).  Isolated basilar or peripheral (femoral, mesenteric resistance) arteries, from either rat or mouse, were studied in a wire myograph.  Key results: S1P concn.-dependently constricted basilar artery in rat, wild-type (WT) and S1P2 null mice, but barely affected vascular tone in S1P3 null mice.  Vasoconstriction to U46619 (a thromboxane analog) or to endothelin-1 did not differ between WT, S1P2 and S1P3 null mice.  JTE-013 inhibited not only S1P-induced vasoconstriction, but also KCl-, U46619- and endothelin-1-induced constriction.  This effect was obsd. in WT as well as in S1P2 null mice.  VPC23019 increased the concn.-dependent vasoconstriction to S1P in both rat and mouse basilar arteries with intact endothelium, but not in rat basilar artery without endothelium.  Phospho-FTY720 concn.-dependently constricted rat basilar arteries, but not femoral or mesenteric resistance arteries, while SEW2871 did not induce any response in the same arteries.  Conclusions and implications: S1P constricts cerebral arteries through S1P3 receptors.  The purported S1P2 receptor antagonist JTE-013 does not appear to be selective, at least in rodents.  Enhancement of S1P-induced contraction by VPC23019 might be related to blockade of S1P1 receptors and NO generation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkx6pcvW_Q37Vg90H21EOLACvtfcHk0ljlMXV0-ZrDDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlyntg%253D%253D&md5=1e8bef7d6f2df66b4436300fab09df06</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707581%26sid%3Dliteratum%253Aachs%26aulast%3DSalomone%26aufirst%3DS.%26aulast%3DPotts%26aufirst%3DE.%2BM.%26aulast%3DTyndall%26aufirst%3DS.%26aulast%3DIp%26aufirst%3DP.%2BC.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DWaeber%26aufirst%3DC.%26atitle%3DAnalysis%2520of%2520Sphingosine%25201-Phosphate%2520Receptors%2520Involved%2520in%2520Constriction%2520of%2520Isolated%2520Cerebral%2520Arteries%2520with%2520Receptor%2520Null%2520Mice%2520and%2520Pharmacological%2520Tools%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D140%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Murakami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taksugi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koide, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasamori, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakura, N.</span><span> </span><span class="NLM_article-title">Sphingosine 1-Phosphate (S1P) Regulates Vascular Contraction via S1P<sub>3</sub> Receptor: Investigation Based on a New S1P<sub>3</sub> Receptor Antagonist</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=704-713&author=A.+Murakamiauthor=H.+Taksugiauthor=S.+Ohnumaauthor=Y.+Koideauthor=A.+Sakuraiauthor=S.+Takedaauthor=T.+Hasegawaauthor=J.+Sasamoriauthor=T.+Konnoauthor=K.+Hayashiauthor=Y.+Watanabeauthor=K.+Moriauthor=Y.+Satoauthor=A.+Takahashiauthor=N.+Mochizukiauthor=N.+Takakura&title=Sphingosine+1-Phosphate+%28S1P%29+Regulates+Vascular+Contraction+via+S1P3+Receptor%3A+Investigation+Based+on+a+New+S1P3+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DA.%26aulast%3DTaksugi%26aufirst%3DH.%26aulast%3DOhnuma%26aufirst%3DS.%26aulast%3DKoide%26aufirst%3DY.%26aulast%3DSakurai%26aufirst%3DA.%26aulast%3DTakeda%26aufirst%3DS.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DSasamori%26aufirst%3DJ.%26aulast%3DKonno%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DMochizuki%26aufirst%3DN.%26aulast%3DTakakura%26aufirst%3DN.%26atitle%3DSphingosine%25201-Phosphate%2520%2528S1P%2529%2520Regulates%2520Vascular%2520Contraction%2520via%2520S1P3%2520Receptor%253A%2520Investigation%2520Based%2520on%2520a%2520New%2520S1P3%2520Receptor%2520Antagonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D77%26spage%3D704%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Saha, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobera, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shardendu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chereku, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marantz, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bürli, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buys, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salyers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrag, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElvain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span> </span><span class="NLM_article-title">Benzofuran Derivatives as Potent, Orally Active S1P1 Receptor Agonists: A Preclinical Lead Molecule for MS</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100227q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=97-101&author=A.+K.+Sahaauthor=X.+Yuauthor=J.+Linauthor=M.+Loberaauthor=A.+Shardenduauthor=S.+Cherekuauthor=N.+Schutzauthor=D.+Segalauthor=Y.+Marantzauthor=D.+McCauleyauthor=S.+Middletonauthor=J.+Siuauthor=R.+W.+B%C3%BCrliauthor=J.+Buysauthor=M.+Hornerauthor=K.+Salyersauthor=M.+Schragauthor=H.+M.+Vargasauthor=Y.+Xuauthor=M.+McElvainauthor=H.+Xu&title=Benzofuran+Derivatives+as+Potent%2C+Orally+Active+S1P1+Receptor+Agonists%3A+A+Preclinical+Lead+Molecule+for+MS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fml100227q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100227q%26sid%3Dliteratum%253Aachs%26aulast%3DSaha%26aufirst%3DA.%2BK.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLobera%26aufirst%3DM.%26aulast%3DShardendu%26aufirst%3DA.%26aulast%3DChereku%26aufirst%3DS.%26aulast%3DSchutz%26aufirst%3DN.%26aulast%3DSegal%26aufirst%3DD.%26aulast%3DMarantz%26aufirst%3DY.%26aulast%3DMcCauley%26aufirst%3DD.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DSiu%26aufirst%3DJ.%26aulast%3DB%25C3%25BCrli%26aufirst%3DR.%2BW.%26aulast%3DBuys%26aufirst%3DJ.%26aulast%3DHorner%26aufirst%3DM.%26aulast%3DSalyers%26aufirst%3DK.%26aulast%3DSchrag%26aufirst%3DM.%26aulast%3DVargas%26aufirst%3DH.%2BM.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DMcElvain%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DH.%26atitle%3DBenzofuran%2520Derivatives%2520as%2520Potent%252C%2520Orally%2520Active%2520S1P1%2520Receptor%2520Agonists%253A%2520A%2520Preclinical%2520Lead%2520Molecule%2520for%2520MS%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D97%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Lucke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levkau, B.</span><span> </span><span class="NLM_article-title">Endothelial Functions of Sphingosine-1-phosphate</span> <span class="citation_source-journal">Cell. Physiol. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1159%2F000315109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=20502008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVOms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=87-96&author=S.+Luckeauthor=B.+Levkau&title=Endothelial+Functions+of+Sphingosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelial Functions of Sphingosine-1-phosphate</span></div><div class="casAuthors">Lucke, Susann; Levkau, Bodo</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-96</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  The biol. active sphingolipid sphingosine-1-phosphate (S1P) plays key functions in the immune, inflammatory, and cardiovascular systems.  In the vasculature, S1P and its receptors are involved in vessel morphogenesis and angiogenesis during embryonic development and in the adult organism both under normal and pathol. conditions.  Via its actions on endothelial and smooth muscle cells, S1P regulates arterial tone, vascular permeability, and tissue perfusion.  Elevated local S1P levels during inflammation induce endothelial adhesion mols., recruit inflammatory cells, and activate dendritic cells.  At the same time, S1P activates a neg. feedback loop that consecutively seals endothelial cell-cell contacts, decreases vascular leakage, and inhibits cytokine-induced leukocyte adhesion.  Thus S1P dets. not only the build-up, magnitude, and duration of an inflammatory reaction but also the pace of its resoln.  This review focuses on the role S1P plays in endothelial function, its receptors and signalling pathways, and the role its major carrier high-d. lipoproteins (HDL) play in its bioavailability and transport.  We will also discuss the potential of interfering with S1P-S1P receptor interactions for the treatment of endothelial disorders and vascular pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgsnbdFMWkH7Vg90H21EOLACvtfcHk0ljlMXV0-ZrDDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVOms74%253D&md5=7cb409784dfea08b42abaa924e5b3bff</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1159%2F000315109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000315109%26sid%3Dliteratum%253Aachs%26aulast%3DLucke%26aufirst%3DS.%26aulast%3DLevkau%26aufirst%3DB.%26atitle%3DEndothelial%2520Functions%2520of%2520Sphingosine-1-phosphate%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2010%26volume%3D26%26spage%3D87%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Fryer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muthukumarana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nodop Mazurek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinallo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaude, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modis, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, G. A.</span><span> </span><span class="NLM_article-title">The Clinically-Tested S1P Receptor Agonists, FTY720 and BAF312, Demonstrate Subtype-Specific Bradycardia (S1P(1)) and Hypertension (S1P(3)) in Rat</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e52985</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e52985&author=R.+M.+Fryerauthor=A.+Muthukumaranaauthor=P.+C.+Harrisonauthor=S.+Nodop+Mazurekauthor=R.+R.+Chenauthor=K.+E.+Harringtonauthor=R.+M.+Dinalloauthor=J.+C.+Horanauthor=L.+Patnaudeauthor=L.+K.+Modisauthor=G.+A.+Reinhart&title=The+Clinically-Tested+S1P+Receptor+Agonists%2C+FTY720+and+BAF312%2C+Demonstrate+Subtype-Specific+Bradycardia+%28S1P%281%29%29+and+Hypertension+%28S1P%283%29%29+in+Rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFryer%26aufirst%3DR.%2BM.%26aulast%3DMuthukumarana%26aufirst%3DA.%26aulast%3DHarrison%26aufirst%3DP.%2BC.%26aulast%3DNodop%2BMazurek%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%2BR.%26aulast%3DHarrington%26aufirst%3DK.%2BE.%26aulast%3DDinallo%26aufirst%3DR.%2BM.%26aulast%3DHoran%26aufirst%3DJ.%2BC.%26aulast%3DPatnaude%26aufirst%3DL.%26aulast%3DModis%26aufirst%3DL.%2BK.%26aulast%3DReinhart%26aufirst%3DG.%2BA.%26atitle%3DThe%2520Clinically-Tested%2520S1P%2520Receptor%2520Agonists%252C%2520FTY720%2520and%2520BAF312%252C%2520Demonstrate%2520Subtype-Specific%2520Bradycardia%2520%2528S1P%25281%2529%2529%2520and%2520Hypertension%2520%2528S1P%25283%2529%2529%2520in%2520Rat%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De52985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Gon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiosses, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">S1P<sub>3</sub> Receptor-Induced Reorganization of Epithelial Tight Junctions Compromises Lung Barrier Integrity and Is Potentiated by TNF</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">9270</span><span class="NLM_x">–</span> <span class="NLM_lpage">9275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=9270-9275&author=Y.+Gonauthor=M.+R.+Woodauthor=W.+B.+Kiossesauthor=E.+Joauthor=M.+G.+Sannaauthor=J.+Chunauthor=H.+Rosen&title=S1P3+Receptor-Induced+Reorganization+of+Epithelial+Tight+Junctions+Compromises+Lung+Barrier+Integrity+and+Is+Potentiated+by+TNF"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGon%26aufirst%3DY.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DKiosses%26aufirst%3DW.%2BB.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DS1P3%2520Receptor-Induced%2520Reorganization%2520of%2520Epithelial%2520Tight%2520Junctions%2520Compromises%2520Lung%2520Barrier%2520Integrity%2520and%2520Is%2520Potentiated%2520by%2520TNF%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D9270%26epage%3D9275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Hamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomatsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, K.</span><span> </span><span class="NLM_article-title">Removal of Sphingosine 1-Phosphate Receptor-3 (S1P<sub>3</sub>) Agonism Is Essential, but Inadequate to Obtain Immunomodulating 2-Aminopropane-1,3-diol S1P<sub>1</sub> Agonists with Reduced Effect on Heart Rate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3154</span><span class="NLM_x">–</span> <span class="NLM_lpage">3168</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901776q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3154-3168&author=M.+Hamadaauthor=M.+Nakamuraauthor=M.+Kiuchiauthor=K.+Marukawaauthor=A.+Tomatsuauthor=K.+Shimanoauthor=N.+Satoauthor=K.+Sugaharaauthor=M.+Asayamaauthor=K.+Takagiauthor=K.+Adachi&title=Removal+of+Sphingosine+1-Phosphate+Receptor-3+%28S1P3%29+Agonism+Is+Essential%2C+but+Inadequate+to+Obtain+Immunomodulating+2-Aminopropane-1%2C3-diol+S1P1+Agonists+with+Reduced+Effect+on+Heart+Rate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm901776q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901776q%26sid%3Dliteratum%253Aachs%26aulast%3DHamada%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DKiuchi%26aufirst%3DM.%26aulast%3DMarukawa%26aufirst%3DK.%26aulast%3DTomatsu%26aufirst%3DA.%26aulast%3DShimano%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DSugahara%26aufirst%3DK.%26aulast%3DAsayama%26aufirst%3DM.%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DAdachi%26aufirst%3DK.%26atitle%3DRemoval%2520of%2520Sphingosine%25201-Phosphate%2520Receptor-3%2520%2528S1P3%2529%2520Agonism%2520Is%2520Essential%252C%2520but%2520Inadequate%2520to%2520Obtain%2520Immunomodulating%25202-Aminopropane-1%252C3-diol%2520S1P1%2520Agonists%2520with%2520Reduced%2520Effect%2520on%2520Heart%2520Rate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3154%26epage%3D3168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">End, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span> </span><span class="NLM_article-title">Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300396r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=333-337&author=S.+Panauthor=N.+Grayauthor=W.+Gaoauthor=Y.+Miauthor=Y.+Fanauthor=X.+Wangauthor=T.+Tuntlandauthor=J.+Cheauthor=S.+Lefebvreauthor=Y.+Chenauthor=A.+Chuauthor=K.+Hinterdingauthor=A.+Gardinauthor=P.+Endauthor=P.+Heiningauthor=C.+Brunsauthor=N.+G.+Cookeauthor=B.+Nuesslein-Hildesheim&title=Discovery+of+BAF312+%28Siponimod%29%2C+a+Potent+and+Selective+S1P+Receptor+Modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fml300396r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300396r%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChu%26aufirst%3DA.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DEnd%26aufirst%3DP.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520BAF312%2520%2528Siponimod%2529%252C%2520a%2520Potent%2520and%2520Selective%2520S1P%2520Receptor%2520Modulator%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D333%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span> </span><span class="NLM_article-title">FTY720 (Fingolimod) in Multiple Sclerosis: Therapeutic Effects in the Immune and Central Nervous System</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">1173</span><span class="NLM_x">–</span> <span class="NLM_lpage">1182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1111%2Fj.1476-5381.2009.00451.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=19814729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=1173-1182&author=V.+Brinkmann&title=FTY720+%28Fingolimod%29+in+Multiple+Sclerosis%3A+Therapeutic+Effects+in+the+Immune+and+Central+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system</span></div><div class="casAuthors">Brinkmann, Volker</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1173-1182</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  FTY720 (fingolimod) is a first-in-class sphingosine 1-phosphate (S1P) receptor modulator that was highly effective in Phase II clin. trials for Multiple Sclerosis (MS).  FTY720 is phosphorylated in vivo by sphingosine kinase-2 to form the active moiety FTY720-phosphate that binds to four of the five G protein-coupled S1P receptor subtypes.  Studies using conditional S1P1 receptor-deficient and sphingosine kinase-deficient mice showed that the egress of lymphocytes from lymph nodes requires signaling of lymphocytic S1P1 receptors by the endogenous ligand S1P.  The S1P mimetic FTY720-phosphate causes internalization and degrdn. of cell membrane-expressed S1P1, thereby antagonizing S1P action at the receptor.  In models of human MS and demyelinating polyneuropathies, functional antagonism of lymphocytic S1P1 slows S1P-driven egress of lymphocytes from lymph nodes, thereby reducing the nos. of autoaggressive TH17 cells that recirculate via lymph and blood to the central nervous system and the sciatic/ischiatic nerves.  Based on its lipophilic nature, FTY720 crosses the blood-brain barrier, and ongoing expts. suggest that the drug also down-modulates S1P1 in neural cells/astrocytes to reduce astrogliosis, a phenomenon assocd. with neurodegeneration in MS.  This may help restore gap-junctional communication of astrocytes with neurons and cells of the blood-brain barrier.  Addnl. effects may result from (down-) modulation of S1P3 in astrocytes and of S1P1 and S1P5 in oligodendrocytes.  In conclusion, FTY720 may act through immune-based and central mechanisms to reduce inflammation and support structural restoration of the central nervous system parenchyma.  Beyond the autoimmune indications, very recent studies suggest that short-term, low-dose administration of FTY720 could help treat chronic (viral) infections.  Differential effects of the drug on the trafficking of naive, central memory and effector memory T cell subsets are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOQw7bGw9977Vg90H21EOLACvtfcHk0lgA-HvLHKx5QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7fO&md5=33c85af3e092990c4c43fbeae5512de4</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00451.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00451.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26atitle%3DFTY720%2520%2528Fingolimod%2529%2520in%2520Multiple%2520Sclerosis%253A%2520Therapeutic%2520Effects%2520in%2520the%2520Immune%2520and%2520Central%2520Nervous%2520System%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D158%26spage%3D1173%26epage%3D1182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Brossard, P.; Hofmann, S.; Cavallaro, M.; Halabi, A.; Dingemanse, J.</span><span> </span><span class="NLM_article-title">Entry-into-Humans Study with ACT-128800, a Selective S1P1 Receptor Agonist: Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics</span>.  <span class="citation_source-book">Clin. Pharmcol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">S63</span><span class="NLM_x">–</span> <span class="NLM_lpage">S64</span>, PII-87; Annual Meeting of the American Society for Clinical Pharmacology & Therapeutics, March 18–21, 2009, Washington DC, USA; <span class="NLM_publisher-name">ASCPT</span>:<span class="NLM_publisher-loc">Alexandria, VA</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=S63-S64&author=P.+Brossard&author=S.+Hofmann&author=M.+Cavallaro&author=A.+Halabi&author=J.+Dingemanse&title=Clin.+Pharmcol.+Ther."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBrossard%26aufirst%3DP.%26atitle%3DEntry-into-Humans%2520Study%2520with%2520ACT-128800%252C%2520a%2520Selective%2520S1P1%2520Receptor%2520Agonist%253A%2520Tolerability%252C%2520Safety%252C%2520Pharmacokinetics%252C%2520and%2520Pharmacodynamics%26btitle%3DClin.%2520Pharmcol.%2520Ther.%26date%3D2009%26spage%3DS63%26epage%3DS64%26pub%3DASCPT" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Gergely, P.; Wallström, E.; Nuesslein-Hildesheim, B.; Bruns, C.; Zécri, F. J.; Cooke, N. G.; Traebert, M.; Tuntland, T.; Rosenberg, M.; Saltzman, M.</span><span> </span><span class="NLM_article-title">Phase I Study with the Selective S1P1/S1P5 Receptor Modulator BAF312 Indicates That S1P1 Rather Than S1P3 Mediates Transient Heart Rate Reduction in Humans</span>. 25th Congress of the European Committe for Treatment and Research in Multiple Sclerosis (ECTRIMS), Sept 9–12,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">, </span>Düsseldorf, Germany; p  <span class="NLM_fpage">P437</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=P437&author=P.+Gergely&author=E.+Wallstr%C3%B6m&author=B.+Nuesslein-Hildesheim&author=C.+Bruns&author=F.+J.+Z%C3%A9cri&author=N.+G.+Cooke&author=M.+Traebert&author=T.+Tuntland&author=M.+Rosenberg&author=M.+Saltzman&title=Phase+I+Study+with+the+Selective+S1P1%2FS1P5+Receptor+Modulator+BAF312+Indicates+That+S1P1+Rather+Than+S1P3+Mediates+Transient+Heart+Rate+Reduction+in+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26atitle%3DPhase%2520I%2520Study%2520with%2520the%2520Selective%2520S1P1%252FS1P5%2520Receptor%2520Modulator%2520BAF312%2520Indicates%2520That%2520S1P1%2520Rather%2520Than%2520S1P3%2520Mediates%2520Transient%2520Heart%2520Rate%2520Reduction%2520in%2520Humans%26date%3D2009%26spage%3DP437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Wallström, E.; Gergely, P.; Nuesslein-Hildesheim, B.; Zécri, F. J.; Cooke, N. G.; Bruns, C.; Luttringer, O.; Sing, T.; Groenewegen, A.; Rosenberg, M.; Saltzman, M.</span><span> </span><span class="NLM_article-title">BAF312, a Selective S1P1/S1P5 Receptor Modulator, Effectively Reduces Absolute Lymphocyte Counts in Human Volunteers and Demonstrates the Relevance of S1P1 in Mediating a Transient Heart Rate Reduction</span>. In 62nd Annual Meeting of the American Academy of Neurology, Toronto, Ontario, Canada,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>p PO5.052.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+Wallstr%C3%B6m&author=P.+Gergely&author=B.+Nuesslein-Hildesheim&author=F.+J.+Z%C3%A9cri&author=N.+G.+Cooke&author=C.+Bruns&author=O.+Luttringer&author=T.+Sing&author=A.+Groenewegen&author=M.+Rosenberg&author=M.+Saltzman&title=BAF312%2C+a+Selective+S1P1%2FS1P5+Receptor+Modulator%2C+Effectively+Reduces+Absolute+Lymphocyte+Counts+in+Human+Volunteers+and+Demonstrates+the+Relevance+of+S1P1+in+Mediating+a+Transient+Heart+Rate+Reduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DWallstr%25C3%25B6m%26aufirst%3DE.%26atitle%3DBAF312%252C%2520a%2520Selective%2520S1P1%252FS1P5%2520Receptor%2520Modulator%252C%2520Effectively%2520Reduces%2520Absolute%2520Lymphocyte%2520Counts%2520in%2520Human%2520Volunteers%2520and%2520Demonstrates%2520the%2520Relevance%2520of%2520S1P1%2520in%2520Mediating%2520a%2520Transient%2520Heart%2520Rate%2520Reduction%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Gergely, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traebert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groenewegen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitaliti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sing, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttringer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumb, W. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltzmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallström, E.</span><span> </span><span class="NLM_article-title">The Selective S1P Receptor Modulator BAF312 Redirects Lymphocyte Distribution and Has Species-Specific Effects on Heart Rate: Translation from Preclinical to Clinical Studies</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1111%2Fj.1476-5381.2012.02061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=22646698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A280%3ADC%252BC38nnsVShuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=1035-1047&author=P.+Gergelyauthor=B.+Nuesslein-Hildesheimauthor=D.+Gueriniauthor=V.+Brinkmannauthor=M.+Traebertauthor=C.+Brunsauthor=S.+Panauthor=N.+S.+Grayauthor=K.+Hinterdingauthor=N.+G.+Cookeauthor=A.+Groenewegenauthor=A.+Vitalitiauthor=T.+Singauthor=O.+Luttringerauthor=J.+Yangauthor=A.+Gardinauthor=N.+Wangauthor=W.+J.+J.+Crumbauthor=M.+Saltzmannauthor=M.+Rosenbergauthor=E.+Wallstr%C3%B6m&title=The+Selective+S1P+Receptor+Modulator+BAF312+Redirects+Lymphocyte+Distribution+and+Has+Species-Specific+Effects+on+Heart+Rate%3A+Translation+from+Preclinical+to+Clinical+Studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate</span></div><div class="casAuthors">Gergely P; Nuesslein-Hildesheim B; Guerini D; Brinkmann V; Traebert M; Bruns C; Pan S; Gray N S; Hinterding K; Cooke N G; Groenewegen A; Vitaliti A; Sing T; Luttringer O; Yang J; Gardin A; Wang N; Crumb W J Jr; Saltzman M; Rosenberg M; Wallstrom E</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1035-47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  BAF312 is a next-generation sphingosine 1-phosphate (S1P) receptor modulator, selective for S1P(1) and S1P(5 ) receptors.  S1P(1) receptors are essential for lymphocyte egress from lymph nodes and a drug target in immune-mediated diseases.  Here, we have characterized the immunomodulatory potential of BAF312 and the S1P receptor-mediated effects on heart rate using preclinical and human data.  EXPERIMENTAL APPROACH:  BAF312 was tested in a rat experimental autoimmune encephalomyelitis (EAE) model.  Electrophysiological recordings of G-protein-coupled inwardly rectifying potassium (GIRK) channels were carried out in human atrial myocytes.  A Phase I multiple-dose trial studied the pharmacokinetics, pharmacodynamics and safety of BAF312 in 48 healthy subjects.  KEY RESULTS:  BAF312 effectively suppressed EAE in rats by internalizing S1P(1) receptors, rendering them insensitive to the egress signal from lymph nodes.  In healthy volunteers, BAF312 caused preferential decreases in CD4(+) T cells, T(naive) , T(central memory) and B cells within 4-6 h.  Cell counts returned to normal ranges within a week after stopping treatment, in line with the elimination half-life of BAF312.  Despite sparing S1P(3) receptors (associated with bradycardia in mice), BAF312 induced rapid, transient (day 1 only) bradycardia in humans.  BAF312-mediated activation of GIRK channels in human atrial myocytes can fully explain the bradycardia.  CONCLUSION AND IMPLICATIONS:  This study illustrates species-specific differences in S1P receptor specificity for first-dose cardiac effects.  Based on its profound but rapidly reversible inhibition of lymphocyte trafficking, BAF312 may have potential as a treatment for immune-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRE_xcO_ghmTOLt9HypzAgQfW6udTcc2ebrVP5SZI3i77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nnsVShuw%253D%253D&md5=82575d2c2d2eeba851919e468e407c48</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02061.x%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DTraebert%26aufirst%3DM.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DGroenewegen%26aufirst%3DA.%26aulast%3DVitaliti%26aufirst%3DA.%26aulast%3DSing%26aufirst%3DT.%26aulast%3DLuttringer%26aufirst%3DO.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DCrumb%26aufirst%3DW.%2BJ.%2BJ.%26aulast%3DSaltzmann%26aufirst%3DM.%26aulast%3DRosenberg%26aufirst%3DM.%26aulast%3DWallstr%25C3%25B6m%26aufirst%3DE.%26atitle%3DThe%2520Selective%2520S1P%2520Receptor%2520Modulator%2520BAF312%2520Redirects%2520Lymphocyte%2520Distribution%2520and%2520Has%2520Species-Specific%2520Effects%2520on%2520Heart%2520Rate%253A%2520Translation%2520from%2520Preclinical%2520to%2520Clinical%2520Studies%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26spage%3D1035%26epage%3D1047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Brossard, P.; Derendorf, H.; Xu, J.; Maatouk, H.; Halabi, A.; Dingemanse, J.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and Pharmacodynamics of Ponesimod, a Selective S1P Receptor Modulator, in the First-in-Human Study</span>.  <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span> [Online early access]. DOI <span class="refDoi"> DOI: 10.1111/bcp.12129</span> . Published Online: April 18, 2013. <a href="http://onlinelibrary.wiley.com/doi/10.1111/bcp.12129/abstract;jsessionid=BB7009BA3B1862F516180A38B14839B0.f03t03" class="extLink">http://onlinelibrary.wiley.com/doi/10.1111/bcp.12129/abstract;jsessionid=BB7009BA3B1862F516180A38B14839B0.f03t03</a></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1111%2Fbcp.12129" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Brossard%2C+P.%3B+Derendorf%2C+H.%3B+Xu%2C+J.%3B+Maatouk%2C+H.%3B+Halabi%2C+A.%3B+Dingemanse%2C+J.+Pharmacokinetics+and+Pharmacodynamics+of+Ponesimod%2C+a+Selective+S1P+Receptor+Modulator%2C+in+the+First-in-Human+Study.+Br.+J.+Clin.+Pharmacol.+%5BOnline+early+access%5D.+DOI+10.1111%2Fbcp.12129.+Published+Online%3A+April+18%2C+2013.+http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.1111%2Fbcp.12129%2Fabstract%3Bjsessionid%3DBB7009BA3B1862F516180A38B14839B0.f03t03"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fbcp.12129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.12129%26sid%3Dliteratum%253Aachs%26aulast%3DBrossard%26aufirst%3DP.%26atitle%3DPharmacokinetics%2520and%2520Pharmacodynamics%2520of%2520Ponesimod%252C%2520a%2520Selective%2520S1P%2520Receptor%2520Modulator%252C%2520in%2520the%2520First-in-Human%2520Study%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26doi%3D10.1111%2Fbcp.12129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Popov, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denisov, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatilov, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagryanskaya, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tkachev, A. V.</span><span> </span><span class="NLM_article-title">Synthesis of New Chiral Heterocycles of the Pyrazole and 2-Isoxazoline Types Form (+)-3-Carene</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">489</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=479-489&author=S.+A.+Popovauthor=A.+Y.+Denisovauthor=Y.+V.+Gatilovauthor=I.+Y.+Bagryanskayaauthor=A.+V.+Tkachev&title=Synthesis+of+New+Chiral+Heterocycles+of+the+Pyrazole+and+2-Isoxazoline+Types+Form+%28%2B%29-3-Carene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPopov%26aufirst%3DS.%2BA.%26aulast%3DDenisov%26aufirst%3DA.%2BY.%26aulast%3DGatilov%26aufirst%3DY.%2BV.%26aulast%3DBagryanskaya%26aufirst%3DI.%2BY.%26aulast%3DTkachev%26aufirst%3DA.%2BV.%26atitle%3DSynthesis%2520of%2520New%2520Chiral%2520Heterocycles%2520of%2520the%2520Pyrazole%2520and%25202-Isoxazoline%2520Types%2520Form%2520%2528%252B%2529-3-Carene%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1994%26volume%3D5%26spage%3D479%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Popov, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tkachev, A. V.</span><span> </span><span class="NLM_article-title">Synthesis of 2-Alkyl and 2-Aryl Pyrimidines from β-Chlorovinyl Ketones of Cyclopentanone Type</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1081%2FSCC-100000204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhvVCit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2001&pages=233-243&author=S.+A.+Popovauthor=A.+V.+Tkachev&title=Synthesis+of+2-Alkyl+and+2-Aryl+Pyrimidines+from+%CE%B2-Chlorovinyl+Ketones+of+Cyclopentanone+Type"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 2-alkyl- and 2-arylpyrimidines from β-chlorovinyl ketones of cyclopentanone type</span></div><div class="casAuthors">Popov, Sergey A.; Tkachev, Alexey V.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-243</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">Amidines react in the presence of NaHCO3 with β-chlorovinyl ketones, prepd. regioselectively by the reaction of 2-acetylcyclopentanone-type diketones with PPh3-CCl4 in 73-78% yield, to afford 2-alkyl(aryl)pyrimidines annelated with cyclopentane derivs. in 79-87% yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofaP86ttI7Z7Vg90H21EOLACvtfcHk0ljPlUnlm3Q_BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhvVCit74%253D&md5=0039c879074cb717439dbff147d32cf3</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1081%2FSCC-100000204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FSCC-100000204%26sid%3Dliteratum%253Aachs%26aulast%3DPopov%26aufirst%3DS.%2BA.%26aulast%3DTkachev%26aufirst%3DA.%2BV.%26atitle%3DSynthesis%2520of%25202-Alkyl%2520and%25202-Aryl%2520Pyrimidines%2520from%2520%25CE%25B2-Chlorovinyl%2520Ketones%2520of%2520Cyclopentanone%2520Type%26jtitle%3DSynth.%2520Commun.%26date%3D2001%26volume%3D31%26spage%3D233%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Gajcy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Librowski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochynski, S.</span><span> </span><span class="NLM_article-title">Concise Synthesis fo Non-protein Amino Acid from Natural Product <i>via</i> Schmidt Reaction</span> <span class="citation_source-journal">Lett. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.2174%2F157017809787893037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Oktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=186-188&author=K.+Gajcyauthor=T.+Librowskiauthor=S.+Lochynski&title=Concise+Synthesis+fo+Non-protein+Amino+Acid+from+Natural+Product+via+Schmidt+Reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Concise synthesis of non-protein amino acid from natural product via Schmidt reaction</span></div><div class="casAuthors">Gajcy, Kamila; Librowski, Tadeusz; Lochynski, Stanislaw</div><div class="citationInfo"><span class="NLM_cas:title">Letters in Organic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">186-188</span>CODEN:
                <span class="NLM_cas:coden">LOCEC7</span>;
        ISSN:<span class="NLM_cas:issn">1570-1786</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">In this work we aimed at finding a concise method for the design of the new pharmacol. active compd. (I), which is a precursor to obtaining non-protein amino acid (II) considered as GABA analog, furthermore it can be used to construct enantiopure, conformationally restricted peptides.  For this purpose the Schmidt reaction was applied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq52ArP3MWjzrVg90H21EOLACvtfcHk0ljPlUnlm3Q_BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Oktr8%253D&md5=8635d35fa2d0858af03d105a37ecb374</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.2174%2F157017809787893037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157017809787893037%26sid%3Dliteratum%253Aachs%26aulast%3DGajcy%26aufirst%3DK.%26aulast%3DLibrowski%26aufirst%3DT.%26aulast%3DLochynski%26aufirst%3DS.%26atitle%3DConcise%2520Synthesis%2520fo%2520Non-protein%2520Amino%2520Acid%2520from%2520Natural%2520Product%2520via%2520Schmidt%2520Reaction%26jtitle%3DLett.%2520Org.%2520Chem.%26date%3D2009%26volume%3D6%26spage%3D186%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Gajcy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pekala, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frackowiak-Wojtasek, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Librowski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochynski, S.</span><span> </span><span class="NLM_article-title">Stereochemistry of Terpene Derivatives. Part 7: Novel Rigidified Amino Acids from (+)-3-Carene Designed as Chiral GABA Analogues</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2015</span><span class="NLM_x">–</span> <span class="NLM_lpage">2020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=2015-2020&author=K.+Gajcyauthor=J.+Pekalaauthor=B.+Frackowiak-Wojtasekauthor=T.+Librowskiauthor=S.+Lochynski&title=Stereochemistry+of+Terpene+Derivatives.+Part+7%3A+Novel+Rigidified+Amino+Acids+from+%28%2B%29-3-Carene+Designed+as+Chiral+GABA+Analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGajcy%26aufirst%3DK.%26aulast%3DPekala%26aufirst%3DJ.%26aulast%3DFrackowiak-Wojtasek%26aufirst%3DB.%26aulast%3DLibrowski%26aufirst%3DT.%26aulast%3DLochynski%26aufirst%3DS.%26atitle%3DStereochemistry%2520of%2520Terpene%2520Derivatives.%2520Part%25207%253A%2520Novel%2520Rigidified%2520Amino%2520Acids%2520from%2520%2528%252B%2529-3-Carene%2520Designed%2520as%2520Chiral%2520GABA%2520Analogues%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2010%26volume%3D21%26spage%3D2015%26epage%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Appel, R.</span><span> </span><span class="NLM_article-title">Tertiary Phosphane/Tetrachloromethane, a Versatile Reagent for Chlorination, Dehydration, and P-N Linkage</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">811</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1975&pages=801-811&author=R.+Appel&title=Tertiary+Phosphane%2FTetrachloromethane%2C+a+Versatile+Reagent+for+Chlorination%2C+Dehydration%2C+and+P-N+Linkage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAppel%26aufirst%3DR.%26atitle%3DTertiary%2520Phosphane%252FTetrachloromethane%252C%2520a%2520Versatile%2520Reagent%2520for%2520Chlorination%252C%2520Dehydration%252C%2520and%2520P-N%2520Linkage%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1975%26volume%3D14%26spage%3D801%26epage%3D811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Popov, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tkachev, A. V.</span><span> </span><span class="NLM_article-title">New Chiral Agents for Resolution of Racemic <i>cis</i>-Permethric and <i>cis</i>-Z-Cyhalothric Acids</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1995&pages=1013-1018&author=S.+A.+Popovauthor=A.+V.+Tkachev&title=New+Chiral+Agents+for+Resolution+of+Racemic+cis-Permethric+and+cis-Z-Cyhalothric+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPopov%26aufirst%3DS.%2BA.%26aulast%3DTkachev%26aufirst%3DA.%2BV.%26atitle%3DNew%2520Chiral%2520Agents%2520for%2520Resolution%2520of%2520Racemic%2520cis-Permethric%2520and%2520cis-Z-Cyhalothric%2520Acids%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1995%26volume%3D6%26spage%3D1013%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Walkowicz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochynski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walkowicz, C.</span><span> </span><span class="NLM_article-title">Stereochemistry of Bicyclo[3.1.0]hexane Derivatives. Part XII. Optically Active 6,6-Dimethylbicyclo[3.1.0]hexan-2-ols</span> <span class="citation_source-journal">Pol. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADyaL38Xmt1ei" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1981&pages=135-140&author=M.+Walkowiczauthor=S.+Lochynskiauthor=C.+Walkowicz&title=Stereochemistry+of+Bicyclo%5B3.1.0%5Dhexane+Derivatives.+Part+XII.+Optically+Active+6%2C6-Dimethylbicyclo%5B3.1.0%5Dhexan-2-ols"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Stereochemistry of bicyclo[3.1.0]hexane derivatives.  Part XII.  Optically active 6,6-dimethylbicyclo[3.1.0]hexan-2-ols</span></div><div class="casAuthors">Walkowicz, Miroslaw; Lochynski, Stanislaw; Walkowicz, Cecylia</div><div class="citationInfo"><span class="NLM_cas:title">Polish Journal of Chemistry</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">135-40</span>CODEN:
                <span class="NLM_cas:coden">PJCHDQ</span>;
        ISSN:<span class="NLM_cas:issn">0137-5083</span>.
    </div><div class="casAbstract">The alcs. (1S,2S,5R)- and (1S,2R,5R)-I (R = OH) were prepd. by ozonolysis of (+)-3-carene, and alk. cyclization to (+)-2-acetyl-6,6-dimethylbicyclo[3.1.0]hex-2-ene, which was hydrogenated to I (R = Ac).  Baeyer-Villiger oxidn. of I (R = Ac) gave I (R = OAc) which on hydrogenolysis gave I (R = OH).  Oxidn. of I (R = OH) isomers gave the same ketone.  The stereochem. of various reaction steps is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwqn8SeHhG8rVg90H21EOLACvtfcHk0lgmTjAn5FgonQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xmt1ei&md5=ab399cf169cb0d9a864b64b92500b2e1</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalkowicz%26aufirst%3DM.%26aulast%3DLochynski%26aufirst%3DS.%26aulast%3DWalkowicz%26aufirst%3DC.%26atitle%3DStereochemistry%2520of%2520Bicyclo%255B3.1.0%255Dhexane%2520Derivatives.%2520Part%2520XII.%2520Optically%2520Active%25206%252C6-Dimethylbicyclo%255B3.1.0%255Dhexan-2-ols%26jtitle%3DPol.%2520J.%2520Chem.%26date%3D1981%26volume%3D55%26spage%3D135%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Malkov, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pernazza, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teply, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meghani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocovsky, P.</span><span> </span><span class="NLM_article-title">Synthesis of New Chiral 2,2′-Bipyridine Ligands and Their Application in Copper-Catalyzed Asymmetric Allylic Oxidation and Cyclopropanation</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">4727</span><span class="NLM_x">–</span> <span class="NLM_lpage">4742</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo034179i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=4727-4742&author=A.+V.+Malkovauthor=D.+Pernazzaauthor=M.+Bellauthor=M.+Bellaauthor=A.+Massaauthor=F.+Teplyauthor=P.+Meghaniauthor=P.+Kocovsky&title=Synthesis+of+New+Chiral+2%2C2%E2%80%B2-Bipyridine+Ligands+and+Their+Application+in+Copper-Catalyzed+Asymmetric+Allylic+Oxidation+and+Cyclopropanation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjo034179i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo034179i%26sid%3Dliteratum%253Aachs%26aulast%3DMalkov%26aufirst%3DA.%2BV.%26aulast%3DPernazza%26aufirst%3DD.%26aulast%3DBell%26aufirst%3DM.%26aulast%3DBella%26aufirst%3DM.%26aulast%3DMassa%26aufirst%3DA.%26aulast%3DTeply%26aufirst%3DF.%26aulast%3DMeghani%26aufirst%3DP.%26aulast%3DKocovsky%26aufirst%3DP.%26atitle%3DSynthesis%2520of%2520New%2520Chiral%25202%252C2%25E2%2580%25B2-Bipyridine%2520Ligands%2520and%2520Their%2520Application%2520in%2520Copper-Catalyzed%2520Asymmetric%2520Allylic%2520Oxidation%2520and%2520Cyclopropanation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D4727%26epage%3D4742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Boatman, D. P.; Schrader, T. O.; Semple, G.; Skinner, P. J.; Jung, J.-K.</span><span> </span><span class="NLM_article-title">Fused Pyrazole Derivatives and Methods of Treatment of Metabolic-Related Disorders Thereof</span>. WO2006069242, Jun 29,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=D.+P.+Boatman&author=T.+O.+Schrader&author=G.+Semple&author=P.+J.+Skinner&author=J.-K.+Jung&title=Fused+Pyrazole+Derivatives+and+Methods+of+Treatment+of+Metabolic-Related+Disorders+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoatman%26aufirst%3DD.%2BP.%26atitle%3DFused%2520Pyrazole%2520Derivatives%2520and%2520Methods%2520of%2520Treatment%2520of%2520Metabolic-Related%2520Disorders%2520Thereof%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Boatman, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrader, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherrier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semple, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sage, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taggart, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carballo-Jane, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richman, J. G.</span><span> </span><span class="NLM_article-title">Potent Tricyclic Pyrazole Tetrazole Agonists of the Nicotinic Acid Receptor (GPR109a)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2797</span><span class="NLM_x">–</span> <span class="NLM_lpage">2800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2797-2800&author=P.+D.+Boatmanauthor=T.+O.+Schraderauthor=M.+Kasemauthor=B.+R.+Johnsonauthor=P.+J.+Skinnerauthor=J.-K.+Jungauthor=J.+Xuauthor=M.+C.+Cherrierauthor=P.+J.+Webbauthor=G.+Sempleauthor=C.+R.+Sageauthor=J.+Knudsenauthor=R.+Chenauthor=A.+K.+Taggartauthor=E.+Carballo-Janeauthor=J.+G.+Richman&title=Potent+Tricyclic+Pyrazole+Tetrazole+Agonists+of+the+Nicotinic+Acid+Receptor+%28GPR109a%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoatman%26aufirst%3DP.%2BD.%26aulast%3DSchrader%26aufirst%3DT.%2BO.%26aulast%3DKasem%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DB.%2BR.%26aulast%3DSkinner%26aufirst%3DP.%2BJ.%26aulast%3DJung%26aufirst%3DJ.-K.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DCherrier%26aufirst%3DM.%2BC.%26aulast%3DWebb%26aufirst%3DP.%2BJ.%26aulast%3DSemple%26aufirst%3DG.%26aulast%3DSage%26aufirst%3DC.%2BR.%26aulast%3DKnudsen%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DTaggart%26aufirst%3DA.%2BK.%26aulast%3DCarballo-Jane%26aufirst%3DE.%26aulast%3DRichman%26aufirst%3DJ.%2BG.%26atitle%3DPotent%2520Tricyclic%2520Pyrazole%2520Tetrazole%2520Agonists%2520of%2520the%2520Nicotinic%2520Acid%2520Receptor%2520%2528GPR109a%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2797%26epage%3D2800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Paine, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buller, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erikson, E. E.</span><span> </span><span class="NLM_article-title">Regioselectivity of Pyrrole Synthesis from Diethyl Aminomalonate and 1,3-Diketones: Further Observations</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3986</span><span class="NLM_x">–</span> <span class="NLM_lpage">3993</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00227a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1987&pages=3986-3993&author=J.+B.+Paineauthor=J.+R.+Broughauthor=K.+K.+Bullerauthor=E.+E.+Erikson&title=Regioselectivity+of+Pyrrole+Synthesis+from+Diethyl+Aminomalonate+and+1%2C3-Diketones%3A+Further+Observations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjo00227a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00227a009%26sid%3Dliteratum%253Aachs%26aulast%3DPaine%26aufirst%3DJ.%2BB.%26aulast%3DBrough%26aufirst%3DJ.%2BR.%26aulast%3DBuller%26aufirst%3DK.%2BK.%26aulast%3DErikson%26aufirst%3DE.%2BE.%26atitle%3DRegioselectivity%2520of%2520Pyrrole%2520Synthesis%2520from%2520Diethyl%2520Aminomalonate%2520and%25201%252C3-Diketones%253A%2520Further%2520Observations%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1987%26volume%3D52%26spage%3D3986%26epage%3D3993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Bolli, M.; Bur, D.; Clozel, M.; Fischli, W.; Lehmann, D.; Mathys, B.; Mueller, C.; Nayler, O.; Scherz, M.; Weller, T.</span><span> </span><span class="NLM_article-title">4-Carbonyl Substituted 1,1,2-Trimethyl-1A,4,5,5A-Tetrahydro-1H-4-Aza-Cyclopropa[a]pentalene Derivatives as Agonists for the G-Protein Coupled Receptor S1P1/EDG1 and Immunsuppressant Agents</span>. WO2005123677, Dec 29,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=M.+Bolli&author=D.+Bur&author=M.+Clozel&author=W.+Fischli&author=D.+Lehmann&author=B.+Mathys&author=C.+Mueller&author=O.+Nayler&author=M.+Scherz&author=T.+Weller&title=4-Carbonyl+Substituted+1%2C1%2C2-Trimethyl-1A%2C4%2C5%2C5A-Tetrahydro-1H-4-Aza-Cyclopropa%5Ba%5Dpentalene+Derivatives+as+Agonists+for+the+G-Protein+Coupled+Receptor+S1P1%2FEDG1+and+Immunsuppressant+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%26atitle%3D4-Carbonyl%2520Substituted%25201%252C1%252C2-Trimethyl-1A%252C4%252C5%252C5A-Tetrahydro-1H-4-Aza-Cyclopropa%255Ba%255Dpentalene%2520Derivatives%2520as%2520Agonists%2520for%2520the%2520G-Protein%2520Coupled%2520Receptor%2520S1P1%252FEDG1%2520and%2520Immunsuppressant%2520Agents%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Alberola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrosa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente, M.</span><span> </span><span class="NLM_article-title">The Reaction of β-Aminoenones with α-Amino Derivatives. Synthesis of 2-Functionalized Pyrroles</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1049</span><span class="NLM_x">–</span> <span class="NLM_lpage">1058</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1990&pages=1049-1058&author=A.+Alberolaauthor=J.+M.+Andresauthor=A.+Gonzalezauthor=R.+Pedrosaauthor=M.+Vicente&title=The+Reaction+of+%CE%B2-Aminoenones+with+%CE%B1-Amino+Derivatives.+Synthesis+of+2-Functionalized+Pyrroles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlberola%26aufirst%3DA.%26aulast%3DAndres%26aufirst%3DJ.%2BM.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DPedrosa%26aufirst%3DR.%26aulast%3DVicente%26aufirst%3DM.%26atitle%3DThe%2520Reaction%2520of%2520%25CE%25B2-Aminoenones%2520with%2520%25CE%25B1-Amino%2520Derivatives.%2520Synthesis%2520of%25202-Functionalized%2520Pyrroles%26jtitle%3DHeterocycles%26date%3D1990%26volume%3D31%26spage%3D1049%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Hombrecher, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horter, G.</span><span> </span><span class="NLM_article-title">Synthesis of Pyrroles via Ethyl N-(3-Oxo-1-alkenyl)glycinates</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">1990</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1055%2Fs-1990-26883" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1990&publication_year=1990&pages=389-391&author=H.+K.+Hombrecherauthor=G.+Horter&title=Synthesis+of+Pyrroles+via+Ethyl+N-%283-Oxo-1-alkenyl%29glycinates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1055%2Fs-1990-26883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1990-26883%26sid%3Dliteratum%253Aachs%26aulast%3DHombrecher%26aufirst%3DH.%2BK.%26aulast%3DHorter%26aufirst%3DG.%26atitle%3DSynthesis%2520of%2520Pyrroles%2520via%2520Ethyl%2520N-%25283-Oxo-1-alkenyl%2529glycinates%26jtitle%3DSynthesis%26date%3D1990%26volume%3D1990%26spage%3D389%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Alberola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrosa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradanos, P.</span><span> </span><span class="NLM_article-title">Regioselective Synthesis of 2-Functionalized Thiophenes by Condensation of α-Mercapto Compounds with β-Amino Enone Derivatives</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2537</span><span class="NLM_x">–</span> <span class="NLM_lpage">2547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1080%2F00397919008053203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADyaK3MXotFCltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1990&pages=2537-2547&author=A.+Alberolaauthor=J.+M.+Andresauthor=A.+Gonzalezauthor=R.+Pedrosaauthor=P.+Pradanos&title=Regioselective+Synthesis+of+2-Functionalized+Thiophenes+by+Condensation+of+%CE%B1-Mercapto+Compounds+with+%CE%B2-Amino+Enone+Derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective synthesis of 2-functionalized thiophenes by condensation of α-mercapto compounds with β-amino enone derivatives</span></div><div class="casAuthors">Alberola, Angel; Andres, Jose M.; Gonzalez, Alfonso; Pedrosa, Rafael; Pradanos, Pedro</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2537-47</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">Reaction of R1COCR2:CR3Cl (R1 = Me, Ph; R2 = H, Me; R3 = Me, Ph) with NaSCH2CO2Et gave 50-70% thiophenes I (R1-R3 as above, R4 = OEt).  R1COCH:CHN+Et3 (R1 = Et, Ph, 4-MeOC6H4, 4-O2NC6H4, Me2CH) reacted with HSCH2COR4 (R4 = HEt, Me, Ph) to give 70-90% R1COCH:CHSCH2COR4, which on reaction with EtONa/EtOH gave I (R1 as above, R2 = R3 = H, R4 = OEt, Me, Ph).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcKt5xsJdc5LVg90H21EOLACvtfcHk0lgn0yubqxID2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXotFCltg%253D%253D&md5=4d01fc252b1a3cad0f3ff24fbf19a50f</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1080%2F00397919008053203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919008053203%26sid%3Dliteratum%253Aachs%26aulast%3DAlberola%26aufirst%3DA.%26aulast%3DAndres%26aufirst%3DJ.%2BM.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DPedrosa%26aufirst%3DR.%26aulast%3DPradanos%26aufirst%3DP.%26atitle%3DRegioselective%2520Synthesis%2520of%25202-Functionalized%2520Thiophenes%2520by%2520Condensation%2520of%2520%25CE%25B1-Mercapto%2520Compounds%2520with%2520%25CE%25B2-Amino%2520Enone%2520Derivatives%26jtitle%3DSynth.%2520Commun.%26date%3D1990%26volume%3D20%26spage%3D2537%26epage%3D2547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Bolli, M.; Bur, D.; Clozel, M.; Fischli, W.; Lehmann, D.; Mathys, B.; Mueller, C.; Nayler, O.; Scherz, M.; Weller, T.</span><span> </span><span class="NLM_article-title">1, 1A, 5, 5A-Tetrahydro-3-thia-cycloprop[a] pentalenes: Tricyclic Thiophene Derivatives as S1P1/EDG1 Receptor Agonists</span>. WO2006010544, Feb 2,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Bolli&author=D.+Bur&author=M.+Clozel&author=W.+Fischli&author=D.+Lehmann&author=B.+Mathys&author=C.+Mueller&author=O.+Nayler&author=M.+Scherz&author=T.+Weller&title=1%2C+1A%2C+5%2C+5A-Tetrahydro-3-thia-cycloprop%5Ba%5D+pentalenes%3A+Tricyclic+Thiophene+Derivatives+as+S1P1%2FEDG1+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%26atitle%3D1%252C%25201A%252C%25205%252C%25205A-Tetrahydro-3-thia-cycloprop%255Ba%255D%2520pentalenes%253A%2520Tricyclic%2520Thiophene%2520Derivatives%2520as%2520S1P1%252FEDG1%2520Receptor%2520Agonists%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Bolli, M.; Lehmann, D.; Mathys, B.; Mueller, C.; Nayler, O.; Velker, J.; Weller, T.</span><span> </span><span class="NLM_article-title">Novel Thiophene Derivatives</span>. WO2006100635, Sep 28,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Bolli&author=D.+Lehmann&author=B.+Mathys&author=C.+Mueller&author=O.+Nayler&author=J.+Velker&author=T.+Weller&title=Novel+Thiophene+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%26atitle%3DNovel%2520Thiophene%2520Derivatives%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Diana, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudewicz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevear, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldous, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldous, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draper, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutko, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oglesby, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkots, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czerniak, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roland, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppermann, J.</span><span> </span><span class="NLM_article-title">Picornavirus Inhibitors: Trifluoromethyl Substitution Provides a Global Protective Effect agains Hepatic Metabolism</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1371</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00008a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1355-1371&author=G.+D.+Dianaauthor=P.+Rudewiczauthor=D.+C.+Pevearauthor=T.+J.+Nitzauthor=S.+C.+Aldousauthor=D.+J.+Aldousauthor=D.+T.+Robinsonauthor=R.+Draperauthor=F.+J.+Dutkoauthor=C.+Aldiauthor=G.+Gendronauthor=R.+C.+Oglesbyauthor=D.+L.+Volkotsauthor=M.+Reumanauthor=R.+R.+Baileyauthor=R.+Czerniakauthor=T.+Blockauthor=R.+Rolandauthor=J.+Oppermann&title=Picornavirus+Inhibitors%3A+Trifluoromethyl+Substitution+Provides+a+Global+Protective+Effect+agains+Hepatic+Metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm00008a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00008a014%26sid%3Dliteratum%253Aachs%26aulast%3DDiana%26aufirst%3DG.%2BD.%26aulast%3DRudewicz%26aufirst%3DP.%26aulast%3DPevear%26aufirst%3DD.%2BC.%26aulast%3DNitz%26aufirst%3DT.%2BJ.%26aulast%3DAldous%26aufirst%3DS.%2BC.%26aulast%3DAldous%26aufirst%3DD.%2BJ.%26aulast%3DRobinson%26aufirst%3DD.%2BT.%26aulast%3DDraper%26aufirst%3DR.%26aulast%3DDutko%26aufirst%3DF.%2BJ.%26aulast%3DAldi%26aufirst%3DC.%26aulast%3DGendron%26aufirst%3DG.%26aulast%3DOglesby%26aufirst%3DR.%2BC.%26aulast%3DVolkots%26aufirst%3DD.%2BL.%26aulast%3DReuman%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DR.%2BR.%26aulast%3DCzerniak%26aufirst%3DR.%26aulast%3DBlock%26aufirst%3DT.%26aulast%3DRoland%26aufirst%3DR.%26aulast%3DOppermann%26aufirst%3DJ.%26atitle%3DPicornavirus%2520Inhibitors%253A%2520Trifluoromethyl%2520Substitution%2520Provides%2520a%2520Global%2520Protective%2520Effect%2520agains%2520Hepatic%2520Metabolism%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D1355%26epage%3D1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Bolli, M.; Lehmann, D.; Mathys, B.; Mueller, C.; Nayler, O.; Velker, J.; Weller, T.</span><span> </span><span class="NLM_article-title">Novel Thiophene Derivatives as Sphingosine-1-phosphate Receptor Agonists</span>. WO2006100633, Sep 28,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Bolli&author=D.+Lehmann&author=B.+Mathys&author=C.+Mueller&author=O.+Nayler&author=J.+Velker&author=T.+Weller&title=Novel+Thiophene+Derivatives+as+Sphingosine-1-phosphate+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%26atitle%3DNovel%2520Thiophene%2520Derivatives%2520as%2520Sphingosine-1-phosphate%2520Receptor%2520Agonists%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Rasmussen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawesson, S.-O.</span><span> </span><span class="NLM_article-title">Studies on Organophosphorus Compounds XLIX. An Improved Method for the Preparation of 2,5-Disubstituted 1,3,4-Thiadiazoles and 1,3,4-Thiadiazole-2(3H)-Thiones</span> <span class="citation_source-journal">Bull. Soc. Chim. Fr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">1985</span><span class="NLM_x">, </span> <span class="NLM_fpage">II/62</span><span class="NLM_x">–</span> <span class="NLM_lpage">II/65</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1985&publication_year=1985&pages=II%2F62-II%2F65&author=P.+B.+Rasmussenauthor=U.+Pedersenauthor=I.+Thomsenauthor=B.+Ydeauthor=S.-O.+Lawesson&title=Studies+on+Organophosphorus+Compounds+XLIX.+An+Improved+Method+for+the+Preparation+of+2%2C5-Disubstituted+1%2C3%2C4-Thiadiazoles+and+1%2C3%2C4-Thiadiazole-2%283H%29-Thiones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRasmussen%26aufirst%3DP.%2BB.%26aulast%3DPedersen%26aufirst%3DU.%26aulast%3DThomsen%26aufirst%3DI.%26aulast%3DYde%26aufirst%3DB.%26aulast%3DLawesson%26aufirst%3DS.-O.%26atitle%3DStudies%2520on%2520Organophosphorus%2520Compounds%2520XLIX.%2520An%2520Improved%2520Method%2520for%2520the%2520Preparation%2520of%25202%252C5-Disubstituted%25201%252C3%252C4-Thiadiazoles%2520and%25201%252C3%252C4-Thiadiazole-2%25283H%2529-Thiones%26jtitle%3DBull.%2520Soc.%2520Chim.%2520Fr.%26date%3D1985%26volume%3D1985%26spage%3DII%252F62%26epage%3DII%252F65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Kiryanov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seed, A. J.</span><span> </span><span class="NLM_article-title">Synthesis of 2-Alkoxy-Substituted Thiophenes, 1,3-Thiazoles, and Related S-Heterocycles via Lawesson’s Reagent-Mediated Cyclization under Microwave Irradiation: Applications for Liquid Crystal Synthesis</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">7925</span><span class="NLM_x">–</span> <span class="NLM_lpage">7929</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo016063x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=7925-7929&author=A.+A.+Kiryanovauthor=P.+Sampsonauthor=A.+J.+Seed&title=Synthesis+of+2-Alkoxy-Substituted+Thiophenes%2C+1%2C3-Thiazoles%2C+and+Related+S-Heterocycles+via+Lawesson%E2%80%99s+Reagent-Mediated+Cyclization+under+Microwave+Irradiation%3A+Applications+for+Liquid+Crystal+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjo016063x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo016063x%26sid%3Dliteratum%253Aachs%26aulast%3DKiryanov%26aufirst%3DA.%2BA.%26aulast%3DSampson%26aufirst%3DP.%26aulast%3DSeed%26aufirst%3DA.%2BJ.%26atitle%3DSynthesis%2520of%25202-Alkoxy-Substituted%2520Thiophenes%252C%25201%252C3-Thiazoles%252C%2520and%2520Related%2520S-Heterocycles%2520via%2520Lawesson%25E2%2580%2599s%2520Reagent-Mediated%2520Cyclization%2520under%2520Microwave%2520Irradiation%253A%2520Applications%2520for%2520Liquid%2520Crystal%2520Synthesis%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D7925%26epage%3D7929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Brain, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, J. M.</span><span> </span><span class="NLM_article-title">Rapid Synthesis of Oxazoles under Microwave Conditions</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1999</span><span class="NLM_x">, </span> <span class="NLM_fpage">1642</span><span class="NLM_x">–</span> <span class="NLM_lpage">1644</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1999&publication_year=1999&pages=1642-1644&author=C.+T.+Brainauthor=J.+M.+Paul&title=Rapid+Synthesis+of+Oxazoles+under+Microwave+Conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrain%26aufirst%3DC.%2BT.%26aulast%3DPaul%26aufirst%3DJ.%2BM.%26atitle%3DRapid%2520Synthesis%2520of%2520Oxazoles%2520under%2520Microwave%2520Conditions%26jtitle%3DSynlett%26date%3D1999%26volume%3D1999%26spage%3D1642%26epage%3D1644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Holub, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Toole-Colin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getzel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argenti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalglish, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miott, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glersaye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCranor, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkowitz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukens, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumpe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupton, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnham, B. S.</span><span> </span><span class="NLM_article-title">Lipid-Lower Effects of Ethyl 2-Phenacyl-3-aryl-1H-pyrrole-4-carboxylates in Rodents</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2004</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2004&publication_year=2004&pages=135-157&author=J.+M.+Holubauthor=K.+O%E2%80%99Toole-Colinauthor=A.+Getzelauthor=A.+Argentiauthor=M.+A.+Evansauthor=D.+C.+Smithauthor=G.+A.+Dalglishauthor=S.+Rifatauthor=D.+L.+Wilsonauthor=B.+M.+Taylorauthor=U.+Miottauthor=J.+Glersayeauthor=K.+S.+Lamauthor=B.+J.+McCranorauthor=J.+D.+Berkowitzauthor=R.+B.+Millerauthor=J.+R.+Lukensauthor=K.+Krumpeauthor=J.+T.+Guptonauthor=B.+S.+Burnham&title=Lipid-Lower+Effects+of+Ethyl+2-Phenacyl-3-aryl-1H-pyrrole-4-carboxylates+in+Rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolub%26aufirst%3DJ.%2BM.%26aulast%3DO%25E2%2580%2599Toole-Colin%26aufirst%3DK.%26aulast%3DGetzel%26aufirst%3DA.%26aulast%3DArgenti%26aufirst%3DA.%26aulast%3DEvans%26aufirst%3DM.%2BA.%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DDalglish%26aufirst%3DG.%2BA.%26aulast%3DRifat%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DD.%2BL.%26aulast%3DTaylor%26aufirst%3DB.%2BM.%26aulast%3DMiott%26aufirst%3DU.%26aulast%3DGlersaye%26aufirst%3DJ.%26aulast%3DLam%26aufirst%3DK.%2BS.%26aulast%3DMcCranor%26aufirst%3DB.%2BJ.%26aulast%3DBerkowitz%26aufirst%3DJ.%2BD.%26aulast%3DMiller%26aufirst%3DR.%2BB.%26aulast%3DLukens%26aufirst%3DJ.%2BR.%26aulast%3DKrumpe%26aufirst%3DK.%26aulast%3DGupton%26aufirst%3DJ.%2BT.%26aulast%3DBurnham%26aufirst%3DB.%2BS.%26atitle%3DLipid-Lower%2520Effects%2520of%2520Ethyl%25202-Phenacyl-3-aryl-1H-pyrrole-4-carboxylates%2520in%2520Rodents%26jtitle%3DMolecules%26date%3D2004%26volume%3D2004%26spage%3D135%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Hedegaard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortensen, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawesson, S.-O.</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3853</span><span class="NLM_x">–</span> <span class="NLM_lpage">3859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hedegaard%2C+B.%3B+Mortensen%2C+J.+Z.%3B+Lawesson%2C+S.-O.Tetrahedron+1971%2C+27%2C+3853%E2%80%933859"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHedegaard%26aufirst%3DB.%26aulast%3DMortensen%26aufirst%3DJ.%2BZ.%26aulast%3DLawesson%26aufirst%3DS.-O.%26jtitle%3DTetrahedron%26date%3D1971%26volume%3D27%26spage%3D3853%26epage%3D3859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Zécri, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landrum, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span> </span><span class="NLM_article-title">Pyrazole Derived from (+)-3-Carene; a Novel Potent, Selective Scaffold for Sphingosine-1-phosphate (S1P<sub>1</sub>) Receptor Agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=35-37&author=F.+J.+Z%C3%A9criauthor=R.+Albertauthor=G.+Landrumauthor=K.+Hinterdingauthor=N.+G.+Cookeauthor=D.+Gueriniauthor=M.+Streiffauthor=C.+Brunsauthor=B.+Nuesslein-Hildesheim&title=Pyrazole+Derived+from+%28%2B%29-3-Carene%3B+a+Novel+Potent%2C+Selective+Scaffold+for+Sphingosine-1-phosphate+%28S1P1%29+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZ%25C3%25A9cri%26aufirst%3DF.%2BJ.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DLandrum%26aufirst%3DG.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DStreiff%26aufirst%3DM.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26atitle%3DPyrazole%2520Derived%2520from%2520%2528%252B%2529-3-Carene%253B%2520a%2520Novel%2520Potent%252C%2520Selective%2520Scaffold%2520for%2520Sphingosine-1-phosphate%2520%2528S1P1%2529%2520Receptor%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D35%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P1 Receptor Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4198</span><span class="NLM_x">–</span> <span class="NLM_lpage">4211</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100181s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4198-4211&author=M.+H.+Bolliauthor=S.+Abeleauthor=C.+Binkertauthor=R.+Bravoauthor=S.+Buchmannauthor=D.+Burauthor=J.+Gatfieldauthor=P.+Hessauthor=C.+Kohlauthor=C.+Mangoldauthor=B.+Mathysauthor=K.+Menyhartauthor=C.+M%C3%BCllerauthor=O.+Naylerauthor=M.+Scherzauthor=G.+Schmidtauthor=V.+Sippelauthor=B.+Steinerauthor=D.+Strasserauthor=A.+Treiberauthor=T.+Weller&title=2-Imino-thiazolidin-4-one+Derivatives+as+Potent%2C+Orally+Active+S1P1+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm100181s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100181s%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBuchmann%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DMangold%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DMenyhart%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSippel%26aufirst%3DV.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DStrasser%26aufirst%3DD.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3D2-Imino-thiazolidin-4-one%2520Derivatives%2520as%2520Potent%252C%2520Orally%2520Active%2520S1P1%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4198%26epage%3D4211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Bolli, M. H.; Velker, J.; Müller, C.; Mathys, B.; Birker, M.; Bravo, R.; Bur, D.; de Kanter, R.; Hess, P.; Kohl, C.; Lehmann, D.; Meyer, S.; Nayler, O.; Rey, M.; Scherz, M.; Steiner, B.</span>, unpublished work.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bolli%2C+M.+H.%3B+Velker%2C+J.%3B+M%C3%BCller%2C+C.%3B+Mathys%2C+B.%3B+Birker%2C+M.%3B+Bravo%2C+R.%3B+Bur%2C+D.%3B+de+Kanter%2C+R.%3B+Hess%2C+P.%3B+Kohl%2C+C.%3B+Lehmann%2C+D.%3B+Meyer%2C+S.%3B+Nayler%2C+O.%3B+Rey%2C+M.%3B+Scherz%2C+M.%3B+Steiner%2C+B.%2C+unpublished+work."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Brockway, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azar, S. H.</span><span> </span><span class="NLM_article-title">A New Method for Continuous Chronic Measurement and Recording of Blood Pressure, Heart Rate and Activity in the Rat via Radio-Telemetry</span> <span class="citation_source-journal">Clin. Exp. Hypertens., Part A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">A13</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">895</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.3109%2F10641969109042094" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A13&publication_year=1991&pages=885-895&author=B.+P.+Brockwayauthor=P.+A.+Millsauthor=S.+H.+Azar&title=A+New+Method+for+Continuous+Chronic+Measurement+and+Recording+of+Blood+Pressure%2C+Heart+Rate+and+Activity+in+the+Rat+via+Radio-Telemetry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.3109%2F10641969109042094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10641969109042094%26sid%3Dliteratum%253Aachs%26aulast%3DBrockway%26aufirst%3DB.%2BP.%26aulast%3DMills%26aufirst%3DP.%2BA.%26aulast%3DAzar%26aufirst%3DS.%2BH.%26atitle%3DA%2520New%2520Method%2520for%2520Continuous%2520Chronic%2520Measurement%2520and%2520Recording%2520of%2520Blood%2520Pressure%252C%2520Heart%2520Rate%2520and%2520Activity%2520in%2520the%2520Rat%2520via%2520Radio-Telemetry%26jtitle%3DClin.%2520Exp.%2520Hypertens.%252C%2520Part%2520A%26date%3D1991%26volume%3DA13%26spage%3D885%26epage%3D895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Guiol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledoussal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgé, J.-M.</span><span> </span><span class="NLM_article-title">A Radiotelemetry System for Chronic Measurement of Blood Pressure and Heart Rate in the Unrestrained Rat Validation of the Method</span> <span class="citation_source-journal">J. Pharmcol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1016%2F1056-8719%2892%2990054-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=1482791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A280%3ADyaK3s7ivFyjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1992&pages=99-105&author=C.+Guiolauthor=C.+Ledoussalauthor=J.-M.+Surg%C3%A9&title=A+Radiotelemetry+System+for+Chronic+Measurement+of+Blood+Pressure+and+Heart+Rate+in+the+Unrestrained+Rat+Validation+of+the+Method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">A radiotelemetry system for chronic measurement of blood pressure and heart rate in the unrestrained rat validation of the method</span></div><div class="casAuthors">Guiol C; Ledoussal C; Surge J M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacological and toxicological methods</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-105</span>
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">Chronic measurements of systemic arterial blood pressure and heart rate via a chronically implanted telemetric transmitter in unrestrained rats, was validated in a three-phase study.  In the first part, week-to-week variability of systolic, diastolic, and mean arterial pressures, and heart rate was found to be minimal over the course of nine weeks.  In the second part, the reproducibility of cardiovascular response to three successive administration of sotalol, an antihypertensive agent, was studied.  In the last part, cardiovascular parameters determined by telemetry were compared to those obtained by direct arterial catheterization and showed a good linear correlation between those two methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8i2XCcqJVRr5oR8RchjrrfW6udTcc2eaTDpYDuXt04Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s7ivFyjug%253D%253D&md5=f501e12d4c69e9c5d9bbf7a85d1d5224</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2F1056-8719%2892%2990054-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1056-8719%252892%252990054-5%26sid%3Dliteratum%253Aachs%26aulast%3DGuiol%26aufirst%3DC.%26aulast%3DLedoussal%26aufirst%3DC.%26aulast%3DSurg%25C3%25A9%26aufirst%3DJ.-M.%26atitle%3DA%2520Radiotelemetry%2520System%2520for%2520Chronic%2520Measurement%2520of%2520Blood%2520Pressure%2520and%2520Heart%2520Rate%2520in%2520the%2520Unrestrained%2520Rat%2520Validation%2520of%2520the%2520Method%26jtitle%3DJ.%2520Pharmcol.%2520Toxicol.%2520Methods%26date%3D1992%26volume%3D28%26spage%3D99%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, J.-P.</span><span> </span><span class="NLM_article-title">Telemetry Monitoring of Pulmonary Arterial Pressure in Freely Moving Rats</span> <span class="citation_source-journal">J. Appl. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1032</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1996&pages=1027-1032&author=P.+Hessauthor=M.+Clozelauthor=J.-P.+Clozel&title=Telemetry+Monitoring+of+Pulmonary+Arterial+Pressure+in+Freely+Moving+Rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DP.%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DClozel%26aufirst%3DJ.-P.%26atitle%3DTelemetry%2520Monitoring%2520of%2520Pulmonary%2520Arterial%2520Pressure%2520in%2520Freely%2520Moving%2520Rats%26jtitle%3DJ.%2520Appl.%2520Physiol.%26date%3D1996%26volume%3D81%26spage%3D1027%26epage%3D1032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Grimont, J.; Le Goff, F.; Bourquin, G.; Silva, J.</span> Quality Assessment and Concentration Determination of Actelion’s Compound Solutions by Automated LCMS and Quantitative NMR. MipTec - The Leading European Event for Drug Discovery, Basel, Switzerland, Sept 20–24,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Grimont%2C+J.%3B+Le+Goff%2C+F.%3B+Bourquin%2C+G.%3B+Silva%2C+J.+Quality+Assessment+and+Concentration+Determination+of+Actelion%E2%80%99s+Compound+Solutions+by+Automated+LCMS+and+Quantitative+NMR.+MipTec+-+The+Leading+European+Event+for+Drug+Discovery%2C+Basel%2C+Switzerland%2C+Sept+20%E2%80%9324%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DGrimont%26aufirst%3DJ.%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 16 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>  . </span><span class="cited-content_cbyCitation_article-title">Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5267-5289. <a href="https://doi.org/10.1021/acs.jmedchem.6b01575" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01575%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DModulators%252Bof%252BSphingosine-1-phosphate%252BPathway%252BBiology%25253A%252BRecent%252BAdvances%252Bof%252BSphingosine-1-phosphate%252BReceptor%252B1%252B%252528S1P1%252529%252BAgonists%252Band%252BFuture%252BPerspectives%26aulast%3DDyckman%26aufirst%3DAlaric%2BJ.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D24102016%26date%3D30032017%26date%3D13072017%26date%3D14032017%26volume%3D60%26issue%3D13%26spage%3D5267%26epage%3D5289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emmanuel H.  Demont</span>, <span class="hlFld-ContribAuthor ">James M.  Bailey</span>, <span class="hlFld-ContribAuthor ">Rino A.  Bit</span>, <span class="hlFld-ContribAuthor ">Jack A.  Brown</span>, <span class="hlFld-ContribAuthor ">Colin A.  Campbell</span>, <span class="hlFld-ContribAuthor ">Nigel  Deeks</span>, <span class="hlFld-ContribAuthor ">Simon J.  Dowell</span>, <span class="hlFld-ContribAuthor ">Colin  Eldred</span>, <span class="hlFld-ContribAuthor ">Pam  Gaskin</span>, <span class="hlFld-ContribAuthor ">James R. J.  Gray</span>, <span class="hlFld-ContribAuthor ">Andrea  Haynes</span>, <span class="hlFld-ContribAuthor ">David J.  Hirst</span>, <span class="hlFld-ContribAuthor ">Duncan S.  Holmes</span>, <span class="hlFld-ContribAuthor ">Umesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Mary A.  Morse</span>, <span class="hlFld-ContribAuthor ">Greg J.  Osborne</span>, <span class="hlFld-ContribAuthor ">Jessica F.  Renaux</span>, <span class="hlFld-ContribAuthor ">Gail A. L.  Seal</span>, <span class="hlFld-ContribAuthor ">Chris A.  Smethurst</span>, <span class="hlFld-ContribAuthor ">Simon  Taylor</span>, <span class="hlFld-ContribAuthor ">Robert  Watson</span>, <span class="hlFld-ContribAuthor ">Robert  Willis</span>, and <span class="hlFld-ContribAuthor ">Jason  Witherington</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (3)
                                     , 1003-1020. <a href="https://doi.org/10.1021/acs.jmedchem.5b01512" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01512%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BTetrahydropyrazolopyridine%252Bas%252BSphingosine%252B1-Phosphate%252BReceptor%252B3%252B%252528S1P3%252529-Sparing%252BS1P1%252BAgonists%252BActive%252Bat%252BLow%252BOral%252BDoses%26aulast%3DDemont%26aufirst%3DEmmanuel%2BH.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D29092015%26date%3D22012016%26date%3D11022016%26date%3D11012016%26volume%3D59%26issue%3D3%26spage%3D1003%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>, <span class="hlFld-ContribAuthor ">Jörg  Velker</span>, <span class="hlFld-ContribAuthor ">Claus  Müller</span>, <span class="hlFld-ContribAuthor ">Boris  Mathys</span>, <span class="hlFld-ContribAuthor ">Magdalena  Birker</span>, <span class="hlFld-ContribAuthor ">Roberto  Bravo</span>, <span class="hlFld-ContribAuthor ">Daniel  Bur</span>, <span class="hlFld-ContribAuthor ">Ruben  de Kanter</span>, <span class="hlFld-ContribAuthor ">Patrick  Hess</span>, <span class="hlFld-ContribAuthor ">Christopher  Kohl</span>, <span class="hlFld-ContribAuthor ">David  Lehmann</span>, <span class="hlFld-ContribAuthor ">Solange  Meyer</span>, <span class="hlFld-ContribAuthor ">Oliver  Nayler</span>, <span class="hlFld-ContribAuthor ">Markus  Rey</span>, <span class="hlFld-ContribAuthor ">Michael  Scherz</span>, and <span class="hlFld-ContribAuthor ">Beat  Steiner</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel S1P1 Receptor Agonists - Part 2: From Bicyclo[3.1.0]hexane-Fused Thiophenes to Isobutyl Substituted Thiophenes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (1)
                                     , 78-97. <a href="https://doi.org/10.1021/jm401456d" title="DOI URL">https://doi.org/10.1021/jm401456d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401456d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401456d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BS1P1%252BReceptor%252BAgonists%252B-%252BPart%252B2%25253A%252BFrom%252BBicyclo%25255B3.1.0%25255Dhexane-Fused%252BThiophenes%252Bto%252BIsobutyl%252BSubstituted%252BThiophenes%26aulast%3DBolli%26aufirst%3DMartin%2BH.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D20092013%26date%3D17122013%26date%3D09012014%26volume%3D57%26issue%3D1%26spage%3D78%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>, <span class="hlFld-ContribAuthor ">Stefan  Abele</span>, <span class="hlFld-ContribAuthor ">Magdalena  Birker</span>, <span class="hlFld-ContribAuthor ">Roberto  Bravo</span>, <span class="hlFld-ContribAuthor ">Daniel  Bur</span>, <span class="hlFld-ContribAuthor ">Ruben  de Kanter</span>, <span class="hlFld-ContribAuthor ">Christopher  Kohl</span>, <span class="hlFld-ContribAuthor ">Julien  Grimont</span>, <span class="hlFld-ContribAuthor ">Patrick  Hess</span>, <span class="hlFld-ContribAuthor ">Cyrille  Lescop</span>, <span class="hlFld-ContribAuthor ">Boris  Mathys</span>, <span class="hlFld-ContribAuthor ">Claus  Müller</span>, <span class="hlFld-ContribAuthor ">Oliver  Nayler</span>, <span class="hlFld-ContribAuthor ">Markus  Rey</span>, <span class="hlFld-ContribAuthor ">Michael  Scherz</span>, <span class="hlFld-ContribAuthor ">Gunther  Schmidt</span>, <span class="hlFld-ContribAuthor ">Jürgen  Seifert</span>, <span class="hlFld-ContribAuthor ">Beat  Steiner</span>, <span class="hlFld-ContribAuthor ">Jörg  Velker</span>, and <span class="hlFld-ContribAuthor ">Thomas  Weller</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel S1P1 Receptor Agonists − Part 3: From Thiophenes to Pyridines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (1)
                                     , 110-130. <a href="https://doi.org/10.1021/jm4014696" title="DOI URL">https://doi.org/10.1021/jm4014696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4014696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4014696%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BS1P1%252BReceptor%252BAgonists%252B%2525E2%252588%252592%252BPart%252B3%25253A%252BFrom%252BThiophenes%252Bto%252BPyridines%26aulast%3DBolli%26aufirst%3DMartin%2BH.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D23092013%26date%3D24122013%26date%3D09012014%26volume%3D57%26issue%3D1%26spage%3D110%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. P.  Yakovleva</span>, <span class="hlFld-ContribAuthor ">K. S.  Denisova</span>, <span class="hlFld-ContribAuthor ">G. R.  Mingaleeva</span>, <span class="hlFld-ContribAuthor ">Yu. V.  Myasoedova</span>, <span class="hlFld-ContribAuthor ">L. R.  Garifullina</span>, <span class="hlFld-ContribAuthor ">N. M.  Ishmuratova</span>, <span class="hlFld-ContribAuthor ">G. Yu.  Ishmuratov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis from Δ3-Carene of Optically Active Macrolides with Fragments of Di- and Triethyleneglycol and Hydrazides of Dicarboxylic Acids. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Natural Compounds</span><span> <strong>2020,</strong> <em>56 </em>
                                    (3)
                                     , 487-491. <a href="https://doi.org/10.1007/s10600-020-03068-1" title="DOI URL">https://doi.org/10.1007/s10600-020-03068-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10600-020-03068-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10600-020-03068-1%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Natural%2520Compounds%26atitle%3DSynthesis%252Bfrom%252B%2525CE%2525943-Carene%252Bof%252BOptically%252BActive%252BMacrolides%252Bwith%252BFragments%252Bof%252BDi-%252Band%252BTriethyleneglycol%252Band%252BHydrazides%252Bof%252BDicarboxylic%252BAcids%26aulast%3DYakovleva%26aufirst%3DM.%2BP.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D3%26spage%3D487%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu. V.  Myasoedova</span>, <span class="hlFld-ContribAuthor ">L. R.  Garifullina</span>, <span class="hlFld-ContribAuthor ">E. R.  Nurieva</span>, <span class="hlFld-ContribAuthor ">N. M.  Ishmuratova</span>, <span class="hlFld-ContribAuthor ">G. Yu  Ishmuratov</span>. </span><span class="cited-content_cbyCitation_article-title">Transformations of Peroxide Products from Ozonolysis of (–)-α-Pinene and (+)-3-Carene by Capric and Benzoic Acid Hydrazides. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Natural Compounds</span><span> <strong>2020,</strong> <em>56 </em>
                                    (2)
                                     , 259-263. <a href="https://doi.org/10.1007/s10600-020-03002-5" title="DOI URL">https://doi.org/10.1007/s10600-020-03002-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10600-020-03002-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10600-020-03002-5%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Natural%2520Compounds%26atitle%3DTransformations%252Bof%252BPeroxide%252BProducts%252Bfrom%252BOzonolysis%252Bof%252B%252528%2525E2%252580%252593%252529-%2525CE%2525B1-Pinene%252Band%252B%252528%25252B%252529-3-Carene%252Bby%252BCapric%252Band%252BBenzoic%252BAcid%252BHydrazides%26aulast%3DMyasoedova%26aufirst%3DYu.%2BV.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D2%26spage%3D259%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kambappa  Vinaya</span>, <span class="hlFld-ContribAuthor ">Ganganahalli K.  Chandrashekara</span>, <span class="hlFld-ContribAuthor ">Prasanna D.  Shivaramu</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot synthesis of 3,5-diaryl substituted-1,2,4-oxadiazoles using
              gem
              -dibromomethylarenes. </span><span class="cited-content_cbyCitation_journal-name">Canadian Journal of Chemistry</span><span> <strong>2019,</strong> <em>97 </em>
                                    (9)
                                     , 690-696. <a href="https://doi.org/10.1139/cjc-2018-0333" title="DOI URL">https://doi.org/10.1139/cjc-2018-0333</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1139/cjc-2018-0333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1139%2Fcjc-2018-0333%26sid%3Dliteratum%253Aachs%26jtitle%3DCanadian%2520Journal%2520of%2520Chemistry%26atitle%3DOne-pot%252Bsynthesis%252Bof%252B3%25252C5-diaryl%252Bsubstituted-1%25252C2%25252C4-oxadiazoles%252Busing%252Bgem%252B-dibromomethylarenes%26aulast%3DVinaya%26aufirst%3DKambappa%26date%3D2019%26volume%3D97%26issue%3D9%26spage%3D690%26epage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui-Zhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Long  Zhao</span>, <span class="hlFld-ContribAuthor ">Cheng-He  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advance in oxazole-based medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>144 </em>, 444-492. <a href="https://doi.org/10.1016/j.ejmech.2017.12.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.12.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.12.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvance%252Bin%252Boxazole-based%252Bmedicinal%252Bchemistry%26aulast%3DZhang%26aufirst%3DHui-Zhen%26date%3D2018%26volume%3D144%26spage%3D444%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olivier  Bezençon</span>, <span class="hlFld-ContribAuthor ">Luboš  Remeň</span>, <span class="hlFld-ContribAuthor ">Sylvia  Richard</span>, <span class="hlFld-ContribAuthor ">Catherine  Roch</span>, <span class="hlFld-ContribAuthor ">Melanie  Kessler</span>, <span class="hlFld-ContribAuthor ">Eric A.  Ertel</span>, <span class="hlFld-ContribAuthor ">Richard  Moon</span>, <span class="hlFld-ContribAuthor ">Jacques  Mawet</span>, <span class="hlFld-ContribAuthor ">Thomas  Pfeifer</span>, <span class="hlFld-ContribAuthor ">Bruno  Capeleto</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and evaluation of Ca v 3.2-selective T-type calcium channel blockers. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (23)
                                     , 5326-5331. <a href="https://doi.org/10.1016/j.bmcl.2017.09.062" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.09.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.09.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.09.062%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Bevaluation%252Bof%252BCa%252Bv%252B3.2-selective%252BT-type%252Bcalcium%252Bchannel%252Bblockers%26aulast%3DBezen%25C3%25A7on%26aufirst%3DOlivier%26date%3D2017%26volume%3D27%26issue%3D23%26spage%3D5326%26epage%3D5331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olivier  Bezençon</span>, <span class="hlFld-ContribAuthor ">Luboš  Remeň</span>, <span class="hlFld-ContribAuthor ">Sylvia  Richard</span>, <span class="hlFld-ContribAuthor ">Catherine  Roch</span>, <span class="hlFld-ContribAuthor ">Melanie  Kessler</span>, <span class="hlFld-ContribAuthor ">Richard  Moon</span>, <span class="hlFld-ContribAuthor ">Jacques  Mawet</span>, <span class="hlFld-ContribAuthor ">Eric A.  Ertel</span>, <span class="hlFld-ContribAuthor ">Thomas  Pfeifer</span>, <span class="hlFld-ContribAuthor ">Bruno  Capeleto</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and evaluation of Ca v 3.1-selective T-type calcium channel blockers. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (23)
                                     , 5322-5325. <a href="https://doi.org/10.1016/j.bmcl.2017.09.063" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.09.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.09.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.09.063%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Bevaluation%252Bof%252BCa%252Bv%252B3.1-selective%252BT-type%252Bcalcium%252Bchannel%252Bblockers%26aulast%3DBezen%25C3%25A7on%26aufirst%3DOlivier%26date%3D2017%26volume%3D27%26issue%3D23%26spage%3D5322%26epage%3D5325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Huang</span>, <span class="hlFld-ContribAuthor ">Wen-Gui  Duan</span>, <span class="hlFld-ContribAuthor ">Gui-Shan  Lin</span>, <span class="hlFld-ContribAuthor ">Kun  Li</span>, <span class="hlFld-ContribAuthor ">Qiong  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antifungal Activity of Novel 3-Caren-5-One Oxime Esters. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (9)
                                     , 1538. <a href="https://doi.org/10.3390/molecules22091538" title="DOI URL">https://doi.org/10.3390/molecules22091538</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22091538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22091538%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BAntifungal%252BActivity%252Bof%252BNovel%252B3-Caren-5-One%252BOxime%252BEsters%26aulast%3DHuang%26aufirst%3DMin%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D9%26spage%3D1538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Cantalupo</span>, <span class="hlFld-ContribAuthor ">A.  Di Lorenzo</span>. </span><span class="cited-content_cbyCitation_article-title">S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2016,</strong> <em>358 </em>
                                    (2)
                                     , 359-370. <a href="https://doi.org/10.1124/jpet.116.233205" title="DOI URL">https://doi.org/10.1124/jpet.116.233205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.116.233205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.116.233205%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DS1P%252BSignaling%252Band%252BDe%252BNovo%252BBiosynthesis%252Bin%252BBlood%252BPressure%252BHomeostasis%26aulast%3DCantalupo%26aufirst%3DA.%26date%3D2016%26date%3D2016%26volume%3D358%26issue%3D2%26spage%3D359%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>, <span class="hlFld-ContribAuthor ">Cyrille  Lescop</span>, <span class="hlFld-ContribAuthor ">Magdalena  Birker</span>, <span class="hlFld-ContribAuthor ">Ruben  de Kanter</span>, <span class="hlFld-ContribAuthor ">Patrick  Hess</span>, <span class="hlFld-ContribAuthor ">Christopher  Kohl</span>, <span class="hlFld-ContribAuthor ">Oliver  Nayler</span>, <span class="hlFld-ContribAuthor ">Markus  Rey</span>, <span class="hlFld-ContribAuthor ">Patrick  Sieber</span>, <span class="hlFld-ContribAuthor ">Jörg  Velker</span>, <span class="hlFld-ContribAuthor ">Thomas  Weller</span>, <span class="hlFld-ContribAuthor ">Beat  Steiner</span>. </span><span class="cited-content_cbyCitation_article-title">Novel S1P1 receptor agonists – Part 5: From amino-to alkoxy-pyridines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>115 </em>, 326-341. <a href="https://doi.org/10.1016/j.ejmech.2016.03.020" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.03.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.03.020%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BS1P1%252Breceptor%252Bagonists%252B%2525E2%252580%252593%252BPart%252B5%25253A%252BFrom%252Bamino-to%252Balkoxy-pyridines%26aulast%3DBolli%26aufirst%3DMartin%2BH.%26date%3D2016%26volume%3D115%26spage%3D326%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cyrille  Lescop</span>, <span class="hlFld-ContribAuthor ">Claus  Müller</span>, <span class="hlFld-ContribAuthor ">Boris  Mathys</span>, <span class="hlFld-ContribAuthor ">Magdalena  Birker</span>, <span class="hlFld-ContribAuthor ">Ruben  de Kanter</span>, <span class="hlFld-ContribAuthor ">Christopher  Kohl</span>, <span class="hlFld-ContribAuthor ">Patrick  Hess</span>, <span class="hlFld-ContribAuthor ">Oliver  Nayler</span>, <span class="hlFld-ContribAuthor ">Markus  Rey</span>, <span class="hlFld-ContribAuthor ">Patrick  Sieber</span>, <span class="hlFld-ContribAuthor ">Beat  Steiner</span>, <span class="hlFld-ContribAuthor ">Thomas  Weller</span>, <span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>. </span><span class="cited-content_cbyCitation_article-title">Novel S1P 1 receptor agonists – Part 4: Alkylaminomethyl substituted aryl head groups. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>116 </em>, 222-238. <a href="https://doi.org/10.1016/j.ejmech.2016.03.048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.03.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.03.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.03.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BS1P%252B1%252Breceptor%252Bagonists%252B%2525E2%252580%252593%252BPart%252B4%25253A%252BAlkylaminomethyl%252Bsubstituted%252Baryl%252Bhead%252Bgroups%26aulast%3DLescop%26aufirst%3DCyrille%26date%3D2016%26volume%3D116%26spage%3D222%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pravin  Mahajan</span>, <span class="hlFld-ContribAuthor ">Mukesh  Nikam</span>, <span class="hlFld-ContribAuthor ">Asha  Chate</span>, <span class="hlFld-ContribAuthor ">Urja  Nimbalkar</span>, <span class="hlFld-ContribAuthor ">Vrushali  Patil</span>, <span class="hlFld-ContribAuthor ">Anil  Bobade</span>, <span class="hlFld-ContribAuthor ">Abhay  Chaudhari</span>, <span class="hlFld-ContribAuthor ">Dattatray  Deolankar</span>, <span class="hlFld-ContribAuthor ">Balasaheb  Javale</span>, <span class="hlFld-ContribAuthor ">Charansingh  Gill</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Antioxidant, Anti-Inflammatory, and Antimicrobial Screening of Newer Thiophene-Fused Arylpyrazolyl 1,3,4-Oxadiazoles. </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2015,</strong> <em>190 </em>
                                    (11)
                                     , 1803-1813. <a href="https://doi.org/10.1080/10426507.2015.1024784" title="DOI URL">https://doi.org/10.1080/10426507.2015.1024784</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2015.1024784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2015.1024784%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DSynthesis%25252C%252BAntioxidant%25252C%252BAnti-Inflammatory%25252C%252Band%252BAntimicrobial%252BScreening%252Bof%252BNewer%252BThiophene-Fused%252BArylpyrazolyl%252B1%25252C3%25252C4-Oxadiazoles%26aulast%3DMahajan%26aufirst%3DPravin%26date%3D2015%26date%3D2015%26volume%3D190%26issue%3D11%26spage%3D1803%26epage%3D1813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julia K.  Archbold</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Martin</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Sweet</span>. </span><span class="cited-content_cbyCitation_article-title">Towards selective lysophospholipid GPCR modulators. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2014,</strong> <em>35 </em>
                                    (5)
                                     , 219-226. <a href="https://doi.org/10.1016/j.tips.2014.03.004" title="DOI URL">https://doi.org/10.1016/j.tips.2014.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2014.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2014.03.004%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DTowards%252Bselective%252Blysophospholipid%252BGPCR%252Bmodulators%26aulast%3DArchbold%26aufirst%3DJulia%2BK.%26date%3D2014%26volume%3D35%26issue%3D5%26spage%3D219%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of sphingosine-1-phosphate, FTY720 (fingolimod, <b>1</b>), and p-FTY720 (p-<b>1</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of the Key Intermediate Chlorovinyl Ketone <b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) O<sub>3</sub>, MeOH, −65 °C, (ii) H<sub>2</sub>O<sub>2</sub>, rt to 35 °C, 2 h, 45–65%; (b) SOCl<sub>2</sub>, MeOH, 0 °C, 30 min, 70%; (c) NaOMe, MeOH, reflux 1 h, 90% crude; (d) PPh<sub>3</sub>, CCl<sub>4</sub>, CHCl<sub>3</sub>, 65 °C 1–3 h, 46–68%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Pyrazole, Pyrrole, and Thiophene Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NH<sub>2</sub>NH<sub>2</sub>·H<sub>2</sub>O, AcOH, MeOH, rt, 1 h, 67%; (b) (dihydro-) cinnamic acid, EDC or TBTU, THF or DMF, 45–57% (compounds <b>2</b>–<b>4</b>); (c) 2-methoxy-benzyl amine, CDI, THF, rt, 1 h, then <b>15</b>, 50 °C, 1 h, 32% (compound <b>5</b>); (d) diethyl oxalate, KOtBu, THF, rt, 1 h; (e) MeOH, HOAc, NH<sub>2</sub>NH<sub>2</sub> H<sub>2</sub>O, rt, 30 min, 14% over two steps; (f) MeI, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 0 °C to rt, 2 h; (g) 2 N aq LiOH, H<sub>2</sub>O, CH<sub>3</sub>CN, 45 °C, 1 h, 25% (over two steps, + 27% of N2-methyl isomer); (h) (1) appropriate benzylamine, Hünig’s base, TBTU, DMF, rt, 4 h, 12–75%; for <b>27</b>, <b>28</b>: (2) 2-bromo-ethanol, 2 N NaOH, MeOH 85 °C, 24 h, 21–54%; (i) diethyl 2-aminomalonate HCl, NaOEt, EtOH, rt, 1 h; (j) 2 N aq LiOH, EtOH, 75 °C, 16 h; (k) TFA, DCM, rt, 15 min, 31–62% (over 3 steps); (l) NaHMDS, pentafluorophenyl 3-(2-methoxyphenyl)propanoate, THF, rt, 15 min, 34%; (m) glycine ethyl ester HCl, Et<sub>3</sub>N, NaHCO<sub>3</sub>, EtOH, 70 °C, 15 h; (n) NaOEt, EtOH, microwave 130 °C, 10 min, 25%; (o) 2 N aq LiOH, EtOH, 65 °C, 18 h, 96%; (p) NaOEt, HSCH<sub>2</sub>COOEt, EtOH, rt, 1 h; (q) NaOEt, EtOH, 75 °C, 1 h; (r) 2 N aq LiOH, EtOH, 75 °C, 2 h, rt, 16 h, 67% over 3 steps.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of 1-Thien-2-yl-propan-1-one Derivatives (for R<sub>1</sub> and R<sub>2</sub>, see Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeLi, diethyl ether, 35 °C, 1–2 h, 44–77%; (b) substituted benzaldehyde, KOH, EtOH, 60–80 °C, 4–6 h; 31%; or substituted benzaldehyde, ∼6 N HCl in 2-propanol, EtOH, rt, 20 h, 42–90%; or 3-(4-formyl-2,6-dimethyl-phenyl)-acrylic acid, 10% w/v NaOH in MeOH, rt, 3 d, 40% (for <b>66</b>); (c) H<sub>2</sub>, Pd/C, EtOH, THF, DIPEA (for <b>66</b>), rt, 1–18 h, 31–89%; (d) 2-bromoethanol (<b>33</b>–<b>45</b>), 3-bromopropanol (<b>46</b>) or (<i>R</i>)- or (<i>S</i>)-3-chloro-propane-1,2-diol (<b>47</b> and <b>48</b>), 2 N aq NaOH, NaI, 2-propanol, 70–90 °C, 4–24 h, 34–87%; or (2,2-dimethyl-1,3-dioxan-5-yl)methanol, Ph<sub>3</sub>P, DEAD, THF, rt, 24 h, 67%, then 6 N HCl in 2-propanol, H<sub>2</sub>O, THF, 1 h, 40% (<b>49</b>), or <b>41</b> or <b>46</b>, methanesulfonyl chloride, Hünig’s base, DCM, rt, 1 h, 84–95%, then appropriate amine or amino acid, Hünig’s base, DMF, 70–85 °C, 7–22 h, 46–73% (<b>50</b>–<b>56</b> and <b>58</b>–<b>60</b>), or epichlorohydrin, 3 N aq NaOH, 2-propanol, rt, 18 h, 63–77%, then ethanolamine, glycine or azetidine-3-carboxylic acid, EtOH, H<sub>2</sub>O, Hünig’s base, 65 °C, 3–5 h, 34–67% (<b>57</b>, <b>61</b>, and <b>62</b>); <b>54</b>, glycolic acid, Hünig’s base, TBTU, DCM, rt, 2 h, 35% (<b>63</b>); or <b>31</b> and epichlorohydrin as for <b>61</b>, then 7 N NH<sub>3</sub> in MeOH, 60–65 °C, 2–4 h, 64–85%, then glycolic acid, Hünig’s base, TBTU, DCM, rt, 1 h, 57% (<b>64</b>); or bromoacetic acid, 3 N NaOH, 2-propanol, 70 °C, 24 h; 15–24% (<b>65</b>); or <b>65</b>, appropriate amine, TBTU, Hünig’s base, DMF, rt, 30 min, 53–75% (<b>67</b>–<b>69</b>); or <b>50</b>, methanesulfonyl chloride, Hünig’s base, DCM, rt, 0.5–2 h, 34% (<b>70</b>).</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Thiophene Derivatives with Five-Membered Heteroaromatic Linkers<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>,4-Dihydroxy-3,5-dimethylbenzamidine, TBTU, Hünig’s base, DMF, rt, 1–6 h; (b) dioxane or toluene, 100 °C, 18–24 h, 39–71% (over 2 steps); (c) (1) (<i>R</i>)-(2,2-dimethyl-1,3-dioxolan-4-yl)methanol, Ph<sub>3</sub>P, DEAD, THF, rt, 24 h, 66% (2) 6 N HCl in 2-propanol, H<sub>2</sub>O, THF, rt, 30 min, 59%; or 3-chloropropane-1,2-diol, 2 N NaOH, isopropanol, 65 °C, 10 h, 50%; (d) 4-(allyloxy)-3,5-dimethylbenzoic acid hydrazide, HOBt, EDC, Et<sub>3</sub>N, DCM, 0 °C, 16 h, 82%; (e) Burgess reagent, THF, microwave irradiation 110 °C, 5 min, 58-70% (for <b>72</b> and <b>76</b>) or Lawesson reagent, THF, microwave irradiation 110 °C, 5 min, 30–41% (for <b>73</b> and <b>77</b>); (f) OsO<sub>4</sub>, NMO, acetone, H<sub>2</sub>O, rt, 16–18 h, 15–48%; (g) 2-amino-4′-allyloxy-3′,5′-dimethyl-acetophenone,<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> HOBt, EDC HCl, Et<sub>3</sub>N, DCM, rt, 5 h, 51%.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0012.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Thiophene Derivatives with Five-Membered Heteroaromatic Linkers<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) thioacetic acid <i>S</i>-cyanomethylester, 2 N aq NaOH, THF, rt, 3 h; (b) 2 N aq NaOH, THF, 90 °C, 4 h, 59% (over 2 steps); (c) KOtBu; HONH<sub>2</sub>–HCl, MeOH, rt, 5 h, 85%; (d) 3,5-dimethyl-4-hydroxy benzoic acid, TBTU, Hünig’s base, DMF, rt, 2–3 h, 46%; (e) toluene, 110 °C, 35 h, 86%; or dioxane, 60 °C, 24 h, 41%; (f) (<i>S</i>)-3-chloro-propane-1,2-diol, 2 N aq NaOH, 2-propanol, 65 °C, 10 h, 18–38%.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure and in vitro activity of the HTS hit <b>2</b> and close analogues thereof.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Some examples of close analogues of the HTS hit <b>1</b> prepared to overcome the instability of <b>2</b> in aqueous media.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Change of blood lymphocyte count after oral administration of <b>85</b> to male Wistar rats. □ vehicle (<i>n</i> = 5); ● 0.3 mg/kg (<i>n</i> = 5); ▲ 1 mg/kg (<i>n</i> = 5); ○ 3 mg/kg (<i>n</i> = 5); ■ 10 mg/kg (<i>n</i> = 5). For experimental details see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. HR in beats per minute (bpm) after oral administration of (A) vehicle, (B) 3, (C) 10, (D) 30, and (E) 100 mg/kg <b>85</b> to male SHR. The HR increase observed during the first 2 h is an artifact of the oral gavage. For experimental details see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> and Hess et al.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/medium/jm-2013-014373_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Results of dose response experiments of compounds (A, B) <b>85</b> and (C, D) <b>1</b> in male SHR. Maximal HR changes (ΔHR in bpm, A, C) and area between curves (ABC, in bpm h; B, D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-23/jm4014373/production/images/large/jm-2013-014373_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014373&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23218" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23218" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 85 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Kappos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalban, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polman, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korn, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radue, E. W.</span><span> </span><span class="NLM_article-title">Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1056%2FNEJMoa052643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=16971719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsFKku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=1124-1140&author=L.+Kapposauthor=J.+Antelauthor=G.+Comiauthor=X.+Montalbanauthor=P.+O%E2%80%99Connorauthor=C.+H.+Polmanauthor=T.+Haasauthor=A.+A.+Kornauthor=G.+Karlssonauthor=E.+W.+Radue&title=Oral+Fingolimod+%28FTY720%29+for+Relapsing+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Oral fingolimod (FTY720) for relapsing multiple sclerosis</span></div><div class="casAuthors">Kappos, Ludwig; Antel, Jack; Comi, Giancarlo; Montalban, Xavier; O'Connor, Paul; Polman, Chris H.; Haas, Tomas; Korn, Alexander A.; Karlsson, Goeril; Radue, Ernst W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1124-1140</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Fingolimod (FTY720) is a new oral immunomodulating agent under evaluation for the treatment of relapsing multiple sclerosis.  We randomly assigned 281 patients to receive oral fingolimod, at a dose of 1.25 mg or 5.0 mg, or a placebo once daily, and we followed these patients for 6 mo with magnetic resonance imaging (MRI) and clin. evaluations (core study, months 0 to 6).  The primary end point was the total no. of gadolinium-enhanced lesions recorded on T1-weighted MRI at monthly intervals for 6 mo.  In an extension study in which the investigators and patients remained unaware of the dose assignments (months 7 to 12), patients who received placebo underwent randomization again to one of the fingolimod doses.  A total of 255 patients completed the core study.  The median total no. of gadolinium-enhanced lesions on MRI was lower with 1.25 mg of fingolimod (1 lesion, P < 0.001) and 5.0 mg of fingolimod (3 lesions, P = 0.006) than with placebo (5 lesions).  The annualized relapse rate was 0.77 in the placebo group, as compared with 0.35 in the group given 1.25 mg of fingolimod (P = 0.009) and 0.36 in the group given 5.0 mg of fingolimod (P = 0.01).  For the 227 patients who completed the extension study, the no. of gadolinium-enhanced lesions and relapse rates remained low in the groups that received continuous fingolimod, and both measures decreased in patients who switched from placebo to fingolimod.  Adverse events included nasopharyngitis, dyspnea, headache, diarrhea, and nausea.  Clin. asymptomatic elevations of alanine aminotransferase levels were more frequent with fingolimod (10 to 12%, vs. 1% in the placebo group).  One case of the posterior reversible encephalopathy syndrome occurred in the 5.0-mg group.  Fingolimod was also assocd. with an initial redn. in the heart rate and a modest decrease in the forced expiratory vol. in 1 s.  In this proof-of-concept study, fingolimod reduced the no. of lesions detected on MRI and clin. disease activity in patients with multiple sclerosis.  Evaluation in larger, longer-term studies is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA4MSvDIuvV7Vg90H21EOLACvtfcHk0lhUOwuThIr96Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsFKku78%253D&md5=2a84e8f5fb92091782406da9dcbc1453</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa052643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa052643%26sid%3Dliteratum%253Aachs%26aulast%3DKappos%26aufirst%3DL.%26aulast%3DAntel%26aufirst%3DJ.%26aulast%3DComi%26aufirst%3DG.%26aulast%3DMontalban%26aufirst%3DX.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%26aulast%3DPolman%26aufirst%3DC.%2BH.%26aulast%3DHaas%26aufirst%3DT.%26aulast%3DKorn%26aufirst%3DA.%2BA.%26aulast%3DKarlsson%26aufirst%3DG.%26aulast%3DRadue%26aufirst%3DE.%2BW.%26atitle%3DOral%2520Fingolimod%2520%2528FTY720%2529%2520for%2520Relapsing%2520Multiple%2520Sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D1124%26epage%3D1140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Kappos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radue, E.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohlfeld, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabresi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selmaj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agoropoulou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leyk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang-Auberson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtin, P.</span><span> </span><span class="NLM_article-title">A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1056%2FNEJMoa0909494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=20089952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvVWltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=387-401&author=L.+Kapposauthor=E.-W.+Radueauthor=P.+O%E2%80%99Connorauthor=C.+Polmanauthor=R.+Hohlfeldauthor=P.+Calabresiauthor=K.+Selmajauthor=C.+Agoropoulouauthor=M.+Leykauthor=L.+Zhang-Aubersonauthor=P.+Burtin&title=A+Placebo-Controlled+Trial+of+Oral+Fingolimod+in+Relapsing+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis</span></div><div class="casAuthors">Kappos, Ludwig; Radue, Ernst-Wilhelm; O'Connor, Paul; Polman, Chris; Hohlfeld, Reinhard; Calabresi, Peter; Selmaj, Krzysztof; Agoropoulou, Catherine; Leyk, Malgorzata; Zhang-Auberson, Lixin; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">387-401</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Oral fingolimod, a sphingosine-1-phosphate-receptor modulator that prevents the egress of lymphocytes from lymph nodes, significantly improved relapse rates and end points measured on magnetic resonance imaging (MRI), as compared with either placebo or i.m. interferon beta-1a, in phase 2 and 3 studies of multiple sclerosis.  METHODS: In our 24-mo, double-blind, randomized study, we enrolled patients who had relapsing-remitting multiple sclerosis, were 18 to 55 years of age, had a score of 0 to 5.5 on the Expanded Disability Status Scale (which ranges from 0 to 10, with higher scores indicating greater disability), and had one or more relapses in the previous year or two or more in the previous 2 years.  Patients received oral fingolimod at a dose of 0.5 mg or 1.25 mg daily or placebo.  End points included the annualized relapse rate (the primary end point) and the time to disability progression (a secondary end point).  RESULTS: A total of 1033 of the 1272 patients (81.2%) completed the study.  The annualized relapse rate was 0.18 with 0.5 mg of fingolimod, 0.16 with 1.25 mg of fingolimod, and 0.40 with placebo (P < 0.001 for either dose vs. placebo).  Fingolimod at doses of 0.5 mg and 1.25 mg significantly reduced the risk of disability progression over the 24-mo period (hazard ratio, 0.70 and 0.68, resp.; P = 0.02 vs. placebo, for both comparisons).  The cumulative probability of disability progression (confirmed after 3 mo) was 17.7% with 0.5 mg of fingolimod, 16.6% with 1.25 mg of fingolimod, and 24.1% with placebo.  Both fingolimod doses were superior to placebo with regard to MRI-related measures (no. of new or enlarged lesions on T2 -weighted images, gadolinium-enhancing lesions, and brain-vol. loss; P < 0.001 for all comparisons at 24 mo).  Causes of study discontinuation and adverse events related to fingolimod included bradycardia and atrioventricular conduction block at the time of fingolimod initiation, macular edema, elevated liver-enzyme levels, and mild hypertension.  CONCLUSIONS: As compared with placebo, both doses of oral fingolimod improved the relapse rate, the risk of disability progression, and end points on MRI.  These benefits will need to be weighed against possible long-term risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZV83ylA8IarVg90H21EOLACvtfcHk0lhUOwuThIr96Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvVWltr4%253D&md5=0c1a63e4b8850f3579b2a8f6c7f28ac0</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0909494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0909494%26sid%3Dliteratum%253Aachs%26aulast%3DKappos%26aufirst%3DL.%26aulast%3DRadue%26aufirst%3DE.-W.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%26aulast%3DPolman%26aufirst%3DC.%26aulast%3DHohlfeld%26aufirst%3DR.%26aulast%3DCalabresi%26aufirst%3DP.%26aulast%3DSelmaj%26aufirst%3DK.%26aulast%3DAgoropoulou%26aufirst%3DC.%26aulast%3DLeyk%26aufirst%3DM.%26aulast%3DZhang-Auberson%26aufirst%3DL.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DA%2520Placebo-Controlled%2520Trial%2520of%2520Oral%2520Fingolimod%2520in%2520Relapsing%2520Multiple%2520Sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D387%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Cohen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Mechanisms of Fingolimod’s Efficacy and Adverse Effects in Multiple Sclerosis</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1002%2Fana.22426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=21520239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVyhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2011&pages=759-777&author=J.+A.+Cohenauthor=J.+Chun&title=Mechanisms+of+Fingolimod%E2%80%99s+Efficacy+and+Adverse+Effects+in+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis</span></div><div class="casAuthors">Cohen, Jeffrey A.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">759-777</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Until recently, all approved multiple sclerosis (MS) disease treatments were administered parenterally.  Oral fingolimod was approved in Sept. 2010 by the US Food and Drug Administration to reduce relapses and disability progression in relapsing forms of MS.  In the clin. trials that led to approval, fingolimod reduced not only acute relapses and magnetic resonance imaging lesion activity but also disability progression and brain vol. loss, suggesting preservation of tissue.  Fingolimod's mechanism of action in MS is not known with certainty.  Its active form, fingolimod-phosphate (fingolimod-P), is a sphingosine 1-phosphate receptor (S1PR) modulator that inhibits egress of lymphocytes from lymph nodes and their recirculation, potentially reducing trafficking of pathogenic cells into the central nervous system (CNS).  Fingolimod also readily penetrates the CNS, and fingolimod-P formed in situ may have direct effects on neural cells.  Fingolimod potently inhibits the MS animal model, exptl. autoimmune encephalomyelitis, but is ineffective in mice with selective deficiency of the S1P1 S1PR subtype on astrocytes despite normal expression in the immune compartment.  These findings suggest that S1PR modulation by fingolimod in both the immune system and CNS, producing a combination of beneficial anti-inflammatory and possibly neuroprotective/reparative effects, may contribute to its efficacy in MS.  In clin. trials, fingolimod was generally safe and well tolerated.  Its interaction with S1PRs in a variety of tissues largely accounts for the reported adverse effects, which were seen more frequently with doses 2.5 to 10× the approved 0.5mg dose.  Fingolimod's unique mechanism of action distinguishes it from all other currently approved MS therapies.  Ann Neurol 2011;69:759-777.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaQ9gv8GATt7Vg90H21EOLACvtfcHk0lgGYbO30tTfIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVyhtLo%253D&md5=8444099f3b8b40bf8fd529e374eaf294</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fana.22426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22426%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DJ.%2BA.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DMechanisms%2520of%2520Fingolimod%25E2%2580%2599s%2520Efficacy%2520and%2520Adverse%2520Effects%2520in%2520Multiple%2520Sclerosis%26jtitle%3DAnn.%2520Neurol.%26date%3D2011%26volume%3D69%26spage%3D759%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieschl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zollinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">21453</span><span class="NLM_x">–</span> <span class="NLM_lpage">21457</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1074%2Fjbc.C200176200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=11967257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+Immune+Modulator+FTY720+Targets+Sphingosine+1-Phosphate+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span></div><div class="casAuthors">Brinkmann, Volker; Davis, Michael D.; Heise, Christopher E.; Albert, Rainer; Cottens, Sylvain; Hof, Robert; Bruns, Christian; Prieschl, Eva; Baumruker, Thomas; Hiestand, Peter; Foster, Carolyn A.; Zollinger, Markus; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21453-21457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis.  In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation.  FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms.  Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compd. is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis.  Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6zyZnHOYNbVg90H21EOLACvtfcHk0lgGYbO30tTfIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D&md5=b59856fffa9ebae7fb8182d18daa025f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200176200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200176200%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520Immune%2520Modulator%2520FTY720%2520Targets%2520Sphingosine%25201-Phosphate%2520Receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-349&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstromauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.-J.+Sheiauthor=D.+Cardauthor=C.+A.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+Lymphocyte+Trafficking+by+Sphingosine-1-Phosphate+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520Lymphocyte%2520Trafficking%2520by%2520Sphingosine-1-Phosphate%2520Receptor%2520Agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornancin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dévay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechtcheriakova, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urtz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span> </span><span class="NLM_article-title">Phosphorylation of the Immunomodulatory Drug FTY720 by Sphingosine Kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">47408</span><span class="NLM_x">–</span> <span class="NLM_lpage">47415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1074%2Fjbc.M307687200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=13129923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Cqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=47408-47415&author=A.+Billichauthor=F.+Bornancinauthor=P.+D%C3%A9vayauthor=D.+Mechtcheriakovaauthor=N.+Urtzauthor=T.+Baumruker&title=Phosphorylation+of+the+Immunomodulatory+Drug+FTY720+by+Sphingosine+Kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of the Immunomodulatory Drug FTY720 by Sphingosine Kinases</span></div><div class="casAuthors">Billich, Andreas; Bornancin, Frederic; Devay, Piroska; Mechtcheriakova, Diana; Urtz, Nicole; Baumruker, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">47408-47415</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The immunomodulatory drug FTY720 is phosphorylated in vivo, and the resulting FTY720 phosphate as a ligand for sphingosine-1-phosphate receptors is responsible for the unique biol. effects of the compd.  So far, phosphorylation of FTY720 by murine sphingosine kinase (SPHK) 1a had been documented.  We found that, while FTY720 is also phosphorylated by human SPHK1, the human type 2 isoform phosphorylates the drug 30-fold more efficiently, because of a lower Km of FTY720 for SPHK2.  Similarly, murine SPHK2 was more efficient than SPHK1a.  Among splice variants of the human SPHKs, an N-terminally extended SPHK2 isoform was even more active than SPHK2 itself.  Further SPHK superfamily members, namely ceramide kinase and a "SPHK-like" protein, failed to phosphorylate sphingosine and FTY720.  Thus, only SPHK1 and 2 appear to be capable of phosphorylating FTY720.  Using selective assay conditions, SPHK1 and 2 activities in murine tissues were measured.  While activity of SPHK2 toward sphingosine was generally lower than of SPHK1, FTY720 phosphorylation was higher under conditions favoring SPHK2.  In human endothelial cells, while activity of SPHK1 toward sphingosine was 2-fold higher than of SPHK2, FTY720 phosphorylation was 7-fold faster under SPHK2 assay conditions.  Finally, FTY720 was poorly phosphorylated in human blood as compared with rodent blood, in line with the low activity of SPHK1 and in particular of SPHK2 in human blood.  To conclude, both SPHK1 and 2 are capable of phosphorylating FTY720, but SPHK2 is quant. more important than SPHK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR5e-dVWnBT7Vg90H21EOLACvtfcHk0lgGYbO30tTfIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Cqtr0%253D&md5=26820503680682863dc76a69ea02fc7e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M307687200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M307687200%26sid%3Dliteratum%253Aachs%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DD%25C3%25A9vay%26aufirst%3DP.%26aulast%3DMechtcheriakova%26aufirst%3DD.%26aulast%3DUrtz%26aufirst%3DN.%26aulast%3DBaumruker%26aufirst%3DT.%26atitle%3DPhosphorylation%2520of%2520the%2520Immunomodulatory%2520Drug%2520FTY720%2520by%2520Sphingosine%2520Kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D47408%26epage%3D47415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Sobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Killer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span> </span><span class="NLM_article-title">Sphingosine-1-Phosphate (S1P) Receptor Agonists Mediate Pro-fibrotic Responses in Normal Human Lung Fibroblasts via S1P<sub>2</sub> and S1P<sub>3</sub> Receptors and Smad-Independent Signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">14839</span><span class="NLM_x">–</span> <span class="NLM_lpage">14851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=14839-14851&author=K.+Sobelauthor=K.+Menyhartauthor=N.+Killerauthor=B.+Renaultauthor=Y.+Bauerauthor=R.+Studerauthor=B.+Steinerauthor=M.+H.+Bolliauthor=O.+Naylerauthor=J.+Gatfield&title=Sphingosine-1-Phosphate+%28S1P%29+Receptor+Agonists+Mediate+Pro-fibrotic+Responses+in+Normal+Human+Lung+Fibroblasts+via+S1P2+and+S1P3+Receptors+and+Smad-Independent+Signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSobel%26aufirst%3DK.%26aulast%3DMenyhart%26aufirst%3DK.%26aulast%3DKiller%26aufirst%3DN.%26aulast%3DRenault%26aufirst%3DB.%26aulast%3DBauer%26aufirst%3DY.%26aulast%3DStuder%26aufirst%3DR.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DGatfield%26aufirst%3DJ.%26atitle%3DSphingosine-1-Phosphate%2520%2528S1P%2529%2520Receptor%2520Agonists%2520Mediate%2520Pro-fibrotic%2520Responses%2520in%2520Normal%2520Human%2520Lung%2520Fibroblasts%2520via%2520S1P2%2520and%2520S1P3%2520Receptors%2520and%2520Smad-Independent%2520Signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D14839%26epage%3D14851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">Expression of the Sphingosine 1-Phosphate Receptor, S1P<sub>1</sub>, on T-cells Controls Thymic Emigration</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">15396</span><span class="NLM_x">–</span> <span class="NLM_lpage">15401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=15396-15401&author=M.+L.+Allendeauthor=J.+L.+Dreierauthor=S.+Mandalaauthor=R.+L.+Proia&title=Expression+of+the+Sphingosine+1-Phosphate+Receptor%2C+S1P1%2C+on+T-cells+Controls+Thymic+Emigration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DDreier%26aufirst%3DJ.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DExpression%2520of%2520the%2520Sphingosine%25201-Phosphate%2520Receptor%252C%2520S1P1%252C%2520on%2520T-cells%2520Controls%2520Thymic%2520Emigration%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D15396%26epage%3D15401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Matloubian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinamon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesneski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Lymphocyte Egress from Thymus and Peripheral Lymphoid Organs Is Dependent on S1P Receptor 1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2004&pages=355-360&author=M.+Matloubianauthor=C.+G.+Loauthor=G.+Cinamonauthor=M.+J.+Lesneskiauthor=Y.+Xuauthor=V.+Brinkmannauthor=M.+L.+Allendeauthor=R.+L.+Proiaauthor=J.+G.+Cyster&title=Lymphocyte+Egress+from+Thymus+and+Peripheral+Lymphoid+Organs+Is+Dependent+on+S1P+Receptor+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatloubian%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DC.%2BG.%26aulast%3DCinamon%26aufirst%3DG.%26aulast%3DLesneski%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DLymphocyte%2520Egress%2520from%2520Thymus%2520and%2520Peripheral%2520Lymphoid%2520Organs%2520Is%2520Dependent%2520on%2520S1P%2520Receptor%25201%26jtitle%3DNature%26date%3D2004%26volume%3D427%26spage%3D355%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neway, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koprak, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Potent S1P Receptor Agonists Replicate the Pharmacologic Actions of the Novel Immune Modulator FTY720</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3351</span><span class="NLM_x">–</span> <span class="NLM_lpage">3355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3351-3355&author=J.+J.+Haleauthor=W.+Newayauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+Rosenbachauthor=J.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=G.+C.+Kooauthor=S.+L.+Koprakauthor=J.+J.+Jacksonauthor=H.+Rosenauthor=S.+Mandala&title=Potent+S1P+Receptor+Agonists+Replicate+the+Pharmacologic+Actions+of+the+Novel+Immune+Modulator+FTY720"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DNeway%26aufirst%3DW.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKoo%26aufirst%3DG.%2BC.%26aulast%3DKoprak%26aufirst%3DS.%2BL.%26aulast%3DJackson%26aufirst%3DJ.%2BJ.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DPotent%2520S1P%2520Receptor%2520Agonists%2520Replicate%2520the%2520Pharmacologic%2520Actions%2520of%2520the%2520Novel%2520Immune%2520Modulator%2520FTY720%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3351%26epage%3D3355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thangada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">S1P1-Selective In Vivo-Active Agonists from High-Throughput Screening: Off-the-Shelf Chemical Probes of Receptor Interactions, Signaling, and Fate</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">715</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1016%2Fj.chembiol.2005.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=15975516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=703-715&author=E.+Joauthor=M.+G.+Sannaauthor=P.+J.+Gonzalez-Cabreraauthor=S.+Thangadaauthor=G.+Tigyiauthor=D.+A.+Osborneauthor=T.+Hlaauthor=A.+L.+Parrillauthor=H.+Rosen&title=S1P1-Selective+In+Vivo-Active+Agonists+from+High-Throughput+Screening%3A+Off-the-Shelf+Chemical+Probes+of+Receptor+Interactions%2C+Signaling%2C+and+Fate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">S1P1-Selective In Vivo-Active Agonists from High- Throughput Screening: Off-the-Shelf Chemical Probes of Receptor Interactions, Signaling, and Fate</span></div><div class="casAuthors">Jo, Euijung; Sanna, M. Germana; Gonzalez-Cabrera, Pedro J.; Thangada, Shobha; Tigyi, Gabor; Osborne, Daniel A.; Hla, Timothy; Parrill, Abby L.; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">703-715</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The essential role of the sphingosine 1-phosphate (S1P) receptor S1P1 in regulating lymphocyte trafficking was demonstrated with the S1P1-selective nanomolar agonist, SEW2871.  Despite its lack of charged headgroup, the tetraarom. compd. SEW2871 binds and activates S1P1 through a combination of hydrophobic and ion-dipole interactions.  Both S1P and SEW2871 activated ERK, Akt, and Rac signaling pathways and induced S1P1 internalization and recycling, unlike FTY720-phosphate, which induces receptor degrdn.  Agonism with receptor recycling is sufficient for alteration of lymphocyte trafficking by S1P and SEW2871.  S1P1 modeling and mutagenesis studies revealed that residues binding the S1P headgroup are required for kinase activation by both S1P and SEW2871.  Therefore, SEW2871 recapitulates the action of S1P in all the signaling pathways examd. and overlaps in interactions with key headgroup binding receptor residues, presumably replacing salt-bridge interactions with ion-dipole interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2m1otCJEz8LVg90H21EOLACvtfcHk0lgqgRETsZ2--Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGht7Y%253D&md5=31a1a616e98d96ba6d9dfbb0a38ed39c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DJo%26aufirst%3DE.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26aulast%3DThangada%26aufirst%3DS.%26aulast%3DTigyi%26aufirst%3DG.%26aulast%3DOsborne%26aufirst%3DD.%2BA.%26aulast%3DHla%26aufirst%3DT.%26aulast%3DParrill%26aufirst%3DA.%2BL.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DS1P1-Selective%2520In%2520Vivo-Active%2520Agonists%2520from%2520High-Throughput%2520Screening%253A%2520Off-the-Shelf%2520Chemical%2520Probes%2520of%2520Receptor%2520Interactions%252C%2520Signaling%252C%2520and%2520Fate%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D703%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">McVerry, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. G. N.</span><span> </span><span class="NLM_article-title">In vitro and in Vivo Modulation of Vascular Barrier Integrity by Sphingosine 1-Phosphate: Mechanistic Insights</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1016%2Fj.cellsig.2004.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=15494205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD2cXos1eqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=131-139&author=B.+J.+McVerryauthor=J.+G.+N.+Garcia&title=In+vitro+and+in+Vivo+Modulation+of+Vascular+Barrier+Integrity+by+Sphingosine+1-Phosphate%3A+Mechanistic+Insights"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights</span></div><div class="casAuthors">McVerry, Bryan J.; Garcia, Joe G. N.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-139</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P), a biol. active lipid growth factor, induces robust endothelial cell activation resulting in cellular locomotion, vascular maturation and angiogenesis.  Recent work by our lab. has demonstrated S1P to enhance the cellular barrier function of the vascular endothelium.  S1P-induced modulation of vascular permeability is effected through profound cytoskeletal reorganization initiated by cell surface receptor-mediated G protein activation and downstream signaling via the Rho family of small GTPases.  The details of the downstream signaling mechanism remain an active area of in vitro investigation.  Translational investigation suggests a profound impact of S1P administration in the modulation of edema formation in disease state manifest as acute inflammatory lung injury in which increased vascular permeability is a hallmark feature.  These data support an exciting potential therapeutic role for S1P in vascular barrier enhancement necessary for the treatment of critically ill patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4F51YD2iELLVg90H21EOLACvtfcHk0liGkAXMny1wHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXos1eqs78%253D&md5=4d45ffb844dbe0853e55fb0a92a9b409</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2004.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2004.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DMcVerry%26aufirst%3DB.%2BJ.%26aulast%3DGarcia%26aufirst%3DJ.%2BG.%2BN.%26atitle%3DIn%2520vitro%2520and%2520in%2520Vivo%2520Modulation%2520of%2520Vascular%2520Barrier%2520Integrity%2520by%2520Sphingosine%25201-Phosphate%253A%2520Mechanistic%2520Insights%26jtitle%3DCell.%2520Signalling%26date%3D2005%26volume%3D17%26spage%3D131%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Wei, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matheu, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahalan, M. D.</span><span> </span><span class="NLM_article-title">Sphingosine 1-Phosphate Type 1 Receptor Agonism Inhibits Transendothelial Migration of Medullary T Cells to Lymphatic Sinuses</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1228</span><span class="NLM_x">–</span> <span class="NLM_lpage">1235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1038%2Fni1269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=16273098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlShur3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=1228-1235&author=S.+H.+Weiauthor=H.+Rosenauthor=M.+P.+Matheuauthor=M.+G.+Sannaauthor=S.-K.+Wangauthor=E.+Joauthor=C.-H.+Wongauthor=I.+Parkerauthor=M.+D.+Cahalan&title=Sphingosine+1-Phosphate+Type+1+Receptor+Agonism+Inhibits+Transendothelial+Migration+of+Medullary+T+Cells+to+Lymphatic+Sinuses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses</span></div><div class="casAuthors">Wei, Sindy H.; Rosen, Hugh; Matheu, Melanie P.; Sanna, M. Germana; Wang, Sheng-Kai; Jo, Euijung; Wong, Chi-Huey; Parker, Ian; Cahalan, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1228-1235</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate type 1 (S1P1) receptor agonists cause sequestration of lymphocytes in secondary lymphoid organs by a mechanism that is not well understood.  One hypothesis proposes that agonists act as "functional antagonists" by binding and internalizing S1P1 receptors on lymphocytes; a second hypothesis proposes instead that S1P1 agonists act on endothelial cells to prevent lymphocyte egress from lymph nodes.  Here, 2-photon imaging of living T cells in explanted lymph nodes after treatment with S1P1 agonists or antagonists has provided insight into the mechanism by which S1P1 agonists function.  The selective S1P1 agonist SEW2871 caused reversible slowing and "log-jamming" of T cells between filled medullary cords and empty sinuses, whereas motility was unaltered in diffuse cortex.  Removal or antagonist competition of SEW2871 permitted recovery of T cell motility in the parenchyma of the medulla and resumption of migration across the stromal endothelial barrier, leading to refilling of sinuses.  The authors' results provide visualization of transendothelial migration of T cells into lymphatic sinuses and suggest that S1P1 agonists act mainly on endothelial cell S1P1 receptors to inhibit lymphocyte migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT6yH1S8NBXbVg90H21EOLACvtfcHk0liGkAXMny1wHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlShur3E&md5=1e8e381a3808c9231937e05a0c010b73</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fni1269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1269%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DS.%2BH.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMatheu%26aufirst%3DM.%2BP.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DWang%26aufirst%3DS.-K.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DWong%26aufirst%3DC.-H.%26aulast%3DParker%26aufirst%3DI.%26aulast%3DCahalan%26aufirst%3DM.%2BD.%26atitle%3DSphingosine%25201-Phosphate%2520Type%25201%2520Receptor%2520Agonism%2520Inhibits%2520Transendothelial%2520Migration%2520of%2520Medullary%2520T%2520Cells%2520to%2520Lymphatic%2520Sinuses%26jtitle%3DNat.%2520Immunol.%26date%3D2005%26volume%3D6%26spage%3D1228%26epage%3D1235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surh, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHeyzer-Williams, M. G.</span><span> </span><span class="NLM_article-title">Rapid Induction of Medullary Thymocyte Phenotypic Maturation and Egress Inhibition by Nanomolar Sphingosine 1-Phosphate Receptor Agonist</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">10907</span><span class="NLM_x">–</span> <span class="NLM_lpage">10912</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=10907-10912&author=H.+Rosenauthor=C.+Alfonsoauthor=C.+D.+Surhauthor=M.+G.+McHeyzer-Williams&title=Rapid+Induction+of+Medullary+Thymocyte+Phenotypic+Maturation+and+Egress+Inhibition+by+Nanomolar+Sphingosine+1-Phosphate+Receptor+Agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DAlfonso%26aufirst%3DC.%26aulast%3DSurh%26aufirst%3DC.%2BD.%26aulast%3DMcHeyzer-Williams%26aufirst%3DM.%2BG.%26atitle%3DRapid%2520Induction%2520of%2520Medullary%2520Thymocyte%2520Phenotypic%2520Maturation%2520and%2520Egress%2520Inhibition%2520by%2520Nanomolar%2520Sphingosine%25201-Phosphate%2520Receptor%2520Agonist%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D10907%26epage%3D10912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Don, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsolais, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matheu, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, W.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahalan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Enhancement of Capillary Leakage and Restoration of Lymphocyte Egress by a Chiral S1P1 Antagonist in Vivo</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">434</span><span class="NLM_x">–</span> <span class="NLM_lpage">441</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1038%2Fnchembio804" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=434-441&author=M.+G.+Sannaauthor=S.-K.+Wangauthor=P.+J.+Gonzalez-Cabreraauthor=A.+Donauthor=D.+Marsolaisauthor=M.+P.+Matheuauthor=S.+H.+Weiauthor=I.+Parkerauthor=E.+Joauthor=W.-C.+Chengauthor=M.+D.+Cahalanauthor=C.-H.+Wongauthor=H.+Rosen&title=Enhancement+of+Capillary+Leakage+and+Restoration+of+Lymphocyte+Egress+by+a+Chiral+S1P1+Antagonist+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnchembio804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio804%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DWang%26aufirst%3DS.-K.%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26aulast%3DDon%26aufirst%3DA.%26aulast%3DMarsolais%26aufirst%3DD.%26aulast%3DMatheu%26aufirst%3DM.%2BP.%26aulast%3DWei%26aufirst%3DS.%2BH.%26aulast%3DParker%26aufirst%3DI.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DCheng%26aufirst%3DW.-C.%26aulast%3DCahalan%26aufirst%3DM.%2BD.%26aulast%3DWong%26aufirst%3DC.-H.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DEnhancement%2520of%2520Capillary%2520Leakage%2520and%2520Restoration%2520of%2520Lymphocyte%2520Egress%2520by%2520a%2520Chiral%2520S1P1%2520Antagonist%2520in%2520Vivo%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D8%26spage%3D434%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Marsolais, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Chemical Modulators of Sphingosine-1-phosphate Receptors as Barrier-Oriented Therapeutic Molecules</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=297-307&author=D.+Marsolaisauthor=H.+Rosen&title=Chemical+Modulators+of+Sphingosine-1-phosphate+Receptors+as+Barrier-Oriented+Therapeutic+Molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarsolais%26aufirst%3DD.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DChemical%2520Modulators%2520of%2520Sphingosine-1-phosphate%2520Receptors%2520as%2520Barrier-Oriented%2520Therapeutic%2520Molecules%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D297%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataraman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaud, J.</span><span> </span><span class="NLM_article-title">The Vascular S1P Gradient—Cellular Sources and Biological Significance</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1781</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1781&publication_year=2008&pages=477-482&author=T.+Hlaauthor=K.+Venkataramanauthor=J.+Michaud&title=The+Vascular+S1P+Gradient%E2%80%94Cellular+Sources+and+Biological+Significance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHla%26aufirst%3DT.%26aulast%3DVenkataraman%26aufirst%3DK.%26aulast%3DMichaud%26aufirst%3DJ.%26atitle%3DThe%2520Vascular%2520S1P%2520Gradient%25E2%2580%2594Cellular%2520Sources%2520and%2520Biological%2520Significance%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2008%26volume%3D1781%26spage%3D477%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Dorsam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graeler, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seroogy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voice, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetzl, E. J.</span><span> </span><span class="NLM_article-title">Transduction of Multiple Effects of Sphingosine 1-Phosphate (S1P) on T Cell Functions by the S1P<sub>1</sub> G Protein-Coupled Receptor</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">3500</span><span class="NLM_x">–</span> <span class="NLM_lpage">3507</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2003&pages=3500-3507&author=G.+Dorsamauthor=M.+H.+Graelerauthor=C.+Seroogyauthor=Y.+Kongauthor=J.+K.+Voiceauthor=E.+J.+Goetzl&title=Transduction+of+Multiple+Effects+of+Sphingosine+1-Phosphate+%28S1P%29+on+T+Cell+Functions+by+the+S1P1+G+Protein-Coupled+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDorsam%26aufirst%3DG.%26aulast%3DGraeler%26aufirst%3DM.%2BH.%26aulast%3DSeroogy%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DY.%26aulast%3DVoice%26aufirst%3DJ.%2BK.%26aulast%3DGoetzl%26aufirst%3DE.%2BJ.%26atitle%3DTransduction%2520of%2520Multiple%2520Effects%2520of%2520Sphingosine%25201-Phosphate%2520%2528S1P%2529%2520on%2520T%2520Cell%2520Functions%2520by%2520the%2520S1P1%2520G%2520Protein-Coupled%2520Receptor%26jtitle%3DJ.%2520Immunol.%26date%3D2003%26volume%3D171%26spage%3D3500%26epage%3D3507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Schwab, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Finding a Way Out: Lymphocyte Egress from Lymphoid Organs</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1301</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1038%2Fni1545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=18026082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlajtr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=1295-1301&author=S.+R.+Schwabauthor=J.+G.+Cyster&title=Finding+a+Way+Out%3A+Lymphocyte+Egress+from+Lymphoid+Organs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Finding a way out: lymphocyte egress from lymphoid organs</span></div><div class="casAuthors">Schwab, Susan R.; Cyster, Jason G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1295-1301</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The egress of lymphocytes from the thymus and secondary lymphoid organs into circulatory fluids is essential for normal immune function.  The discovery that a small-mol. inhibitor of lymphocyte exit, FTY720, is a ligand for sphingosine 1-phosphate (S1P) receptors led to studies demonstrating that S1P receptor type 1 (S1P1) is needed in T cells and B cells for their egress from lymphoid organs.  S1P exists in higher concns. in blood and lymph than in lymphoid organs, and this differential is also required for lymphocyte exit.  Transcriptional and post-translational mechanisms regulate S1P1 and thus the egress of lymphocytes.  In this review we discuss the body of evidence supporting a model in which lymphocyte egress is promoted by encounter with S1P at exit sites.  We relate this model to work examg. the effects of S1P receptor agonists on endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWY-Rk111SmLVg90H21EOLACvtfcHk0lhmgaQD2kwQYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlajtr7J&md5=ccf7ef06130d3ebd218707ac92618f36</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fni1545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1545%26sid%3Dliteratum%253Aachs%26aulast%3DSchwab%26aufirst%3DS.%2BR.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DFinding%2520a%2520Way%2520Out%253A%2520Lymphocyte%2520Egress%2520from%2520Lymphoid%2520Organs%26jtitle%3DNat.%2520Immunol.%26date%3D2007%26volume%3D8%26spage%3D1295%26epage%3D1301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Pappu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelissen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regard, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camerer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coughlin, S. R.</span><span> </span><span class="NLM_article-title">Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=295-298&author=R.+Pappuauthor=S.+R.+Schwabauthor=I.+Cornelissenauthor=J.+P.+Pereiraauthor=J.+B.+Regardauthor=Y.+Xuauthor=E.+Camererauthor=Y.-W.+Zhengauthor=Y.+Huangauthor=J.+G.+Cysterauthor=S.+R.+Coughlin&title=Promotion+of+Lymphocyte+Egress+into+Blood+and+Lymph+by+Distinct+Sources+of+Sphingosine-1-Phosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPappu%26aufirst%3DR.%26aulast%3DSchwab%26aufirst%3DS.%2BR.%26aulast%3DCornelissen%26aufirst%3DI.%26aulast%3DPereira%26aufirst%3DJ.%2BP.%26aulast%3DRegard%26aufirst%3DJ.%2BB.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DCamerer%26aufirst%3DE.%26aulast%3DZheng%26aufirst%3DY.-W.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26aulast%3DCoughlin%26aufirst%3DS.%2BR.%26atitle%3DPromotion%2520of%2520Lymphocyte%2520Egress%2520into%2520Blood%2520and%2520Lymph%2520by%2520Distinct%2520Sources%2520of%2520Sphingosine-1-Phosphate%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D295%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Sensken, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagarajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graeler, M. H.</span><span> </span><span class="NLM_article-title">Local Inactivation of Spingosine 1-Phosphate in Lymph Nodes Induces Lymphopenia</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">3432</span><span class="NLM_x">–</span> <span class="NLM_lpage">3440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=3432-3440&author=S.-C.+Senskenauthor=M.+Nagarajanauthor=C.+Bodeauthor=M.+H.+Graeler&title=Local+Inactivation+of+Spingosine+1-Phosphate+in+Lymph+Nodes+Induces+Lymphopenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSensken%26aufirst%3DS.-C.%26aulast%3DNagarajan%26aufirst%3DM.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DGraeler%26aufirst%3DM.%2BH.%26atitle%3DLocal%2520Inactivation%2520of%2520Spingosine%25201-Phosphate%2520in%2520Lymph%2520Nodes%2520Induces%2520Lymphopenia%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26spage%3D3432%26epage%3D3440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Berst, F.; Grosche, P.; Janser, P.; Zecri, F.; Bollbuck, B.</span><span> </span><span class="NLM_article-title">N-Biaryl (Hetero) Arylsulphonamide Derivatives Useful in the Treatment of Diseases Mediated by Lymphocyte Interactions</span>. WO2008028937 A1, March 13,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=F.+Berst&author=P.+Grosche&author=P.+Janser&author=F.+Zecri&author=B.+Bollbuck&title=N-Biaryl+%28Hetero%29+Arylsulphonamide+Derivatives+Useful+in+the+Treatment+of+Diseases+Mediated+by+Lymphocyte+Interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerst%26aufirst%3DF.%26atitle%3DN-Biaryl%2520%2528Hetero%2529%2520Arylsulphonamide%2520Derivatives%2520Useful%2520in%2520the%2520Treatment%2520of%2520Diseases%2520Mediated%2520by%2520Lymphocyte%2520Interactions%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Tarrasón, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aulí, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustafa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolgachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domènech, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prats, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domínguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auilar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calbet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pont, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunkel, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godessart, N.</span><span> </span><span class="NLM_article-title">The Sphingosine-1-phosphate Receptor-1 Antagonist, W146, Causes Early and Short-Lasting Peripheral Blood Lymphophenia in Mice</span> <span class="citation_source-journal">Int. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1773</span><span class="NLM_x">–</span> <span class="NLM_lpage">1779</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1016%2Fj.intimp.2011.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtl2rtbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=1773-1779&author=G.+Tarras%C3%B3nauthor=M.+Aul%C3%ADauthor=S.+Mustafaauthor=V.+Dolgachevauthor=M.+T.+Dom%C3%A8nechauthor=N.+Pratsauthor=M.+Dom%C3%ADnguezauthor=R.+L%C3%B3pezauthor=N.+Auilarauthor=M.+Calbetauthor=M.+Pontauthor=G.+Milliganauthor=S.+L.+Kunkelauthor=N.+Godessart&title=The+Sphingosine-1-phosphate+Receptor-1+Antagonist%2C+W146%2C+Causes+Early+and+Short-Lasting+Peripheral+Blood+Lymphophenia+in+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice</span></div><div class="casAuthors">Tarrason, Gema; Auli, Mariona; Mustafa, Sanam; Dolgachev, Vladislav; Domenech, Maria Teresa; Prats, Neus; Dominguez, Maria; Lopez, Rosa; Aguilar, Nuria; Calbet, Marta; Pont, Merce; Milligan, Graeme; Kunkel, Steven L.; Godessart, Nuria</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1773-1779</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Agonists of the sphingosine-1-phosphate (S1P) receptors, like fingolimod (FTY720), are a novel class of immunomodulators.  Administration of these compds. prevents the egress of lymphocytes from primary and secondary lymphoid organs causing peripheral blood lymphopenia.  Although it is well established that lymphopenia is mediated by S1P receptor type 1 (S1P1), the exact mechanism is still controversial.  The most favored hypothesis states that S1P1 agonists cause internalization and loss of the cell surface receptor on lymphocytes, preventing them to respond to S1P.  Hence, S1P1 agonists would behave in vivo as functional antagonists of the receptor.  For this hypothesis to be valid, a true S1P1 antagonist should also induce lymphopenia.  However, it has been reported that S1P1 antagonists fail to show this effect, arguing against the concept.  Our study demonstrates that a S1P1 antagonist, W146, induces a significant but transient blood lymphopenia in mice and a parallel increase in CD4+ and CD8+ lymphocytes in lymph nodes.  Treatment with W146 also causes the accumulation of mature T cells in the medulla of the thymus and moreover, it induces lung edema.  We show that both the S1P1 antagonist and a S1P1 agonist cause lymphopenia in vivo in spite of their different effects on receptor expression in vitro.  Although the antagonist purely blocks the receptor and the agonist causes its disappearance from the cell surface, the response to the endogenous ligand is prevented in both cases.  Our results support the hypothesis that lymphopenia evoked by S1P1 agonists is due to functional antagonism of S1P1 in lymphocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrmlMSoa8mELVg90H21EOLACvtfcHk0lhmgaQD2kwQYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtl2rtbrM&md5=e41b01746cd1fe520bfb36508dfca689</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2011.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2011.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DTarras%25C3%25B3n%26aufirst%3DG.%26aulast%3DAul%25C3%25AD%26aufirst%3DM.%26aulast%3DMustafa%26aufirst%3DS.%26aulast%3DDolgachev%26aufirst%3DV.%26aulast%3DDom%25C3%25A8nech%26aufirst%3DM.%2BT.%26aulast%3DPrats%26aufirst%3DN.%26aulast%3DDom%25C3%25ADnguez%26aufirst%3DM.%26aulast%3DL%25C3%25B3pez%26aufirst%3DR.%26aulast%3DAuilar%26aufirst%3DN.%26aulast%3DCalbet%26aufirst%3DM.%26aulast%3DPont%26aufirst%3DM.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DKunkel%26aufirst%3DS.%2BL.%26aulast%3DGodessart%26aufirst%3DN.%26atitle%3DThe%2520Sphingosine-1-phosphate%2520Receptor-1%2520Antagonist%252C%2520W146%252C%2520Causes%2520Early%2520and%2520Short-Lasting%2520Peripheral%2520Blood%2520Lymphophenia%2520in%2520Mice%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2011%26volume%3D11%26spage%3D1773%26epage%3D1779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Fujii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtake, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukasawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiozawa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goitsuka, R.</span><span> </span><span class="NLM_article-title">Lymphopenia Induced by a Novel Selective S1P<sub>1</sub> Antagonist Structurally Unrelated to S1P</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1821</span><span class="NLM_x">, </span> <span class="NLM_fpage">600</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1821&publication_year=2012&pages=600-606&author=Y.+Fujiiauthor=H.+Ohtakeauthor=N.+Onoauthor=T.+Haraauthor=T.+Sakuraiauthor=S.+Takahashiauthor=T.+Takayamaauthor=Y.+Fukasawaauthor=F.+Shiozawaauthor=N.+Tsukaharaauthor=T.+Hirayamaauthor=Y.+Igarashiauthor=R.+Goitsuka&title=Lymphopenia+Induced+by+a+Novel+Selective+S1P1+Antagonist+Structurally+Unrelated+to+S1P"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DY.%26aulast%3DOhtake%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DN.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DTakayama%26aufirst%3DT.%26aulast%3DFukasawa%26aufirst%3DY.%26aulast%3DShiozawa%26aufirst%3DF.%26aulast%3DTsukahara%26aufirst%3DN.%26aulast%3DHirayama%26aufirst%3DT.%26aulast%3DIgarashi%26aufirst%3DY.%26aulast%3DGoitsuka%26aufirst%3DR.%26atitle%3DLymphopenia%2520Induced%2520by%2520a%2520Novel%2520Selective%2520S1P1%2520Antagonist%2520Structurally%2520Unrelated%2520to%2520S1P%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2012%26volume%3D1821%26spage%3D600%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Fujii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtake, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakazawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goitsuka, R.</span><span> </span><span class="NLM_article-title">Amelioration of Collagen-Induced Arthritis by a Novel S1P<sub>1</sub> Antagonist with Immunomodulatory Activities</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">188</span><span class="NLM_x">, </span> <span class="NLM_fpage">206</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2012&pages=206-215&author=Y.+Fujiiauthor=T.+Hirayamaauthor=H.+Ohtakeauthor=N.+Onoauthor=T.+Inoueauthor=T.+Sakuraiauthor=T.+Takayamaauthor=K.+Matsumotoauthor=N.+Tsukaharaauthor=S.+Hidanoauthor=N.+Harimaauthor=K.+Nakazawaauthor=Y.+Igarashiauthor=R.+Goitsuka&title=Amelioration+of+Collagen-Induced+Arthritis+by+a+Novel+S1P1+Antagonist+with+Immunomodulatory+Activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DY.%26aulast%3DHirayama%26aufirst%3DT.%26aulast%3DOhtake%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DN.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DT.%26aulast%3DTakayama%26aufirst%3DT.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DTsukahara%26aufirst%3DN.%26aulast%3DHidano%26aufirst%3DS.%26aulast%3DHarima%26aufirst%3DN.%26aulast%3DNakazawa%26aufirst%3DK.%26aulast%3DIgarashi%26aufirst%3DY.%26aulast%3DGoitsuka%26aufirst%3DR.%26atitle%3DAmelioration%2520of%2520Collagen-Induced%2520Arthritis%2520by%2520a%2520Novel%2520S1P1%2520Antagonist%2520with%2520Immunomodulatory%2520Activities%26jtitle%3DJ.%2520Immunol.%26date%3D2012%26volume%3D188%26spage%3D206%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweitzer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persohn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balatoni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuschel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span> </span><span class="NLM_article-title">Brain Penetration of the Oral Immunomodulatory Drug FTY720 and Its Phosphorylation in the Central Nervous System during Experimental Autoimmune Encephalomyelitis: Consequences for Mode of Action in Multiple Sclerosis</span> <span class="citation_source-journal">J. Pharmcol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1124%2Fjpet.107.127183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=17682127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ynsLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2007&pages=469-476&author=C.+A.+Fosterauthor=L.+M.+Howardauthor=A.+Schweitzerauthor=E.+Persohnauthor=P.+C.+Hiestandauthor=B.+Balatoniauthor=R.+Reuschelauthor=C.+Beerliauthor=M.+Schwartzauthor=A.+Billich&title=Brain+Penetration+of+the+Oral+Immunomodulatory+Drug+FTY720+and+Its+Phosphorylation+in+the+Central+Nervous+System+during+Experimental+Autoimmune+Encephalomyelitis%3A+Consequences+for+Mode+of+Action+in+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis</span></div><div class="casAuthors">Foster, Carolyn A.; Howard, Laurence M.; Schweitzer, Alain; Persohn, Elke; Hiestand, Peter C.; Balatoni, Balazs; Reuschel, Roland; Beerli, Christian; Schwartz, Manuela; Billich, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">469-476</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">FTY720 [2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride] is an oral sphingosine-1-phosphate receptor modulator under development for the treatment of multiple sclerosis (MS).  The drug is phosphorylated in vivo by sphingosine kinase 2 to its bioactive form, FTY720-P.  Although treatment with FTY720 is accompanied by a redn. of the peripheral lymphocyte count, its efficacy in MS and exptl. autoimmune encephalomyelitis (EAE) may be due to addnl., direct effects in the central nervous system (CNS).  We now show that FTY720 localizes to the CNS white matter, preferentially along myelin sheaths.  Brain trough levels of FTY720 and FTY720-P in rat EAE are of the same magnitude and dose dependently increase; they are in the range of 40 to 540 ng/g in the brain tissue at efficacious doses and exceed blood concns. severalfold.  In a rat model of chronic EAE, prolonged treatment with 0.03 mg/kg was efficacious, but limiting the dosing period failed to prevent EAE despite a significant decrease in blood lymphocytes.  FTY720 effectiveness is likely due to a culmination of mechanisms involving redn. of autoreactive T cells, neuroprotective influence of FTY720-P in the CNS, and inhibition of inflammatory mediators in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq37e2tpDlreLVg90H21EOLACvtfcHk0lh2kJYD2R14kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ynsLfP&md5=a4f414517a4b567e8d8905f0da2b4706</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.127183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.127183%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DHoward%26aufirst%3DL.%2BM.%26aulast%3DSchweitzer%26aufirst%3DA.%26aulast%3DPersohn%26aufirst%3DE.%26aulast%3DHiestand%26aufirst%3DP.%2BC.%26aulast%3DBalatoni%26aufirst%3DB.%26aulast%3DReuschel%26aufirst%3DR.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DSchwartz%26aufirst%3DM.%26aulast%3DBillich%26aufirst%3DA.%26atitle%3DBrain%2520Penetration%2520of%2520the%2520Oral%2520Immunomodulatory%2520Drug%2520FTY720%2520and%2520Its%2520Phosphorylation%2520in%2520the%2520Central%2520Nervous%2520System%2520during%2520Experimental%2520Autoimmune%2520Encephalomyelitis%253A%2520Consequences%2520for%2520Mode%2520of%2520Action%2520in%2520Multiple%2520Sclerosis%26jtitle%3DJ.%2520Pharmcol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D323%26spage%3D469%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Balatoni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storch, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swoboda, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schönborn, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koziel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambrou, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span> </span><span class="NLM_article-title">FTY720 Sustains and Restores Neuronal Function in the DA Rat Model of MOG-Induced Experimental Autoimmune Encephalomyelitis</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">316</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1016%2Fj.brainresbull.2007.06.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=17845905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWhs7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=307-316&author=B.+Balatoniauthor=M.+K.+Storchauthor=E.-M.+Swobodaauthor=V.+Sch%C3%B6nbornauthor=A.+Kozielauthor=G.+N.+Lambrouauthor=P.+C.+Hiestandauthor=R.+Weissertauthor=C.+A.+Foster&title=FTY720+Sustains+and+Restores+Neuronal+Function+in+the+DA+Rat+Model+of+MOG-Induced+Experimental+Autoimmune+Encephalomyelitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis</span></div><div class="casAuthors">Balatoni, Balazs; Storch, Maria K.; Swoboda, Eva-M.; Schoenborn, Vinzenz; Koziel, Agnieszka; Lambrou, George N.; Hiestand, Peter C.; Weissert, Robert; Foster, Carolyn A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">307-316</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">FTY720 (fingolimod) is an oral sphingosine 1-phosphate (S1P) receptor modulator under development for the treatment of multiple sclerosis (MS).  To elucidate its effects in the central nervous system (CNS), we compared functional parameters of nerve conductance in the DA rat model of myelin oligodendrocyte glycoprotein (MOG)-induced exptl. autoimmune encephalomyelitis (EAE) after preventive and therapeutic treatment.  We demonstrate that prophylactic therapy protected against the emergence of EAE symptoms, neuropathol., and disturbances to visual and somatosensory evoked potentials (VEP, SEP).  Moreover, therapeutic treatment from day 25 to 45 markedly reversed paralysis in established EAE and normalized the electrophysiol. responses, correlating with decreased demyelination in the brain and spinal cord.  The effectiveness of FTY720 in this model is likely due to several contributing factors.  Evidence thus far supports its role in the redn. of inflammation and preservation of blood-brain-barrier integrity.  FTY720 may also act via S1P receptors in glial cells to promote endogenous repair mechanisms that complement its immunomodulatory action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFwogDXcfLFrVg90H21EOLACvtfcHk0lh2kJYD2R14kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWhs7jL&md5=5fb8cec643e3ca6d7b35eaf3b020b873</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresbull.2007.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresbull.2007.06.023%26sid%3Dliteratum%253Aachs%26aulast%3DBalatoni%26aufirst%3DB.%26aulast%3DStorch%26aufirst%3DM.%2BK.%26aulast%3DSwoboda%26aufirst%3DE.-M.%26aulast%3DSch%25C3%25B6nborn%26aufirst%3DV.%26aulast%3DKoziel%26aufirst%3DA.%26aulast%3DLambrou%26aufirst%3DG.%2BN.%26aulast%3DHiestand%26aufirst%3DP.%2BC.%26aulast%3DWeissert%26aufirst%3DR.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26atitle%3DFTY720%2520Sustains%2520and%2520Restores%2520Neuronal%2520Function%2520in%2520the%2520DA%2520Rat%2520Model%2520of%2520MOG-Induced%2520Experimental%2520Autoimmune%2520Encephalomyelitis%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2007%26volume%3D74%26spage%3D307%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Dev, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullershausen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilbe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mir, A.</span><span> </span><span class="NLM_article-title">Brain Sphingosine-1-phosphate Receptors: Implication for FTY720 in the Treatment of Multiple Sclerosis</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1016%2Fj.pharmthera.2007.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=17961662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2008&pages=77-93&author=K.+K.+Devauthor=F.+Mullershausenauthor=H.+Mattesauthor=R.+R.+Kuhnauthor=G.+Bilbeauthor=D.+Hoyerauthor=A.+Mir&title=Brain+Sphingosine-1-phosphate+Receptors%3A+Implication+for+FTY720+in+the+Treatment+of+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis</span></div><div class="casAuthors">Dev, Kumlesh K.; Mullershausen, Florian; Mattes, Henri; Kuhn, Rainer R.; Bilbe, Graeme; Hoyer, Daniel; Mir, Anis</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-93</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Multiple sclerosis (MS) is an autoimmune, neurol. disability with unknown etiol.  The current therapies available for MS work by an immunomodulatory action, preventing T-cell- and macrophage-mediated destruction of brain-resident oligodendrocytes and axonal loss.  Recently, FTY720 (fingolimod) was shown to significantly reduce relapse rates in MS patients and is currently in Phase III clin. trials.  This drug attenuates trafficking of harmful T cells entering the brain by regulating sphingosine-1-phosphate (S1P) receptors.  Here, we outline the direct roles that S1P receptors play in the central nervous system (CNS) and discuss addnl. modalities by which FTY720 may provide direct neuroprotection in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYlyd4S2EeELVg90H21EOLACvtfcHk0li5k0-3ieFQEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtL3J&md5=d5cf04a35f8bb06f3e094d2e75c698c0</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DDev%26aufirst%3DK.%2BK.%26aulast%3DMullershausen%26aufirst%3DF.%26aulast%3DMattes%26aufirst%3DH.%26aulast%3DKuhn%26aufirst%3DR.%2BR.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DMir%26aufirst%3DA.%26atitle%3DBrain%2520Sphingosine-1-phosphate%2520Receptors%253A%2520Implication%2520for%2520FTY720%2520in%2520the%2520Treatment%2520of%2520Multiple%2520Sclerosis%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D117%26spage%3D77%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Miron, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antel, J. P.</span><span> </span><span class="NLM_article-title">Central Nervous System-Directed Effects of FTY720 (Fingolimod)</span> <span class="citation_source-journal">J. Neurol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1016%2Fj.jns.2008.06.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=18678377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1eitr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=2008&pages=13-17&author=V.+E.+Mironauthor=A.+Schubartauthor=J.+P.+Antel&title=Central+Nervous+System-Directed+Effects+of+FTY720+%28Fingolimod%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Central nervous system-directed effects of FTY720 (fingolimod)</span></div><div class="casAuthors">Miron, Veronique E.; Schubart, Anna; Antel, Jack P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Neurological Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">13-17</span>CODEN:
                <span class="NLM_cas:coden">JNSCAG</span>;
        ISSN:<span class="NLM_cas:issn">0022-510X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  FTY720, also known as fingolimod, is an orally administered sphingosine-1-phosphate (S1P) analog that is under investigation as a therapy for both relapsing-remitting (RR) and progressive forms of multiple sclerosis (MS).  The demonstrated beneficial effect of FTY720 on disease activity in RR-MS patients and in the animal model exptl. autoimmune encephalomyelitis (EAE) is largely attributed to effects on the systemic immune system.  In addn., unlike other current systemic immuno-modulators used in MS, the lipophilic nature of FTY720 allows it to cross the blood-brain barrier (BBB).  Since S1P receptors are expressed on all cell types, FTY720 has the potential to exert effects directly on the BBB and on resident cells of the CNS.  The latter include cells implicated in regulating immune reactivity within the CNS (astrocytes, microglia), those that are targeted by the disease process (oligodendrocytes, neurons), and those involved in repair (oligodendrocyte progenitor cells).  In vitro studies document the dose-dependent effects of FTY720 on neural cell survival, differentiation, and cytoskeletal dynamics.  Animal model studies, specifically EAE, indicate an overall neuroprotective effect of FTY720 mediated at least in part by its actions within the CNS.  Ongoing studies will need to define the direct and indirect (via immune-modulation) effects of FTY720 on the CNS across the broad clin. spectrum of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUQKb02aQLcLVg90H21EOLACvtfcHk0li5k0-3ieFQEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1eitr3P&md5=9077c2ceb142106644dc112dfbb1bc10</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.jns.2008.06.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jns.2008.06.031%26sid%3Dliteratum%253Aachs%26aulast%3DMiron%26aufirst%3DV.%2BE.%26aulast%3DSchubart%26aufirst%3DA.%26aulast%3DAntel%26aufirst%3DJ.%2BP.%26atitle%3DCentral%2520Nervous%2520System-Directed%2520Effects%2520of%2520FTY720%2520%2528Fingolimod%2529%26jtitle%3DJ.%2520Neurol.%2520Sci.%26date%3D2008%26volume%3D274%26spage%3D13%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Miron, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soliven, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antel, J. P.</span><span> </span><span class="NLM_article-title">Cyclical and Dose-Dependent Responses of Adult Human Mature Oligodendrocytes to Fingolimod</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">1143</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.2353%2Fajpath.2008.080478" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=18772343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CjtL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2008&pages=1143-1152&author=V.+E.+Mironauthor=J.+A.+Hallauthor=T.+E.+Kennedyauthor=B.+Solivenauthor=J.+P.+Antel&title=Cyclical+and+Dose-Dependent+Responses+of+Adult+Human+Mature+Oligodendrocytes+to+Fingolimod"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclical and dose-dependent response of adult human mature oligodendrocytes to fingolimod</span></div><div class="casAuthors">Miron, Veronique E.; Hall, Jeffery A.; Kennedy, Timothy E.; Soliven, Betty; Antel, Jack P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1143-1152</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Fingolimod is a sphingosine-1-phosphate (S1P) analog that has been used in clin. trials as a systemic immunomodulatory therapy for multiple sclerosis.  Fingolimod readily accesses the central nervous system, raising the issue of its direct effects on neural cells.  We assessed the effects of active fingolimod on dissocd. cultures of mature, myelin-producing oligodendrocytes (OLGs) derived from adult human brain.  Human OLGs express S1P receptor transcripts in relative abundance of S1P5>S1P3>S1P1, with undetectable levels of S1P4.  Low doses of fingolimod (100 pmol/L to 1 nmol/L) induced initial membrane elaboration (2 days), subsequent retraction (4 days), and recurrence of extension with prolonged treatment (8 days).  Higher doses (10 nmol/L to 1 μmol/L) caused the opposite modulation of membrane dynamics.  Retraction was rescued by co-treatment with the S1P3/S1P5 pathway antagonist, suramin, and was assocd. with RhoA-mediated cytoskeletal signaling.  Membrane elaboration was mimicked using the S1P1 agonist SEW2871.  Fingolimod rescued human OLGs from serum and glucose deprivation-induced apoptosis, which was reversed with suramin co-treatment and mimicked using an S1P5 agonist.  High doses of fingolimod induced an initial down-regulation of S1P5 mRNA levels relative to control (4 h), subsequent up-regulation (2 days), and recurrent down-regulation (8 days).  S1P1 mRNA levels were inversely regulated compared with S1P5.  These results indicate that fingolimod modulates maturity- and species-specific OLG membrane dynamics and survival responses that are directly relevant for myelin integrity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtGHQOOEJgsrVg90H21EOLACvtfcHk0li5k0-3ieFQEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CjtL%252FN&md5=392836c44953f7a1d88767a5f88ef04a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2008.080478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2008.080478%26sid%3Dliteratum%253Aachs%26aulast%3DMiron%26aufirst%3DV.%2BE.%26aulast%3DHall%26aufirst%3DJ.%2BA.%26aulast%3DKennedy%26aufirst%3DT.%2BE.%26aulast%3DSoliven%26aufirst%3DB.%26aulast%3DAntel%26aufirst%3DJ.%2BP.%26atitle%3DCyclical%2520and%2520Dose-Dependent%2520Responses%2520of%2520Adult%2520Human%2520Mature%2520Oligodendrocytes%2520to%2520Fingolimod%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2008%26volume%3D173%26spage%3D1143%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H.-P.</span><span> </span><span class="NLM_article-title">Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=91-101&author=J.+Chunauthor=H.-P.+Hartung&title=Mechanism+of+Action+of+Oral+Fingolimod+%28FTY720%29+in+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DHartung%26aufirst%3DH.-P.%26atitle%3DMechanism%2520of%2520Action%2520of%2520Oral%2520Fingolimod%2520%2528FTY720%2529%2520in%2520Multiple%2520Sclerosis%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2010%26volume%3D33%26spage%3D91%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Lee, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Neurological S1P Signalling as an Emerging Mechanism of Action of Oral FTY720 (Fingolimod) in Multiple Sclerosis</span> <span class="citation_source-journal">Arch. Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1567</span><span class="NLM_x">–</span> <span class="NLM_lpage">1574</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1007%2Fs12272-010-1008-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlOqtr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=1567-1574&author=C.+W.+Leeauthor=J.+W.+Choiauthor=J.+Chun&title=Neurological+S1P+Signalling+as+an+Emerging+Mechanism+of+Action+of+Oral+FTY720+%28Fingolimod%29+in+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (Fingolimod) in multiple sclerosis</span></div><div class="casAuthors">Lee, Chang Wook; Choi, Ji Woong; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1567-1574</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">A review.  FTY720 (fingolimod, Novartis) is a promising investigational drug for relapsing forms of multiple sclerosis (MS), an autoimmune and neurodegenerative disorder of the central nervous system.  It is currently under FDA review in the United States, and could represent the first approved oral treatment for MS.  Extensive, ongoing clin. trials in Phase II/III have supported both the efficacy and safety of FTY720.  FTY720 itself is not bioactive, but when phosphorylated (FTY720-P) by sphingosine kinase 2, it becomes active through modulation of 4 of the 5 known G protein-coupled sphingosine 1-phosphate (S1P) receptors.  The mechanism of action (MOA) is thought to be immunol., where FTY720 alters lymphocyte trafficking via S1P1.  However, MOA for FTY720 in MS may also involve a direct, neurol. action within the central nervous system in view of documented S1P receptor-mediated signaling influences in the brain, and this review considers observations that support an emerging neurol. MOA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph7gXXxPKanLVg90H21EOLACvtfcHk0lh1aAEU4zOCEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlOqtr%252FK&md5=92caa8d7d6e2fcaa4d9d1286314b8d87</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs12272-010-1008-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-010-1008-5%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DNeurological%2520S1P%2520Signalling%2520as%2520an%2520Emerging%2520Mechanism%2520of%2520Action%2520of%2520Oral%2520FTY720%2520%2528Fingolimod%2529%2520in%2520Multiple%2520Sclerosis%26jtitle%3DArch.%2520Pharm.%2520Res.%26date%3D2010%26volume%3D33%26spage%3D1567%26epage%3D1574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kipp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amor, S.</span><span> </span><span class="NLM_article-title">FTY720 on the Way from the Base Camp to the Summit of the Mountain: Relevance for Remyelination</span> <span class="citation_source-journal">Mult. Scler. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1177%2F1352458512438723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Cit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=258-263&author=M.+Kippauthor=S.+Amor&title=FTY720+on+the+Way+from+the+Base+Camp+to+the+Summit+of+the+Mountain%3A+Relevance+for+Remyelination"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination</span></div><div class="casAuthors">Kipp, M.; Amor, S.</div><div class="citationInfo"><span class="NLM_cas:title">Multiple Sclerosis Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">258-263</span>CODEN:
                <span class="NLM_cas:coden">MSJUAP</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  FTY720 (fingolimod; Gilenya), a sphingosine 1-phosphate (S1P) receptor modulator, is the first oral disease-modifying therapy to be approved for the treatment of relapsing-remitting multiple sclerosis.  FTY720 is rapidly converted in vivo to the active S-fingolimod-phosphate, which binds to S1P receptors.  This action inhibits egress of lymphocytes from the lymph nodes, preventing entry into the blood and thus infiltration into the central nervous system.  More recent studies, however, convincingly show that FTY720 crosses the blood-brain barrier, where it is thought to act on S1P receptors on cells within the central nervous system, such as astrocytes, oligodendrocytes or microglia.  Here we discuss the evidence showing that FTY720 also plays a role in remyelination and repair within the brain.  While the mechanisms of action still require firm elucidation, it is clear that FTY720 could also be reparative, extending its therapeutic potential for multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKA78G9IbOg7Vg90H21EOLACvtfcHk0lh1aAEU4zOCEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Cit78%253D&md5=ecd15c846c60079f5f794e9f5ce239cc</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1177%2F1352458512438723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1352458512438723%26sid%3Dliteratum%253Aachs%26aulast%3DKipp%26aufirst%3DM.%26aulast%3DAmor%26aufirst%3DS.%26atitle%3DFTY720%2520on%2520the%2520Way%2520from%2520the%2520Base%2520Camp%2520to%2520the%2520Summit%2520of%2520the%2520Mountain%253A%2520Relevance%2520for%2520Remyelination%26jtitle%3DMult.%2520Scler.%2520J.%26date%3D2012%26volume%3D18%26spage%3D258%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Awad, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouse, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khutsishvili, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okusa, M. D.</span><span> </span><span class="NLM_article-title">Chronic Sphingosine 1 - Phosphate 1 Receptor Activation Attenuates Early-Stage Diabetic Nephropathy Independent of Lymphocytes</span> <span class="citation_source-journal">Kidney Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1090</span><span class="NLM_x">–</span> <span class="NLM_lpage">1098</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1038%2Fki.2010.544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltlyju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=1090-1098&author=A.+S.+Awadauthor=M.+D.+Rouseauthor=K.+Khutsishviliauthor=L.+Huangauthor=W.+K.+Boltonauthor=K.+R.+Lynchauthor=M.+D.+Okusa&title=Chronic+Sphingosine+1+-+Phosphate+1+Receptor+Activation+Attenuates+Early-Stage+Diabetic+Nephropathy+Independent+of+Lymphocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes</span></div><div class="casAuthors">Awad, Alaa S.; Rouse, Michael D.; Khutsishvili, Konstantine; Huang, Liping; Bolton, W. Kline; Lynch, Kevin R.; Okusa, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1090-1098</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P), a pleiotropic lipid mediator, binds to five related G-protein-coupled receptors to exert its effects.  As S1P1 receptor (S1P1R) activation blocks kidney inflammation in acute renal injury, we tested whether activation of S1P1Rs ameliorates renal injury in early-stage diabetic nephropathy (DN) in rats.  Urinary albumin excretion increased in vehicle-treated diabetic rats (single injection of streptozotocin), compared with controls, and was assocd. with tubule injury and increased urinary tumor necrosis factor-α (TNF-α) at 9 wk.  These effects were significantly reduced by FTY720, a non-selective, or SEW2871, a selective S1P1R agonist.  Interestingly, only FTY720 was assocd. with reduced total lymphocyte levels.  Albuminuria was reduced by SEW2871 in both Rag-1 (T- and B-cell deficient) and wild-type diabetic mice after 6 wk, suggesting that the effect was independent of lymphocytes.  Another receptor, S1P3R, did not contribute to the FTY720-mediated protection, as albuminuria was also reduced in diabetic S1P3R knockout mice.  Further, both agonists restored WT-1 staining along with podocin and nephrin mRNA expression, suggesting podocyte protection.  This was corroborated in vitro, as SEW2871 reduced TNF-α and vascular endothelial growth factor mRNA expression in immortalized podocytes grown in media contg. high glucose.  Whether targeting kidney S1P1Rs will be a useful therapeutic measure in DN will need direct testing.  Kidney International (2011) 79, 1090-1098; doi:10.1038/ki.2010.544; published online 2 Feb. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Mrjewsi7q7Vg90H21EOLACvtfcHk0lh1aAEU4zOCEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltlyju78%253D&md5=a1948344ffbd1bb4a86de1e1edb6f25d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fki.2010.544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fki.2010.544%26sid%3Dliteratum%253Aachs%26aulast%3DAwad%26aufirst%3DA.%2BS.%26aulast%3DRouse%26aufirst%3DM.%2BD.%26aulast%3DKhutsishvili%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DBolton%26aufirst%3DW.%2BK.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DOkusa%26aufirst%3DM.%2BD.%26atitle%3DChronic%2520Sphingosine%25201%2520-%2520Phosphate%25201%2520Receptor%2520Activation%2520Attenuates%2520Early-Stage%2520Diabetic%2520Nephropathy%2520Independent%2520of%2520Lymphocytes%26jtitle%3DKidney%2520Int.%26date%3D2011%26volume%3D79%26spage%3D1090%26epage%3D1098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Miron, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwin, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarjour, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soliven, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antel, J. P.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">2682</span><span class="NLM_x">–</span> <span class="NLM_lpage">2694</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.2353%2Fajpath.2010.091234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=20413685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptFKrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2010&pages=2682-2694&author=V.+E.+Mironauthor=S.+K.+Ludwinauthor=P.+J.+Darlingtonauthor=A.+A.+Jarjourauthor=B.+Solivenauthor=T.+E.+Kennedyauthor=J.+P.+Antel&title=Fingolimod+%28FTY720%29+Enhances+Remyelination+Following+Demyelination+of+Organotypic+Cerebellar+Slices"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices</span></div><div class="casAuthors">Miron, Veronique E.; Ludwin, Samuel K.; Darlington, Peter J.; Jarjour, Andrew A.; Soliven, Betty; Kennedy, Timothy E.; Antel, Jack P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2682-2694</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Remyelination, which occurs subsequent to demyelination, contributes to functional recovery and is mediated by oligodendrocyte progenitor cells (OPCs) that have differentiated into myelinating cells.  Therapeutics that impact remyelination in the CNS could be crit. determinants of long-term functional outcome in multiple sclerosis (MS).  Fingolimod is a S1P receptor modulator in MS clin. trials due to systemic anti-inflammatory properties, yet may impact cells within the CNS by crossing the blood-brain barrier.  Previous studies using isolated dissocd. cultures indicate that neural cells express S1P receptors and respond to receptor engagement.  Our objective was to assess the effects of fingolimod on myelinrelated processes within a multicellular environment that maintains physiol. cell-cell interactions, using organotypic cerebellar slice cultures.  Fingolimod treatment had no impact on myelin under basal conditions.  Fingolimod treatment subsequent to lysolecithin-induced demyelination enhanced remyelination and process extension by OPCs and mature oligodendrocytes, while increasing microglia nos. and immunoreactivity for the astrocytic marker glial fibrillary acidic protein.  The no. of phagocytosing microglia was not increased by fingolimod.  Using S1P receptor specific agonists and antagonists, we detd. that fingolimod-induced effects on remyelination and astrogliosis were mediated primarily through S1P3 and S1P5, whereas enhanced microgliosis was mediated through S1P1 and S1P5.  Taken together, these data demonstrate that fingolimod modulates multiple neuroglial cell responses, resulting in enhanced remyelination in organotypic slice cultures that maintain the complex cellular interactions of the mammalian brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGradvge9335h7Vg90H21EOLACvtfcHk0lh1aAEU4zOCEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptFKrs7c%253D&md5=6e7efa55ed7482a64dad66c6ec384de8</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2010.091234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2010.091234%26sid%3Dliteratum%253Aachs%26aulast%3DMiron%26aufirst%3DV.%2BE.%26aulast%3DLudwin%26aufirst%3DS.%2BK.%26aulast%3DDarlington%26aufirst%3DP.%2BJ.%26aulast%3DJarjour%26aufirst%3DA.%2BA.%26aulast%3DSoliven%26aufirst%3DB.%26aulast%3DKennedy%26aufirst%3DT.%2BE.%26aulast%3DAntel%26aufirst%3DJ.%2BP.%26atitle%3DFingolimod%2520%2528FTY720%2529%2520Enhances%2520Remyelination%2520Following%2520Demyelination%2520of%2520Organotypic%2520Cerebellar%2520Slices%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2010%26volume%3D176%26spage%3D2682%26epage%3D2694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Mattes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dev, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouhelal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barske, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasparini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mir, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osinde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasdelen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haessig, S.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Selective and Potent Orally Active S1P5 Agonists</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1693</span><span class="NLM_x">–</span> <span class="NLM_lpage">1696</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1693-1696&author=H.+Mattesauthor=K.+K.+Devauthor=R.+Bouhelalauthor=C.+Barskeauthor=F.+Gaspariniauthor=D.+Gueriniauthor=A.+K.+Mirauthor=D.+Orainauthor=M.+Osindeauthor=A.+Picardauthor=C.+Duboisauthor=E.+Tasdelenauthor=S.+Haessig&title=Design+and+Synthesis+of+Selective+and+Potent+Orally+Active+S1P5+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMattes%26aufirst%3DH.%26aulast%3DDev%26aufirst%3DK.%2BK.%26aulast%3DBouhelal%26aufirst%3DR.%26aulast%3DBarske%26aufirst%3DC.%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DMir%26aufirst%3DA.%2BK.%26aulast%3DOrain%26aufirst%3DD.%26aulast%3DOsinde%26aufirst%3DM.%26aulast%3DPicard%26aufirst%3DA.%26aulast%3DDubois%26aufirst%3DC.%26aulast%3DTasdelen%26aufirst%3DE.%26aulast%3DHaessig%26aufirst%3DS.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Selective%2520and%2520Potent%2520Orally%2520Active%2520S1P5%2520Agonists%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1693%26epage%3D1696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Choi, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teo, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">FTY720 (Fingolimod) Efficacy in an Animal Model of Multiple Sclerosis Requires Astrocyte Sphingosine 1-Phosphate Receptor 1 (S1P<sub>1</sub>) Modulation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">751</span><span class="NLM_x">–</span> <span class="NLM_lpage">756</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=751-756&author=J.+W.+Choiauthor=S.+E.+Gardellauthor=D.+R.+Herrauthor=R.+Riveraauthor=C.-W.+Leeauthor=K.+Noguchiauthor=S.+T.+Teoauthor=Y.+C.+Yungauthor=M.+Luauthor=G.+Kennedyauthor=J.+Chun&title=FTY720+%28Fingolimod%29+Efficacy+in+an+Animal+Model+of+Multiple+Sclerosis+Requires+Astrocyte+Sphingosine+1-Phosphate+Receptor+1+%28S1P1%29+Modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DGardell%26aufirst%3DS.%2BE.%26aulast%3DHerr%26aufirst%3DD.%2BR.%26aulast%3DRivera%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.-W.%26aulast%3DNoguchi%26aufirst%3DK.%26aulast%3DTeo%26aufirst%3DS.%2BT.%26aulast%3DYung%26aufirst%3DY.%2BC.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DKennedy%26aufirst%3DG.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DFTY720%2520%2528Fingolimod%2529%2520Efficacy%2520in%2520an%2520Animal%2520Model%2520of%2520Multiple%2520Sclerosis%2520Requires%2520Astrocyte%2520Sphingosine%25201-Phosphate%2520Receptor%25201%2520%2528S1P1%2529%2520Modulation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D751%26epage%3D756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Selecting against S1P<sub>3</sub> Enhances the Acute Cardiovascular Tolerability of 3-(N-Benzyl)aminopropylphosphonic Acid S1P Receptor Agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3501</span><span class="NLM_x">–</span> <span class="NLM_lpage">3505</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3501-3505&author=J.+J.+Haleauthor=G.+Dohertyauthor=L.+Tothauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+Rosenbachauthor=J.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Forrestauthor=S.-Y.+Sunauthor=S.+Westauthor=H.+Xieauthor=N.+Nomuraauthor=H.+Rosenauthor=S.+Mandala&title=Selecting+against+S1P3+Enhances+the+Acute+Cardiovascular+Tolerability+of+3-%28N-Benzyl%29aminopropylphosphonic+Acid+S1P+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DToth%26aufirst%3DL.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DSelecting%2520against%2520S1P3%2520Enhances%2520the%2520Acute%2520Cardiovascular%2520Tolerability%2520of%25203-%2528N-Benzyl%2529aminopropylphosphonic%2520Acid%2520S1P%2520Receptor%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3501%26epage%3D3505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1124%2Fjpet.103.062828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=14747617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=758-768&author=M.+Forrestauthor=S.-Y.+Sunauthor=R.+Hajduauthor=J.+Bergstromauthor=D.+Cardauthor=G.+Dohertyauthor=J.+Haleauthor=C.+Keohaneauthor=C.+Meyersauthor=J.+Milliganauthor=S.+Millsauthor=N.+Nomuraauthor=H.+Rosenauthor=M.+Rosenbachauthor=G.-J.+Sheiauthor=I.+I.+Singerauthor=M.+Tianauthor=S.+Westauthor=V.+Whiteauthor=J.+Xieauthor=R.+L.+Proiaauthor=S.+Mandala&title=Immune+Cell+Regulation+and+Cardiovascular+Effects+of+Sphingosine+1-Phosphate+Receptor+Agonists+in+Rodents+Are+Mediated+via+Distinct+Receptor+Subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span></div><div class="casAuthors">Forrest, M.; Sun, S.-Y.; Hajdu, R.; Bergstrom, J.; Card, D.; Doherty, G.; Hale, J.; Keohane, C.; Meyers, C.; Milligan, J.; Mills, S.; Nomura, N.; Rosen, H.; Rosenbach, M.; Shei, G.-J.; Singer, I. I.; Tian, M.; West, S.; White, V.; Xie, J.; Proia, R. L.; Mandala, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">758-768</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a bioactive lysolipid with pleiotropic functions mediated through a family of G protein-coupled receptors, S1P1,2,3,4,5.  Physiol. effects of S1P receptor agonists include regulation of cardiovascular function and immunosuppression via redistribution of lymphocytes from blood to secondary lymphoid organs.  The phosphorylated metabolite of the immunosuppressant agent FTY720 (2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol) and other phosphonate analogs with differential receptor selectivity were investigated.  No significant species differences in compd. potency or rank order of activity on receptors cloned from human, murine, and rat sources were obsd.  All synthetic analogs were high-affinity agonists on S1P1, with IC50 values for ligand binding between 0.3 and 14 nM.  The correlation between S1P1 receptor activation and the ED50 for lymphocyte redn. was highly significant (p < 0.001) and lower for the other receptors.  In contrast to S1P1-mediated effects on lymphocyte recirculation, three lines of evidence link S1P3 receptor activity with acute toxicity and cardiovascular regulation: compd. potency on S1P3 correlated with toxicity and bradycardia; the shift in potency of phosphorylated-FTY720 for inducing lymphopenia vs. bradycardia and hypertension was consistent with affinity for S1P1 relative to S1P3; and toxicity, bradycardia, and hypertension were absent in S1P3-/- mice.  Blood pressure effects of agonists in anesthetized rats were complex, whereas hypertension was the predominant effect in conscious rats and mice.  Immunolocalization of S1P3 in rodent heart revealed abundant expression on myocytes and perivascular smooth muscle cells consistent with regulation of bradycardia and hypertension, whereas S1P1 expression was restricted to the vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKo2vpih4eoLVg90H21EOLACvtfcHk0ljbe0vbOMOPIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D&md5=27183d4991bffbc5d2b88174b1386d5a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062828%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DC.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DSinger%26aufirst%3DI.%2BI.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DImmune%2520Cell%2520Regulation%2520and%2520Cardiovascular%2520Effects%2520of%2520Sphingosine%25201-Phosphate%2520Receptor%2520Agonists%2520in%2520Rodents%2520Are%2520Mediated%2520via%2520Distinct%2520Receptor%2520Subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D758%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P<sub>1</sub> and S1P<sub>3</sub>, Respectively, Regulate Lymphocyte Recirculation and Heart Rate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">13839</span><span class="NLM_x">–</span> <span class="NLM_lpage">13848</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=13839-13848&author=M.+G.+Sannaauthor=J.+Liaoauthor=E.+Joauthor=C.+Alfonsoauthor=M.-Y.+Ahnauthor=M.+S.+Petersonauthor=B.+Webbauthor=S.+Lefebvreauthor=J.+Chunauthor=N.+Grayauthor=H.+Rosen&title=Sphingosine+1-Phosphate+%28S1P%29+Receptor+Subtypes+S1P1+and+S1P3%2C+Respectively%2C+Regulate+Lymphocyte+Recirculation+and+Heart+Rate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DAlfonso%26aufirst%3DC.%26aulast%3DAhn%26aufirst%3DM.-Y.%26aulast%3DPeterson%26aufirst%3DM.%2BS.%26aulast%3DWebb%26aufirst%3DB.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DSphingosine%25201-Phosphate%2520%2528S1P%2529%2520Receptor%2520Subtypes%2520S1P1%2520and%2520S1P3%252C%2520Respectively%252C%2520Regulate%2520Lymphocyte%2520Recirculation%2520and%2520Heart%2520Rate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D13839%26epage%3D13848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Salomone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyndall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ip, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waeber, C.</span><span> </span><span class="NLM_article-title">Analysis of Sphingosine 1-Phosphate Receptors Involved in Constriction of Isolated Cerebral Arteries with Receptor Null Mice and Pharmacological Tools</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1038%2Fsj.bjp.0707581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=18026125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlyntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=140-147&author=S.+Salomoneauthor=E.+M.+Pottsauthor=S.+Tyndallauthor=P.+C.+Ipauthor=J.+Chunauthor=V.+Brinkmannauthor=C.+Waeber&title=Analysis+of+Sphingosine+1-Phosphate+Receptors+Involved+in+Constriction+of+Isolated+Cerebral+Arteries+with+Receptor+Null+Mice+and+Pharmacological+Tools"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools</span></div><div class="casAuthors">Salomone, S.; Potts, E. M.; Tyndall, S.; Ip, P. C.; Chun, J.; Brinkmann, V.; Waeber, C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-147</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: Sphingosine 1-phosphate (S1P) selectively and potently constricts isolated cerebral arteries, but this response has not been pharmacol. characterized.  Exptl. approach: The receptor subtype(s) involved in S1P-induced cerebrovascular constriction were characterized using genetic (S1P2 and S1P3 receptor null mice) and pharmacol. tools (phospho-FTY720, a S1P1/3/4/5 receptor agonist; SEW2871, a S1P1 receptor agonist, JTE-013, a S1P2 receptor antagonist, VPC23019, a S1P1/3 receptor antagonist).  Isolated basilar or peripheral (femoral, mesenteric resistance) arteries, from either rat or mouse, were studied in a wire myograph.  Key results: S1P concn.-dependently constricted basilar artery in rat, wild-type (WT) and S1P2 null mice, but barely affected vascular tone in S1P3 null mice.  Vasoconstriction to U46619 (a thromboxane analog) or to endothelin-1 did not differ between WT, S1P2 and S1P3 null mice.  JTE-013 inhibited not only S1P-induced vasoconstriction, but also KCl-, U46619- and endothelin-1-induced constriction.  This effect was obsd. in WT as well as in S1P2 null mice.  VPC23019 increased the concn.-dependent vasoconstriction to S1P in both rat and mouse basilar arteries with intact endothelium, but not in rat basilar artery without endothelium.  Phospho-FTY720 concn.-dependently constricted rat basilar arteries, but not femoral or mesenteric resistance arteries, while SEW2871 did not induce any response in the same arteries.  Conclusions and implications: S1P constricts cerebral arteries through S1P3 receptors.  The purported S1P2 receptor antagonist JTE-013 does not appear to be selective, at least in rodents.  Enhancement of S1P-induced contraction by VPC23019 might be related to blockade of S1P1 receptors and NO generation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkx6pcvW_Q37Vg90H21EOLACvtfcHk0lg1ME7WvA_GYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlyntg%253D%253D&md5=1e8bef7d6f2df66b4436300fab09df06</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707581%26sid%3Dliteratum%253Aachs%26aulast%3DSalomone%26aufirst%3DS.%26aulast%3DPotts%26aufirst%3DE.%2BM.%26aulast%3DTyndall%26aufirst%3DS.%26aulast%3DIp%26aufirst%3DP.%2BC.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DWaeber%26aufirst%3DC.%26atitle%3DAnalysis%2520of%2520Sphingosine%25201-Phosphate%2520Receptors%2520Involved%2520in%2520Constriction%2520of%2520Isolated%2520Cerebral%2520Arteries%2520with%2520Receptor%2520Null%2520Mice%2520and%2520Pharmacological%2520Tools%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D140%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Murakami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taksugi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koide, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasamori, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakura, N.</span><span> </span><span class="NLM_article-title">Sphingosine 1-Phosphate (S1P) Regulates Vascular Contraction via S1P<sub>3</sub> Receptor: Investigation Based on a New S1P<sub>3</sub> Receptor Antagonist</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=704-713&author=A.+Murakamiauthor=H.+Taksugiauthor=S.+Ohnumaauthor=Y.+Koideauthor=A.+Sakuraiauthor=S.+Takedaauthor=T.+Hasegawaauthor=J.+Sasamoriauthor=T.+Konnoauthor=K.+Hayashiauthor=Y.+Watanabeauthor=K.+Moriauthor=Y.+Satoauthor=A.+Takahashiauthor=N.+Mochizukiauthor=N.+Takakura&title=Sphingosine+1-Phosphate+%28S1P%29+Regulates+Vascular+Contraction+via+S1P3+Receptor%3A+Investigation+Based+on+a+New+S1P3+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DA.%26aulast%3DTaksugi%26aufirst%3DH.%26aulast%3DOhnuma%26aufirst%3DS.%26aulast%3DKoide%26aufirst%3DY.%26aulast%3DSakurai%26aufirst%3DA.%26aulast%3DTakeda%26aufirst%3DS.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DSasamori%26aufirst%3DJ.%26aulast%3DKonno%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DMochizuki%26aufirst%3DN.%26aulast%3DTakakura%26aufirst%3DN.%26atitle%3DSphingosine%25201-Phosphate%2520%2528S1P%2529%2520Regulates%2520Vascular%2520Contraction%2520via%2520S1P3%2520Receptor%253A%2520Investigation%2520Based%2520on%2520a%2520New%2520S1P3%2520Receptor%2520Antagonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D77%26spage%3D704%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Saha, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobera, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shardendu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chereku, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marantz, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bürli, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buys, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salyers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrag, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElvain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span> </span><span class="NLM_article-title">Benzofuran Derivatives as Potent, Orally Active S1P1 Receptor Agonists: A Preclinical Lead Molecule for MS</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100227q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=97-101&author=A.+K.+Sahaauthor=X.+Yuauthor=J.+Linauthor=M.+Loberaauthor=A.+Shardenduauthor=S.+Cherekuauthor=N.+Schutzauthor=D.+Segalauthor=Y.+Marantzauthor=D.+McCauleyauthor=S.+Middletonauthor=J.+Siuauthor=R.+W.+B%C3%BCrliauthor=J.+Buysauthor=M.+Hornerauthor=K.+Salyersauthor=M.+Schragauthor=H.+M.+Vargasauthor=Y.+Xuauthor=M.+McElvainauthor=H.+Xu&title=Benzofuran+Derivatives+as+Potent%2C+Orally+Active+S1P1+Receptor+Agonists%3A+A+Preclinical+Lead+Molecule+for+MS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fml100227q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100227q%26sid%3Dliteratum%253Aachs%26aulast%3DSaha%26aufirst%3DA.%2BK.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLobera%26aufirst%3DM.%26aulast%3DShardendu%26aufirst%3DA.%26aulast%3DChereku%26aufirst%3DS.%26aulast%3DSchutz%26aufirst%3DN.%26aulast%3DSegal%26aufirst%3DD.%26aulast%3DMarantz%26aufirst%3DY.%26aulast%3DMcCauley%26aufirst%3DD.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DSiu%26aufirst%3DJ.%26aulast%3DB%25C3%25BCrli%26aufirst%3DR.%2BW.%26aulast%3DBuys%26aufirst%3DJ.%26aulast%3DHorner%26aufirst%3DM.%26aulast%3DSalyers%26aufirst%3DK.%26aulast%3DSchrag%26aufirst%3DM.%26aulast%3DVargas%26aufirst%3DH.%2BM.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DMcElvain%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DH.%26atitle%3DBenzofuran%2520Derivatives%2520as%2520Potent%252C%2520Orally%2520Active%2520S1P1%2520Receptor%2520Agonists%253A%2520A%2520Preclinical%2520Lead%2520Molecule%2520for%2520MS%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D97%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Lucke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levkau, B.</span><span> </span><span class="NLM_article-title">Endothelial Functions of Sphingosine-1-phosphate</span> <span class="citation_source-journal">Cell. Physiol. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1159%2F000315109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=20502008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVOms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=87-96&author=S.+Luckeauthor=B.+Levkau&title=Endothelial+Functions+of+Sphingosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelial Functions of Sphingosine-1-phosphate</span></div><div class="casAuthors">Lucke, Susann; Levkau, Bodo</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-96</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  The biol. active sphingolipid sphingosine-1-phosphate (S1P) plays key functions in the immune, inflammatory, and cardiovascular systems.  In the vasculature, S1P and its receptors are involved in vessel morphogenesis and angiogenesis during embryonic development and in the adult organism both under normal and pathol. conditions.  Via its actions on endothelial and smooth muscle cells, S1P regulates arterial tone, vascular permeability, and tissue perfusion.  Elevated local S1P levels during inflammation induce endothelial adhesion mols., recruit inflammatory cells, and activate dendritic cells.  At the same time, S1P activates a neg. feedback loop that consecutively seals endothelial cell-cell contacts, decreases vascular leakage, and inhibits cytokine-induced leukocyte adhesion.  Thus S1P dets. not only the build-up, magnitude, and duration of an inflammatory reaction but also the pace of its resoln.  This review focuses on the role S1P plays in endothelial function, its receptors and signalling pathways, and the role its major carrier high-d. lipoproteins (HDL) play in its bioavailability and transport.  We will also discuss the potential of interfering with S1P-S1P receptor interactions for the treatment of endothelial disorders and vascular pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgsnbdFMWkH7Vg90H21EOLACvtfcHk0lhZyr8Vr0kw3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVOms74%253D&md5=7cb409784dfea08b42abaa924e5b3bff</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1159%2F000315109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000315109%26sid%3Dliteratum%253Aachs%26aulast%3DLucke%26aufirst%3DS.%26aulast%3DLevkau%26aufirst%3DB.%26atitle%3DEndothelial%2520Functions%2520of%2520Sphingosine-1-phosphate%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2010%26volume%3D26%26spage%3D87%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Fryer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muthukumarana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nodop Mazurek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinallo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaude, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modis, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, G. A.</span><span> </span><span class="NLM_article-title">The Clinically-Tested S1P Receptor Agonists, FTY720 and BAF312, Demonstrate Subtype-Specific Bradycardia (S1P(1)) and Hypertension (S1P(3)) in Rat</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e52985</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e52985&author=R.+M.+Fryerauthor=A.+Muthukumaranaauthor=P.+C.+Harrisonauthor=S.+Nodop+Mazurekauthor=R.+R.+Chenauthor=K.+E.+Harringtonauthor=R.+M.+Dinalloauthor=J.+C.+Horanauthor=L.+Patnaudeauthor=L.+K.+Modisauthor=G.+A.+Reinhart&title=The+Clinically-Tested+S1P+Receptor+Agonists%2C+FTY720+and+BAF312%2C+Demonstrate+Subtype-Specific+Bradycardia+%28S1P%281%29%29+and+Hypertension+%28S1P%283%29%29+in+Rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFryer%26aufirst%3DR.%2BM.%26aulast%3DMuthukumarana%26aufirst%3DA.%26aulast%3DHarrison%26aufirst%3DP.%2BC.%26aulast%3DNodop%2BMazurek%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%2BR.%26aulast%3DHarrington%26aufirst%3DK.%2BE.%26aulast%3DDinallo%26aufirst%3DR.%2BM.%26aulast%3DHoran%26aufirst%3DJ.%2BC.%26aulast%3DPatnaude%26aufirst%3DL.%26aulast%3DModis%26aufirst%3DL.%2BK.%26aulast%3DReinhart%26aufirst%3DG.%2BA.%26atitle%3DThe%2520Clinically-Tested%2520S1P%2520Receptor%2520Agonists%252C%2520FTY720%2520and%2520BAF312%252C%2520Demonstrate%2520Subtype-Specific%2520Bradycardia%2520%2528S1P%25281%2529%2529%2520and%2520Hypertension%2520%2528S1P%25283%2529%2529%2520in%2520Rat%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De52985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Gon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiosses, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">S1P<sub>3</sub> Receptor-Induced Reorganization of Epithelial Tight Junctions Compromises Lung Barrier Integrity and Is Potentiated by TNF</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">9270</span><span class="NLM_x">–</span> <span class="NLM_lpage">9275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=9270-9275&author=Y.+Gonauthor=M.+R.+Woodauthor=W.+B.+Kiossesauthor=E.+Joauthor=M.+G.+Sannaauthor=J.+Chunauthor=H.+Rosen&title=S1P3+Receptor-Induced+Reorganization+of+Epithelial+Tight+Junctions+Compromises+Lung+Barrier+Integrity+and+Is+Potentiated+by+TNF"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGon%26aufirst%3DY.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DKiosses%26aufirst%3DW.%2BB.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DS1P3%2520Receptor-Induced%2520Reorganization%2520of%2520Epithelial%2520Tight%2520Junctions%2520Compromises%2520Lung%2520Barrier%2520Integrity%2520and%2520Is%2520Potentiated%2520by%2520TNF%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D9270%26epage%3D9275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Hamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomatsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, K.</span><span> </span><span class="NLM_article-title">Removal of Sphingosine 1-Phosphate Receptor-3 (S1P<sub>3</sub>) Agonism Is Essential, but Inadequate to Obtain Immunomodulating 2-Aminopropane-1,3-diol S1P<sub>1</sub> Agonists with Reduced Effect on Heart Rate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3154</span><span class="NLM_x">–</span> <span class="NLM_lpage">3168</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901776q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3154-3168&author=M.+Hamadaauthor=M.+Nakamuraauthor=M.+Kiuchiauthor=K.+Marukawaauthor=A.+Tomatsuauthor=K.+Shimanoauthor=N.+Satoauthor=K.+Sugaharaauthor=M.+Asayamaauthor=K.+Takagiauthor=K.+Adachi&title=Removal+of+Sphingosine+1-Phosphate+Receptor-3+%28S1P3%29+Agonism+Is+Essential%2C+but+Inadequate+to+Obtain+Immunomodulating+2-Aminopropane-1%2C3-diol+S1P1+Agonists+with+Reduced+Effect+on+Heart+Rate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm901776q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901776q%26sid%3Dliteratum%253Aachs%26aulast%3DHamada%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DKiuchi%26aufirst%3DM.%26aulast%3DMarukawa%26aufirst%3DK.%26aulast%3DTomatsu%26aufirst%3DA.%26aulast%3DShimano%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DSugahara%26aufirst%3DK.%26aulast%3DAsayama%26aufirst%3DM.%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DAdachi%26aufirst%3DK.%26atitle%3DRemoval%2520of%2520Sphingosine%25201-Phosphate%2520Receptor-3%2520%2528S1P3%2529%2520Agonism%2520Is%2520Essential%252C%2520but%2520Inadequate%2520to%2520Obtain%2520Immunomodulating%25202-Aminopropane-1%252C3-diol%2520S1P1%2520Agonists%2520with%2520Reduced%2520Effect%2520on%2520Heart%2520Rate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3154%26epage%3D3168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">End, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span> </span><span class="NLM_article-title">Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300396r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=333-337&author=S.+Panauthor=N.+Grayauthor=W.+Gaoauthor=Y.+Miauthor=Y.+Fanauthor=X.+Wangauthor=T.+Tuntlandauthor=J.+Cheauthor=S.+Lefebvreauthor=Y.+Chenauthor=A.+Chuauthor=K.+Hinterdingauthor=A.+Gardinauthor=P.+Endauthor=P.+Heiningauthor=C.+Brunsauthor=N.+G.+Cookeauthor=B.+Nuesslein-Hildesheim&title=Discovery+of+BAF312+%28Siponimod%29%2C+a+Potent+and+Selective+S1P+Receptor+Modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fml300396r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300396r%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChu%26aufirst%3DA.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DEnd%26aufirst%3DP.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520BAF312%2520%2528Siponimod%2529%252C%2520a%2520Potent%2520and%2520Selective%2520S1P%2520Receptor%2520Modulator%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D333%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span> </span><span class="NLM_article-title">FTY720 (Fingolimod) in Multiple Sclerosis: Therapeutic Effects in the Immune and Central Nervous System</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">1173</span><span class="NLM_x">–</span> <span class="NLM_lpage">1182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1111%2Fj.1476-5381.2009.00451.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=19814729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=1173-1182&author=V.+Brinkmann&title=FTY720+%28Fingolimod%29+in+Multiple+Sclerosis%3A+Therapeutic+Effects+in+the+Immune+and+Central+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system</span></div><div class="casAuthors">Brinkmann, Volker</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1173-1182</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  FTY720 (fingolimod) is a first-in-class sphingosine 1-phosphate (S1P) receptor modulator that was highly effective in Phase II clin. trials for Multiple Sclerosis (MS).  FTY720 is phosphorylated in vivo by sphingosine kinase-2 to form the active moiety FTY720-phosphate that binds to four of the five G protein-coupled S1P receptor subtypes.  Studies using conditional S1P1 receptor-deficient and sphingosine kinase-deficient mice showed that the egress of lymphocytes from lymph nodes requires signaling of lymphocytic S1P1 receptors by the endogenous ligand S1P.  The S1P mimetic FTY720-phosphate causes internalization and degrdn. of cell membrane-expressed S1P1, thereby antagonizing S1P action at the receptor.  In models of human MS and demyelinating polyneuropathies, functional antagonism of lymphocytic S1P1 slows S1P-driven egress of lymphocytes from lymph nodes, thereby reducing the nos. of autoaggressive TH17 cells that recirculate via lymph and blood to the central nervous system and the sciatic/ischiatic nerves.  Based on its lipophilic nature, FTY720 crosses the blood-brain barrier, and ongoing expts. suggest that the drug also down-modulates S1P1 in neural cells/astrocytes to reduce astrogliosis, a phenomenon assocd. with neurodegeneration in MS.  This may help restore gap-junctional communication of astrocytes with neurons and cells of the blood-brain barrier.  Addnl. effects may result from (down-) modulation of S1P3 in astrocytes and of S1P1 and S1P5 in oligodendrocytes.  In conclusion, FTY720 may act through immune-based and central mechanisms to reduce inflammation and support structural restoration of the central nervous system parenchyma.  Beyond the autoimmune indications, very recent studies suggest that short-term, low-dose administration of FTY720 could help treat chronic (viral) infections.  Differential effects of the drug on the trafficking of naive, central memory and effector memory T cell subsets are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOQw7bGw9977Vg90H21EOLACvtfcHk0lhZyr8Vr0kw3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7fO&md5=33c85af3e092990c4c43fbeae5512de4</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00451.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00451.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26atitle%3DFTY720%2520%2528Fingolimod%2529%2520in%2520Multiple%2520Sclerosis%253A%2520Therapeutic%2520Effects%2520in%2520the%2520Immune%2520and%2520Central%2520Nervous%2520System%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D158%26spage%3D1173%26epage%3D1182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Brossard, P.; Hofmann, S.; Cavallaro, M.; Halabi, A.; Dingemanse, J.</span><span> </span><span class="NLM_article-title">Entry-into-Humans Study with ACT-128800, a Selective S1P1 Receptor Agonist: Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics</span>.  <span class="citation_source-book">Clin. Pharmcol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">S63</span><span class="NLM_x">–</span> <span class="NLM_lpage">S64</span>, PII-87; Annual Meeting of the American Society for Clinical Pharmacology & Therapeutics, March 18–21, 2009, Washington DC, USA; <span class="NLM_publisher-name">ASCPT</span>:<span class="NLM_publisher-loc">Alexandria, VA</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=S63-S64&author=P.+Brossard&author=S.+Hofmann&author=M.+Cavallaro&author=A.+Halabi&author=J.+Dingemanse&title=Clin.+Pharmcol.+Ther."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBrossard%26aufirst%3DP.%26atitle%3DEntry-into-Humans%2520Study%2520with%2520ACT-128800%252C%2520a%2520Selective%2520S1P1%2520Receptor%2520Agonist%253A%2520Tolerability%252C%2520Safety%252C%2520Pharmacokinetics%252C%2520and%2520Pharmacodynamics%26btitle%3DClin.%2520Pharmcol.%2520Ther.%26date%3D2009%26spage%3DS63%26epage%3DS64%26pub%3DASCPT" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Gergely, P.; Wallström, E.; Nuesslein-Hildesheim, B.; Bruns, C.; Zécri, F. J.; Cooke, N. G.; Traebert, M.; Tuntland, T.; Rosenberg, M.; Saltzman, M.</span><span> </span><span class="NLM_article-title">Phase I Study with the Selective S1P1/S1P5 Receptor Modulator BAF312 Indicates That S1P1 Rather Than S1P3 Mediates Transient Heart Rate Reduction in Humans</span>. 25th Congress of the European Committe for Treatment and Research in Multiple Sclerosis (ECTRIMS), Sept 9–12,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">, </span>Düsseldorf, Germany; p  <span class="NLM_fpage">P437</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=P437&author=P.+Gergely&author=E.+Wallstr%C3%B6m&author=B.+Nuesslein-Hildesheim&author=C.+Bruns&author=F.+J.+Z%C3%A9cri&author=N.+G.+Cooke&author=M.+Traebert&author=T.+Tuntland&author=M.+Rosenberg&author=M.+Saltzman&title=Phase+I+Study+with+the+Selective+S1P1%2FS1P5+Receptor+Modulator+BAF312+Indicates+That+S1P1+Rather+Than+S1P3+Mediates+Transient+Heart+Rate+Reduction+in+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26atitle%3DPhase%2520I%2520Study%2520with%2520the%2520Selective%2520S1P1%252FS1P5%2520Receptor%2520Modulator%2520BAF312%2520Indicates%2520That%2520S1P1%2520Rather%2520Than%2520S1P3%2520Mediates%2520Transient%2520Heart%2520Rate%2520Reduction%2520in%2520Humans%26date%3D2009%26spage%3DP437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Wallström, E.; Gergely, P.; Nuesslein-Hildesheim, B.; Zécri, F. J.; Cooke, N. G.; Bruns, C.; Luttringer, O.; Sing, T.; Groenewegen, A.; Rosenberg, M.; Saltzman, M.</span><span> </span><span class="NLM_article-title">BAF312, a Selective S1P1/S1P5 Receptor Modulator, Effectively Reduces Absolute Lymphocyte Counts in Human Volunteers and Demonstrates the Relevance of S1P1 in Mediating a Transient Heart Rate Reduction</span>. In 62nd Annual Meeting of the American Academy of Neurology, Toronto, Ontario, Canada,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>p PO5.052.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+Wallstr%C3%B6m&author=P.+Gergely&author=B.+Nuesslein-Hildesheim&author=F.+J.+Z%C3%A9cri&author=N.+G.+Cooke&author=C.+Bruns&author=O.+Luttringer&author=T.+Sing&author=A.+Groenewegen&author=M.+Rosenberg&author=M.+Saltzman&title=BAF312%2C+a+Selective+S1P1%2FS1P5+Receptor+Modulator%2C+Effectively+Reduces+Absolute+Lymphocyte+Counts+in+Human+Volunteers+and+Demonstrates+the+Relevance+of+S1P1+in+Mediating+a+Transient+Heart+Rate+Reduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DWallstr%25C3%25B6m%26aufirst%3DE.%26atitle%3DBAF312%252C%2520a%2520Selective%2520S1P1%252FS1P5%2520Receptor%2520Modulator%252C%2520Effectively%2520Reduces%2520Absolute%2520Lymphocyte%2520Counts%2520in%2520Human%2520Volunteers%2520and%2520Demonstrates%2520the%2520Relevance%2520of%2520S1P1%2520in%2520Mediating%2520a%2520Transient%2520Heart%2520Rate%2520Reduction%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Gergely, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traebert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groenewegen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitaliti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sing, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttringer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumb, W. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltzmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallström, E.</span><span> </span><span class="NLM_article-title">The Selective S1P Receptor Modulator BAF312 Redirects Lymphocyte Distribution and Has Species-Specific Effects on Heart Rate: Translation from Preclinical to Clinical Studies</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1111%2Fj.1476-5381.2012.02061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=22646698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A280%3ADC%252BC38nnsVShuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=1035-1047&author=P.+Gergelyauthor=B.+Nuesslein-Hildesheimauthor=D.+Gueriniauthor=V.+Brinkmannauthor=M.+Traebertauthor=C.+Brunsauthor=S.+Panauthor=N.+S.+Grayauthor=K.+Hinterdingauthor=N.+G.+Cookeauthor=A.+Groenewegenauthor=A.+Vitalitiauthor=T.+Singauthor=O.+Luttringerauthor=J.+Yangauthor=A.+Gardinauthor=N.+Wangauthor=W.+J.+J.+Crumbauthor=M.+Saltzmannauthor=M.+Rosenbergauthor=E.+Wallstr%C3%B6m&title=The+Selective+S1P+Receptor+Modulator+BAF312+Redirects+Lymphocyte+Distribution+and+Has+Species-Specific+Effects+on+Heart+Rate%3A+Translation+from+Preclinical+to+Clinical+Studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate</span></div><div class="casAuthors">Gergely P; Nuesslein-Hildesheim B; Guerini D; Brinkmann V; Traebert M; Bruns C; Pan S; Gray N S; Hinterding K; Cooke N G; Groenewegen A; Vitaliti A; Sing T; Luttringer O; Yang J; Gardin A; Wang N; Crumb W J Jr; Saltzman M; Rosenberg M; Wallstrom E</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1035-47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  BAF312 is a next-generation sphingosine 1-phosphate (S1P) receptor modulator, selective for S1P(1) and S1P(5 ) receptors.  S1P(1) receptors are essential for lymphocyte egress from lymph nodes and a drug target in immune-mediated diseases.  Here, we have characterized the immunomodulatory potential of BAF312 and the S1P receptor-mediated effects on heart rate using preclinical and human data.  EXPERIMENTAL APPROACH:  BAF312 was tested in a rat experimental autoimmune encephalomyelitis (EAE) model.  Electrophysiological recordings of G-protein-coupled inwardly rectifying potassium (GIRK) channels were carried out in human atrial myocytes.  A Phase I multiple-dose trial studied the pharmacokinetics, pharmacodynamics and safety of BAF312 in 48 healthy subjects.  KEY RESULTS:  BAF312 effectively suppressed EAE in rats by internalizing S1P(1) receptors, rendering them insensitive to the egress signal from lymph nodes.  In healthy volunteers, BAF312 caused preferential decreases in CD4(+) T cells, T(naive) , T(central memory) and B cells within 4-6 h.  Cell counts returned to normal ranges within a week after stopping treatment, in line with the elimination half-life of BAF312.  Despite sparing S1P(3) receptors (associated with bradycardia in mice), BAF312 induced rapid, transient (day 1 only) bradycardia in humans.  BAF312-mediated activation of GIRK channels in human atrial myocytes can fully explain the bradycardia.  CONCLUSION AND IMPLICATIONS:  This study illustrates species-specific differences in S1P receptor specificity for first-dose cardiac effects.  Based on its profound but rapidly reversible inhibition of lymphocyte trafficking, BAF312 may have potential as a treatment for immune-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRE_xcO_ghmTOLt9HypzAgQfW6udTcc2eZKYVaXk4sbRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nnsVShuw%253D%253D&md5=82575d2c2d2eeba851919e468e407c48</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02061.x%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DTraebert%26aufirst%3DM.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DGroenewegen%26aufirst%3DA.%26aulast%3DVitaliti%26aufirst%3DA.%26aulast%3DSing%26aufirst%3DT.%26aulast%3DLuttringer%26aufirst%3DO.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DCrumb%26aufirst%3DW.%2BJ.%2BJ.%26aulast%3DSaltzmann%26aufirst%3DM.%26aulast%3DRosenberg%26aufirst%3DM.%26aulast%3DWallstr%25C3%25B6m%26aufirst%3DE.%26atitle%3DThe%2520Selective%2520S1P%2520Receptor%2520Modulator%2520BAF312%2520Redirects%2520Lymphocyte%2520Distribution%2520and%2520Has%2520Species-Specific%2520Effects%2520on%2520Heart%2520Rate%253A%2520Translation%2520from%2520Preclinical%2520to%2520Clinical%2520Studies%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26spage%3D1035%26epage%3D1047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Brossard, P.; Derendorf, H.; Xu, J.; Maatouk, H.; Halabi, A.; Dingemanse, J.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and Pharmacodynamics of Ponesimod, a Selective S1P Receptor Modulator, in the First-in-Human Study</span>.  <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span> [Online early access]. DOI <span class="refDoi"> DOI: 10.1111/bcp.12129</span> . Published Online: April 18, 2013. <a href="http://onlinelibrary.wiley.com/doi/10.1111/bcp.12129/abstract;jsessionid=BB7009BA3B1862F516180A38B14839B0.f03t03" class="extLink">http://onlinelibrary.wiley.com/doi/10.1111/bcp.12129/abstract;jsessionid=BB7009BA3B1862F516180A38B14839B0.f03t03</a></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1111%2Fbcp.12129" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Brossard%2C+P.%3B+Derendorf%2C+H.%3B+Xu%2C+J.%3B+Maatouk%2C+H.%3B+Halabi%2C+A.%3B+Dingemanse%2C+J.+Pharmacokinetics+and+Pharmacodynamics+of+Ponesimod%2C+a+Selective+S1P+Receptor+Modulator%2C+in+the+First-in-Human+Study.+Br.+J.+Clin.+Pharmacol.+%5BOnline+early+access%5D.+DOI+10.1111%2Fbcp.12129.+Published+Online%3A+April+18%2C+2013.+http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.1111%2Fbcp.12129%2Fabstract%3Bjsessionid%3DBB7009BA3B1862F516180A38B14839B0.f03t03"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fbcp.12129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.12129%26sid%3Dliteratum%253Aachs%26aulast%3DBrossard%26aufirst%3DP.%26atitle%3DPharmacokinetics%2520and%2520Pharmacodynamics%2520of%2520Ponesimod%252C%2520a%2520Selective%2520S1P%2520Receptor%2520Modulator%252C%2520in%2520the%2520First-in-Human%2520Study%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26doi%3D10.1111%2Fbcp.12129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Popov, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denisov, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatilov, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagryanskaya, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tkachev, A. V.</span><span> </span><span class="NLM_article-title">Synthesis of New Chiral Heterocycles of the Pyrazole and 2-Isoxazoline Types Form (+)-3-Carene</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">489</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=479-489&author=S.+A.+Popovauthor=A.+Y.+Denisovauthor=Y.+V.+Gatilovauthor=I.+Y.+Bagryanskayaauthor=A.+V.+Tkachev&title=Synthesis+of+New+Chiral+Heterocycles+of+the+Pyrazole+and+2-Isoxazoline+Types+Form+%28%2B%29-3-Carene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPopov%26aufirst%3DS.%2BA.%26aulast%3DDenisov%26aufirst%3DA.%2BY.%26aulast%3DGatilov%26aufirst%3DY.%2BV.%26aulast%3DBagryanskaya%26aufirst%3DI.%2BY.%26aulast%3DTkachev%26aufirst%3DA.%2BV.%26atitle%3DSynthesis%2520of%2520New%2520Chiral%2520Heterocycles%2520of%2520the%2520Pyrazole%2520and%25202-Isoxazoline%2520Types%2520Form%2520%2528%252B%2529-3-Carene%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1994%26volume%3D5%26spage%3D479%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Popov, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tkachev, A. V.</span><span> </span><span class="NLM_article-title">Synthesis of 2-Alkyl and 2-Aryl Pyrimidines from β-Chlorovinyl Ketones of Cyclopentanone Type</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1081%2FSCC-100000204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhvVCit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2001&pages=233-243&author=S.+A.+Popovauthor=A.+V.+Tkachev&title=Synthesis+of+2-Alkyl+and+2-Aryl+Pyrimidines+from+%CE%B2-Chlorovinyl+Ketones+of+Cyclopentanone+Type"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 2-alkyl- and 2-arylpyrimidines from β-chlorovinyl ketones of cyclopentanone type</span></div><div class="casAuthors">Popov, Sergey A.; Tkachev, Alexey V.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-243</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">Amidines react in the presence of NaHCO3 with β-chlorovinyl ketones, prepd. regioselectively by the reaction of 2-acetylcyclopentanone-type diketones with PPh3-CCl4 in 73-78% yield, to afford 2-alkyl(aryl)pyrimidines annelated with cyclopentane derivs. in 79-87% yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofaP86ttI7Z7Vg90H21EOLACvtfcHk0li-5D4_5QxHMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhvVCit74%253D&md5=0039c879074cb717439dbff147d32cf3</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1081%2FSCC-100000204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FSCC-100000204%26sid%3Dliteratum%253Aachs%26aulast%3DPopov%26aufirst%3DS.%2BA.%26aulast%3DTkachev%26aufirst%3DA.%2BV.%26atitle%3DSynthesis%2520of%25202-Alkyl%2520and%25202-Aryl%2520Pyrimidines%2520from%2520%25CE%25B2-Chlorovinyl%2520Ketones%2520of%2520Cyclopentanone%2520Type%26jtitle%3DSynth.%2520Commun.%26date%3D2001%26volume%3D31%26spage%3D233%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Gajcy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Librowski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochynski, S.</span><span> </span><span class="NLM_article-title">Concise Synthesis fo Non-protein Amino Acid from Natural Product <i>via</i> Schmidt Reaction</span> <span class="citation_source-journal">Lett. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.2174%2F157017809787893037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Oktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=186-188&author=K.+Gajcyauthor=T.+Librowskiauthor=S.+Lochynski&title=Concise+Synthesis+fo+Non-protein+Amino+Acid+from+Natural+Product+via+Schmidt+Reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Concise synthesis of non-protein amino acid from natural product via Schmidt reaction</span></div><div class="casAuthors">Gajcy, Kamila; Librowski, Tadeusz; Lochynski, Stanislaw</div><div class="citationInfo"><span class="NLM_cas:title">Letters in Organic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">186-188</span>CODEN:
                <span class="NLM_cas:coden">LOCEC7</span>;
        ISSN:<span class="NLM_cas:issn">1570-1786</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">In this work we aimed at finding a concise method for the design of the new pharmacol. active compd. (I), which is a precursor to obtaining non-protein amino acid (II) considered as GABA analog, furthermore it can be used to construct enantiopure, conformationally restricted peptides.  For this purpose the Schmidt reaction was applied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq52ArP3MWjzrVg90H21EOLACvtfcHk0li-5D4_5QxHMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Oktr8%253D&md5=8635d35fa2d0858af03d105a37ecb374</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.2174%2F157017809787893037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157017809787893037%26sid%3Dliteratum%253Aachs%26aulast%3DGajcy%26aufirst%3DK.%26aulast%3DLibrowski%26aufirst%3DT.%26aulast%3DLochynski%26aufirst%3DS.%26atitle%3DConcise%2520Synthesis%2520fo%2520Non-protein%2520Amino%2520Acid%2520from%2520Natural%2520Product%2520via%2520Schmidt%2520Reaction%26jtitle%3DLett.%2520Org.%2520Chem.%26date%3D2009%26volume%3D6%26spage%3D186%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Gajcy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pekala, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frackowiak-Wojtasek, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Librowski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochynski, S.</span><span> </span><span class="NLM_article-title">Stereochemistry of Terpene Derivatives. Part 7: Novel Rigidified Amino Acids from (+)-3-Carene Designed as Chiral GABA Analogues</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2015</span><span class="NLM_x">–</span> <span class="NLM_lpage">2020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=2015-2020&author=K.+Gajcyauthor=J.+Pekalaauthor=B.+Frackowiak-Wojtasekauthor=T.+Librowskiauthor=S.+Lochynski&title=Stereochemistry+of+Terpene+Derivatives.+Part+7%3A+Novel+Rigidified+Amino+Acids+from+%28%2B%29-3-Carene+Designed+as+Chiral+GABA+Analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGajcy%26aufirst%3DK.%26aulast%3DPekala%26aufirst%3DJ.%26aulast%3DFrackowiak-Wojtasek%26aufirst%3DB.%26aulast%3DLibrowski%26aufirst%3DT.%26aulast%3DLochynski%26aufirst%3DS.%26atitle%3DStereochemistry%2520of%2520Terpene%2520Derivatives.%2520Part%25207%253A%2520Novel%2520Rigidified%2520Amino%2520Acids%2520from%2520%2528%252B%2529-3-Carene%2520Designed%2520as%2520Chiral%2520GABA%2520Analogues%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2010%26volume%3D21%26spage%3D2015%26epage%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Appel, R.</span><span> </span><span class="NLM_article-title">Tertiary Phosphane/Tetrachloromethane, a Versatile Reagent for Chlorination, Dehydration, and P-N Linkage</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">811</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1975&pages=801-811&author=R.+Appel&title=Tertiary+Phosphane%2FTetrachloromethane%2C+a+Versatile+Reagent+for+Chlorination%2C+Dehydration%2C+and+P-N+Linkage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAppel%26aufirst%3DR.%26atitle%3DTertiary%2520Phosphane%252FTetrachloromethane%252C%2520a%2520Versatile%2520Reagent%2520for%2520Chlorination%252C%2520Dehydration%252C%2520and%2520P-N%2520Linkage%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1975%26volume%3D14%26spage%3D801%26epage%3D811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Popov, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tkachev, A. V.</span><span> </span><span class="NLM_article-title">New Chiral Agents for Resolution of Racemic <i>cis</i>-Permethric and <i>cis</i>-Z-Cyhalothric Acids</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1995&pages=1013-1018&author=S.+A.+Popovauthor=A.+V.+Tkachev&title=New+Chiral+Agents+for+Resolution+of+Racemic+cis-Permethric+and+cis-Z-Cyhalothric+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPopov%26aufirst%3DS.%2BA.%26aulast%3DTkachev%26aufirst%3DA.%2BV.%26atitle%3DNew%2520Chiral%2520Agents%2520for%2520Resolution%2520of%2520Racemic%2520cis-Permethric%2520and%2520cis-Z-Cyhalothric%2520Acids%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1995%26volume%3D6%26spage%3D1013%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Walkowicz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochynski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walkowicz, C.</span><span> </span><span class="NLM_article-title">Stereochemistry of Bicyclo[3.1.0]hexane Derivatives. Part XII. Optically Active 6,6-Dimethylbicyclo[3.1.0]hexan-2-ols</span> <span class="citation_source-journal">Pol. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADyaL38Xmt1ei" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1981&pages=135-140&author=M.+Walkowiczauthor=S.+Lochynskiauthor=C.+Walkowicz&title=Stereochemistry+of+Bicyclo%5B3.1.0%5Dhexane+Derivatives.+Part+XII.+Optically+Active+6%2C6-Dimethylbicyclo%5B3.1.0%5Dhexan-2-ols"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Stereochemistry of bicyclo[3.1.0]hexane derivatives.  Part XII.  Optically active 6,6-dimethylbicyclo[3.1.0]hexan-2-ols</span></div><div class="casAuthors">Walkowicz, Miroslaw; Lochynski, Stanislaw; Walkowicz, Cecylia</div><div class="citationInfo"><span class="NLM_cas:title">Polish Journal of Chemistry</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">135-40</span>CODEN:
                <span class="NLM_cas:coden">PJCHDQ</span>;
        ISSN:<span class="NLM_cas:issn">0137-5083</span>.
    </div><div class="casAbstract">The alcs. (1S,2S,5R)- and (1S,2R,5R)-I (R = OH) were prepd. by ozonolysis of (+)-3-carene, and alk. cyclization to (+)-2-acetyl-6,6-dimethylbicyclo[3.1.0]hex-2-ene, which was hydrogenated to I (R = Ac).  Baeyer-Villiger oxidn. of I (R = Ac) gave I (R = OAc) which on hydrogenolysis gave I (R = OH).  Oxidn. of I (R = OH) isomers gave the same ketone.  The stereochem. of various reaction steps is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwqn8SeHhG8rVg90H21EOLACvtfcHk0ljE5iDjgj2pdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xmt1ei&md5=ab399cf169cb0d9a864b64b92500b2e1</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalkowicz%26aufirst%3DM.%26aulast%3DLochynski%26aufirst%3DS.%26aulast%3DWalkowicz%26aufirst%3DC.%26atitle%3DStereochemistry%2520of%2520Bicyclo%255B3.1.0%255Dhexane%2520Derivatives.%2520Part%2520XII.%2520Optically%2520Active%25206%252C6-Dimethylbicyclo%255B3.1.0%255Dhexan-2-ols%26jtitle%3DPol.%2520J.%2520Chem.%26date%3D1981%26volume%3D55%26spage%3D135%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Malkov, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pernazza, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teply, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meghani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocovsky, P.</span><span> </span><span class="NLM_article-title">Synthesis of New Chiral 2,2′-Bipyridine Ligands and Their Application in Copper-Catalyzed Asymmetric Allylic Oxidation and Cyclopropanation</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">4727</span><span class="NLM_x">–</span> <span class="NLM_lpage">4742</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo034179i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=4727-4742&author=A.+V.+Malkovauthor=D.+Pernazzaauthor=M.+Bellauthor=M.+Bellaauthor=A.+Massaauthor=F.+Teplyauthor=P.+Meghaniauthor=P.+Kocovsky&title=Synthesis+of+New+Chiral+2%2C2%E2%80%B2-Bipyridine+Ligands+and+Their+Application+in+Copper-Catalyzed+Asymmetric+Allylic+Oxidation+and+Cyclopropanation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjo034179i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo034179i%26sid%3Dliteratum%253Aachs%26aulast%3DMalkov%26aufirst%3DA.%2BV.%26aulast%3DPernazza%26aufirst%3DD.%26aulast%3DBell%26aufirst%3DM.%26aulast%3DBella%26aufirst%3DM.%26aulast%3DMassa%26aufirst%3DA.%26aulast%3DTeply%26aufirst%3DF.%26aulast%3DMeghani%26aufirst%3DP.%26aulast%3DKocovsky%26aufirst%3DP.%26atitle%3DSynthesis%2520of%2520New%2520Chiral%25202%252C2%25E2%2580%25B2-Bipyridine%2520Ligands%2520and%2520Their%2520Application%2520in%2520Copper-Catalyzed%2520Asymmetric%2520Allylic%2520Oxidation%2520and%2520Cyclopropanation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D4727%26epage%3D4742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Boatman, D. P.; Schrader, T. O.; Semple, G.; Skinner, P. J.; Jung, J.-K.</span><span> </span><span class="NLM_article-title">Fused Pyrazole Derivatives and Methods of Treatment of Metabolic-Related Disorders Thereof</span>. WO2006069242, Jun 29,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=D.+P.+Boatman&author=T.+O.+Schrader&author=G.+Semple&author=P.+J.+Skinner&author=J.-K.+Jung&title=Fused+Pyrazole+Derivatives+and+Methods+of+Treatment+of+Metabolic-Related+Disorders+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoatman%26aufirst%3DD.%2BP.%26atitle%3DFused%2520Pyrazole%2520Derivatives%2520and%2520Methods%2520of%2520Treatment%2520of%2520Metabolic-Related%2520Disorders%2520Thereof%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Boatman, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrader, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherrier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semple, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sage, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taggart, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carballo-Jane, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richman, J. G.</span><span> </span><span class="NLM_article-title">Potent Tricyclic Pyrazole Tetrazole Agonists of the Nicotinic Acid Receptor (GPR109a)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2797</span><span class="NLM_x">–</span> <span class="NLM_lpage">2800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2797-2800&author=P.+D.+Boatmanauthor=T.+O.+Schraderauthor=M.+Kasemauthor=B.+R.+Johnsonauthor=P.+J.+Skinnerauthor=J.-K.+Jungauthor=J.+Xuauthor=M.+C.+Cherrierauthor=P.+J.+Webbauthor=G.+Sempleauthor=C.+R.+Sageauthor=J.+Knudsenauthor=R.+Chenauthor=A.+K.+Taggartauthor=E.+Carballo-Janeauthor=J.+G.+Richman&title=Potent+Tricyclic+Pyrazole+Tetrazole+Agonists+of+the+Nicotinic+Acid+Receptor+%28GPR109a%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoatman%26aufirst%3DP.%2BD.%26aulast%3DSchrader%26aufirst%3DT.%2BO.%26aulast%3DKasem%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DB.%2BR.%26aulast%3DSkinner%26aufirst%3DP.%2BJ.%26aulast%3DJung%26aufirst%3DJ.-K.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DCherrier%26aufirst%3DM.%2BC.%26aulast%3DWebb%26aufirst%3DP.%2BJ.%26aulast%3DSemple%26aufirst%3DG.%26aulast%3DSage%26aufirst%3DC.%2BR.%26aulast%3DKnudsen%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DTaggart%26aufirst%3DA.%2BK.%26aulast%3DCarballo-Jane%26aufirst%3DE.%26aulast%3DRichman%26aufirst%3DJ.%2BG.%26atitle%3DPotent%2520Tricyclic%2520Pyrazole%2520Tetrazole%2520Agonists%2520of%2520the%2520Nicotinic%2520Acid%2520Receptor%2520%2528GPR109a%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2797%26epage%3D2800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Paine, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buller, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erikson, E. E.</span><span> </span><span class="NLM_article-title">Regioselectivity of Pyrrole Synthesis from Diethyl Aminomalonate and 1,3-Diketones: Further Observations</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3986</span><span class="NLM_x">–</span> <span class="NLM_lpage">3993</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00227a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1987&pages=3986-3993&author=J.+B.+Paineauthor=J.+R.+Broughauthor=K.+K.+Bullerauthor=E.+E.+Erikson&title=Regioselectivity+of+Pyrrole+Synthesis+from+Diethyl+Aminomalonate+and+1%2C3-Diketones%3A+Further+Observations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjo00227a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00227a009%26sid%3Dliteratum%253Aachs%26aulast%3DPaine%26aufirst%3DJ.%2BB.%26aulast%3DBrough%26aufirst%3DJ.%2BR.%26aulast%3DBuller%26aufirst%3DK.%2BK.%26aulast%3DErikson%26aufirst%3DE.%2BE.%26atitle%3DRegioselectivity%2520of%2520Pyrrole%2520Synthesis%2520from%2520Diethyl%2520Aminomalonate%2520and%25201%252C3-Diketones%253A%2520Further%2520Observations%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1987%26volume%3D52%26spage%3D3986%26epage%3D3993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Bolli, M.; Bur, D.; Clozel, M.; Fischli, W.; Lehmann, D.; Mathys, B.; Mueller, C.; Nayler, O.; Scherz, M.; Weller, T.</span><span> </span><span class="NLM_article-title">4-Carbonyl Substituted 1,1,2-Trimethyl-1A,4,5,5A-Tetrahydro-1H-4-Aza-Cyclopropa[a]pentalene Derivatives as Agonists for the G-Protein Coupled Receptor S1P1/EDG1 and Immunsuppressant Agents</span>. WO2005123677, Dec 29,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=M.+Bolli&author=D.+Bur&author=M.+Clozel&author=W.+Fischli&author=D.+Lehmann&author=B.+Mathys&author=C.+Mueller&author=O.+Nayler&author=M.+Scherz&author=T.+Weller&title=4-Carbonyl+Substituted+1%2C1%2C2-Trimethyl-1A%2C4%2C5%2C5A-Tetrahydro-1H-4-Aza-Cyclopropa%5Ba%5Dpentalene+Derivatives+as+Agonists+for+the+G-Protein+Coupled+Receptor+S1P1%2FEDG1+and+Immunsuppressant+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%26atitle%3D4-Carbonyl%2520Substituted%25201%252C1%252C2-Trimethyl-1A%252C4%252C5%252C5A-Tetrahydro-1H-4-Aza-Cyclopropa%255Ba%255Dpentalene%2520Derivatives%2520as%2520Agonists%2520for%2520the%2520G-Protein%2520Coupled%2520Receptor%2520S1P1%252FEDG1%2520and%2520Immunsuppressant%2520Agents%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Alberola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrosa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente, M.</span><span> </span><span class="NLM_article-title">The Reaction of β-Aminoenones with α-Amino Derivatives. Synthesis of 2-Functionalized Pyrroles</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1049</span><span class="NLM_x">–</span> <span class="NLM_lpage">1058</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1990&pages=1049-1058&author=A.+Alberolaauthor=J.+M.+Andresauthor=A.+Gonzalezauthor=R.+Pedrosaauthor=M.+Vicente&title=The+Reaction+of+%CE%B2-Aminoenones+with+%CE%B1-Amino+Derivatives.+Synthesis+of+2-Functionalized+Pyrroles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlberola%26aufirst%3DA.%26aulast%3DAndres%26aufirst%3DJ.%2BM.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DPedrosa%26aufirst%3DR.%26aulast%3DVicente%26aufirst%3DM.%26atitle%3DThe%2520Reaction%2520of%2520%25CE%25B2-Aminoenones%2520with%2520%25CE%25B1-Amino%2520Derivatives.%2520Synthesis%2520of%25202-Functionalized%2520Pyrroles%26jtitle%3DHeterocycles%26date%3D1990%26volume%3D31%26spage%3D1049%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Hombrecher, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horter, G.</span><span> </span><span class="NLM_article-title">Synthesis of Pyrroles via Ethyl N-(3-Oxo-1-alkenyl)glycinates</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">1990</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1055%2Fs-1990-26883" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1990&publication_year=1990&pages=389-391&author=H.+K.+Hombrecherauthor=G.+Horter&title=Synthesis+of+Pyrroles+via+Ethyl+N-%283-Oxo-1-alkenyl%29glycinates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1055%2Fs-1990-26883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1990-26883%26sid%3Dliteratum%253Aachs%26aulast%3DHombrecher%26aufirst%3DH.%2BK.%26aulast%3DHorter%26aufirst%3DG.%26atitle%3DSynthesis%2520of%2520Pyrroles%2520via%2520Ethyl%2520N-%25283-Oxo-1-alkenyl%2529glycinates%26jtitle%3DSynthesis%26date%3D1990%26volume%3D1990%26spage%3D389%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Alberola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrosa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradanos, P.</span><span> </span><span class="NLM_article-title">Regioselective Synthesis of 2-Functionalized Thiophenes by Condensation of α-Mercapto Compounds with β-Amino Enone Derivatives</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2537</span><span class="NLM_x">–</span> <span class="NLM_lpage">2547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1080%2F00397919008053203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A528%3ADyaK3MXotFCltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1990&pages=2537-2547&author=A.+Alberolaauthor=J.+M.+Andresauthor=A.+Gonzalezauthor=R.+Pedrosaauthor=P.+Pradanos&title=Regioselective+Synthesis+of+2-Functionalized+Thiophenes+by+Condensation+of+%CE%B1-Mercapto+Compounds+with+%CE%B2-Amino+Enone+Derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective synthesis of 2-functionalized thiophenes by condensation of α-mercapto compounds with β-amino enone derivatives</span></div><div class="casAuthors">Alberola, Angel; Andres, Jose M.; Gonzalez, Alfonso; Pedrosa, Rafael; Pradanos, Pedro</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2537-47</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">Reaction of R1COCR2:CR3Cl (R1 = Me, Ph; R2 = H, Me; R3 = Me, Ph) with NaSCH2CO2Et gave 50-70% thiophenes I (R1-R3 as above, R4 = OEt).  R1COCH:CHN+Et3 (R1 = Et, Ph, 4-MeOC6H4, 4-O2NC6H4, Me2CH) reacted with HSCH2COR4 (R4 = HEt, Me, Ph) to give 70-90% R1COCH:CHSCH2COR4, which on reaction with EtONa/EtOH gave I (R1 as above, R2 = R3 = H, R4 = OEt, Me, Ph).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcKt5xsJdc5LVg90H21EOLACvtfcHk0lg27zYcHzBt0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXotFCltg%253D%253D&md5=4d01fc252b1a3cad0f3ff24fbf19a50f</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1080%2F00397919008053203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919008053203%26sid%3Dliteratum%253Aachs%26aulast%3DAlberola%26aufirst%3DA.%26aulast%3DAndres%26aufirst%3DJ.%2BM.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DPedrosa%26aufirst%3DR.%26aulast%3DPradanos%26aufirst%3DP.%26atitle%3DRegioselective%2520Synthesis%2520of%25202-Functionalized%2520Thiophenes%2520by%2520Condensation%2520of%2520%25CE%25B1-Mercapto%2520Compounds%2520with%2520%25CE%25B2-Amino%2520Enone%2520Derivatives%26jtitle%3DSynth.%2520Commun.%26date%3D1990%26volume%3D20%26spage%3D2537%26epage%3D2547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Bolli, M.; Bur, D.; Clozel, M.; Fischli, W.; Lehmann, D.; Mathys, B.; Mueller, C.; Nayler, O.; Scherz, M.; Weller, T.</span><span> </span><span class="NLM_article-title">1, 1A, 5, 5A-Tetrahydro-3-thia-cycloprop[a] pentalenes: Tricyclic Thiophene Derivatives as S1P1/EDG1 Receptor Agonists</span>. WO2006010544, Feb 2,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Bolli&author=D.+Bur&author=M.+Clozel&author=W.+Fischli&author=D.+Lehmann&author=B.+Mathys&author=C.+Mueller&author=O.+Nayler&author=M.+Scherz&author=T.+Weller&title=1%2C+1A%2C+5%2C+5A-Tetrahydro-3-thia-cycloprop%5Ba%5D+pentalenes%3A+Tricyclic+Thiophene+Derivatives+as+S1P1%2FEDG1+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%26atitle%3D1%252C%25201A%252C%25205%252C%25205A-Tetrahydro-3-thia-cycloprop%255Ba%255D%2520pentalenes%253A%2520Tricyclic%2520Thiophene%2520Derivatives%2520as%2520S1P1%252FEDG1%2520Receptor%2520Agonists%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Bolli, M.; Lehmann, D.; Mathys, B.; Mueller, C.; Nayler, O.; Velker, J.; Weller, T.</span><span> </span><span class="NLM_article-title">Novel Thiophene Derivatives</span>. WO2006100635, Sep 28,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Bolli&author=D.+Lehmann&author=B.+Mathys&author=C.+Mueller&author=O.+Nayler&author=J.+Velker&author=T.+Weller&title=Novel+Thiophene+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%26atitle%3DNovel%2520Thiophene%2520Derivatives%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Diana, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudewicz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevear, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldous, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldous, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draper, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutko, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oglesby, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkots, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czerniak, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roland, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppermann, J.</span><span> </span><span class="NLM_article-title">Picornavirus Inhibitors: Trifluoromethyl Substitution Provides a Global Protective Effect agains Hepatic Metabolism</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1371</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00008a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1355-1371&author=G.+D.+Dianaauthor=P.+Rudewiczauthor=D.+C.+Pevearauthor=T.+J.+Nitzauthor=S.+C.+Aldousauthor=D.+J.+Aldousauthor=D.+T.+Robinsonauthor=R.+Draperauthor=F.+J.+Dutkoauthor=C.+Aldiauthor=G.+Gendronauthor=R.+C.+Oglesbyauthor=D.+L.+Volkotsauthor=M.+Reumanauthor=R.+R.+Baileyauthor=R.+Czerniakauthor=T.+Blockauthor=R.+Rolandauthor=J.+Oppermann&title=Picornavirus+Inhibitors%3A+Trifluoromethyl+Substitution+Provides+a+Global+Protective+Effect+agains+Hepatic+Metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm00008a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00008a014%26sid%3Dliteratum%253Aachs%26aulast%3DDiana%26aufirst%3DG.%2BD.%26aulast%3DRudewicz%26aufirst%3DP.%26aulast%3DPevear%26aufirst%3DD.%2BC.%26aulast%3DNitz%26aufirst%3DT.%2BJ.%26aulast%3DAldous%26aufirst%3DS.%2BC.%26aulast%3DAldous%26aufirst%3DD.%2BJ.%26aulast%3DRobinson%26aufirst%3DD.%2BT.%26aulast%3DDraper%26aufirst%3DR.%26aulast%3DDutko%26aufirst%3DF.%2BJ.%26aulast%3DAldi%26aufirst%3DC.%26aulast%3DGendron%26aufirst%3DG.%26aulast%3DOglesby%26aufirst%3DR.%2BC.%26aulast%3DVolkots%26aufirst%3DD.%2BL.%26aulast%3DReuman%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DR.%2BR.%26aulast%3DCzerniak%26aufirst%3DR.%26aulast%3DBlock%26aufirst%3DT.%26aulast%3DRoland%26aufirst%3DR.%26aulast%3DOppermann%26aufirst%3DJ.%26atitle%3DPicornavirus%2520Inhibitors%253A%2520Trifluoromethyl%2520Substitution%2520Provides%2520a%2520Global%2520Protective%2520Effect%2520agains%2520Hepatic%2520Metabolism%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D1355%26epage%3D1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Bolli, M.; Lehmann, D.; Mathys, B.; Mueller, C.; Nayler, O.; Velker, J.; Weller, T.</span><span> </span><span class="NLM_article-title">Novel Thiophene Derivatives as Sphingosine-1-phosphate Receptor Agonists</span>. WO2006100633, Sep 28,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Bolli&author=D.+Lehmann&author=B.+Mathys&author=C.+Mueller&author=O.+Nayler&author=J.+Velker&author=T.+Weller&title=Novel+Thiophene+Derivatives+as+Sphingosine-1-phosphate+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%26atitle%3DNovel%2520Thiophene%2520Derivatives%2520as%2520Sphingosine-1-phosphate%2520Receptor%2520Agonists%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Rasmussen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawesson, S.-O.</span><span> </span><span class="NLM_article-title">Studies on Organophosphorus Compounds XLIX. An Improved Method for the Preparation of 2,5-Disubstituted 1,3,4-Thiadiazoles and 1,3,4-Thiadiazole-2(3H)-Thiones</span> <span class="citation_source-journal">Bull. Soc. Chim. Fr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">1985</span><span class="NLM_x">, </span> <span class="NLM_fpage">II/62</span><span class="NLM_x">–</span> <span class="NLM_lpage">II/65</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1985&publication_year=1985&pages=II%2F62-II%2F65&author=P.+B.+Rasmussenauthor=U.+Pedersenauthor=I.+Thomsenauthor=B.+Ydeauthor=S.-O.+Lawesson&title=Studies+on+Organophosphorus+Compounds+XLIX.+An+Improved+Method+for+the+Preparation+of+2%2C5-Disubstituted+1%2C3%2C4-Thiadiazoles+and+1%2C3%2C4-Thiadiazole-2%283H%29-Thiones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRasmussen%26aufirst%3DP.%2BB.%26aulast%3DPedersen%26aufirst%3DU.%26aulast%3DThomsen%26aufirst%3DI.%26aulast%3DYde%26aufirst%3DB.%26aulast%3DLawesson%26aufirst%3DS.-O.%26atitle%3DStudies%2520on%2520Organophosphorus%2520Compounds%2520XLIX.%2520An%2520Improved%2520Method%2520for%2520the%2520Preparation%2520of%25202%252C5-Disubstituted%25201%252C3%252C4-Thiadiazoles%2520and%25201%252C3%252C4-Thiadiazole-2%25283H%2529-Thiones%26jtitle%3DBull.%2520Soc.%2520Chim.%2520Fr.%26date%3D1985%26volume%3D1985%26spage%3DII%252F62%26epage%3DII%252F65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Kiryanov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seed, A. J.</span><span> </span><span class="NLM_article-title">Synthesis of 2-Alkoxy-Substituted Thiophenes, 1,3-Thiazoles, and Related S-Heterocycles via Lawesson’s Reagent-Mediated Cyclization under Microwave Irradiation: Applications for Liquid Crystal Synthesis</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">7925</span><span class="NLM_x">–</span> <span class="NLM_lpage">7929</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo016063x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=7925-7929&author=A.+A.+Kiryanovauthor=P.+Sampsonauthor=A.+J.+Seed&title=Synthesis+of+2-Alkoxy-Substituted+Thiophenes%2C+1%2C3-Thiazoles%2C+and+Related+S-Heterocycles+via+Lawesson%E2%80%99s+Reagent-Mediated+Cyclization+under+Microwave+Irradiation%3A+Applications+for+Liquid+Crystal+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjo016063x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo016063x%26sid%3Dliteratum%253Aachs%26aulast%3DKiryanov%26aufirst%3DA.%2BA.%26aulast%3DSampson%26aufirst%3DP.%26aulast%3DSeed%26aufirst%3DA.%2BJ.%26atitle%3DSynthesis%2520of%25202-Alkoxy-Substituted%2520Thiophenes%252C%25201%252C3-Thiazoles%252C%2520and%2520Related%2520S-Heterocycles%2520via%2520Lawesson%25E2%2580%2599s%2520Reagent-Mediated%2520Cyclization%2520under%2520Microwave%2520Irradiation%253A%2520Applications%2520for%2520Liquid%2520Crystal%2520Synthesis%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D7925%26epage%3D7929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Brain, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, J. M.</span><span> </span><span class="NLM_article-title">Rapid Synthesis of Oxazoles under Microwave Conditions</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1999</span><span class="NLM_x">, </span> <span class="NLM_fpage">1642</span><span class="NLM_x">–</span> <span class="NLM_lpage">1644</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1999&publication_year=1999&pages=1642-1644&author=C.+T.+Brainauthor=J.+M.+Paul&title=Rapid+Synthesis+of+Oxazoles+under+Microwave+Conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrain%26aufirst%3DC.%2BT.%26aulast%3DPaul%26aufirst%3DJ.%2BM.%26atitle%3DRapid%2520Synthesis%2520of%2520Oxazoles%2520under%2520Microwave%2520Conditions%26jtitle%3DSynlett%26date%3D1999%26volume%3D1999%26spage%3D1642%26epage%3D1644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Holub, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Toole-Colin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getzel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argenti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalglish, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miott, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glersaye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCranor, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkowitz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukens, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumpe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupton, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnham, B. S.</span><span> </span><span class="NLM_article-title">Lipid-Lower Effects of Ethyl 2-Phenacyl-3-aryl-1H-pyrrole-4-carboxylates in Rodents</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2004</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2004&publication_year=2004&pages=135-157&author=J.+M.+Holubauthor=K.+O%E2%80%99Toole-Colinauthor=A.+Getzelauthor=A.+Argentiauthor=M.+A.+Evansauthor=D.+C.+Smithauthor=G.+A.+Dalglishauthor=S.+Rifatauthor=D.+L.+Wilsonauthor=B.+M.+Taylorauthor=U.+Miottauthor=J.+Glersayeauthor=K.+S.+Lamauthor=B.+J.+McCranorauthor=J.+D.+Berkowitzauthor=R.+B.+Millerauthor=J.+R.+Lukensauthor=K.+Krumpeauthor=J.+T.+Guptonauthor=B.+S.+Burnham&title=Lipid-Lower+Effects+of+Ethyl+2-Phenacyl-3-aryl-1H-pyrrole-4-carboxylates+in+Rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolub%26aufirst%3DJ.%2BM.%26aulast%3DO%25E2%2580%2599Toole-Colin%26aufirst%3DK.%26aulast%3DGetzel%26aufirst%3DA.%26aulast%3DArgenti%26aufirst%3DA.%26aulast%3DEvans%26aufirst%3DM.%2BA.%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DDalglish%26aufirst%3DG.%2BA.%26aulast%3DRifat%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DD.%2BL.%26aulast%3DTaylor%26aufirst%3DB.%2BM.%26aulast%3DMiott%26aufirst%3DU.%26aulast%3DGlersaye%26aufirst%3DJ.%26aulast%3DLam%26aufirst%3DK.%2BS.%26aulast%3DMcCranor%26aufirst%3DB.%2BJ.%26aulast%3DBerkowitz%26aufirst%3DJ.%2BD.%26aulast%3DMiller%26aufirst%3DR.%2BB.%26aulast%3DLukens%26aufirst%3DJ.%2BR.%26aulast%3DKrumpe%26aufirst%3DK.%26aulast%3DGupton%26aufirst%3DJ.%2BT.%26aulast%3DBurnham%26aufirst%3DB.%2BS.%26atitle%3DLipid-Lower%2520Effects%2520of%2520Ethyl%25202-Phenacyl-3-aryl-1H-pyrrole-4-carboxylates%2520in%2520Rodents%26jtitle%3DMolecules%26date%3D2004%26volume%3D2004%26spage%3D135%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Hedegaard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortensen, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawesson, S.-O.</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3853</span><span class="NLM_x">–</span> <span class="NLM_lpage">3859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hedegaard%2C+B.%3B+Mortensen%2C+J.+Z.%3B+Lawesson%2C+S.-O.Tetrahedron+1971%2C+27%2C+3853%E2%80%933859"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHedegaard%26aufirst%3DB.%26aulast%3DMortensen%26aufirst%3DJ.%2BZ.%26aulast%3DLawesson%26aufirst%3DS.-O.%26jtitle%3DTetrahedron%26date%3D1971%26volume%3D27%26spage%3D3853%26epage%3D3859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Zécri, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landrum, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span> </span><span class="NLM_article-title">Pyrazole Derived from (+)-3-Carene; a Novel Potent, Selective Scaffold for Sphingosine-1-phosphate (S1P<sub>1</sub>) Receptor Agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=35-37&author=F.+J.+Z%C3%A9criauthor=R.+Albertauthor=G.+Landrumauthor=K.+Hinterdingauthor=N.+G.+Cookeauthor=D.+Gueriniauthor=M.+Streiffauthor=C.+Brunsauthor=B.+Nuesslein-Hildesheim&title=Pyrazole+Derived+from+%28%2B%29-3-Carene%3B+a+Novel+Potent%2C+Selective+Scaffold+for+Sphingosine-1-phosphate+%28S1P1%29+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZ%25C3%25A9cri%26aufirst%3DF.%2BJ.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DLandrum%26aufirst%3DG.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DStreiff%26aufirst%3DM.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26atitle%3DPyrazole%2520Derived%2520from%2520%2528%252B%2529-3-Carene%253B%2520a%2520Novel%2520Potent%252C%2520Selective%2520Scaffold%2520for%2520Sphingosine-1-phosphate%2520%2528S1P1%2529%2520Receptor%2520Agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D35%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P1 Receptor Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4198</span><span class="NLM_x">–</span> <span class="NLM_lpage">4211</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100181s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4198-4211&author=M.+H.+Bolliauthor=S.+Abeleauthor=C.+Binkertauthor=R.+Bravoauthor=S.+Buchmannauthor=D.+Burauthor=J.+Gatfieldauthor=P.+Hessauthor=C.+Kohlauthor=C.+Mangoldauthor=B.+Mathysauthor=K.+Menyhartauthor=C.+M%C3%BCllerauthor=O.+Naylerauthor=M.+Scherzauthor=G.+Schmidtauthor=V.+Sippelauthor=B.+Steinerauthor=D.+Strasserauthor=A.+Treiberauthor=T.+Weller&title=2-Imino-thiazolidin-4-one+Derivatives+as+Potent%2C+Orally+Active+S1P1+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm100181s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100181s%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBuchmann%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DMangold%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DMenyhart%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSippel%26aufirst%3DV.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DStrasser%26aufirst%3DD.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3D2-Imino-thiazolidin-4-one%2520Derivatives%2520as%2520Potent%252C%2520Orally%2520Active%2520S1P1%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4198%26epage%3D4211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Bolli, M. H.; Velker, J.; Müller, C.; Mathys, B.; Birker, M.; Bravo, R.; Bur, D.; de Kanter, R.; Hess, P.; Kohl, C.; Lehmann, D.; Meyer, S.; Nayler, O.; Rey, M.; Scherz, M.; Steiner, B.</span>, unpublished work.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bolli%2C+M.+H.%3B+Velker%2C+J.%3B+M%C3%BCller%2C+C.%3B+Mathys%2C+B.%3B+Birker%2C+M.%3B+Bravo%2C+R.%3B+Bur%2C+D.%3B+de+Kanter%2C+R.%3B+Hess%2C+P.%3B+Kohl%2C+C.%3B+Lehmann%2C+D.%3B+Meyer%2C+S.%3B+Nayler%2C+O.%3B+Rey%2C+M.%3B+Scherz%2C+M.%3B+Steiner%2C+B.%2C+unpublished+work."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Brockway, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azar, S. H.</span><span> </span><span class="NLM_article-title">A New Method for Continuous Chronic Measurement and Recording of Blood Pressure, Heart Rate and Activity in the Rat via Radio-Telemetry</span> <span class="citation_source-journal">Clin. Exp. Hypertens., Part A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">A13</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">895</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.3109%2F10641969109042094" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A13&publication_year=1991&pages=885-895&author=B.+P.+Brockwayauthor=P.+A.+Millsauthor=S.+H.+Azar&title=A+New+Method+for+Continuous+Chronic+Measurement+and+Recording+of+Blood+Pressure%2C+Heart+Rate+and+Activity+in+the+Rat+via+Radio-Telemetry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.3109%2F10641969109042094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10641969109042094%26sid%3Dliteratum%253Aachs%26aulast%3DBrockway%26aufirst%3DB.%2BP.%26aulast%3DMills%26aufirst%3DP.%2BA.%26aulast%3DAzar%26aufirst%3DS.%2BH.%26atitle%3DA%2520New%2520Method%2520for%2520Continuous%2520Chronic%2520Measurement%2520and%2520Recording%2520of%2520Blood%2520Pressure%252C%2520Heart%2520Rate%2520and%2520Activity%2520in%2520the%2520Rat%2520via%2520Radio-Telemetry%26jtitle%3DClin.%2520Exp.%2520Hypertens.%252C%2520Part%2520A%26date%3D1991%26volume%3DA13%26spage%3D885%26epage%3D895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Guiol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledoussal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgé, J.-M.</span><span> </span><span class="NLM_article-title">A Radiotelemetry System for Chronic Measurement of Blood Pressure and Heart Rate in the Unrestrained Rat Validation of the Method</span> <span class="citation_source-journal">J. Pharmcol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm4014373&amp;key=10.1016%2F1056-8719%2892%2990054-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm4014373&amp;key=1482791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm4014373&amp;key=1%3ACAS%3A280%3ADyaK3s7ivFyjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1992&pages=99-105&author=C.+Guiolauthor=C.+Ledoussalauthor=J.-M.+Surg%C3%A9&title=A+Radiotelemetry+System+for+Chronic+Measurement+of+Blood+Pressure+and+Heart+Rate+in+the+Unrestrained+Rat+Validation+of+the+Method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">A radiotelemetry system for chronic measurement of blood pressure and heart rate in the unrestrained rat validation of the method</span></div><div class="casAuthors">Guiol C; Ledoussal C; Surge J M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacological and toxicological methods</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-105</span>
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">Chronic measurements of systemic arterial blood pressure and heart rate via a chronically implanted telemetric transmitter in unrestrained rats, was validated in a three-phase study.  In the first part, week-to-week variability of systolic, diastolic, and mean arterial pressures, and heart rate was found to be minimal over the course of nine weeks.  In the second part, the reproducibility of cardiovascular response to three successive administration of sotalol, an antihypertensive agent, was studied.  In the last part, cardiovascular parameters determined by telemetry were compared to those obtained by direct arterial catheterization and showed a good linear correlation between those two methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8i2XCcqJVRr5oR8RchjrrfW6udTcc2eZyv1ZSp7_e2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s7ivFyjug%253D%253D&md5=f501e12d4c69e9c5d9bbf7a85d1d5224</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2F1056-8719%2892%2990054-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1056-8719%252892%252990054-5%26sid%3Dliteratum%253Aachs%26aulast%3DGuiol%26aufirst%3DC.%26aulast%3DLedoussal%26aufirst%3DC.%26aulast%3DSurg%25C3%25A9%26aufirst%3DJ.-M.%26atitle%3DA%2520Radiotelemetry%2520System%2520for%2520Chronic%2520Measurement%2520of%2520Blood%2520Pressure%2520and%2520Heart%2520Rate%2520in%2520the%2520Unrestrained%2520Rat%2520Validation%2520of%2520the%2520Method%26jtitle%3DJ.%2520Pharmcol.%2520Toxicol.%2520Methods%26date%3D1992%26volume%3D28%26spage%3D99%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, J.-P.</span><span> </span><span class="NLM_article-title">Telemetry Monitoring of Pulmonary Arterial Pressure in Freely Moving Rats</span> <span class="citation_source-journal">J. Appl. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1032</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1996&pages=1027-1032&author=P.+Hessauthor=M.+Clozelauthor=J.-P.+Clozel&title=Telemetry+Monitoring+of+Pulmonary+Arterial+Pressure+in+Freely+Moving+Rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DP.%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DClozel%26aufirst%3DJ.-P.%26atitle%3DTelemetry%2520Monitoring%2520of%2520Pulmonary%2520Arterial%2520Pressure%2520in%2520Freely%2520Moving%2520Rats%26jtitle%3DJ.%2520Appl.%2520Physiol.%26date%3D1996%26volume%3D81%26spage%3D1027%26epage%3D1032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Grimont, J.; Le Goff, F.; Bourquin, G.; Silva, J.</span> Quality Assessment and Concentration Determination of Actelion’s Compound Solutions by Automated LCMS and Quantitative NMR. MipTec - The Leading European Event for Drug Discovery, Basel, Switzerland, Sept 20–24,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Grimont%2C+J.%3B+Le+Goff%2C+F.%3B+Bourquin%2C+G.%3B+Silva%2C+J.+Quality+Assessment+and+Concentration+Determination+of+Actelion%E2%80%99s+Compound+Solutions+by+Automated+LCMS+and+Quantitative+NMR.+MipTec+-+The+Leading+European+Event+for+Drug+Discovery%2C+Basel%2C+Switzerland%2C+Sept+20%E2%80%9324%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DGrimont%26aufirst%3DJ.%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i34"><a href="/doi/suppl/10.1021/jm4014373">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_64244"></div></div></div></div></div><hr /></hr><p class="last">Experimental details on synthesis and characterization of all target compounds and corresponding building blocks not described in the main text are given; the structure of compound <b>17</b> as determined by single crystal X-ray analysis; figures showing mean arterial blood pressure (MAP) recordings in telemetrized SHR after administration of compound <b>85</b>, and heart rate recordings in SHR after administration of compounds <b>1</b> and <b>57</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm4014373/suppl_file/jm4014373_si_001.pdf">jm4014373_si_001.pdf (1.92 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The corresponding data set has been deposited at the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, United Kingdom, <a href="http://www.ccdc.cam.ac.uk/" class="extLink">http://www.ccdc.cam.ac.uk/</a>, under the following deposition number: 969024 (isomer of compound <b>17</b>, see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm4014373&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-23%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm4014373%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm4014373" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                940KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679939083de73d6c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
